{
  "meta": {
    "title": "Aiims_May_2017_2017_05_07",
    "url": "https://brainandscalpel.vercel.app/aiims-may-2017-2017-05-07-b3c86a6e.html",
    "scrapedAt": "2025-11-29T18:15:39.083Z"
  },
  "questions": [
    {
      "id": 50000,
      "choices": [
        {
          "id": 200000,
          "text": "<p><span style=\"font-size:12.0pt;\">Chlorine compound</span></p>"
        },
        {
          "id": 200001,
          "text": "<p><span style=\"font-size:12.0pt;\">Phenolic compound</span></p>"
        },
        {
          "id": 200002,
          "text": "<p><span style=\"font-size:12.0pt;\">Quaternary ammonium compounds</span></p>"
        },
        {
          "id": 200003,
          "text": "<p><span style=\"font-size:12.0pt;\">Alcoholic compounds</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A blood spill in the operation theatre must be cleaned with? (INICET MAY 2017)</span></p>",
      "unique_key": "Q5521359",
      "question_audio": null,
      "question_video": null,
      "map_id": 34844452,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Chlorine compound</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Sodium hypochlorite, a compound of chlorine, is the <strong>best disinfectant for surface blood spills</strong>. It is used with a <strong>concentration of 0.5-5%.</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">If the spill contains large amounts of blood or body fluids, clean the visible matter with disposable absorbent material and discard the contaminated materials in appropriate, labelled containment.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Phenolic compound: </strong>Phenolic compounds are effective disinfectants but are generally less effective against a broad spectrum of bloodborne pathogens compared to chlorine compounds.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Quaternary ammonium compounds</strong>: Quaternary ammonium compounds are good for general disinfection but are not recommended for blood spills as they are less effective against non-enveloped viruses and spores.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Alcoholic compounds: </strong>Alcohol-based disinfectants are effective for surface disinfection but are not ideal for blood spills as they can coagulate proteins, making blood more difficult to clean.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">For cleaning a blood spill in the operation theatre, sodium hypochlorite, a chlorine compound, is the best disinfectant due to its effectiveness in inactivating a wide range of pathogens and its suitability for such critical environments.</span></p>",
      "correct_choice_id": 200000,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50001,
      "choices": [
        {
          "id": 200004,
          "text": "<p><span style=\"font-size:12.0pt;\">Bezold-Jarisch reflex</span></p>"
        },
        {
          "id": 200005,
          "text": "<p><span style=\"font-size:12.0pt;\">Bainbridge reflex</span></p>"
        },
        {
          "id": 200006,
          "text": "<p><span style=\"font-size:12.0pt;\">Cushing reflex</span></p>"
        },
        {
          "id": 200007,
          "text": "<p><span style=\"font-size:12.0pt;\">J reflex</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Reflex responsible for tachycardia during right atrial distension?</span></p>",
      "unique_key": "Q3134819",
      "question_audio": null,
      "question_video": null,
      "map_id": 34394957,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Bainbridge reflex</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Bainbridge reflex is a cardioaccelerator reflex that increases the heart rate when venous return is increased. Since this reflex arises from right atrium, it is also called right atrial reflex.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/28/screenshot-2024-05-28-175130.png\" alt=\"\" width=\"300\" height=\"419\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options :</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Bezold-Jarisch Reflex: </strong>Bezold-Jarisch reflex is the reflex characterized by bradycardia and hypotension, caused by stimulation of chemoreceptors present in the wall of left ventricles by substances such as alkaloids. It is also called coronary chemoreflex. Vagal fibers form the afferent and efferent pathways of this reflex.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Cushing Reflex: </strong>Cushing reflex is a protective reflex that helps save the brain tissues from ischemic effects during the periods of reduced cerebral blood flow. It is also called Cushing reaction, response or phenomenon.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong> </span><span style=\"font-size:12.0pt;\"><strong>J Reflex: </strong>Apnea followed by rapid breathing, bradycardia, and hypotension due to J receptor (C-receptor, juxta-pulmonary capillary receptor) stimulation.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The Bainbridge reflex is a cardiovascular reflex that increases heart rate in response to increased venous return, enhancing cardiac output to match the increased blood flow into the heart.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/28/screenshot-2024-05-28-175130.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200005,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50002,
      "choices": [
        {
          "id": 200008,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Oesophagus</span></p>"
        },
        {
          "id": 200009,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Aorta</span></p>"
        },
        {
          "id": 200010,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Inferior vena cava</span></p>"
        },
        {
          "id": 200011,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Sympathetic Chain</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11.0pt;\">The structure passing through the central tendon of the diaphragm is: (</span>AIIMS May 2017)</p>",
      "unique_key": "Q6433675",
      "question_audio": null,
      "question_video": null,
      "map_id": 34438157,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt;\"><strong>Ans. C. Inferior vena cava</strong></span></p><p> </p><p><span style=\"font-size:11pt;\"><strong>Explanation:</strong></span></p><p> </p><p><span style=\"font-size:11pt;\">The inferior vena cava is a major vein that returns deoxygenated blood from the lower half of the body to the right atrium of the heart. The IVC passes through the diaphragm via the caval opening, which is situated to the right of the central tendon. This opening allows the IVC to move between the thoracic and abdominal cavities.</span></p><p> </p><p><span style=\"font-size:11pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:11pt;\"><strong>Option A. Oesophagus:</strong> The esophagus passes through an opening in the diaphragm called the esophageal hiatus, which is located just to the left of the central tendon. This allows the esophagus to traverse from the thoracic cavity to the abdominal cavity.</span></p><p> </p><p><span style=\"font-size:11pt;\"><strong>Option B</strong>. <strong>Aorta</strong>: The descending (thoracic) aorta carries oxygenated blood from the heart to the lower parts of the body. It passes through the diaphragm via the aortic hiatus, which is posterior to the central tendon. The aorta then continues its descent into the abdominal cavity.</span></p><p> </p><p><span style=\"font-size:11pt;\"><strong>Option D</strong>. <strong>Sympathetic Chain</strong>: The sympathetic chain, also known as the sympathetic trunk or sympathetic ganglia, consists of a series of ganglia connected by nerve fibers. It runs vertically along each side of the vertebral column and is not directly associated with the diaphragm or its central tendon.</span></p><p> </p><p><span style=\"font-size:11pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:11pt;\"><strong>The diaphragm has three anatomic openings:</strong> the aortic hiatus (T12), the esophageal hiatus (T10), and the caval foramen (T8)</span></p><p> </p><ul><li><span style=\"font-size:11pt;\">The inferior vena cava passes through the central tendon of the diaphragm from the caval foramen.</span></li><li><span style=\"font-size:11pt;\">Esophagus passes through the esophageal hiatus.</span></li><li><span style=\"font-size:11pt;\">Aorta passes through the aortic hiatus.</span></li></ul><p> </p><p><span style=\"font-size:11pt;\">Sympathetic chain passes through the minor apertures crossing the crura of the diaphragm.</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/25/inicet-anat-2017-11.jpg\" alt=\"\" width=\"700\" height=\"457\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/25/inicet-anat-2017-11.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200010,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50003,
      "choices": [
        {
          "id": 200012,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Endothelium independent coronary vasodilation</span></span></span></p>"
        },
        {
          "id": 200013,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Reduced cardiac contractility</span></span></span></p>"
        },
        {
          "id": 200014,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increased left ventricular end diastolic volume</span></span></span></p>"
        },
        {
          "id": 200015,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Decreased diastolic perfusion pressure</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A patient with Prinzmetal angina is administered isosorbide mononitrate and is noticed to have symptomatic relief. What is the mechanism of action of nitrate in this case? (AIIMS MAY 2017)</span></span></p>",
      "unique_key": "Q1986116",
      "question_audio": null,
      "question_video": null,
      "map_id": 34330239,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Endothelium independent coronary vasodilation</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Nitrates cause endothelium-independent coronary vasodilation when treating Prinzmetal angina.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Coronary artery vasospasm is the underlying cause of Prinzmetal angina. By relaxing the smooth muscles of the epicardial coronary arteries, nitrates treat coronary artery spasm.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The main mechanism of action of nitrates in the event of stable angina is preferred vein dilation (by increasing cGMP). Venous return to the heart is reduced as a result of venous dilatation (preload). Due to the reduction in ventricular end-diastolic volume, myocardial oxygen consumption also reduces.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\">Option </span></strong><strong><span style=\"font-family:\"Calibri\",sans-serif\">B. <strong><span style=\"font-family:\"Calibri\",sans-serif\">Reduced cardiac contractility</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: This is not the primary mechanism of action of nitrates in relieving Prinzmetal angina. Nitrates primarily work by vasodilation rather than affecting myocardial contractility.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\">Option </span></strong><strong><span style=\"font-family:\"Calibri\",sans-serif\">C. <strong><span style=\"font-family:\"Calibri\",sans-serif\">Increased left ventricular end diastolic volume</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Nitrates generally reduce the preload (venous return) by dilating veins, which can lead to a decrease in left ventricular end-diastolic volume, not an increase.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\">Option </span></strong><strong><span style=\"font-family:\"Calibri\",sans-serif\">D. <strong><span style=\"font-family:\"Calibri\",sans-serif\">Decreased diastolic perfusion pressure</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: While nitrates can lower blood pressure, the primary therapeutic effect in Prinzmetal angina is not related to diastolic perfusion pressure but to the direct vasodilation of the coronary arteries.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Nitrates provide symptomatic relief in Prinzmetal angina through endothelium-independent coronary vasodilation, which helps to alleviate coronary artery spasms and restore proper blood flow to the heart muscle.</span></span></p>",
      "correct_choice_id": 200012,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50004,
      "choices": [
        {
          "id": 200016,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Food poisoning</span></span></p>"
        },
        {
          "id": 200017,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Toxic shock syndrome</span></span></p>"
        },
        {
          "id": 200018,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Septicemia</span></span></p>"
        },
        {
          "id": 200019,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Staphylococcal scalded skin syndrome</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Which of the following staphylococcal infections is not toxin-mediated? </span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">(AIIMS MAY 2017)</span></span></p>",
      "unique_key": "Q6542953",
      "question_audio": null,
      "question_video": null,
      "map_id": 34235431,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans</span></strong><span style=\"font-size:12.0pt\">. <strong>C) Septicemia</strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Septicemia (also known as bloodstream infection) caused by Staphylococcus aureus is not mediated by toxins but by the direct invasion of the bloodstream by the bacterial organisms. This leads to the systemic immune response, triggering widespread inflammation, resulting in the clinical manifestations of sepsis such as fever, hypotension, and organ dysfunction.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Food poisoning: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Food poisoning caused by Staphylococcus aureus is mediated by <strong>enterotoxins</strong>, which are pre-formed toxins in contaminated food. Symptoms such as nausea, vomiting, and diarrhea occur rapidly after ingestion due to these toxins.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Toxic shock syndrome: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Toxic shock syndrome (TSS) is a toxin-mediated condition caused by <strong>toxic shock syndrome toxin-1 (TSST-1)</strong>, produced by Staphylococcus aureus. This exotoxin leads to severe systemic symptoms like fever, rash, hypotension, and multiorgan dysfunction.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Staphylococcal scalded skin syndrome (SSSS): </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">SSSS is mediated by the <strong>exfoliative toxin</strong>, which causes separation of the epidermis, leading to widespread blistering and skin peeling, mimicking a burn.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Septicemia </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">caused by Staphylococcus aureus is an infection due to bacterial invasion and is <strong>not toxin-mediated</strong>, whereas conditions like food poisoning, toxic shock syndrome, and staphylococcal scalded skin syndrome are caused by staphylococcal toxins.</span></span></span></p>",
      "correct_choice_id": 200018,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50005,
      "choices": [
        {
          "id": 200020,
          "text": "<p><span style=\"font-size:12.0pt;\">Ototoxicity</span></p>"
        },
        {
          "id": 200021,
          "text": "<p><span style=\"font-size:12.0pt;\">Meniere's disease</span></p>"
        },
        {
          "id": 200022,
          "text": "<p><span style=\"font-size:12.0pt;\">Otosclerosis</span></p>"
        },
        {
          "id": 200023,
          "text": "<p><span style=\"font-size:12.0pt;\">Noise-induced hearing loss</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A young woman, aged 25, presented with hearing impairment that emerged shortly after her initial pregnancy. Provided below is her audiometry findings. What could be the potential diagnosis for this case? (AIIMS MAY 2017)</span></p><p style=\"text-align:justify;\"> </p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/29/picture1_OzxJVV9.jpg\" alt=\"\" width=\"400\" height=\"277\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/29/picture1_OzxJVV9.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q2911046",
      "question_audio": null,
      "question_video": null,
      "map_id": 34280220,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Otosclerosis</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Hearing loss that developed shortly after the first pregnancy along with Carhart's notch seen in the audiogram is suggestive of otosclerosis.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Interpretation of the given audiogram:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Blue color indicates the left ear.</span></li><li><span style=\"font-size:12.0pt;\">x indicates AC and threshold is >15 dB and hence AC is abnormal. So it indicates conductive deafness.</span></li><li><span style=\"font-size:12.0pt;\">] indicates BC and threshold is <25dB. A characteristic dip in the BC curve at 2000 Hz called Carhart’s notch is seen.</span></li><li><span style=\"font-size:12.0pt;\">The air-bone gap is a feature of conductive hearing loss.</span></li><li><span style=\"font-size:12.0pt;\">Hence, left-sided otosclerosis is the diagnosis.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A:</strong> Ototoxicity causes SNHL and shows a high-frequency hearing loss in the SNHL curve.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B:</strong> Meniere's disease shows a low-frequency loss in the SNHL curve.</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/19/screenshot-2024-06-19-134405.png\" alt=\"\" width=\"500\" height=\"433\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D:</strong> Noise-induced hearing loss - PTA shows a characteristic Acoustic dip at 4000 Hz (Boiler’s Notch).</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/19/screenshot-2024-06-19-134415.png\" alt=\"\" width=\"500\" height=\"400\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/15/whatsapp-image-2023-08-29-at-165320_page_1.jpg\" alt=\"\" width=\"1000\" height=\"1441\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/19/screenshot-2024-06-19-134405.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200022,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50006,
      "choices": [
        {
          "id": 200024,
          "text": "<p><span style=\"font-size:12.0pt;\">Carotid-cavernous fistula</span></p>"
        },
        {
          "id": 200025,
          "text": "<p><span style=\"font-size:12.0pt;\">Pseudoaneurysm of internal carotid artery</span></p>"
        },
        {
          "id": 200026,
          "text": "<p><span style=\"font-size:12.0pt;\">Tumor blush of angiofibroma</span></p>"
        },
        {
          "id": 200027,
          "text": "<p><span style=\"font-size:12.0pt;\">Extensive head and neck hemangioma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the most likely diagnosis according to the given image? (AIIMS MAY 2017)</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/26/untitled-122.jpg\" alt=\"\" width=\"250\" height=\"327\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/26/untitled-122.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q7073587",
      "question_audio": null,
      "question_video": null,
      "map_id": 34168573,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Pseudoaneurysm of internal carotid artery</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The given image shows a digital subtraction angiography of ICA and it shows an outpouching of the contrast suggestive of a pseudoaneurysm of the internal carotid artery as marked by the arrow.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A</strong>. <strong>C</strong></span><span style=\"background-color:white;color:#202124;font-size:12.0pt;\"><strong>arotid-cavernous fistula (CCF)</strong> is </span><span style=\"color:#040c28;font-size:12.0pt;\">the result of an abnormal vascular connection between the internal carotid artery (ICA) and the cavernous sinus</span><span style=\"background-color:white;color:#202124;font-size:12.0pt;\">. Pulsatile proptosis of eye would be the pathognomic clinical finding. DSA would reveal enlarged draining superior ophthalmic vein.</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/26/untitled-123.jpg\" alt=\"\" width=\"442\" height=\"441\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option </strong></span><span style=\"background-color:white;color:#202124;font-size:12.0pt;\"><strong>C. Tumor blush of angiofibroma </strong>would show feeder vessels from internal maxillary artery of ECA.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Extensive head and neck hemangioma</strong> would show multiple tortuous vessels supplying a mass which is not seen here.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"background-color:white;color:#0d0d0d;font-size:10.5pt;\">A pseudoaneurysm of the internal carotid artery is characterized by an outpouching of contrast material in angiographic studies, as seen in the provided DSA image. This finding is distinct from other vascular abnormalities such as carotid-cavernous fistulas, angiofibromas, or hemangiomas.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/26/untitled-123.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200025,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50007,
      "choices": [
        {
          "id": 200028,
          "text": "<p><span style=\"font-size:12.0pt;\">Indirect immunofluorescence</span></p>"
        },
        {
          "id": 200029,
          "text": "<p><span style=\"font-size:12.0pt;\">Seller stain for negri bodies</span></p>"
        },
        {
          "id": 200030,
          "text": "<p><span style=\"font-size:12.0pt;\">Viral culture</span></p>"
        },
        {
          "id": 200031,
          "text": "<p><span style=\"font-size:12.0pt;\">Real time PCR</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 28-year-old male who has been admitted with symptoms of altered sensorium and hydrophobia, indicating a potential case of rabies, you have obtained corneal scrapings for further investigation. Now, which test would you select to establish a conclusive diagnosis of the condition?</span><span style=\"font-size:10.5pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET</span> <span style=\"font-size:12.0pt;\">MAY 2017)</span></p>",
      "unique_key": "Q2008693",
      "question_audio": null,
      "question_video": null,
      "map_id": 34928366,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Viral Culture</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Altered sensorium and hydrophobia is suggestive of rabies which can be diagnosed by viral culture from corneal scrapings.</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/29/screenshot-2024-06-29-123912.png\" alt=\"\" width=\"1000\" height=\"400\"></p><p> </p><p><span style=\"font-size:12.0pt;\">Multiple tests in succession/simultaneously are the best. <strong>Usually, Direct Fluorescent Antibody test followed by virus isolation/culture is useful.</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Virus isolation through culture: best specimens are <strong>brain and saliva</strong>. CSF, corneal smears and centrifuged urine can also be used.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A:</strong> Serological tests like <strong>indirect immunofluorescence</strong> are insensitive.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B: Seller stain for negri bodies </strong>can only be demonstrated in brain (<strong>pyramidal cells of Ammon's horn, and the Purkinje cells of the cerebellum are the most common site).</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D:</strong> <strong>Real time-PCR</strong> Amplification Detection of rabies virus RNA is highly sensitive and specific. This technique can detect virus in fresh saliva samples, skin, CS, and brain tissues. However, it is not confirmatory test.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Viral culture from corneal scrapings is the most definitive test for diagnosing rabies in a patient presenting with altered sensorium and hydrophobia.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/29/screenshot-2024-06-29-123912.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200030,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50008,
      "choices": [
        {
          "id": 200032,
          "text": "<p><span style=\"font-size:12.0pt;\">Obtuse angled mucor</span></p>"
        },
        {
          "id": 200033,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute angled penicillium</span></p>"
        },
        {
          "id": 200034,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute angled branching aspergillus</span></p>"
        },
        {
          "id": 200035,
          "text": "<p><span style=\"font-size:12.0pt;\">Obtuse angled Rhizopus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the organism in the given slide stained with Gomori methenamine silver stain? (INICET MAY 2017)</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images.jpg\" width=\"259\" height=\"194\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q5370533",
      "question_audio": null,
      "question_video": null,
      "map_id": 34358097,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Acute angled branching aspergillus</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The given slide stained with GMS shows <strong>acute-angled (45°) uniform, branching septate hyphae</strong> which is suggestive of Aspergillus species.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Aspergillus species grow rapidly, producing <strong>aerial hyphae that bear characteristic conidial</strong> structures. Long aseptate conidiophores are seen with terminal vesicles on which phialides are arranged in basipetal chains.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The following image shows LPCB mount of Aspergillus fumigatus showing the long conidiophores with terminal vesicles.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/22/untitled-176.jpg\" alt=\"\" width=\"400\" height=\"268\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Obtuse angled mucor: </strong>Mucor produces non-septate, broad hyphae with aerial sporangiophores which end in a sporangium.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Acute angled penicillium: </strong>Penicillium produces septate hyphae with branched, septate and brush-like conidiophores.</span></p><p> </p><p><strong>Option D.</strong><span style=\"font-size:14px;\"> </span><span style=\"font-size:12.0pt;\"><strong>Obtuse angled Rhizopus: </strong></span><span style=\"font-size:12pt;\">Rhizopus appears similar to Mucor but it has rhizoids with sporangiophores arising in groups directly above the rhizoids.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Gomori methenamine silver (GMS) stain shows characteristic features of Aspergillus species. These features include acute-angled (45°) uniform branching septate hyphae.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/22/untitled-176.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200034,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50009,
      "choices": [
        {
          "id": 200036,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">AIDP with migraine </span></span></span></span></p>"
        },
        {
          "id": 200037,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Right side paralysis</span></span></span></span></p>"
        },
        {
          "id": 200038,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Acute intermittent porphyria</span></span></span></span></p>"
        },
        {
          "id": 200039,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Conversion disorder</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:black\">A 22-year-old female patient came with complaints of vomiting and a decrease in movement of the right leg. In the past, she has had episodes of violent and aggressive behavior and abdominal pain. Which of the following is the most probable diagnosis? (AIIMS MAY 2017)</span></span></span></p>",
      "unique_key": "Q3137015",
      "question_audio": null,
      "question_video": null,
      "map_id": 34655394,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Acute intermittent porphyria</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Vomiting & decreased movements of right leg in young female with previous history of abdominal pain and mental symptoms like violent and aggressive behavior points towards acute intermittent porphyria.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Acute intermittent porphyria is an <strong>autosomal dominant disorder</strong>.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is due to <strong>deficiency of HMB Synthase enzyme</strong>. </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">ACUTE INTERMITTENT PORPHYRIA</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Clinical features: </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Common precipitating factors include endogenous and exogeneous steroids, porphyrinogenic drugs, alcohol ingestion and low-calorie diets, usually instituted for weight loss.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Symptoms are <strong>more common in women</strong>, suggesting a role for estrogens or progestins.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Abdominal pain, the most common symptom is usually steady and poorly localized but maybe cramping.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Nausea, vomiting, constipation, tachycardia hypertension, mental symptoms, pain in the limbs, head, neck or chest, muscle weakness, sensory loss, dysuria, and urinary retention are characteristic. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The <strong>peripheral neuropathy is due to neurologic axonal degeneration</strong> (rather than demyelination) and primarily affects motor neurons.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Mental symptoms</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> such as anxiety, insomnia, depression, disorientation, hallucination and paranoia can occur in acute attacks. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Seizures can be due to neurologic effects or to hyponatremia</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> (due to hypothalamic involvement and inappropriate vasopressin secretion or from electrolyte depletion due to vomiting, diarrhea, poor intake or excess renal sodium loss).</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Diagnosis:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">ALA & PBG levels are substantially increased in plasma and urine, especially during acute attacks.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Treatment:</span></strong> </span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">I.V. Hemin</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> is more effective and should be used as first line therapy for all acute attacks.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. AIDP with migraine:</span></strong><span style=\"font-size:12.0pt\"> Incorrect because AIDP (Acute Inflammatory Demyelinating Polyneuropathy) presents with rapid onset muscle weakness and decreased reflexes, not specifically associated with vomiting or abdominal pain.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Right side paralysis:</span></strong><span style=\"font-size:12.0pt\"> Incorrect as this diagnosis does not account for the broader spectrum of symptoms including behavioral changes and abdominal pain.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Conversion disorder:</span></strong><span style=\"font-size:12.0pt\"> Incorrect because conversion disorder involves symptoms that suggest neurological or medical conditions but are actually manifestations of psychological conflict or needs. The specific clinical presentation and past medical history in this case strongly point towards a physiological rather than psychological cause.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The acute intermittent porphyria presents with a complex array of symptoms, including neurological, gastrointestinal, and psychiatric manifestations, and is associated with specific triggers and a genetic basis. Elevated ALA and PBG levels during attacks are diagnostic.</span></span></span></p>",
      "correct_choice_id": 200038,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50010,
      "choices": [
        {
          "id": 200040,
          "text": "<p><span style=\"font-size:12.0pt;\">Ebola</span></p>"
        },
        {
          "id": 200041,
          "text": "<p><span style=\"font-size:12.0pt;\">Yellow fever</span></p>"
        },
        {
          "id": 200042,
          "text": "<p><span style=\"font-size:12.0pt;\">Crimean congo hemorrhagic fever</span></p>"
        },
        {
          "id": 200043,
          "text": "<p><span style=\"font-size:12.0pt;\">Marbur</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A confirmed case of which of the following viral hemorrhagic fevers was found in India? (INICET MAY 2017)</span></p>",
      "unique_key": "Q9053091",
      "question_audio": null,
      "question_video": null,
      "map_id": 34341827,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Crimean congo hemorrhagic fever</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Crimean Congo hemorrhagic fever (CCHF) is a severe form of viral hemorrhagic fever caused by the Nairovirus species. This disease is zoonotic, meaning it originates from animals, with ticks acting as vectors.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Crimean Congo Hemorrhagic Fever (CCHF):</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Causative Agent:</strong> Nairovirus species.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Transmission:</strong> The primary vectors are ticks, specifically those of the Hyalomma genus.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Outbreaks:</strong> The disease can spread through person-to-person transmission, particularly in healthcare settings, where it poses a significant risk to healthcare workers and patients.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Symptoms:</strong> Include fever, muscle pain, dizziness, neck pain and stiffness, backache, headache, sore eyes, and photophobia. Severe cases can lead to extensive hemorrhaging.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Ebola: </strong>Ebola is another severe viral hemorrhagic fever but has not been reported in India. It primarily affects regions in Africa.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Yellow fever: </strong>Yellow fever is a mosquito-borne viral hemorrhagic disease endemic to Africa and South America. It has not been reported in India.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Marburg:</strong> Marburg virus causes a severe hemorrhagic fever similar to Ebola. It has also not been reported in India and is primarily found in Africa.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Crimean Congo hemorrhagic fever (CCHF) is the viral hemorrhagic fever that has been confirmed in India. It is caused by the Nairovirus species and is transmitted by ticks, with potential for person-to-person transmission, especially in healthcare settings.</span></p>",
      "correct_choice_id": 200042,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50011,
      "choices": [
        {
          "id": 200044,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">20-25 Hz</span></span></p>"
        },
        {
          "id": 200045,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">30-35 Hz</span></span></p>"
        },
        {
          "id": 200046,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">15-20 Hz</span></span></p>"
        },
        {
          "id": 200047,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">10-15 Hz</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Given below is the demonstration of tetanisation in the gastrocnemius muscle of a frog. Identify the tetanising frequency? (</span></span>AIIMS May 2017)</p>\r\n\r\n<p style=\"text-align:justify\"> </p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/28/screenshot-2024-05-28-165727_Gis8eaW.png\" style=\"height:351px; width:400px\" /></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/28/screenshot-2024-05-28-165727_Gis8eaW.png\" alt=\"Question Image\"></p>",
      "unique_key": "Q2852331",
      "question_audio": null,
      "question_video": null,
      "map_id": 34619216,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) 20-25 Hz</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tetanizing frequency demonstrated by the muscle is 25Hz.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tetanizing frequency: Rate of stimulation at which summation of contractions will occur</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tetanizing frequency can be calculated as </span><span style=\"font-size:12.0pt\"><span style=\"font-family:Wingdings\">à</span></span><span style=\"font-size:12.0pt\"> <strong>1/contraction period.</strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">As per the graph - </span></span></span></p>\r\n\r\n<ul style=\"list-style-type:circle\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">﻿﻿Paper speed - 1000mm/sec.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">﻿﻿y-axis represents force of muscle contraction millivolts</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">x-axis represents duration of contraction in milliseconds with a scale of 10mm</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">﻿﻿The scale on the x-axis is 10mm.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">﻿﻿Area under the graph is the muscle contraction.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Contraction period the duration from latent period to maximum force of contraction</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">So, in the given graph, </span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Contraction period is approximately 4 scales i.e., 40 mm.</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">As the speed of the paper is 1000mm/sec, contraction period = 40mm = (40/1000) = 40 msec = 0.04sec</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tetanizing frequency = 1/contraction period = 1/0.04 = 100/4 = 25Hz.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Tetanisation</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">As the frequency increases, there comes a point where each new contraction occurs before the preceding one is over. As a result, the second contraction is added partially to the first, so that the total strength of contraction rises progressively with increasing frequency. When the frequency reaches a critical level, the successive contractions eventually become so rapid that they fuse together, and the whole muscle contraction appears to be completely smooth and continuous. This is called tetanization.  </span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/28/screenshot-2024-05-28-165901.png\" style=\"height:407px; width:500px\" /></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/28/screenshot-2024-05-28-165901.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200044,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50012,
      "choices": [
        {
          "id": 200048,
          "text": "<p><span style=\"font-size:12pt;\">Hypertension diagnosed at 10 weeks of gestation </span></p>"
        },
        {
          "id": 200049,
          "text": "<p><span style=\"font-size:12pt;\">Diabetic retinopathy</span></p>"
        },
        {
          "id": 200050,
          "text": "<p><span style=\"font-size:12pt;\">Diabetic nephropathy </span></p>"
        },
        {
          "id": 200051,
          "text": "<p><span style=\"font-size:12pt;\">Episode of seizure</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Pregnant women with which of the following is called systemic hypertension? (INICET MAY 2017)        </span></p>",
      "unique_key": "Q1710449",
      "question_audio": null,
      "question_video": null,
      "map_id": 34521496,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Hypertension diagnosed at 10 weeks of gestation</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">Systemic hypertension in pregnancy is classified as chronic hypertension if it is diagnosed in the first trimester or if hypertension persists beyond 12 weeks postpartum. Hypertension present before pregnancy or diagnosed before the 20th week of gestation also qualifies as chronic hypertension. This is distinct from gestational hypertension, which develops after 20 weeks of gestation in a previously normotensive woman.</span></p><p> </p><ul><li><span style=\"font-size:12pt;\"><strong>Chronic Hypertension:</strong> Defined as blood pressure of ≥ 140/90 mm Hg that was present before pregnancy or diagnosed before the 20th week of gestation.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option B. Diabetic retinopathy:</strong> This condition is a complication of diabetes affecting the eyes, not a direct indicator of systemic hypertension.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C. Diabetic nephropathy:</strong> This is a complication of diabetes that affects the kidneys and can be associated with hypertension, but it is not specific to the definition of systemic hypertension in pregnancy.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D. Episode of seizure:</strong> Seizures in the context of pregnancy are associated with eclampsia, a severe form of preeclampsia, but do not directly define systemic hypertension.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">Systemic hypertension in pregnancy is diagnosed if high blood pressure is present before pregnancy, is diagnosed before 20 weeks of gestation, or persists beyond 12 weeks postpartum.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 1778, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 200048,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50013,
      "choices": [
        {
          "id": 200052,
          "text": "<p><span style=\"font-size:12.0pt;\">Myasthenia gravis</span></p>"
        },
        {
          "id": 200053,
          "text": "<p><span style=\"font-size:12.0pt;\">6th nerve palsy</span></p>"
        },
        {
          "id": 200054,
          "text": "<p><span style=\"font-size:12.0pt;\">3rd nerve palsy</span></p>"
        },
        {
          "id": 200055,
          "text": "<p><span style=\"font-size:12.0pt;\">Horner syndrome</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A patient presents with unilateral ptosis with hypotropia in the same eye. He was given an IV injection, following which the symptoms go away. Which of the following is the most likely diagnosis? (</span>AIIMS May 2017)</p>",
      "unique_key": "Q2479994",
      "question_audio": null,
      "question_video": null,
      "map_id": 34915082,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Myasthenia gravis</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Only Myasthenia gravis, among the conditions mentioned above, would show dramatic improvement after administration of an injection (Anti-ChE medication).</span></p><p> </p><p><span style=\"font-size:12.0pt;\">In myasthenia gravis, there is unilateral myogenic ptosis where, after a short rest, the symptoms recover rapidly.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">A quick test in the office can be to ask the patient to look up and hold that position, and then observe if there is fatiguability of the levator muscle such that the upper eyelids start to drift downwards while the patient is looking up. The definitive diagnosis is made through various clinical, pharmacological and serologic tests.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Diagnostic Tests</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>1. Edrophonium (Tensilon) Test:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Edrophonium chloride inhibits acetylcholinesterase, thereby prolonging the presence of acetylcholine at the neuromuscular junction. This results in enhanced muscle strength. This test is only useful in patients with objective, measurable findings on physical exam, like <u>ptosis</u> or a tropia. In <u>ptosis</u>, a positive test is the elevation of eyelids in 2-5 minutes post administration of Tensilon. A negative response is no improvement within 3 minutes.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>2. Ice Test:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">This is also a simple diagnostic test that can be done in the clinic. It is highly sensitive and specific for MG. The ice test is useful for ptosis. An ice pack is applied to the affected upper eyelid for 2-5 minutes. A positive test is the improvement of ptosis by > 2mm or more. This transient improvement in ptosis is due to the cold decreasing the acetylcholinesterase break-down of acetylcholine at the neuromuscular junction. </span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. 6th nerve palsy:</strong> This condition primarily causes abduction deficit (inability to move the eye laterally), which would not explain the ptosis nor improve with Anti-ChE medications.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. 3rd nerve palsy:</strong> Though it can cause ptosis and eye movement abnormalities, symptoms are due to mechanical dysfunctions or nerve damage and do not improve quickly with Anti-ChE medications.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Horner syndrome:</strong> Characterized by ptosis, miosis (pupil constriction), and anhidrosis (lack of sweating), but does not involve hypotropia or improve dramatically with Anti-ChE medications.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Myasthenia gravis</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">A disease characterized by generalized muscle weakness and rapidly developing fatigue of the muscles due to autoimmune damage of the acetylcholine receptors that take place at the post-synaptic membrane.</span></li><li><span style=\"font-size:12.0pt;\">The symptoms fluctuate and, after a short rest, recovery follows rapidly in the early stages.</span></li><li><span style=\"font-size:12.0pt;\">Ptosis and failure of convergence are early and prominent features.</span></li><li><span style=\"font-size:12.0pt;\">A remarkable temporary improvement in the action of the muscles is obtained by injections of Prostigmine or edrophonium intravenously which lead to acetylcholine accumulation.</span></li><li><span style=\"font-size:12.0pt;\">The resultant increase in acetylcholine available at the receptor sites leads to an improvement in the muscular function, confirming the diagnosis.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Note:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The single most sensitive test for Myasthenia Gravis - Single fiber Electromyography</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The single most specific test for Myasthenia Gravis - AChR antibodies</span></p>",
      "correct_choice_id": 200052,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50014,
      "choices": [
        {
          "id": 200056,
          "text": "<p><span style=\"font-size:12.0pt;\">Leiomyoma</span></p>"
        },
        {
          "id": 200057,
          "text": "<p><span style=\"font-size:12.0pt;\">Schwannoma</span></p>"
        },
        {
          "id": 200058,
          "text": "<p><span style=\"font-size:12.0pt;\">Rhabdomyosarcoma</span></p>"
        },
        {
          "id": 200059,
          "text": "<p><span style=\"font-size:12.0pt;\">Fibromatosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 14-year-old patient presents with bilateral proptosis. The biopsy from the region shows this pattern. What is the likely diagnosis?</span> (AIIMS MAY 2017)</p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/33.jpg\" alt=\"\" width=\"300\" height=\"200\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/33.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q1359103",
      "question_audio": null,
      "question_video": null,
      "map_id": 34975471,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Schwannoma</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The given clinical history and biopsy picture is characteristic of schwannoma showing hypercellular areas (Antoni A), including Verocay bodies, as well as looser (hypocellular) areas, myxoid regions (Antoni B).</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/34.jpg\" alt=\"\" width=\"400\" height=\"257\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/35.jpg\" alt=\"\" width=\"400\" height=\"200\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Schwannomas are well-circumscribed, encapsulated masses that are attached to the nerve but can be separated from it. Tumors form firm, gray masses that may have areas of cystic and xanthomatous change.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">On microscopic examination tumors show a mixture of two growth patterns:</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">In the <strong>Antoni A pattern of growth</strong>, elongated cells with cytoplasmic processes are arranged in fascicles in areas of moderate to high cellularity and scant stromal matrix; the <strong>“nuclear-free zones” of processes that lie between the regions of nuclear palisading are termed Verocay bodies.</strong></span></li><li><span style=\"font-size:12.0pt;\">In the <strong>Antoni B pattern of growth</strong>, the tumor is less densely cellular (hypocellular) and consists of a loose meshwork of cells, <strong>microcysts</strong> and myxoid stroma.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Leiomyoma</strong>: Leiomyomas are benign smooth muscle tumors that do not typically present with the histological features observed in the provided image, such as Verocay bodies or the Antoni A/B patterns seen in schwannomas.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Rhabdomyosarcoma</strong>: Rhabdomyosarcoma is a malignant tumor of skeletal muscle origin, often characterized by spindle-shaped cells and cross-striations on histology. It lacks the distinctive Antoni A and B patterns seen in schwannomas.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Fibromatosis</strong>: Fibromatosis refers to a group of benign fibrous tissue proliferations that are locally aggressive but lack the encapsulated, well-circumscribed nature of schwannomas. The histology of fibromatosis does not show the Antoni A and B patterns or Verocay bodies.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Schwannomas are benign nerve sheath tumors with distinct Antoni A and B growth patterns, including Verocay bodies. These features, along with the clinical presentation, are key to the diagnosis.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Clinical presentations: </span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_ufuhqjF.png\" width=\"1178\" height=\"951\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbins and Cotran Pathologic basis of disease, 8th edition, Page no - 2595</strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/34.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200057,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50015,
      "choices": [
        {
          "id": 200060,
          "text": "<p><span style=\"font-size:12.0pt;\">Strap his thorax, abdomen and lower limbs on a stretcher</span></p>"
        },
        {
          "id": 200061,
          "text": "<p><span style=\"font-size:12.0pt;\">Apply a cervical collar</span></p>"
        },
        {
          "id": 200062,
          "text": "<p><span style=\"font-size:12.0pt;\">Put patient on lateral position and shift him immediately</span></p>"
        },
        {
          "id": 200063,
          "text": "<p><span style=\"font-size:12.0pt;\">Roll the patient and put on a hard board</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following are done to transport a polytrauma patient who is conscious except? (AIIMS MAY 2017)</span></p>",
      "unique_key": "Q8157356",
      "question_audio": null,
      "question_video": null,
      "map_id": 34556945,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Put patient on lateral position and shift him immediately</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">This option is not a standard practice when transporting conscious polytrauma patients. Shifting a conscious patient to a lateral position and immediately moving them can risk further injury and discomfort.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Strap his thorax, abdomen, and lower limbs on a stretcher: </strong>This is a common and necessary practice when transporting a conscious polytrauma patient. It helps secure the patient to the stretcher to prevent movement and further injury during transport.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Apply a cervical collar: </strong>This is done to immobilize the cervical spine, till a cervical injury is ruled out.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Roll the patient and put on a hardboard: </strong>Rolling a conscious polytrauma patient and placing them on a hardboard (spinal board) can be a part of the standard protocol for immobilizing the spine and minimizing movement during transport. This is done to prevent potential spinal cord injuries.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Patients with polytrauma are shifted in supine or prone position (not in lateral position) by laying them over a firm surface, in order to restrict the spinal movement.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">As per ATLS guidelines, in patients with trauma, airway management is first done along with cervical spine stabilization. All trauma patients unless proven otherwise are considered to have an injured vertebral column.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The patient is placed supine on a firm surface without rotating or bending the spinal column and a rigid cervical collar (Philadelphia collar) is applied.</span></p>",
      "correct_choice_id": 200062,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50016,
      "choices": [
        {
          "id": 200064,
          "text": "<p><span style=\"font-size:12.0pt;\">Von Gierke's disease</span></p>"
        },
        {
          "id": 200065,
          "text": "<p><span style=\"font-size:12.0pt;\">Pompe's disease</span></p>"
        },
        {
          "id": 200066,
          "text": "<p><span style=\"font-size:12.0pt;\">McArdle's disease</span></p>"
        },
        {
          "id": 200067,
          "text": "<p><span style=\"font-size:12.0pt;\">Cori's disease</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 10-year-old boy rapidly develops hypoglycemia after moderate activity. Blood examination reveals raised levels of ketone bodies, lactic acid, and triglycerides. On examination, the liver and kidneys are found to be enlarged. Histopathology of the liver shows deposits of glycogen in an excess amount. What is the diagnosis? (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">AIIMS May 2017)</span></p>",
      "unique_key": "Q8530147",
      "question_audio": null,
      "question_video": null,
      "map_id": 34883361,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Von Gierke's disease</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Clinical features are suggestive of Von Gierke’s disease (type I)</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Salient features of Von Gierke’s Disease –</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">It is the <strong>most common type </strong>of glycogen storage disease.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Glucose-6-phosphatase is deficient.</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Fasting hypoglycemia that does not respond to stimulation by adrenaline</strong>. The glucose cannot be released from liver during overnight fasting .</span></li><li><span style=\"font-size:12.0pt;\"><strong>Clinical Features: Hyperlipidemia, lactic acidosis and ketosis.</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Glucose-6-phosphate is accumulated, so it is channeled to HMP shunt pathway producing more ribose and more purine nucleotides.</strong></span></li><li><span style=\"font-size:12.0pt;\">Purines are then catabolized to uric acid, leading to <strong>hyperuricemia</strong></span></li><li><span style=\"font-size:12.0pt;\">Glycogen gets deposited in liver. <strong>Massive liver enlargement </strong>may lead to cirrhosis.</span></li><li><span style=\"font-size:12.0pt;\">Children usually die in early childhood.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Renomegaly</strong></span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Pompe's disease:</strong> This is a glycogen storage disease characterized by a deficiency of acid alpha-glucosidase. It primarily affects muscles and causes cardiomegaly but does not present with the same biochemical profile as Von Gierke’s disease.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. McArdle's disease:</strong> This is characterized by a deficiency in muscle phosphorylase and primarily affects muscle metabolism, leading to muscle cramps and myoglobinuria after exercise, but not the described biochemical abnormalities or hepatomegaly.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Cori's disease:</strong> Also known as Forbes disease or glycogen storage disease type III, it is caused by a deficiency of the debranching enzyme. While it can cause hepatomegaly and hypoglycemia, it does not present with the specific profile of ketonemia, lactic acidosis, and hyperlipidemia seen in Von Gierke's disease.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/05/screenshot-2024-06-05-175941.jpg\" alt=\"\" width=\"1000\" height=\"1083\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/05/screenshot-2024-06-05-175941.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200064,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50017,
      "choices": [
        {
          "id": 200068,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Only vial 1 can be used</span></p>"
        },
        {
          "id": 200069,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Vials 1 and 2 can be used</span></p>"
        },
        {
          "id": 200070,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Vials 1, 2, and 3 can be used</span></p>"
        },
        {
          "id": 200071,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">All vials can be used</span></p>"
        }
      ],
      "text": "<p><span style=\"color:black;font-size:12.0pt;\">Dr. Sunita, a medical officer in a rural health clinic, is tasked with ensuring the potency and safety of vaccines. She comes across several vaccine vials, each with a Vaccine Vial Monitor (VVM) attached. The VVMs change color to indicate the cumulative exposure of the vaccine to heat, thus helping in determining the viability of the vaccine. She notices varying degrees of color changes across these VVMs. Given this scenario, which of the following choices correctly identifies which vaccine vials, based on the observed VVM color changes, should be considered safe for use? (AIIMS MAY 2017)</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/20/screenshot-2024-09-20-113411.png\" alt=\"\" width=\"200\" height=\"1073\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/20/screenshot-2024-09-20-113411.png\" alt=\"Question Image\"></p>",
      "unique_key": "Q4417558",
      "question_audio": null,
      "question_video": null,
      "map_id": 34448346,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. B) Vials 1 and 2 can be used</strong></span></p><p> </p><ul><li><span style=\"color:black;font-size:12.0pt;\">Based on the image provided, it's evident that only vials 1 and 2 are suitable for use because the inner squares of these vials color lighter than the outer circles.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Vaccine vial monitors (VVM) are heat-sensitive indicators routinely used to monitor heat exposure of the vaccine and determine vaccine viability as the vaccine vial moves across the supply chain.</span></li><li><span style=\"color:black;font-size:12.0pt;\">VVMs change color as the vaccine is exposed to cumulative heat. If the color of inner square is similar or darker than the outer circle, the vaccine vial should be discarded.</span></li><li><span style=\"color:black;font-size:12.0pt;\">A VVM can be used to assess vaccine potency and not vaccine efficacy.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Expiry date can’t be determined by VVM and has no relation to extend the expiry date.</span></li><li><span style=\"color:black;font-size:12.0pt;\">If the square and the circle are the same in colour, then the vaccine should be discarded.</span></li></ul><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/18/picture2.jpg\" alt=\"\" width=\"700\" height=\"372\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/18/picture1_YnCLGDy.jpg\" alt=\"\" width=\"800\" height=\"580\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/18/picture2.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200069,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50018,
      "choices": [
        {
          "id": 200072,
          "text": "<p><span style=\"font-size:12.0pt;\">Cri-du-chat syndrome</span></p>"
        },
        {
          "id": 200073,
          "text": "<p><span style=\"font-size:12.0pt;\">Bloom syndrome</span></p>"
        },
        {
          "id": 200074,
          "text": "<p><span style=\"font-size:12.0pt;\">Angelman syndrome</span></p>"
        },
        {
          "id": 200075,
          "text": "<p><span style=\"font-size:12.0pt;\">Fragile X syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the disease shown in the karyotype: (AIIMS MAY 2017)</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/77.jpg\" alt=\"\" width=\"400\" height=\"315\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/77.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q6895305",
      "question_audio": null,
      "question_video": null,
      "map_id": 34886933,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Cri-du-chat syndrome</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Cri-du-chat syndrome: partial deletion of short arm of Chr 5, leads to cat-like cry, microcephaly, mental retardation, and congenital heart disease.</span></li><li><span style=\"font-size:12.0pt;\">Bloom syndrome: rare autosomal recessive disorder, characterized by short stature, sun sensitivity, predeposition of development of cancer and genomic instability.</span></li><li><span style=\"font-size:12.0pt;\">Angelman syndrome: caused by deletion in maternal chromosome 15 or paternal uniparental disomy, affects nervous system, delayed development, intellectual disability, severe speech impairment, and ataxia.</span></li><li><span style=\"font-size:12.0pt;\">Fragile X syndrome: genetic disorder, also known as Martin-Bell syndrome, most common cause of inherited mental retardation (among X-linked disorders), intellectual disability, and autism.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Bloom syndrome:</strong> features are:</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Short stature</span></li><li><span style=\"font-size:12.0pt;\">Sun sensitive rash over the nose and nose and cheeks</span></li><li><span style=\"font-size:12.0pt;\">Immune deficiency </span></li><li><span style=\"font-size:12.0pt;\">Insulin resistance that resembles Type 2 Diabetes</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\">The question doesn’t mention such feature. Therefore, bloom syndrome is not the right answer</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Angelman syndrome</strong>:<strong> </strong>remember “angel is the mother” therefore, in this syndrome maternal gene is deleted. It is one of the examples of uniparental disomy. The clinical features are:</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/picture3_oUxOdWo.jpg\" alt=\"\" width=\"300\" height=\"321\"></p><p> </p><ol style=\"list-style-type:lower-alpha;\"><li><span style=\"font-size:12.0pt;\">Maternal gene is deleted</span></li><li><span style=\"font-size:12.0pt;\">Paternal gene is doubled</span></li><li><span style=\"font-size:12.0pt;\">Dev delay</span></li><li><span style=\"font-size:12.0pt;\">Intellectual disability</span></li><li><span style=\"font-size:12.0pt;\">Microcephaly</span></li><li><span style=\"font-size:12.0pt;\">Hyperactive</span></li><li><span style=\"font-size:12.0pt;\">Spontaneous laughter - Happy Puppets</span></li><li><span style=\"font-size:12.0pt;\">Hypertonia</span></li><li><span style=\"font-size:12.0pt;\"><strong>UBE3A GENE ON Chr 15 is defective/absent</strong></span></li></ol><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. fragile x syndrome</strong>: it is the second most common non preventable cause of mental retardation. The features are:</span></p><p> </p><ol style=\"list-style-type:upper-alpha;\"><li><span style=\"font-size:12.0pt;\">Male patient</span></li><li><span style=\"font-size:12.0pt;\">Large ears</span></li><li><span style=\"font-size:12.0pt;\">Large testes</span></li><li><span style=\"font-size:12.0pt;\">Intellectual disability</span></li><li><span style=\"font-size:12.0pt;\">Nose will NOT be large</span></li></ol><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Cri-du-chat syndrome is identified by a partial deletion on the short arm of chromosome 5, leading to distinctive clinical features such as a cat-like cry, microcephaly, and intellectual disability.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/picture3_oUxOdWo.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200072,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50019,
      "choices": [
        {
          "id": 200076,
          "text": "<p><span style=\"font-size:12.0pt;\">Balantidium coli</span></p>"
        },
        {
          "id": 200077,
          "text": "<p><span style=\"font-size:12.0pt;\">Entamoeba dispar</span></p>"
        },
        {
          "id": 200078,
          "text": "<p><span style=\"font-size:12.0pt;\">Cryptosporidium</span></p>"
        },
        {
          "id": 200079,
          "text": "<p><span style=\"font-size:12.0pt;\">Giardia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the organism given in the image below? (INICET MAY 2017)</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/30/untitled-283.jpg\" alt=\"\" width=\"300\" height=\"250\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/30/untitled-283.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q6984452",
      "question_audio": null,
      "question_video": null,
      "map_id": 34041892,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Balantidium coli</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The given image is the trophozoite form of the Balantidium coli.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Balantidium coli occurs in two stages</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Trophozoites are oval in shape and contain two nuclei. There is the presence of cilia over the entire surface and are larger around the mouth. Its anterior end is narrow and the posterior end is broad. At the anterior end, there is a groove leading to the mouth (cytostome). Posteriorly, there is a small anal pore (cytopyge).</span></li><li><span style=\"font-size:12.0pt;\">Cysts are smaller, round with a micronucleus, a macronucleus and many contractile vacuoles.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\">Living trophozoites/cysts are yellowish or greenish in color on wet mount.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/22/untitled-177.jpg\" alt=\"\" width=\"600\" height=\"345\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Entamoeba dispar: </strong>Entamoeba dispar is morphologically identical to Entamoeba histolytica but non-pathogenic. It does not have the characteristic cilia and shape seen in Balantidium coli.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Cryptosporidium: </strong>Cryptosporidium species are small protozoans that cause cryptosporidiosis. They appear as small, round oocysts and do not have cilia.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Giardia:</strong> Giardia lamblia is a flagellated protozoan that causes giardiasis. Its trophozoites have a distinctive pear shape with flagella and two nuclei that resemble \"eyes.\"</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Balantidium coli is characterized by its oval shape, presence of cilia, and distinct anterior and posterior ends in the trophozoite form. The trophozoite stage contains two nuclei and is motile, while the cyst stage is smaller and round, aiding in transmission and infection.</span></li></ul><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/22/untitled-177.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200076,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50020,
      "choices": [
        {
          "id": 200080,
          "text": "<p><span style=\"font-size:11pt;\">Mark b</span></p>"
        },
        {
          "id": 200081,
          "text": "<p><span style=\"font-size:11pt;\">Mark d</span></p>"
        },
        {
          "id": 200082,
          "text": "<p><span style=\"font-size:11pt;\">Mark a</span></p>"
        },
        {
          "id": 200083,
          "text": "<p><span style=\"font-size:11pt;\">Mark c</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt;\">Nucleus pulposus is derived from? </span>(AIIMS 2017)</p><p style=\"text-align:justify;\"> </p><p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/25/inicet-anat-2017-1.jpg\" alt=\"\" width=\"300\" height=\"157\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/25/inicet-anat-2017-1.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q8178963",
      "question_audio": null,
      "question_video": null,
      "map_id": 34512828,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt;\"><strong>Ans. A. Mark b</strong></span></p><p> </p><p><span style=\"font-size:11pt;\"><strong>Explanation:</strong></span></p><p> </p><ul><li><span style=\"font-size:11pt;\">The notochord is a rod-like structure that forms during embryonic development and serves as the foundation for the future vertebral column.</span></li><li><span style=\"font-size:11pt;\">The nucleus pulposus, the central gel-like core of the intervertebral disc, is derived from the notochord. The notochord initially provides structural support to the developing embryo and later contributes to the formation of the intervertebral discs.</span></li></ul><p> </p><p><span style=\"font-size:11pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/14/screenshot-2024-05-14-114543.png\" alt=\"\" width=\"300\" height=\"147\"></span></p><p> </p><p><span style=\"font-size:11pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:11pt;\"><strong>Option B. Mark d. Ectoderm:</strong></span></p><p> </p><ul><li><span style=\"font-size:11pt;\">The ectoderm is another primary germ layer of the developing embryo and gives rise to structures such as the nervous system, skin, and epidermal tissues.</span></li><li><span style=\"font-size:11pt;\">The ectoderm does not contribute to the formation of the nucleus pulposus.</span></li></ul><p> </p><p><span style=\"font-size:11pt;\"><strong>Option C. Mark a. Intraembryonic Mesoderm:</strong></span></p><p> </p><ul><li><span style=\"font-size:11pt;\">The intraembryonic mesoderm is a layer of embryonic tissue that gives rise to various structures in the developing embryo, including muscles, bones, and connective tissues.</span></li><li><span style=\"font-size:11pt;\">While mesoderm does play a role in the development of the vertebral column and its associated structures, the nucleus pulposus specifically derives from the notochord.</span></li></ul><p> </p><p><span style=\"font-size:11pt;\"><strong>Option D. Mark c. Endoderm:</strong></span></p><p> </p><ul><li><span style=\"font-size:11pt;\">The endoderm is one of the three primary germ layers of the developing embryo and gives rise to the epithelial linings of various organs, including the gastrointestinal tract, respiratory tract, and other internal organs.</span></li><li><span style=\"font-size:11pt;\">The endoderm is not directly involved in the formation of the nucleus pulposus.</span></li></ul><p> </p><p><span style=\"font-size:11pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:11pt;\"><strong>Gastrulation (Embryonic development of the germ layers):</strong></span></p><p> </p><ul><li><span style=\"font-size:11pt;\">Gastrulation is the early embryological process by which an embryo changes from a one-dimensional layer of epithelial cells (blastula) to a multilayered structure known as a gastrula.</span></li><li><span style=\"font-size:11pt;\">The notochord is a rod-like embryological structure that is derived during gastrulation and plays an important role in vertebrate development.</span></li><li><span style=\"font-size:11pt;\">The nucleus pulposus is the gelatinous centre of the intervertebral disc formed by the expansion of the notochord (by its remnants). As a result, it is derived from the notochord.</span></li></ul><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/14/screenshot-2024-05-14-114543.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200080,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50021,
      "choices": [
        {
          "id": 200084,
          "text": "<p>1</p>"
        },
        {
          "id": 200085,
          "text": "<p>2</p>"
        },
        {
          "id": 200086,
          "text": "<p>3</p>"
        },
        {
          "id": 200087,
          "text": "<p>4</p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In a surgery, the orthopedic surgeon asks you for bone holding forceps. Correctly identify bone holding forceps among the instruments in the tray as shown below.(AIIMS MAY 2017)</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/15/screenshot-2024-05-15-112808.JPG\" alt=\"\" width=\"300\" height=\"657\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/15/screenshot-2024-05-15-112808.JPG\" alt=\"Question Image\"></p>",
      "unique_key": "Q2573569",
      "question_audio": null,
      "question_video": null,
      "map_id": 34414735,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) 4</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D)</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>SURGICAL INSTRUMENTS</strong></span></p><p> </p><p style=\"margin-left:80px;text-align:right;\"><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/17/whatsapp-image-2023-06-12-at-190121011010201026_page_68_page_83_AJMegAp.jpg\" alt=\"\" width=\"700\" height=\"1016\"></strong></span></p><p style=\"margin-left:80px;text-align:right;\"> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Out of the given options, the bone holding forceps is the shown in the option 4.</span></li><li><span style=\"font-size:12.0pt;\">Option 1 is the bone cutter.</span></li><li><span style=\"font-size:12.0pt;\">Option 2 is the bone nibbler.</span></li><li><span style=\"font-size:12.0pt;\">Option 3 is the bone plate holding forceps.</span></li></ul><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/17/whatsapp-image-2023-06-12-at-190121011010201026_page_68_page_83_AJMegAp.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200087,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50022,
      "choices": [
        {
          "id": 200088,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">I - A, II - B, III - C, IV - D</span></p>"
        },
        {
          "id": 200089,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">I - C, II - D, III - A, IV - B</span></p>"
        },
        {
          "id": 200090,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">I - D, II - C, III - A, IV - B</span></p>"
        },
        {
          "id": 200091,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">I - B, II - A, III - D, IV - C</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">During a medical ethics seminar, Dr. Sharma discussed a series of international declarations that guide medical professionals in upholding ethical principles in various scenarios. These declarations were born out of historical events and societal needs to ensure the welfare of patients and respect human rights. Can you match these declarations with their respective significance? (AIIMS MAY 2017)</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/20/screenshot-2024-09-20-115842.png\" alt=\"\" width=\"1000\" height=\"307\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/20/screenshot-2024-09-20-115842.png\" alt=\"Question Image\"></p>",
      "unique_key": "Q7621007",
      "question_audio": null,
      "question_video": null,
      "map_id": 34333026,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. B) I - C, II - D, III - A, IV - B</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Geneva Declaration:</strong> It is primarily focused on the physician's dedication to the humanitarian goals of medicine, emphasizing the commitment of the medical profession to human welfare and ethics. This declaration is assigned significance C.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Oslo Declaration:</strong> It deals with issues surrounding therapeutic abortion, offering guidelines and ethical considerations for medical professionals when abortion is a factor in medical treatment. This declaration is assigned significance D.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Tokyo Declaration:</strong> Provides guidelines for physicians concerning the ethical treatment of detainees and prisoners, specifically regarding torture and other forms of cruel, inhuman, or degrading treatment. This declaration is assigned significance A.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Helsinki Declaration:</strong> A cornerstone document that outlines ethical principles for the medical community concerning human experimentation. This declaration provides comprehensive guidelines intended to protect the dignity, rights, safety, and well-being of research subjects. It is assigned significance B.</span></li></ul><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/20/screenshot-2024-09-20-120210.png\" alt=\"\" width=\"1000\" height=\"319\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/20/screenshot-2024-09-20-120210.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200089,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50023,
      "choices": [
        {
          "id": 200092,
          "text": "<p style=\"margin-left:4px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Aspirin & clopidogrel</span></span></span></span></p>"
        },
        {
          "id": 200093,
          "text": "<p style=\"margin-left:4px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Mannitol</span></span></span></span></p>"
        },
        {
          "id": 200094,
          "text": "<p style=\"margin-left:4px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Decompressive surgery </span></span></span></span></p>"
        },
        {
          "id": 200095,
          "text": "<p style=\"margin-left:4px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Mechanical thrombectomy</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">A 53-year-old man was admitted with history of a cerebrovascular accident 2 days ago. The patient is drowsy with minimal response. CT findings is shown in the image below. What will be your next line of management? (AIIMS MAY 2017)</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/26/nm59.jpg\" style=\"height:299px; width:250px\" /></span></span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/26/nm59.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q7180491",
      "question_audio": null,
      "question_video": null,
      "map_id": 34687618,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Decompressive surgery</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The CT scan image shows significant edema and midline shift affecting more than 50% of the Middle Cerebral Artery (MCA) territory. This extensive edema, along with the patient's low Glasgow Coma Scale (GCS) score, indicates severe brain swelling and increased intracranial pressure (ICP). In such cases, medical management alone (like mannitol for reducing ICP) may not be sufficient.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Guidelines for urgent decompression: </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">NIH Stroke scale > 15</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Time < 48 hours</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Age 18-60yrs</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Territory infarct > 145cm<sup>3</sup><sup> </sup>or > 50% MCA territory </span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Informed consent that surgery improves survival but the patient may have significant disability. </span></span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Medical management of brain edema and increased intracranial pressure (ICP) may not be successful when significant swelling occurs in the cerebral or cerebellar hemisphere. </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Therefore, a decompressive craniectomy should be considered to relieve the mass effect of the swollen cerebral or cerebellar hemisphere on the thalamus, brainstem and network projections to the cortex, which is manifested predominantly by decreased levels of arousal.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Aspirin & clopidogrel:</span></strong><span style=\"font-size:12.0pt\"> Incorrect as these medications are used for preventing further thrombotic events but are not suitable in the acute management of severe edema and brain shift.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Mannitol:</span></strong><span style=\"font-size:12.0pt\"> Incorrect for sole use in this severe case, as it might not adequately control the mass effect and high ICP shown.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Mechanical thrombectomy:</span></strong><span style=\"font-size:12.0pt\"> Incorrect because the primary issue in the CT image is the significant brain swelling and herniation risk, not an occlusion that can be resolved by thrombectomy at this stage.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The cases of significant cerebral edema with midline shift, as seen on CT in acute stroke settings, decompressive surgery is often necessary to prevent fatal outcomes and manage increased intracranial pressure effectively.</span></span></span></p>",
      "correct_choice_id": 200094,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50024,
      "choices": [
        {
          "id": 200096,
          "text": "<p><span style=\"font-size:12.0pt;\">E. vermicularis</span></p>"
        },
        {
          "id": 200097,
          "text": "<p><span style=\"font-size:12.0pt;\">A. duodenal</span></p>"
        },
        {
          "id": 200098,
          "text": "<p><span style=\"font-size:12.0pt;\">B. coli</span></p>"
        },
        {
          "id": 200099,
          "text": "<p><span style=\"font-size:12.0pt;\">E. Histolytica</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following life cycle is given below? (INICET MAY 2017)</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/30/1-micro-3.jpg\" alt=\"\" width=\"600\" height=\"699\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/30/1-micro-3.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q3593601",
      "question_audio": null,
      "question_video": null,
      "map_id": 34747196,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) E. Histolytica</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The given life cycle is of Entamoeba histolytica.</span></li><li><span style=\"font-size:12.0pt;\">Its life cycle includes 2 stages - the motile trophozoite and the non-motile cyst, both of which are seen in the image shown above. The transmission is primarily by the <strong>fecal-oral route</strong>. There is no animal reservoir.</span></li><li><span style=\"font-size:12.0pt;\">The ingested cysts differentiate into trophozoites in the ileum which invade the colonic epithelium. The trophozoites penetrate to the submucosal layer and form abscesses which break down to form <strong>flask-shaped ulcer.</strong></span></li><li><span style=\"font-size:12.0pt;\">The trophozoites multiply by binary fission and produce cysts, and both stages are passed in the feces.</span></li><li><span style=\"font-size:12.0pt;\">Trophozoites are rapidly destroyed outside the body<strong>. Cysts survive in the external environment and are responsible for transmission.</strong></span></li><li><span style=\"font-size:12.0pt;\"><u>The most frequent site of systemic disease is the liver.</u></span></li><li><span style=\"font-size:12.0pt;\">The genus Entamoeba has four morphologically identical species - E. histolytica, E. dispar, E. bangladeshi, and E. moshkovskii. E. moshkovskii which was initially thought to be non-pathogenic has recently been shown to be a causative agent of non-invasive diarrhea.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. E. vermicularis: </strong>Enterobius vermicularis, also known as pinworm, has a simple life cycle that involves ingestion of eggs, hatching in the intestine, and laying eggs around the anus. It does not form trophozoites or cysts.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. A. duodenal: </strong>Ancylostoma duodenale, a hookworm, has a life cycle involving skin penetration by larvae, migration through the bloodstream to the lungs, ascent to the throat, and finally ingestion to the intestine where they mature. It does not have cysts or trophozoites.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. B. coli: </strong>Balantidium coli is a ciliate protozoan with a life cycle that involves a cyst stage and a trophozoite stage, similar to E. histolytica. However, it is characterized by the presence of cilia and typically associated with pigs as a reservoir.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The life cycle of Entamoeba histolytica includes the motile trophozoite and the non-motile cyst stages, with transmission primarily by the fecal-oral route. The most frequent site of systemic disease caused by E. histolytica is the liver.</span></p>",
      "correct_choice_id": 200099,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50025,
      "choices": [
        {
          "id": 200100,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">125 ml/cm H20</span></span></span></p>"
        },
        {
          "id": 200101,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">150 ml/cm H20</span></span></span></p>"
        },
        {
          "id": 200102,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">50 ml/cm H20</span></span></span></p>"
        },
        {
          "id": 200103,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">62.5 ml/cm H20</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A 30-year-old patient with respiratory volume of 500ml. The intrapleural pressure measured -4 before inspiration and -8 at the end of inspiration. The pulmonary compliance of the patient is</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">? (</span></span>AIIMS May 2017)</p>",
      "unique_key": "Q7336449",
      "question_audio": null,
      "question_video": null,
      "map_id": 34801010,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans: A) 125 ml/cm H20</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The compliance of a system is defined as the change in volume that occurs per unit change in the pressure of the system. </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Compliance is, therefore, a measurement of the elastic resistance of a system.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pulmonary compliance (C)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> total compliance of both lungs, measuring the extent to which the lungs will expand (change in volume of lungs) for each unit increase in the trans-pulmonary pressure (when enough time is allowed for the system to reach equilibrium).</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Compliance = Change in lung volume / Change in pressure</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In the given case, change in lung volume is 500 and change in transpulmonary pressure is 4</span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Compliance = 500/4 = 125 ml/cm H20</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#0d0d0d\">Pulmonary compliance measures the change in lung volume per unit change in transpulmonary pressure. It is a crucial indicator of the lung's ability to expand and is affected in various pulmonary diseases.</span></span></span></span></p>",
      "correct_choice_id": 200100,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50026,
      "choices": [
        {
          "id": 200104,
          "text": "<p><span style=\"font-size:12.0pt;\">Invasive candidiasis</span></p>"
        },
        {
          "id": 200105,
          "text": "<p><span style=\"font-size:12.0pt;\">Rhizopus</span></p>"
        },
        {
          "id": 200106,
          "text": "<p><span style=\"font-size:12.0pt;\">Cryptococcus</span></p>"
        },
        {
          "id": 200107,
          "text": "<p><span style=\"font-size:12.0pt;\">Mucormycosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">1,3 beta D- glucan is helpful for identification of? (INICET MAY 2017)</span></p>",
      "unique_key": "Q1522358",
      "question_audio": null,
      "question_video": null,
      "map_id": 34443819,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Invasive candidiasis</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">1,3 beta D- glucan is helpful for the identification of Invasive candidiasis (invasive fungal infections).</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Beta 1-3 glucan assay test detects the presence of (1-3)-3-d-glucan (BDG) which is an abundant cell wall polysaccharide found in most fungi <strong>except <u>cryptococci, mucor,</u> zygomycetes and blastomyces dermatitidis.</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Rhizopus: </strong>Rhizopus is a genus of fungi causing mucormycosis, which typically does not produce significant amounts of (1,3)-β-D-glucan. Therefore, the BDG assay is not useful for detecting Rhizopus infections.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Cryptococcus:</strong> Cryptococcus species, which cause cryptococcosis, have a polysaccharide capsule that does not contain (1,3)-β-D-glucan, rendering the BDG assay ineffective for its detection.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Mucormycosis:</strong> Mucormycosis is caused by fungi in the order Mucorales, which do not produce (1,3)-β-D-glucan in significant amounts. Thus, the BDG assay is not applicable for diagnosing mucormycosis.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">1,3 beta D-glucan is helpful for the identification of invasive candidiasis by detecting the presence of (1,3)-β-D-glucan in the blood, a cell wall component of many pathogenic fungi, but it is not effective for detecting infections caused by fungi such as Cryptococcus, Rhizopus, and Mucormycosis.</span></p>",
      "correct_choice_id": 200104,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50027,
      "choices": [
        {
          "id": 200108,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">10</span></p>"
        },
        {
          "id": 200109,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">5</span></p>"
        },
        {
          "id": 200110,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">6</span></p>"
        },
        {
          "id": 200111,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">4</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the marked foramen does the mandibular division of the trigeminal nerve pass through? (</span>AIIMS May 2017)</p><p style=\"text-align:justify;\"> </p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/08/picture4.jpg\" alt=\"\" width=\"300\" height=\"293\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/08/picture4.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q1595608",
      "question_audio": null,
      "question_video": null,
      "map_id": 34370781,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt;\"><strong>Ans. D. 4</strong></span></p><p> </p><p><span style=\"font-size:11pt;\"><strong>Explanation</strong></span></p><p> </p><p><span style=\"font-size:11pt;\">The mandibular division of the trigeminal nerve passes through the foramen ovale which is marked as 4 in the above image.</span></p><p> </p><p><span style=\"font-size:11pt;\">The foramen ovale is also located in the greater wing of the sphenoid bone.</span></p><p> </p><p><span style=\"font-size:11pt;\">The structure that passes through the foramen ovale is the mandibular nerve (the third division of the trigeminal nerve, Cranial Nerve V3). It carries sensory information from the face and provides motor innervation to the muscles of mastication.</span></p><p> </p><p>Foramen ovale is situated anterior and medial to foramen spinosum, and is larger in size than spinosum.</p><p><br>Structures passing vis foramen ovale can be remembered by the following mnemonic<br>M - Mandibular nerve (3rd division of trigeminal)<br>A - Accessory meningeal artery<br>L - Lesser petrosal nerve<br>E - emissary veins<br> </p><p> </p><p><span style=\"font-size:11pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:11pt;\"><strong>Option A. Foramen Spinosum:</strong></span></p><p> </p><ul><li><span style=\"font-size:11pt;\">The foramen spinosum is a small foramen located in the greater wing of the sphenoid bone, near the foramen ovale.</span></li><li><span style=\"font-size:11pt;\">The structure that passes through the foramen spinosum is the middle meningeal artery. This artery supplies blood to the meninges, the protective layers surrounding the brain and spinal cord.</span></li></ul><p> </p><p><span style=\"font-size:11pt;\"><strong>Option B. Internal Acoustic Meatus:</strong></span></p><p> </p><ul><li><span style=\"font-size:11pt;\">The internal acoustic meatus is located in the petrous part of the temporal bone.</span></li><li><span style=\"font-size:11pt;\">Several important structures pass through this foramen:</span><ol><li><span style=\"font-size:11pt;\"><strong>Facial nerve (Cranial Nerve VII): </strong>It carries motor and sensory fibers related to the muscles of facial expression and taste sensations from the anterior two-thirds of the tongue.</span></li><li><span style=\"font-size:11pt;\">V<strong>estibulocochlear nerve (Cranial Nerve VIII)</strong>: It carries sensory information related to hearing and balance.</span></li></ol></li></ul><p> </p><p><span style=\"font-size:11pt;\"><strong>Option C. Jugular Foramen:</strong></span></p><p> </p><ul><li><span style=\"font-size:11pt;\">The jugular foramen is located at the junction of the temporal and occipital bones, near the base of the skull.</span></li><li><span style=\"font-size:11pt;\">Several structures pass through the jugular foramen:</span><ol><li><span style=\"font-size:11pt;\"><strong>Glossopharyngeal nerve (Cranial Nerve IX)</strong>: It carries motor and sensory fibers to the pharynx and taste sensations from the posterior one-third of the tongue.</span></li><li><span style=\"font-size:11pt;\"><strong>Vagus nerve (Cranial Nerve X): </strong>It carries motor and sensory fibers to various organs in the thorax and abdomen and plays a crucial role in autonomic functions.</span></li><li><span style=\"font-size:11pt;\"><strong>Accessory nerve (Cranial Nerve XI)</strong>: It supplies motor fibers to the sternocleidomastoid and trapezius muscles.</span></li><li><span style=\"font-size:11pt;\"><strong>Internal jugular vein:</strong> It is a major vein that drains blood from the brain and parts of the face.</span></li></ol></li></ul><p> </p><p><span style=\"font-size:11.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/08/picture5.jpg\" alt=\"\" width=\"500\" height=\"535\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/08/picture5.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200111,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50028,
      "choices": [
        {
          "id": 200112,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Hypersecreting adenoma</span></p>"
        },
        {
          "id": 200113,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Papillary carcinoma thyroid</span></p>"
        },
        {
          "id": 200114,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Grave’s disease</span></p>"
        },
        {
          "id": 200115,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Lateral aberrant thyroid</span></p>"
        }
      ],
      "text": "<p><span style=\"color:black;font-size:12.0pt;\">Below is a radioactive scan for thyroid pathology. which of the following is the most probable diagnosis: (AIIMS MAY 2017)</span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/26/nm56.jpg\" alt=\"\" width=\"300\" height=\"256\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/26/nm56.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q1335121",
      "question_audio": null,
      "question_video": null,
      "map_id": 34988171,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Hypersecreting Adenoma</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Image findings are suggestive of hypersecreting adenoma.</span></p><p> </p><ol><li><span style=\"color:black;font-size:12.0pt;\">Increased uptake in the right lobe at the thyroid</span></li><li><span style=\"color:black;font-size:12.0pt;\">Suppressed uptake in left lobe of thyroid</span></li></ol><p> </p><p><span style=\"font-size:12.0pt;\">These findings are highly suggestive of a hypersecreting adenoma. This condition occurs when a benign tumor in the thyroid gland produces thyroid hormone independently of the normal regulatory mechanisms, leading to an overactive area (hot spot) in one part of the thyroid, with suppression of activity in the rest of the gland due to negative feedback mechanisms.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Papillary carcinoma of the thyroid:</strong> Incorrect as this type of cancer typically presents with a \"cold nodule,\" which shows reduced or no uptake on a radioactive scan. The scan shows no areas of reduced uptake indicative of a cold nodule.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Grave’s disease:</strong> Incorrect because Grave's disease generally causes a diffuse increase in uptake across the entire thyroid gland due to widespread stimulation of thyroid tissue. The scan does not show diffuse uptake, which rules out Grave's disease.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Lateral aberrant thyroid:</strong> Incorrect as this condition involves ectopic thyroid tissue that might appear as functioning thyroid tissue outside the normal location. The scan does not indicate any ectopic thyroid tissue.</span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Hypersecreting adenoma in the thyroid is characterized by increased radioactive uptake in one area of the thyroid with suppression in other areas, reflecting independent hormone production from the adenoma.</span></p>",
      "correct_choice_id": 200112,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50029,
      "choices": [
        {
          "id": 200116,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Image 2</span></span></span></p>"
        },
        {
          "id": 200117,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Image 1</span></span></span></p>"
        },
        {
          "id": 200118,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Image 4</span></span></span></p>"
        },
        {
          "id": 200119,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Image 3</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Endoscopic and barium swallow images of a lesion in the esophagus of a patient are as shown below. What is the expected histopathological finding?</span></span> (AIIMS MAY 2017)</p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/36.jpg\" style=\"height:251px; width:300px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/37.jpg\" style=\"height:417px; width:300px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/38.jpg\" style=\"height:281px; width:400px\" /></span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/36.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q7288526",
      "question_audio": null,
      "question_video": null,
      "map_id": 34308586,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Image 3 </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The shows an esophageal exophytic growth on endoscopy. <strong>Barium swallow reveals an</strong> <strong>apple core appearance in the middle 1/3 of the esophagus suggestive of squamous cell carcinoma</strong>. The characteristic histopathological finding in this condition are nests of stratified malignant cells and keratin pearls, which are noted in image 3.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In contrast to adenocarcinoma, half of squamous cell carcinomas occur in the middle third of the esophagus. Squamous cell carcinoma begins as an in-situ lesion termed squamous dysplasia (this lesion is referred to as intraepithelial neoplasia or carcinoma in situ at other sites). Early lesions appear as small, gray-white, plaque-like thickenings. Over months to years, they grow into tumor masses that may be polypoid or exophytic and protrude into and obstruct the lumen.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/04/screenshot-2024-09-04-110450.png\" style=\"height:249px; width:600px\" /></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Squamous cell carcinoma of the esophagus typically occurs in the middle third of the esophagus and is characterized histologically by nests of stratified malignant cells and keratin pearls, as seen in Image 3.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Robbins and Cotran Pathologic basis of disease 8th edition Pg 1472, 1473</span></strong></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/04/screenshot-2024-09-04-110450.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200119,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50030,
      "choices": [
        {
          "id": 200120,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Saddle type</span></p>"
        },
        {
          "id": 200121,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Plane</span></p>"
        },
        {
          "id": 200122,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Ellipsoid</span></p>"
        },
        {
          "id": 200123,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Ball and socket joint</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11.0pt;\">The talocalcaneonavicular joint is a?</span></p>",
      "unique_key": "Q3732777",
      "question_audio": null,
      "question_video": null,
      "map_id": 34601421,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt;\"><strong>Ans. D. Ball and socket joint</strong></span></p><p> </p><p><span style=\"font-size:11pt;\"><strong>Explanation:</strong></span></p><p> </p><p><span style=\"font-size:11pt;\">The talocalcaneonavicular joint is a ball and socket joint.</span></p><p> </p><ul><li><span style=\"font-size:11pt;\">The ball part is formed by the rounded head of the talus.</span></li><li><span style=\"font-size:11pt;\">The socket is formed by 3 structures:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:11pt;\">Posterior surface of the navicular</span></li><li><span style=\"font-size:11pt;\">Anterior articular surface of the calcaneus</span></li><li><span style=\"color:black;font-size:11.0pt;\">Upper surface of the plantar calcaneo-navicular ligament (spring ligament).</span></li></ul></li></ul><p> </p><p><span style=\"color:black;font-size:10.5pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/25/inicet-anat-2017-8.jpg\" alt=\"\" width=\"500\" height=\"217\"></span></p><p> </p><p><span style=\"font-size:11pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:11pt;\"><strong>Option A. Saddle Type: </strong>A saddle joint, also known as a sellar joint, is a type of synovial joint found in the thumb (between the trapezium bone and the first metacarpal bone). It allows movement in two planes, such as flexion-extension and abduction-adduction. The talocalcaneonavicular joint does not fit this description.</span></p><p> </p><p><span style=\"font-size:11pt;\"><strong>Option B. Plane: </strong>A plane joint, also called a gliding joint, allows for limited sliding or gliding movements between flat articular surfaces. While there are gliding joints in the foot, the talocalcaneonavicular joint is not primarily classified as a plane joint.</span></p><p> </p><p><span style=\"font-size:11pt;\"><strong>Option C. Ellipsoid (Condyloid):</strong> An ellipsoid joint, also known as a condyloid joint, is a synovial joint that allows movement in two planes: flexion-extension and abduction-adduction. This type of joint has an oval-shaped convex surface fitting into an elliptical concave surface.</span></p><p> </p><p><span style=\"font-size:11pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:11pt;\">A ball and socket joint is characterized by a spherical head fitting into a cup-like socket. This type of joint allows for a wide range of motion in multiple planes. The talocalcaneonavicular joint is  a ball and socket joint.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/25/inicet-anat-2017-8.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200123,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50031,
      "choices": [
        {
          "id": 200124,
          "text": "<p><span style=\"font-size:12.0pt;\">Fungus</span></p>"
        },
        {
          "id": 200125,
          "text": "<p><span style=\"font-size:12.0pt;\">Virus</span></p>"
        },
        {
          "id": 200126,
          "text": "<p><span style=\"font-size:12.0pt;\">Aquatic Protistan protozoa</span></p>"
        },
        {
          "id": 200127,
          "text": "<p><span style=\"font-size:12.0pt;\">Bacteria</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Under which of the following, Rhinosporidium seeberi is classified?</span></p>",
      "unique_key": "Q8755987",
      "question_audio": null,
      "question_video": null,
      "map_id": 34137700,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Aquatic Protistan protozoa</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong><u>RHINOSPORIDIOSIS</u></strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Causative organism: <strong>Rhinosporidium Seeberi </strong>(earlier considered fungus, now classified under protozoa)</span></li><li><span style=\"font-size:12.0pt;\">Life cycle: 3 stages: <i><strong>Trophic, Sporangium formation, Endospore production</strong></i>.</span></li><li><span style=\"font-size:12.0pt;\">Spread by contaminated water of ponds, seen commonly in coastal areas</span></li><li><span style=\"font-size:12.0pt;\">Appearance: leafy, <strong>polypoidal mass</strong>, pink to purple (strawberry), <strong>bleeds on touch</strong>.</span></li><li><span style=\"font-size:12.0pt;\">Complaints: Blood tinged nasal discharge & stuffiness</span></li><li><span style=\"font-size:12.0pt;\">Diagnosis by biopsy (spores bursting through chitinous wall of sporangia)</span></li><li><span style=\"font-size:12.0pt;\">Treatment: <strong>Diathermy excision with base cauterization ± Dapsone</strong></span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A:</strong> Although previously considered a fungus, current classifications based on molecular analysis place Rhinosporidium seeberi under protozoa.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B:</strong> Viruses are infectious agents that replicate inside the living cells of organisms which is not a characteristic of Rhinosporidium seeberi.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D:</strong> Bacteria are single-celled microorganisms with simple internal structures, quite distinct from the complex life cycle and morphology of Rhinosporidium seeberi.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Rhinosporidium seeberi, responsible for rhinosporidiosis, is classified as an aquatic Protistan protozoa, not a fungus, highlighting the importance of accurate organism classification in understanding transmission and management of infections.</span></p>",
      "correct_choice_id": 200126,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50032,
      "choices": [
        {
          "id": 200128,
          "text": "<p style=\"margin-right:44px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Not more than 10% of the people benefitted by the drug could be due to chance</span></span></span></span></p>"
        },
        {
          "id": 200129,
          "text": "<p style=\"margin-right:91px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">90% of patients will be benefitted by giving the drug</span></span></span></span></p>"
        },
        {
          "id": 200130,
          "text": "<p style=\"margin-right:91px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">The test is 90% reproducible</span></span></span></span></p>"
        },
        {
          "id": 200131,
          "text": "<p style=\"margin-right:90px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">90% of test results could have occurred by chance</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:black\">An investigative study was conducted in Mumbai wherein a promising new antihypertensive medication was evaluated for its potential efficacy. Initial clinical trials with a diverse cohort of patients with chronic hypertension revealed promising results in managing elevated blood pressure levels. The efficacy of the drug was measured meticulously, and upon analyzing the data, a p-value of < 0.10 was documented. Given this statistical information and considering the nuances of research interpretation, which of the following statements best elucidates the implications of this p-value in terms of the drug's effect? (AIIMS MAY 2017)</span></span></span></p>",
      "unique_key": "Q7959540",
      "question_audio": null,
      "question_video": null,
      "map_id": 34255846,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Ans. A) Not more than 10% of the people benefitted by the drug could be due to chance</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">A P-value of less than 0.10 suggests that the likelihood of the drug's benefits occurring due to chance is no higher than 10%.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\"> INTERPRETATION:</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Out of 100 repeated tests, a statistically insignificant difference will occur only 10 times, while a statistically significant difference will emerge 90 times.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">There is a 10% probability of incorrectly concluding that a drug is beneficial when it is not, which can happen in statistical studies when deciding whether to accept or reject a null hypothesis.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">The P value is compared to a predetermined threshold value 'a'; if the P value is less than 'a', the test is considered statistically significant, and the null hypothesis is rejected.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The p-value is a statistical parameter used to evaluate whether the results of an experiment are statistically significant. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In this case, a p-value of < 0.10 suggests there is up to a 10% chance that the observed benefits from the antihypertensive drug could be due to random variation rather than a true effect of the drug.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 200128,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50033,
      "choices": [
        {
          "id": 200132,
          "text": "<p><span style=\"font-size:12.0pt;\">Sestamibi scan</span></p>"
        },
        {
          "id": 200133,
          "text": "<p><span style=\"font-size:12.0pt;\">MRI</span></p>"
        },
        {
          "id": 200134,
          "text": "<p><span style=\"font-size:12.0pt;\">Ultrasonogram</span></p>"
        },
        {
          "id": 200135,
          "text": "<p><span style=\"font-size:12.0pt;\">CT scan</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 40-year-old woman presented with complaints of bone pain and abdominal cramps with persistent low mood. Which of the following would be the best investigation for a definitive diagnosis? (AIIMS 2017)</span></p>",
      "unique_key": "Q9903090",
      "question_audio": null,
      "question_video": null,
      "map_id": 34101756,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Sestamibi scan</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The clinical features of 40-year-old woman with bone pain and abdominal cramps along with persistent low mood is suggestive of hypercalcemia, which could be due to primary Hyperparathyroidism.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">IOC for parathyroid adenoma: Tc99-Sestamibi scan</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/26/untitled-120.jpg\" alt=\"\" width=\"680\" height=\"319\"></span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/23/screenshot-2024-05-23-094350_Wfkcwuw.png\" alt=\"\" width=\"900\" height=\"52\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. MRI (Magnetic Resonance Imaging):</strong> While useful for detailed soft tissue imaging, MRI is not the first choice for detecting parathyroid adenomas.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Ultrasonogram:</strong> Can be used to locate parathyroid adenomas but has limitations in sensitivity and specificity compared to the Sestamibi scan.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. CT scan (Computed Tomography):</strong> Provides good anatomic detail but is less specific than the Sestamibi scan for parathyroid adenomas and is not the primary diagnostic tool for suspected hyperparathyroidism.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">For a definitive diagnosis in patients presenting with symptoms indicative of hypercalcemia and suspected primary hyperparathyroidism, a Sestamibi scan is the investigation of choice due to its specificity and ability to perform detailed scintigraphic imaging.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/26/untitled-120.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200132,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50034,
      "choices": [
        {
          "id": 200136,
          "text": "<p><span style=\"font-size:12pt;\">McNaughten's Rule</span></p>"
        },
        {
          "id": 200137,
          "text": "<p><span style=\"font-size:12pt;\">Curren’s Rule</span></p>"
        },
        {
          "id": 200138,
          "text": "<p><span style=\"font-size:12pt;\">Durham's Rule</span></p>"
        },
        {
          "id": 200139,
          "text": "<p><span style=\"font-size:12pt;\">American Law Institute Test</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Criminal responsibility of Insane is defined in: (</span>AIIMS Nov 2017)</p>",
      "unique_key": "Q3232119",
      "question_audio": null,
      "question_video": null,
      "map_id": 34384192,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A. McNaughten's Rule</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">“McNaughten’s Rule” also known as “Legal test of insanity”,</span><span style=\"font-size:9pt;\"> </span><span style=\"font-size:12.0pt;\">“right or wrong test” is the legal standard for determining criminal responsibility in cases of insanity.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Other Options</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option B. Curren's rule: </strong>of 1964 states that an accused person is not criminally responsible, if at the time of committing the act, he did not have the capacity to regulate his conduct to the requirements of the law, as a result of mental disease or defect.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C. Durham 's rule: </strong>of 1954 States that an accused person is not criminally responsible if his unlawful act is the product of mental disease or mental defect.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. American law institute test: </strong>(1972) A person is not responsible for the crime, if at the time of committing it, he lacks adequate capacity to appreciate the criminality of his conduct or to adjust it to the requirements of the law.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">McNaughten's rule is defined by section 84 of the Indian Penal Code (IPC)</span></p><p> </p><p><span style=\"font-size:12pt;\">It states that \"A person of unsound mind is not liable for an act.\"</span></p><p> </p><p><span style=\"font-size:12pt;\">It implies that the defendant was unable to distinguish between right and wrong or otherwise didn't understand what they did because of a \"disease of the mind.\"</span></p>",
      "correct_choice_id": 200136,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50035,
      "choices": [
        {
          "id": 200140,
          "text": "<p><span style=\"font-size:12.0pt;\">Exchange transfusion</span></p>"
        },
        {
          "id": 200141,
          "text": "<p><span style=\"font-size:12.0pt;\">Stop breastfeeding and start phototherapy</span></p>"
        },
        {
          "id": 200142,
          "text": "<p><span style=\"font-size:12.0pt;\">IV fluids and phototherapy</span></p>"
        },
        {
          "id": 200143,
          "text": "<p><span style=\"font-size:12.0pt;\">Continue breastfeeding</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 4-day old baby is active and feeding well. He has a bilirubin level of 8 mg/dl. What is the next step in the management of the baby? (AIIMS MAY 2017)</span></p>",
      "unique_key": "Q4141777",
      "question_audio": null,
      "question_video": null,
      "map_id": 34550811,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Continue breastfeeding.</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">On the fourth day, this child's bilirubin level is only 8 mg/dl, indicating physiologic jaundice. Because the child is active and feeding well, the mother should be encouraged to continue breastfeeding on a regular and exclusive basis.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Physiological jaundice/Icterus neonatorum is caused by increased bilirubin production from foetal red blood cell breakdown combined with a transient limitation in bilirubin conjugation by the immature neonatal liver.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">It usually appears on the second or third day after birth, peaks on the fourth day at 5-6 mg/dL, and then drops to 2 mg/dL between the fifth and seventh days.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Note: Features suggestive of pathological jaundice:</span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\">Jaundice appears within the first 24 hours after birth.</span></li><li><span style=\"font-size:12.0pt;\">Jaundice present at or beyond age 3 weeks or sick infant.</span></li><li><span style=\"font-size:12.0pt;\">Elevated direct (or conjugated) bilirubin level.</span></li><li><span style=\"font-size:12.0pt;\">Total Serum Bilirubin (TSB) levels above the expected normal range -Jaundice is seen in the mid-abdomen (= 15 mg/dL) and soles (- 20 mg/dL).</span></li><li><span style=\"font-size:12.0pt;\">Total Serum Bilirubin concentration not responding to phototherapy.</span></li><li><span style=\"font-size:12.0pt;\">Total Serum Bilirubin rising rapidly (i.e., crossing percentiles) in an infant receiving phototherapy.</span></li></ol><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-145422.png\" alt=\"\" width=\"1000\" height=\"546\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Exchange transfusion:</strong> exchange transfusion is not the correct option.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Indications of exchange transfusion are:</span></p><p> </p><ol style=\"list-style-type:lower-alpha;\"><li><span style=\"font-size:12.0pt;\">History of Direct coombs test positive</span></li><li><span style=\"font-size:12.0pt;\">Cord hemoglobin < 5gm/cl and cord bilirubin >10 mg /dl</span></li><li><span style=\"font-size:12.0pt;\">History of sibling death / erythroblastosis fetalis</span></li></ol><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Stop breastfeeding and start phototherapy</strong>: We don’t stop breast feeding unless the baby is a case of galactosemia or lactose intolerance because in these conditions breast feeding is contraindicated.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. IV fluids and phototherapy</strong>: IV fluids is not the right option as the baby is feeding well. We don’t give IV fluids to a baby who is feeding well.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">In cases of physiological jaundice with mild to moderate bilirubin levels and a well-feeding, active infant, the appropriate management is to continue breastfeeding without additional interventions.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-145422.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200143,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50036,
      "choices": [
        {
          "id": 200144,
          "text": "<p><span style=\"font-size:12.0pt;\">Benedict test and heat coagulation test</span></p>"
        },
        {
          "id": 200145,
          "text": "<p><span style=\"font-size:12.0pt;\">Heat coagulation test</span></p>"
        },
        {
          "id": 200146,
          "text": "<p><span style=\"font-size:12.0pt;\">Rothera's test</span></p>"
        },
        {
          "id": 200147,
          "text": "<p><span style=\"font-size:12.0pt;\">Heat coagulation test and Rothera's test</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which test will be positive in starvation state in urine? (</span>AIIMS May 2017)</p>",
      "unique_key": "Q1413567",
      "question_audio": null,
      "question_video": null,
      "map_id": 34482003,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Rothera’s test</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Detectable levels of<strong> ketone bodies in urine (ketonuria) </strong>are seen in conditions characterized by <strong>increased ketogenesis such as starvation</strong>. The urine test done for ketone bodies is the <strong>Rothera's test in</strong> <strong>which formation of a purple ring indicates presence of ketone bodies</strong>.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Benedict test and heat coagulation test:</strong> Used to detect reducing sugars (such as glucose, fructose, and lactose) in urine. In the presence of reducing sugars, Benedict's reagent changes color from blue to green, yellow, or red, depending on the concentration of the sugar. This test is not specific to ketone bodies and is used primarily to diagnose conditions like diabetes mellitus where reducing sugars are present in the urine.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Heat coagulation test:</strong> Used to detect proteins in urine. When the urine sample is heated, the presence of proteins causes the formation of a precipitate or cloudiness. This test is used to diagnose conditions like proteinuria, seen in kidney disease, but it does not detect ketone bodies.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Gerhardt's test - Ketone bodies in urine.</span></li><li><span style=\"font-size:12.0pt;\">Benedict' test - Reducing sugars.</span></li><li><span style=\"font-size:12.0pt;\">Heat coagulation test - Proteins.</span></li><li><span style=\"font-size:12.0pt;\">Rothera’s test – detect Ketone bodies in urine.</span></li></ul>",
      "correct_choice_id": 200146,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50037,
      "choices": [
        {
          "id": 200148,
          "text": "<p><span style=\"font-size:12.0pt;\">Continuous air bubbles coming out of the underwater drain</span></p>"
        },
        {
          "id": 200149,
          "text": "<p><span style=\"font-size:12.0pt;\">Oscillation of water column in the tube</span></p>"
        },
        {
          "id": 200150,
          "text": "<p><span style=\"font-size:12.0pt;\">Chest X-ray</span></p>"
        },
        {
          "id": 200151,
          "text": "<p><span style=\"font-size:12.0pt;\">Auscultation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Proper functioning of an ICD tube is checked by: (AIIMS MAY 2017)</span></p>",
      "unique_key": "Q4479479",
      "question_audio": null,
      "question_video": null,
      "map_id": 34654647,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Oscillation of water column in the tube</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Functioning of the ICD tube can be confirmed by seeing the column of water in the chest tube oscillate up and down during respiration.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The oscillation or fluctuation of the water column in the water seal chamber of an ICD tube is a key indicator of proper functioning. This movement indicates that there is a patent (open) airway between the pleural space and the water seal, allowing air and fluid to exit the pleural cavity and preventing air from re-entering during inhalation. It's a visual confirmation that the ICD is effectively draining the pleural space.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Continuous air bubbles coming out of the underwater drain</strong>: While air bubbles can sometimes be seen in the water seal chamber of an ICD system, their presence does not necessarily indicate proper functioning.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option</strong> </span><span style=\"font-size:12.0pt;\"><strong>C.</strong> <strong>Chest X-ray</strong>: While a chest X-ray can provide valuable information about the position and placement of the ICD tube, it is not typically used as the primary method for checking its ongoing functioning. X-rays are often performed initially after tube insertion to confirm placement.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option</strong> </span><span style=\"font-size:12.0pt;\"><strong>D.</strong> <strong>Auscultation</strong>: Auscultation can help assess lung sounds and detect any abnormalities, but it may not be the most direct method for checking the functioning of an ICD tube.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/09/screenshot-2024-09-09-170748.png\" alt=\"\" width=\"400\" height=\"184\"></strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">An intercostal drainage (ICD) tube is a thin, plastic tube that's inserted into the pleural space. The pleural space is the area between the chest wall and the lungs. </span></p><p> </p><p><span style=\"font-size:12.0pt;\">The ICD tube is used to drain abnormal collections in the pleural cavity. It helps remove: Air (pneumothorax), Blood (hemothorax), Fluid (pleural effusion or hydrothorax, Chyle (chylothorax, Purulence (empyema. </span></p><p> </p><p><span style=\"font-size:12.0pt;\">The ICD tube creates negative pressure in the chest cavity, which allows the lung to re-expand. </span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/09/screenshot-2024-09-09-170748.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200149,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50038,
      "choices": [
        {
          "id": 200152,
          "text": "<p><span style=\"font-size:12.0pt;\">Conversion of pyruvate to Acetyl CoA</span></p>"
        },
        {
          "id": 200153,
          "text": "<p><span style=\"font-size:12.0pt;\">Conversion of pyruvate to Oxaloacetate</span></p>"
        },
        {
          "id": 200154,
          "text": "<p><span style=\"font-size:12.0pt;\">Conversion of pyruvate to Acetaldehyde</span></p>"
        },
        {
          "id": 200155,
          "text": "<p><span style=\"font-size:12.0pt;\">Conversion of pyruvate to Lactic acid</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the anaplerotic reaction among the following? (</span>AIIMS May 2017)</p>",
      "unique_key": "Q4578121",
      "question_audio": null,
      "question_video": null,
      "map_id": 34446747,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Conversion of pyruvate to Oxaloacetate</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Anaplerotic reactions are “filling up” reactions or “influx” reactions or “replenishing” reactions which supply 4-carbon units to the TCA cycle</strong>.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>The important anaplerotic reactions are:</strong></span></p><p> </p><ol style=\"list-style-type:upper-alpha;\"><li><span style=\"font-size:12.0pt;\">Pyruvate to oxaloacetate by <strong>pyruvate carboxylase</strong> enzyme. It needs ATP.</span></li><li><span style=\"font-size:12.0pt;\">Glutamate is transaminated to alpha keto glutarate; and aspartate to oxaloacetate.</span></li><li><span style=\"font-size:12.0pt;\">Pyruvate can be carboxylated to malate by <strong>NADP+ dependent malic enzyme.</strong></span></li></ol><p> </p><p><span style=\"font-size:12.0pt;\">The citric acid cycle acts as a source of precursors of biosynthetic pathways, e.g., heme is synthesized from succinyl CoA and aspartate from oxaloacetate. To counterbalance such losses, and <strong>to keep the concentrations of the 4-carbon units in the cell, anaplerotic reactions are essential</strong>. This is called anaplerotic role of TCA cycle (Greek word, ana = up; plerotikos = to fill)</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Conversion of pyruvate to Acetyl CoA: </strong>This is not an anaplerotic reaction; it is a part of the link between glycolysis and the TCA cycle.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Conversion of pyruvate to Acetaldehyde: </strong>This reaction is part of ethanol fermentation, not an anaplerotic reaction.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Conversion of pyruvate to Lactic acid: </strong>This is part of anaerobic glycolysis (fermentation), not an anaplerotic reaction.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Anaplerotic reactions, such as the conversion of pyruvate to oxaloacetate, are crucial for maintaining the levels of TCA cycle intermediates, enabling the cycle to function efficiently and support biosynthetic demands.</span></p>",
      "correct_choice_id": 200153,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50039,
      "choices": [
        {
          "id": 200156,
          "text": "<p><span style=\"font-size:12.0pt;\">ESWL</span></p>"
        },
        {
          "id": 200157,
          "text": "<p><span style=\"font-size:12.0pt;\">Percutaneous Nephrolithotomy</span></p>"
        },
        {
          "id": 200158,
          "text": "<p><span style=\"font-size:12.0pt;\">Ureteroscopic removal</span></p>"
        },
        {
          "id": 200159,
          "text": "<p><span style=\"font-size:12.0pt;\">Open pyelolithotomy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient is diagnosed with Renal calculus of > 4 cm of the Staghorn type. What is the best management modality in this case? (AIIMS MAY 2017)</span></p>",
      "unique_key": "Q7453499",
      "question_audio": null,
      "question_video": null,
      "map_id": 34085461,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Percutaneous Nephrolithotomy</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">PCNL is the preferred treatment for large and complex kidney stones, especially Staghorn calculi. It involves making a small incision in the patient's back to access the kidney directly. A nephroscope is then used to remove or break up the stone. PCNL is highly effective in managing large stones like Staghorn calculi.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. ESWL (Extracorporeal Shock Wave Lithotripsy): </strong>ESWL is a non-invasive procedure that uses shock waves to break up kidney stones into smaller pieces, making them easier to pass. While ESWL is effective for smaller kidney stones (<2cm), it may not be as successful for very large and complex Staghorn calculi.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Ureteroscopic removal: </strong>Ureteroscopy is a procedure that involves inserting a thin, flexible tube (ureteroscope) through the urethra and bladder to reach the stone in the kidney or upper urinary tract. While it can be effective for ureteric stones, it may not be the best choice for Staghorn calculi, especially those larger than 4 cm.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Open pyelolithotomy: </strong>This may be done in cases where PCNL fails or is contra-indicated.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Percutaneous Nephrolithotomy (PCNL) is the gold standard for the management of large and complex stones, like in this case.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">PCNL is indicated in</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Staghorn calculi - Stone >2 cm</span></li><li><span style=\"font-size:12.0pt;\">Multiple stones - >1 cm</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\">ESWL is only 45-60% efficacious in the treatment of large stones. Also, it causes frequent complications including pain, hydronephrosis, fever, and occasional urosepsis, due to difficulties in the passage of stone particles, especially when there has been insufficient disintegration.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Complications of percutaneous nephrolithotomy include:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Hemorrhage from the punctured renal parenchyma</span></li><li><span style=\"font-size:12.0pt;\">Perforation of the collecting system with extravasation of saline irrigant</span></li><li><span style=\"font-size:12.0pt;\">Perforation of the colon or pleural cavity during placement of the percutaneous track</span></li></ul>",
      "correct_choice_id": 200157,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50040,
      "choices": [
        {
          "id": 200160,
          "text": "<p><span style=\"font-size:12.0pt;\">Shortened and externally rotated</span></p>"
        },
        {
          "id": 200161,
          "text": "<p><span style=\"font-size:12.0pt;\">Shortened and adducted</span></p>"
        },
        {
          "id": 200162,
          "text": "<p><span style=\"font-size:12.0pt;\">Extended, abducted and externally rotated</span></p>"
        },
        {
          "id": 200163,
          "text": "<p><span style=\"font-size:12.0pt;\">Abducted and internally rotated</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 75-year-old male after a fall in bathroom had hip fracture as seen in the pelvic X-ray below. What will be the position of the left lower limb?(AIIMS MAY 2017)</span></p><p style=\"text-align:justify;\"> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/02/untitled-599.jpg\" alt=\"\" width=\"300\" height=\"240\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/02/untitled-599.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q6815743",
      "question_audio": null,
      "question_video": null,
      "map_id": 34517311,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Shortened and externally rotated</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>HIP FRACTURE</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The given image in the question shows a <strong>displaced femoral neck fracture</strong>.</span></li><li><span style=\"font-size:12.0pt;\">Femoral neck fractures are a specific type of <strong>intracapsular hip fracture</strong>.</span></li><li><span style=\"font-size:12.0pt;\">Femoral neck fractures are associated with <strong>low energy falls in the elderly</strong>.</span></li><li><span style=\"font-size:12.0pt;\">In <strong>younger</strong> patients, the cause is usually <strong>secondary to high-energy trauma</strong> such as fall from a substantial height or motor vehicle accidents. </span></li><li><span style=\"font-size:12.0pt;\"><strong>Risk factors</strong> for femoral neck fractures include <strong>female</strong> gender, <strong>decreased mobility</strong>, and <strong>low bone</strong> <strong>density</strong>.</span></li><li><span style=\"font-size:12.0pt;\">70% of all hip fractures occur in <strong>women</strong>. </span></li><li><span style=\"font-size:12.0pt;\">Symptoms include <strong>pain in the groin</strong> or pain referred along the medial side of the thigh and knee in an <strong>impacted fracture</strong>.</span></li><li><span style=\"font-size:12.0pt;\">In a <strong>displaced fracture</strong>, there will be <strong>pain in the entire hip</strong>. </span></li><li><span style=\"font-size:12.0pt;\">In an <strong>impacted fracture</strong>, there is <strong>no obvious clinical deformity</strong> on examination. There is <strong>mild discomfort in the active/passive hip range of motion</strong>, and <strong>pain with percussion over the greater trochanter</strong>.</span></li><li><span style=\"font-size:12.0pt;\">In <strong>displaced fractures</strong>, the leg appears in <strong>external rotation and abduction</strong> deformity with <strong>shortening</strong> of the limb.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/15/screenshot-2024-05-15-110736.JPG\" alt=\"\" width=\"500\" height=\"403\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The given image shows a displaced femoral neck fracture in the elderly patient.</span></li><li><span style=\"font-size:12.0pt;\">Following the fracture, the limb appears shortened with external rotation and abduction deformity at the hip.</span></li></ul><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/15/screenshot-2024-05-15-110736.JPG\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200160,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50041,
      "choices": [
        {
          "id": 200164,
          "text": "<p><span style=\"color:#231f20;font-size:12.0pt;\">Head</span></p>"
        },
        {
          "id": 200165,
          "text": "<p><span style=\"color:#231f20;font-size:12.0pt;\">Neck</span></p>"
        },
        {
          "id": 200166,
          "text": "<p><span style=\"color:#231f20;font-size:12.0pt;\">Shaft</span></p>"
        },
        {
          "id": 200167,
          "text": "<p><span style=\"color:#231f20;font-size:12.0pt;\">Base</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which part of 2nd metatarsal is involved in the march fracture?(AIIMS MAY 2017)</span></p>",
      "unique_key": "Q8726537",
      "question_audio": null,
      "question_video": null,
      "map_id": 34455287,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Neck</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>MARCH FRACTURE</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">March fracture is a <strong>stress fatigue fracture of second metatarsal neck > 3rd metatarsal neck</strong>.</span></li><li><span style=\"font-size:12.0pt;\">The <strong>second metatarsal is more prone</strong> to injury due to its <strong>limited motion from strong ligamentous attachment</strong> to the first and second cuneiforms and length compared to the other foot metatarsals.</span></li><li><span style=\"font-size:12.0pt;\">They result from a <strong>sudden increase in the intensity, duration, and frequency</strong> of activity without sufficient rest.</span></li><li><span style=\"font-size:12.0pt;\">The <strong>repetitive impact</strong> on the metatarsals with weight-bearing exercises causes <strong>microfractures</strong>, which consolidate into stress fractures and are <strong>not the result of a single traumatic event</strong>.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/15/screenshot-2024-05-15-111207.JPG\" alt=\"\" width=\"200\" height=\"397\"></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Common Fracture Eponyms:</strong></span></li></ul><p> </p><p><span style=\"color:#231f20;font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/17/whatsapp-image-2023-06-12-at-190121011010201026_page_68_page_84.jpg\" alt=\"\" width=\"700\" height=\"918\"></strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The march fracture involves the neck of the 2<sup>nd</sup> metatarsal followed by 3<sup>rd</sup> metatarsal.</span></li><li><span style=\"font-size:12.0pt;\">It is a stress fracture of the metatarsal.</span></li></ul><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/15/screenshot-2024-05-15-111207.JPG\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200165,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50042,
      "choices": [
        {
          "id": 200168,
          "text": "<p><span style=\"font-size:12.0pt;\">Mycobacteria</span></p>"
        },
        {
          "id": 200169,
          "text": "<p><span style=\"font-size:12.0pt;\">Nocardia</span></p>"
        },
        {
          "id": 200170,
          "text": "<p><span style=\"font-size:12.0pt;\">Actinomyces</span></p>"
        },
        {
          "id": 200171,
          "text": "<p><span style=\"font-size:12.0pt;\">Corynebacterium</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The following slide is given as a spotter in your microbiology practical examination. Identify the following organism? (INICET MAY 2017)</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/22/untitled-179.jpg\" alt=\"\" width=\"300\" height=\"228\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/22/untitled-179.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q2783421",
      "question_audio": null,
      "question_video": null,
      "map_id": 34914495,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Mycobacteria</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The image shows pink non-branching acid-fast bacilli on a blue background. These findings are consistent with the staining characteristics of mycobacteria. The stain used is the Ziehl-Neelsen stain.</span></li><li><span style=\"font-size:12.0pt;\">Nocardia is partially acid-fast and appears as branching filaments.</span></li><li><span style=\"font-size:12.0pt;\">Actinomyces and Corynebacterium are non-acid-fast.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B:</strong> The image below shows <strong>Nocardia </strong>stained using an acid-fast staining technique.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/30/untitled-287.jpg\" alt=\"\" width=\"400\" height=\"263\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C:</strong> The image given below is of a gram-stained specimen of <strong>Actinomyces </strong>israelii.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/30/untitled-288.jpg\" alt=\"\" width=\"400\" height=\"374\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D:</strong> The images below show the staining characteristics of <strong>Corynebacterium </strong>diphtheriae.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/30/untitled-289.jpg\" alt=\"\" width=\"500\" height=\"435\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Mycobacterium tuberculosis, appear as pink bacilli on a blue background when stained with Ziehl-Neelsen stain due to their acid-fast properties.</span></li><li><span style=\"font-size:12.0pt;\">They have a high lipid content in their cell walls, which retains the carbol fuchsin dye even after treatment with acid-alcohol, a hallmark of acid-fast organisms.</span></li></ul><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/30/untitled-287.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200168,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50043,
      "choices": [
        {
          "id": 200172,
          "text": "<p><span style=\"font-size:12.0pt;\">The patient should not be shifted and portable X-ray machine should be used after neck Stabilization</span></p>"
        },
        {
          "id": 200173,
          "text": "<p><span style=\"font-size:12.0pt;\">The doctor will instruct the radiographer to take cervical and chest X ray</span></p>"
        },
        {
          "id": 200174,
          "text": "<p><span style=\"font-size:12.0pt;\">The doctor will instruct the radiographer to take cervical X ray AP and lateral view without any cervical support</span></p>"
        },
        {
          "id": 200175,
          "text": "<p><span style=\"font-size:12.0pt;\">The doctor should order a cervical X ray and shift the patient from the trolley by himself</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A victim of a road traffic accident presented with paralysis of both his upper and lower limbs. He has not passed urine and tenderness is elicited in the cervical region. What will be your advice? (AIIMS MAY 2017)</span></p>",
      "unique_key": "Q9787029",
      "question_audio": null,
      "question_video": null,
      "map_id": 34854458,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) The patient should not be shifted and portable X-ray machine should be used after neck stabilization</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The given clinical situation is suggestive of a cervical spine injury due to trauma. The patient should not be shifted and a portable X-ray machine should be used after neck stabilization.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">This option is correct because the patient is experiencing paralysis of both upper and lower limbs, which is indicative of a potential cervical spine injury. In such cases, it is crucial not to move the patient until the cervical spine is stabilized to prevent any further damage. Using a portable X-ray machine can help assess the cervical spine without the need to move the patient.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. The doctor will instruct the radiographer to take cervical and chest X-rays</strong>: The patient's cervical spine must be stabilized before any radiographic evaluation is performed.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. The doctor will instruct the radiographer to take cervical X-ray AP and lateral views without any cervical support</strong>: This option is not advisable because taking X-rays without cervical support can potentially worsen the patient's condition if there is a cervical spine injury. The patient's neck should be stabilized before any imaging is done.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. The doctor should order a cervical X-ray and shift the patient from the trolley by himself</strong>: This option is not recommended because moving the patient without proper cervical spine stabilization can lead to further injury. The priority should be to immobilize the cervical spine and use imaging techniques that do not require moving the patient.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Management in a trauma patient with suspected cervical fracture consists of:</span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\">The immediate step in the management of blunt/penetrating cervical trauma cases is spinal immobilization with a rigid cervical collar and a long spine board</span></li><li><span style=\"font-size:12.0pt;\">It is followed by eliciting extremity movement to grossly assess spinal cord function. Tenderness over the injured vertebrae or the presence of a deformity is indicated an associated fracture.</span></li></ol><p> </p><p><span style=\"font-size:12.0pt;\">Imaging is done by X-ray or CT with portable X-ray machines being preferred to avoid further injury while mobilizing the patient. They are useful in visualizing thoracic and lumbar vertebrae but they cannot be used to visualize the cervicothoracic junction.</span></p>",
      "correct_choice_id": 200172,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50044,
      "choices": [
        {
          "id": 200176,
          "text": "<p><span style=\"font-size:12.0pt;\">Adenoid cystic carcinoma</span></p>"
        },
        {
          "id": 200177,
          "text": "<p><span style=\"font-size:12.0pt;\">Pleomorphic adenoma</span></p>"
        },
        {
          "id": 200178,
          "text": "<p><span style=\"font-size:12.0pt;\">Mucoepidermoid carcinoma</span></p>"
        },
        {
          "id": 200179,
          "text": "<p><span style=\"font-size:12.0pt;\">Malignant mixed tumor</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which is the most common lacrimal gland tumor? (</span>AIIMS May 2017)</p>",
      "unique_key": "Q8802309",
      "question_audio": null,
      "question_video": null,
      "map_id": 34379618,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Pleomorphic adenoma</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Pleomorphic adenoma is the most common lacrimal gland tumor.</span></li><li><span style=\"font-size:12.0pt;\">It is also the most common epithelial tumor of the lacrimal gland.</span></li><li><span style=\"font-size:12.0pt;\">The most common epithelial tumors, in order of frequency, are as follows:</span><ol style=\"list-style-type:decimal;\"><li><span style=\"font-size:12.0pt;\">Benign mixed tumor (BMT), also known as a pleomorphic adenoma (PA)</span></li><li><span style=\"font-size:12.0pt;\">Adenoid cystic carcinoma (ACC)</span></li><li><span style=\"font-size:12.0pt;\">Pleomorphic adenocarcinoma (ACA)</span></li><li><span style=\"font-size:12.0pt;\">Mucoepidermoid carcinoma</span></li></ol></li></ul><p> </p><p><span style=\"font-size:12.0pt;\">Note: Most common malignant epithelial tumor of the lacrimal gland: Adenoid cystic carcinoma.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Adenoid cystic carcinoma:</strong> Adenoid cystic carcinoma is a malignant tumor that can occur in various glands in the body, including the lacrimal gland. It is characterized by slow growth and the tendency to invade nearby structures.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Mucoepidermoid carcinoma</strong>: Mucoepidermoid carcinoma is another type of malignant tumor that can affect the lacrimal gland. It is characterized by a combination of mucin-secreting and squamous (epidermoid) cells.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Malignant mixed tumor</strong>: Malignant mixed tumor, also known as carcinoma ex pleomorphic adenoma, occurs when a previously benign pleomorphic adenoma transforms into a malignant tumor. It is less common than pleomorphic adenoma but represents a more aggressive form of lacrimal gland tumor.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Pleomorphic adenoma is the most common lacrimal gland tumor. It is usually benign and arises from the glandular tissue. It can sometimes have a mixture of cell types, hence the name \"pleomorphic.\"</span></p>",
      "correct_choice_id": 200177,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50045,
      "choices": [
        {
          "id": 200180,
          "text": "<p><span style=\"font-size:12pt;\">Low LH and FSH</span></p>"
        },
        {
          "id": 200181,
          "text": "<p><span style=\"font-size:12pt;\">Low testosterone</span></p>"
        },
        {
          "id": 200182,
          "text": "<p><span style=\"font-size:12pt;\">Oligospermia</span></p>"
        },
        {
          "id": 200183,
          "text": "<p><span style=\"font-size:12pt;\">Low prolactin levels</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A couple with 2 children who are not able to conceive for over an year now present to the OPD. The male partner is diagnosed to be having hypogonadotrophic hypogonadism. Which of the following is not true? (INICET MAY 2017)</span></p>",
      "unique_key": "Q2693015",
      "question_audio": null,
      "question_video": null,
      "map_id": 34951269,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Low prolactin levels</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">Hypogonadotropic hypogonadism in males is characterized by a deficiency of gonadotropins (LH and FSH), which leads to low testosterone levels and impaired spermatogenesis. This condition often results in oligospermia or azoospermia, contributing to infertility. Additionally, hypogonadotropic hypogonadism is frequently associated with hyperprolactinemia rather than low prolactin levels.</span></p><p> </p><ul><li><span style=\"font-size:12pt;\"><strong>Low LH and FSH:</strong> Hypogonadotropic hypogonadism is marked by low levels of luteinizing hormone (LH) and follicle-stimulating hormone (FSH) due to inadequate secretion from the pituitary gland.</span></li><li><span style=\"font-size:12pt;\"><strong>Low testosterone:</strong> The low levels of LH lead to reduced stimulation of Leydig cells in the testes, resulting in low testosterone levels.</span></li><li><span style=\"font-size:12pt;\"><strong>Oligospermia:</strong> The low levels of FSH result in impaired spermatogenesis, often leading to oligospermia or azoospermia.</span></li><li><span style=\"font-size:12pt;\"><strong>Low prolactin levels (Incorrect):</strong> Hypogonadotropic hypogonadism is associated with hyperprolactinemia, not low prolactin levels. Elevated prolactin can inhibit the secretion of gonadotropins, further exacerbating the condition.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A. Low LH and FSH:</strong> True. Gonadotropin deficiency is a hallmark of hypogonadotropic hypogonadism.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option B. Low testosterone:</strong> True. The deficiency in LH leads to low testosterone production.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C. Oligospermia:</strong> True. The deficiency in FSH leads to impaired spermatogenesis, causing oligospermia or azoospermia.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">A male with hypogonadotropic hypogonadism will have high prolactin levels, low gonadotropins (LH and FSH), low testosterone, and often oligospermia or azoospermia.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 199, DC Dutta’s Textbook of Gynecology 8<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 200183,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50046,
      "choices": [
        {
          "id": 200184,
          "text": "<p><span style=\"font-size:12pt;\">5 cm</span></p>"
        },
        {
          "id": 200185,
          "text": "<p><span style=\"font-size:12pt;\">8 cm</span></p>"
        },
        {
          "id": 200186,
          "text": "<p><span style=\"font-size:12pt;\">4 cm</span></p>"
        },
        {
          "id": 200187,
          "text": "<p><span style=\"font-size:12pt;\">6 cm</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">According to the latest labour care guidelines, the partogram is plotted in regular intervals after _ cm dilatation: (INICET MAY 2017)</span></p>",
      "unique_key": "Q6444862",
      "question_audio": null,
      "question_video": null,
      "map_id": 34684029,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) 5 cm</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">Earlier, in the WHO modified partograph, labor is graphed and analysis includes use of action lines and alert lines.</span></li><li><span style=\"font-size:12pt;\">In this partograph, the plotting starts in active phase (4cm)</span></li><li><span style=\"font-size:12pt;\">The alert line is plotted at a cervical dilatation rate of 1cm/h</span></li><li><span style=\"font-size:12pt;\">The action line is plotted 4h to the right of the alert line</span></li><li><span style=\"background-color:transparent;font-size:12pt;\"> The 1st marking is always on the alert line</span></li><li><span style=\"font-size:12pt;\">The WHO modified partograph has now been replaced by the WHO labor care guide where the new definition of active labor is 5 cm</span></li></ul><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_F6uAbxo.png\" width=\"1337\" height=\"340\"></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">As per the WHO modified partograph, plotting is started at 4cm cervical dilatation, and the 1<sup>st</sup> marking is always on the alert line</span></li><li><span style=\"font-size:12pt;\">As per the Labor Care Guide, plotting is started at 5 cm cervical dilatation</span></li></ul><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_F6uAbxo.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200184,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50047,
      "choices": [
        {
          "id": 200188,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Hippocampus</span></p>"
        },
        {
          "id": 200189,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Habenular</span></p>"
        },
        {
          "id": 200190,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Mamm</span><span style=\"font-size:12.0pt;\">ill</span><span style=\"color:black;font-size:12.0pt;\">ary bod</span><span style=\"font-size:12.0pt;\">y</span></p>"
        },
        {
          "id": 200191,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Amygdala</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the origin of the fibers marked by the arrow? (AIIMS MAY 2017)</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/25/2.jpg\" alt=\"\" width=\"300\" height=\"200\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/25/2.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q9632692",
      "question_audio": null,
      "question_video": null,
      "map_id": 34421398,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt;\"><strong>Ans. A. Hippocampus</strong></span></p><p> </p><p><span style=\"font-size:11pt;\"><strong>Explanation:</strong></span></p><p> </p><ul><li><span style=\"font-size:11pt;\">The above image is the cross-section of the human brain in which the marked arrow indicates the fornix.</span></li><li><span style=\"font-size:11pt;\">Fornix belongs to projectional fibers which are the type of white matter fibers. Fornix forms the efferent fibers of the hippocampus and connects it with the mammillary body. Hence the origin of fibers is hippocampus</span></li><li><span style=\"font-size:11pt;\">The fornix is a white matter bundle located in the medial aspect of the cerebral hemispheres which arises from the hippocampus and ends in the mamillary body of the hypothalamus.</span></li><li><span style=\"font-size:11pt;\">It connects various nodes of a limbic circuitry and is believed to play a key role in cognition and episodic memory recall.</span></li><li><span style=\"font-size:11pt;\">Fornix is an example of association fiber and is supplied by the anterior cerebral artery.</span></li><li><span style=\"font-size:11pt;\">The hippocampus is a seahorse-shaped structure located within the temporal lobes of the brain. The fornix originates from the hippocampus. Specifically, it receives input from the hippocampus and sends axons that project back to the hippocampus. This loop of connections is involved in memory formation and retrieval.</span></li></ul><p> </p><p><span style=\"font-size:11pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:11pt;\"><strong>Option B. Habenular:</strong> The habenular nuclei are small structures located near the thalamus and are involved in various functions, including the regulation of the pineal gland's activity. The fornix is not directly associated with the habenular nuclei. Instead, it primarily connects the hippocampus to other structures in the limbic system.</span></p><p> </p><p><span style=\"font-size:11pt;\"><strong>Option C. Mammillary Body: </strong>The mammillary bodies are a pair of small, round structures located on the undersurface of the brain. The fornix connects the hippocampus to the mammillary bodies. This connection is an essential component of the Papez circuit, a neural circuit involved in memory and emotion.</span></p><p> </p><p><span style=\"font-size:11pt;\"><strong>Option D. Amygdala:</strong> The amygdala is an almond-shaped structure located deep within the temporal lobes and plays a key role in processing emotions, particularly fear and emotional memory. While the amygdala is part of the limbic system, it is not directly connected to the fornix. Instead, the amygdala communicates with other limbic structures through various neural pathways.</span></p><p> </p><p><span style=\"font-size:11pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/25/untitled-84.jpg\" alt=\"\" width=\"400\" height=\"263\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/25/untitled-84.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200188,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50048,
      "choices": [
        {
          "id": 200192,
          "text": "<p><span style=\"font-size:12pt;\">No need additional dose since she is ICT negative</span></p>"
        },
        {
          "id": 200193,
          "text": "<p><span style=\"font-size:12pt;\">Give another dose of Anti-D 72 hour postpartum irrespective of baby blood group</span></p>"
        },
        {
          "id": 200194,
          "text": "<p><span style=\"font-size:12pt;\">Give another dose of Anti-D 72 hour postpartum depending on the baby blood group</span></p>"
        },
        {
          "id": 200195,
          "text": "<p><span style=\"font-size:12pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Rh negative mother, ICT negative was given Anti D during 28 weeks of pregnancy. Which of the following is the ideal one? (INICET MAY 2017)</span></p>",
      "unique_key": "Q1441006",
      "question_audio": null,
      "question_video": null,
      "map_id": 34170951,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Give another dose of Anti-D 72 hour postpartum depending on the baby blood group</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">In Rh-negative women with an Rh-positive partner, Anti-D immunoglobulin prophylaxis is administered to prevent Rh sensitization. If the mother is ICT (Indirect Coombs Test) negative, an initial dose of Anti-D (300 mcg IM) is given at 28 weeks of gestation. Following delivery, an additional dose of Anti-D should be administered within 72 hours if the newborn is Rh-positive. This prevents the mother from forming antibodies against Rh-positive fetal red blood cells that might have entered her circulation during delivery.</span></p><p> </p><ul><li><span style=\"font-size:12pt;\"><strong>Anti-D (300 mcg IM) at 28 weeks:</strong> Given if ICT is negative.</span></li><li><span style=\"font-size:12pt;\"><strong>Postpartum dose within 72 hours:</strong> Required if the baby is Rh-positive. This dose is essential to neutralize any fetal Rh-positive red cells that might have entered the mother's bloodstream during delivery.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options :</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A. No need for an additional dose since she is ICT negative:</strong> Incorrect. Even if the ICT is negative, an additional dose is necessary postpartum if the baby is Rh-positive to prevent sensitization.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option B. Give another dose of Anti-D 72 hours postpartum irrespective of baby blood group:</strong> Incorrect. The postpartum dose is only required if the baby is Rh-positive.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D. All of the above:</strong> Incorrect as not all options are correct.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">Prophylaxis in Rh-negative women with an Rh-positive partner involves giving Anti-D (300 mcg IM) at 28 weeks (if ICT is negative) and repeating the dose within 72 hours after delivery if the baby is Rh-positive.</span></p>",
      "correct_choice_id": 200194,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50049,
      "choices": [
        {
          "id": 200196,
          "text": "<p><span style=\"font-size:12pt;\">Reassure and advice regular follow up once in 6 months</span></p>"
        },
        {
          "id": 200197,
          "text": "<p><span style=\"font-size:12pt;\">Confirm USG findings by ordering CT scan</span></p>"
        },
        {
          "id": 200198,
          "text": "<p><span style=\"font-size:12pt;\">Do an exploratory laparoscopy to visualize the nature of cyst</span></p>"
        },
        {
          "id": 200199,
          "text": "<p><span style=\"font-size:12pt;\">Do CA-125 levels, if normal advise regular check up</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 62-year-old female with history of ovarian carcinoma in the mother achieved menopause with smooth transition. She is on hormone replacement therapy. She developed abdominal pain. On examination, a right adnexal mass was palpable and non-tender. On ultrasound, a 3 X 3 cm smooth cyst in her ovary was noted. What is the next best step? (INICET MAY 2017)</span></p>",
      "unique_key": "Q2420158",
      "question_audio": null,
      "question_video": null,
      "map_id": 34766139,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Do CA-125 levels, if normal advise regular check up</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">The next best step in managing a postmenopausal woman with a small (3 x 3 cm) smooth ovarian cyst is to measure CA-125 levels. CA-125 is a tumor marker used to assess the risk of ovarian cancer, especially in postmenopausal women. Given the benign characteristics of the cyst on ultrasound and the small size, the initial step is to evaluate CA-125 levels:</span></p><p> </p><ul><li><span style=\"font-size:12pt;\"><strong>CA-125 Levels:</strong> If the CA-125 levels are normal (less than 35), the patient can be advised to have regular follow-ups.</span></li><li><span style=\"font-size:12pt;\"><strong>Regular Follow-ups:</strong> If CA-125 levels are normal, a transvaginal ultrasound (TVS) should be repeated in 6-12 weeks to monitor the cyst. If the cyst persists but remains benign, yearly TVS is recommended.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A. Reassure and advise regular follow-up once in 6 months:</strong> While reassurance is part of the management, initial evaluation with CA-125 is necessary to rule out malignancy before deciding on the follow-up schedule.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option B. Confirm USG findings by ordering a CT scan:</strong> A CT scan is not the first-line investigation for a simple cyst with benign features. Initial evaluation with CA-125 is more appropriate.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C. Do an exploratory laparoscopy to visualize the nature of the cyst:</strong> This is invasive and not indicated for a small, benign-appearing cyst without other concerning features.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/18/screenshot-2023-11-18-104932.jpg\" alt=\"\" width=\"1000\" height=\"873\"></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">Simple cysts in the post-menopausal age grp:</span></p><p> </p><ul><li><span style=\"font-size:12pt;\">≤ 1cm: Considered normal</span></li><li><span style=\"font-size:12pt;\">≤ 5 cm: Ca125; if normal, repeat in 6-12 weeks</span></li><li><span style=\"font-size:12pt;\">> 6 cm: Surgical evaluation</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 217, Williams Gynecology 3<sup>rd</sup> edition</strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/18/screenshot-2023-11-18-104932.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200199,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50050,
      "choices": [
        {
          "id": 200200,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Protrusion</span></p>"
        },
        {
          "id": 200201,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Elevation</span></p>"
        },
        {
          "id": 200202,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Depression</span></p>"
        },
        {
          "id": 200203,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Retraction</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11.0pt;\">Among the following, what is the function of the green muscles marked? (</span>AIIMS May 2017)</p><p style=\"text-align:justify;\"> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/25/inicet-anat-2017-3.jpg\" alt=\"\" width=\"250\" height=\"273\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/25/inicet-anat-2017-3.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q2997526",
      "question_audio": null,
      "question_video": null,
      "map_id": 34741783,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt;\"><strong>Ans. C. Depression</strong></span></p><p> </p><p><span style=\"font-size:11pt;\"><strong>Explanation:</strong></span></p><p> </p><p>The muscle marked in green is the lateral pterygoid muscle, and its primary function among the given options is depression of the mandible (opening the mouth). \"Depression is brought about mainly by the lateral pterygoid\" and it is \"indispensible for actively opening the mouth.\"</p><p>The lateral pterygoid has the following actions:</p><ul><li>Depression of the mandible (primary active opener of the mouth)</li><li>Protrusion of the mandible</li><li>When one side contracts, it turns the chin to the opposite side</li></ul><p> </p><p>While the digastric, geniohyoid, and mylohyoid muscles assist in depression, they primarily help when the mouth is opened wide or against resistance. The lateral pterygoid is the main muscle responsible for actively opening the mouth during normal function.<br> </p><p> </p><p><span style=\"font-size:11pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:11pt;\"><strong>Option A. Protrusion:</strong></span></p><p> </p><ul><li><span style=\"font-size:11pt;\">Protrusion refers to the forward movement of the lower jaw (mandible).</span></li><li><span style=\"font-size:11pt;\">The lateral along with medial pterygoid muscle are responsible for protruding the mandible. When this muscle contracts on both sides, it causes the jaw to move forward.</span></li></ul><p> </p><p><span style=\"font-size:11pt;\"><strong>Option B. Elevation:</strong></span></p><p> </p><ul><li><span style=\"font-size:11pt;\">Elevation refers to the upward movement of the mandible, closing the mouth.</span></li><li><span style=\"font-size:11pt;\">The primary muscles responsible for jaw elevation are the masseter, temporalis, and medial pterygoid muscles. The lateral pterygoid's main function is not jaw elevation but rather protrusion.</span></li></ul><p> </p><p><span style=\"font-size:11pt;\"><strong>Option D. Retraction:</strong></span></p><p> </p><ul><li><span style=\"font-size:11pt;\">Retraction refers to the backward movement of the mandible.</span></li><li><span style=\"font-size:11pt;\">The primary muscles involved in jaw retraction are the temporalis and the posterior fibers of the digastric muscle. The lateral pterygoid is not primarily responsible for this movement.</span></li></ul><p> </p><p><span style=\"font-size:11pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:11.0pt;\"><strong>Muscles of mastication</strong></span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/08/screenshot-2023-11-08-172431.jpg\" alt=\"\" width=\"1000\" height=\"837\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/08/screenshot-2023-11-08-172431.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200202,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50051,
      "choices": [
        {
          "id": 200204,
          "text": "<p><span style=\"font-size:12.0pt;\">Point of maximum tension in a fracture</span></p>"
        },
        {
          "id": 200205,
          "text": "<p><span style=\"font-size:12.0pt;\">Relaxed tension lines in skin</span></p>"
        },
        {
          "id": 200206,
          "text": "<p><span style=\"font-size:12.0pt;\">Collagen and elastin lines in stab injury</span></p>"
        },
        {
          "id": 200207,
          "text": "<p><span style=\"font-size:12.0pt;\">Point of tension in hanging</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What are Kraissl’s lines?</span>(AIIMS MAY 2017)</p>",
      "unique_key": "Q1785197",
      "question_audio": null,
      "question_video": null,
      "map_id": 34710856,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Relaxed tension lines in skin</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Kraissl’s lines, also known as relaxed skin tension lines (RSTLs), are lines on the skin that indicate the natural orientation of the skin under minimal or no tension. They are used in surgical planning, particularly in cosmetic surgery, to guide incisions so that they heal with the least visible scars. Kraissl’s lines differ from Langer's lines, which also describe lines of skin tension but are based on the alignment of collagen fibers within the dermis and are typically used to predict surgical wound healing outcomes.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/29/picture11_HpNWWUh.jpg\" alt=\"\" width=\"300\" height=\"373\"></span></p><p> </p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A.</strong> <strong>Point of maximum tension in a fracture:</strong> Refers to the area where the mechanical stress is greatest on a broken bone, unrelated to skin tension lines.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C.</strong> <strong>Collagen and elastin lines in stab injury:</strong> Would refer to the orientation of these fibers in response to a penetrating trauma, which is not what Kraissl’s lines describe.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D.</strong> <strong>Point of tension in hanging: </strong>Refers to the mechanical stress points exerted during a hanging, specifically on the neck, which has no relation to the relaxed skin tension lines described by Kraissl.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span><br> </p><p><span style=\"font-size:12.0pt;\">Kraissl’s lines are crucial for surgical incision planning to ensure scars are minimally visible following healing, highlighting the importance of understanding skin tension dynamics in medical procedures.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/29/picture11_HpNWWUh.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200205,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50052,
      "choices": [
        {
          "id": 200208,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Triangular</span></p>"
        },
        {
          "id": 200209,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Quadrilateral</span></p>"
        },
        {
          "id": 200210,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Pentagonal</span></p>"
        },
        {
          "id": 200211,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Linear</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11.0pt;\">Shape of Trapezius muscle is? (</span>AIIMS May 2017)</p>",
      "unique_key": "Q5180690",
      "question_audio": null,
      "question_video": null,
      "map_id": 34655047,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt;\"><strong>Ans. A. Triangular</strong></span></p><p> </p><p><span style=\"font-size:11pt;\"><strong>Explanation:</strong></span></p><p> </p><ul><li><span style=\"font-size:11pt;\">The trapezius muscle is a large, triangular and paired muscle located on the posterior aspect of the neck and thorax. </span></li><li><span style=\"color:black;font-size:11.0pt;\">Each trapezius muscle is flat and triangularly shaped, with the base of the triangle situated along the vertebral column (the muscle's origin) and the apex pointing toward the tip of the shoulder (the muscle's insertion).</span></li></ul><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/25/inicet-anat-2017-12.jpg\" alt=\"\" width=\"300\" height=\"443\"></p><p> </p><ul><li><span style=\"font-size:11pt;\">Trapezius muscle shape:</span><ul><li><span style=\"font-size:11pt;\">Considering left or right side - triangular shape</span></li><li><span style=\"font-size:11pt;\">Considering both sides together - diamond shaped, hence named \"trapezius\"</span></li></ul></li></ul><p> </p><p><span style=\"font-size:11pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:11pt;\"><strong>Trapezius muscle:</strong></span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/23/whatsapp-image-2023-06-12-at-190121011010201026_page_68_page_258.jpg\" alt=\"\" width=\"1000\" height=\"469\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/25/inicet-anat-2017-12.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200208,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50053,
      "choices": [
        {
          "id": 200212,
          "text": "<p><span style=\"font-size:12.0pt;\">Inborn errors of metabolism</span></p>"
        },
        {
          "id": 200213,
          "text": "<p><span style=\"font-size:12.0pt;\">Blood grouping</span></p>"
        },
        {
          "id": 200214,
          "text": "<p><span style=\"font-size:12.0pt;\">Bilirubin testing</span></p>"
        },
        {
          "id": 200215,
          "text": "<p><span style=\"font-size:12.0pt;\">Coombs Test</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Dried blood spot (DBS) testing is commonly done in infants for: (AIIMS MAY 2017)</span></p>",
      "unique_key": "Q6984778",
      "question_audio": null,
      "question_video": null,
      "map_id": 34810661,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Inborn errors of metabolism.</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Dried Blood Spot (DBS) testing is a crucial tool used in neonatal screening for detecting <strong>inborn errors of metabolism</strong>. This test involves taking a small blood sample from the infant's heel, which is then dried on a filter paper and sent for analysis. <strong>Tandem mass spectrometry (TMS)</strong> is the primary technique used to analyze the sample for a wide range of metabolic disorders, such as phenylketonuria (PKU), maple syrup urine disease (MSUD), and others. Early detection through DBS testing allows for prompt diagnosis and treatment, significantly improving the prognosis for affected infants.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Blood grouping:</strong> Blood grouping in neonates is typically done in cases of suspected neonatal jaundice to rule out Rh or ABO incompatibility, not using DBS testing.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Bilirubin testing:</strong> Bilirubin levels are tested to evaluate jaundice in neonates, particularly in cases of Rh or ABO incompatibility or breastfeeding-related jaundice, but this is not done using DBS.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Coombs Test:</strong> The Coombs test is used to detect antibodies that may cause hemolysis in conditions like hemolytic disease of the newborn. It is not performed using dried blood spots.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Dried Blood Spot (DBS) testing is primarily used for the early detection of inborn errors of metabolism in infants, using tandem mass spectrometry (TMS).</span></p>",
      "correct_choice_id": 200212,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50054,
      "choices": [
        {
          "id": 200216,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Increased activity of lipoprotein lipase and decreased activity of hormone sensitive lipase </span></span></span></span></p>"
        },
        {
          "id": 200217,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Increased activity of hormone sensitive lipase and decreased lipoprotein lipase activity</span></span></span></span></p>"
        },
        {
          "id": 200218,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Increase in peripheral function of LDL receptors</span></span></span></span></p>"
        },
        {
          "id": 200219,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Increased in activity of hepatic lipase</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:black\">The value of TG and VLDL are high in chronic diabetes because of which of the following reasons: (AIIMS MAY 2017)</span></span></span></p>",
      "unique_key": "Q6540813",
      "question_audio": null,
      "question_video": null,
      "map_id": 34791984,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Increased activity of hormone sensitive lipase and decreased lipoprotein lipase activity.</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In chronic diabetes, increase in hormone sensitive lipase and decrease in lipoprotein is seen, due to which values of TG and VLDL are increased. </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Insulin has inhibitory effect on hormone sensitive lipase</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">. In diabetes, low insulin corresponds to an increase in hormone sensitive lipase activity. This <strong>promotes breakdown of lipids and release of TG, and free fatty acids</strong> from the adipose tissue. </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Insulin induces the activity of lipoprotein lipase, which is present on capillary walls</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">. LPL promotes hydrolysis of TG and degradation of transport proteins, VLDL and chylomicrons. In diabetes, low insulin leads to decreased LPL activity which corresponds to increase in VLDL and TG.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Increased activity of lipoprotein lipase and decreased activity of hormone sensitive lipase:</span></strong><span style=\"font-size:12.0pt\"> Incorrect because in diabetes, the activities of these enzymes are reversed; HSL activity is increased, and LPL activity is decreased.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Increase in peripheral function of LDL receptors:</span></strong><span style=\"font-size:12.0pt\"> Incorrect because LDL receptor function generally affects LDL levels, not directly influencing VLDL or triglyceride levels.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Increased in activity of hepatic lipase:</span></strong><span style=\"font-size:12.0pt\"> Incorrect for this context as hepatic lipase primarily affects the metabolism of HDL and to a lesser extent LDL, not directly impacting TG and VLDL levels in the way described for this scenario.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In chronic diabetes, the combination of increased hormone sensitive lipase activity (due to low insulin levels) and decreased lipoprotein lipase activity leads to higher levels of triglycerides and VLDL. This reflects the central role of insulin in lipid metabolism regulation.</span></span></span></p>",
      "correct_choice_id": 200217,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50055,
      "choices": [
        {
          "id": 200220,
          "text": "<p><span style=\"color:#374151;font-size:12.0pt;\">Delusion of grandiosity</span></p>"
        },
        {
          "id": 200221,
          "text": "<p><span style=\"color:#374151;font-size:12.0pt;\">Delusion of persecution</span></p>"
        },
        {
          "id": 200222,
          "text": "<p><span style=\"color:#374151;font-size:12.0pt;\">Delusion of grandiosity and persecution</span></p>"
        },
        {
          "id": 200223,
          "text": "<p><span style=\"color:#374151;font-size:12.0pt;\">Delusion of grandiosity, persecution and reference</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"color:#374151;font-size:12.0pt;\">A patient believes he is the most important person in the world, his neighbors and family members are attempting to hurt him out of jealousy. His wife claims contrary, claiming that he has only recently begun acting in this manner, and that he previously worked calmly as a school teacher. He's probably suffering from? (</span>AIIMS May 2017)</p>",
      "unique_key": "Q8780512",
      "question_audio": null,
      "question_video": null,
      "map_id": 34589286,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"color:#374151;font-size:12.0pt;\"><strong>Ans. C) Delusion of grandiosity and persecution</strong></span></p><p> </p><p><span style=\"color:#374151;font-size:12.0pt;\">The patient's belief that he is the most important person in the world indicates a <strong>delusion of grandiosity</strong>. His belief that his neighbors and family members are attempting to hurt him due to jealousy represents a <strong>delusion of persecution</strong>. Both types of delusions are present in this scenario.</span></p><p> </p><p><span style=\"color:#374151;font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"color:#374151;font-size:12.0pt;\"><strong>Option A. Delusion of grandiosity:</strong> Delusion of grandiosity is evident, but this choice doesn't encompass the persecutory beliefs he holds.</span></p><p> </p><p><span style=\"color:#374151;font-size:12.0pt;\"><strong>Option B. Delusion of persecution: </strong>While the patient does display delusions of persecution, this choice neglects the grandiose delusion.</span></p><p> </p><p><span style=\"color:#374151;font-size:12.0pt;\"><strong>Option D. Delusion of grandiosity, persecution and reference:</strong> The patient clearly exhibits delusions of grandiosity and persecution, but there's no evidence in the provided information suggesting a delusion of reference.</span></p><p> </p><p><span style=\"color:#374151;font-size:12.0pt;\"><strong>Educational Objective: </strong></span></p><p> </p><p><span style=\"color:#374151;font-size:12.0pt;\">Delusional disorders are characterized by the presence of one or more delusions that persist for at least one month.</span></p><p> </p><p><span style=\"color:#374151;font-size:12.0pt;\"><strong>Reference: Kaplan & Sadock’s Synopsis of Psychiatry, 12th edition, Page 245-246.</strong></span></p>",
      "correct_choice_id": 200222,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50056,
      "choices": [
        {
          "id": 200224,
          "text": "<p><span style=\"font-size:12.0pt;\">3' →</span><span style=\"font-size:10.5pt;\"> </span><span style=\"font-size:12.0pt;\">5' Exonuclease</span></p>"
        },
        {
          "id": 200225,
          "text": "<p><span style=\"font-size:12.0pt;\">5' →</span><span style=\"font-size:10.5pt;\"> </span><span style=\"font-size:12.0pt;\">3' Exonuclease</span></p>"
        },
        {
          "id": 200226,
          "text": "<p><span style=\"font-size:12.0pt;\">5' → 3' DNA polymerase</span></p>"
        },
        {
          "id": 200227,
          "text": "<p><span style=\"font-size:12.0pt;\">3' → 5' DNA polymerase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Klenow fragment lacks the activity of? (</span>AIIMS May 2017)</p>",
      "unique_key": "Q6521750",
      "question_audio": null,
      "question_video": null,
      "map_id": 34600399,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B)  5’</strong></span>→<span style=\"font-size:12.0pt;\"><strong> 3’ Exonuclease</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>DNA polymerase I (Kornberg’s enzyme)</strong> was isolated from Escherichia coli. It is a repair enzyme. It has both 3’ to 5’ and 5’ to 3’ exonuclease activities. When 5’ to 3’ exonuclease domain is removed, the remaining fragment retains the <strong>polymerization and proofreading activities</strong>; it is then called <strong>Klenow fragment</strong>. It is <strong>widely used in recombinant DNA technology.</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The Klenow fragment retains the polymerization (5' </span>→<span style=\"font-size:12.0pt;\"> 3' DNA polymerase) and proofreading (3' </span>→<span style=\"font-size:12.0pt;\"> 5' exonuclease) activities but lacks the 5' </span>→<span style=\"font-size:12.0pt;\"> 3' exonuclease activity. Because of these retained activities, the Klenow fragment is widely used in recombinant DNA technology for applications that require DNA synthesis and proofreading without the degradation of the DNA template.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. 3' </strong></span>→<span style=\"font-size:12.0pt;\"><strong> 5' Exonuclease:</strong> The Klenow fragment retains this activity, which allows it to proofread and correct errors during DNA synthesis.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. 5' </strong></span>→<span style=\"font-size:12.0pt;\"><strong> 3' DNA polymerase:</strong> The Klenow fragment retains this activity, which is essential for synthesizing new DNA strands.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. 3' </strong></span>→<span style=\"font-size:12.0pt;\"><strong> 5' DNA polymerase:</strong> This activity is not applicable in the context of DNA polymerase I and the Klenow fragment, as DNA polymerase functions in the 5' </span>→<span style=\"font-size:12.0pt;\"> 3' direction for synthesis.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The Klenow fragment of DNA polymerase I retains the 5' </span>→<span style=\"font-size:12.0pt;\"> 3' DNA polymerase and 3' </span>→<span style=\"font-size:12.0pt;\"> 5' exonuclease (proofreading) activities but lacks the 5' </span>→<span style=\"font-size:12.0pt;\"> 3' exonuclease activity, making it useful for specific applications in recombinant DNA technology.</span></p>",
      "correct_choice_id": 200225,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50057,
      "choices": [
        {
          "id": 200228,
          "text": "<p><span style=\"font-size:12.0pt;\">Rosuvastatin + fenofibrate</span></p>"
        },
        {
          "id": 200229,
          "text": "<p><span style=\"font-size:12.0pt;\">Atorvastatin 80 mg</span></p>"
        },
        {
          "id": 200230,
          "text": "<p><span style=\"font-size:12.0pt;\">Fenofibrate</span></p>"
        },
        {
          "id": 200231,
          "text": "<p><span style=\"font-size:12.0pt;\">Rosuvastatin 10 mg</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old man, post-MI, had the following lab values. Which of the following must be his treatment plan?</span><span style=\"color:black;font-size:12.0pt;\"> (AIIMS MAY 2017)</span></p><p> </p><p><span style=\"font-size:12.0pt;\">LDL - 125mg/dl</span></p><p> </p><p><span style=\"font-size:12.0pt;\">HDL - 33mg/dl</span></p><p> </p><p><span style=\"font-size:12.0pt;\">TGL - 270mg/dl</span></p>",
      "unique_key": "Q3785242",
      "question_audio": null,
      "question_video": null,
      "map_id": 34953891,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Atorvastatin 80 mg</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Post-MI patients require aggressive management to reduce the risk of future cardiovascular events. The lab values indicate elevated LDL and triglycerides, along with low HDL. The treatment plan includes the use of high-intensity statin therapy, which is recommended to significantly lower LDL cholesterol as part of secondary prevention strategies in atherosclerotic cardiovascular disease (ASCVD). Atorvastatin 80 mg falls under the category of high-intensity statins and is effective in lowering LDL cholesterol significantly, which helps in reducing the risk of recurrent cardiovascular events.</span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Rosuvastatin + fenofibrate:</strong> This combination might be considered if there were specific concerns about triglyceride levels that could not be managed by statin therapy alone. However, the primary goal post-MI is to manage LDL levels aggressively with high-intensity statins.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Fenofibrate:</strong> Fenofibrate primarily targets triglycerides and would not be the first choice when the primary objective is to lower LDL cholesterol post-MI.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Rosuvastatin 10 mg:</strong> While rosuvastatin is effective in lowering LDL cholesterol, a lower dose may not be sufficient for high-risk patients post-MI.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The high-intensity statin therapy, such as atorvastatin 80 mg, is essential in the management of patients after an MI to reduce the risk of subsequent cardiovascular events, regardless of initial cholesterol levels. This approach aligns with guidelines that emphasize aggressive LDL reduction in patients with established cardiovascular disease.</span></p>",
      "correct_choice_id": 200229,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50058,
      "choices": [
        {
          "id": 200232,
          "text": "<p><span style=\"font-size:12.0pt;\">Pneumothorax</span></p>"
        },
        {
          "id": 200233,
          "text": "<p><span style=\"font-size:12.0pt;\">Pleural effusion</span></p>"
        },
        {
          "id": 200234,
          "text": "<p><span style=\"font-size:12.0pt;\">Fat embolism</span></p>"
        },
        {
          "id": 200235,
          "text": "<p><span style=\"font-size:12.0pt;\">Congestive cardiac failure</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A patient had a femur fracture for which internal fixation was done. Two days later, the patient developed sudden onset shortness of breath with low grade fever. What is the likely cause? (AIIMS MAY 2017)</span></p>",
      "unique_key": "Q5553144",
      "question_audio": null,
      "question_video": null,
      "map_id": 34223405,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Fat embolism</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>FAT EMBOLISM</strong></span></p><ul><li><span style=\"font-size:12.0pt;\"><strong>Fracture Femur with Breathlessness after 48 hours</strong> – think of fat embolism!</span></li><li><span style=\"font-size:12.0pt;\">Fat embolism refers to the presence of <strong>fat globules in vital organs and peripheral circulation after fracture</strong> of a long bone or other major trauma.</span></li><li><span style=\"font-size:12.0pt;\">Fat embolism syndrome (FES) reflects a <strong>serious systemic manifestation</strong> as a consequence to these emboli.</span></li><li><span style=\"font-size:12.0pt;\">Fat originates from the site of trauma, particularly from the injured marrow.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Fat globules > 10 mm</strong> are considered significant.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Salient Features:</strong></span><ul><li><span style=\"font-size:12.0pt;\">Presence of fat globules in pulmonary circulation.</span></li><li><span style=\"font-size:12.0pt;\">Precipitated by physical trauma such as fracture of long bones, soft tissue trauma, and burns.</span></li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Clinical Features:</strong></span><ul><li><span style=\"font-size:12.0pt;\">Clinical signs and symptoms develop after a asymptomatic latent period of about <strong>12 - 48 hours</strong>.</span></li><li><span style=\"font-size:12.0pt;\">Early warning signs are a slight rise in temperature and pulse rate (tachycardia).</span></li><li><span style=\"font-size:12.0pt;\"><strong>The classical triad of fat embolism syndrome is:</strong></span><ul><li><span style=\"font-size:12.0pt;\"><strong>Respiratory symptoms:</strong> Dyspnea or tachypnea.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Neurological symptoms:</strong> Confusion or disorientation.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Petechial rash: </strong>In axilla, neck, periumbilical area, conjunctiva of lower lid, front and back of chest, shoulder.</span></li></ul></li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Diagnosis:</strong></span><ul><li><span style=\"font-size:12.0pt;\">FES is distinct from the presence of fat emboli.</span></li><li><span style=\"font-size:12.0pt;\">Symptoms usually occur 1-3 days after a traumatic injury and are predominantly pulmonary (shortness of breath, hypoxemia), neurological (agitation, delirium, or coma), dermatological (petechial rash), and hematological (anemia, low platelets).</span></li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Diagnostic Criterion for Fat Embolism:</strong></span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/15/screenshot-2024-05-15-103933.JPG\" alt=\"\" width=\"1000\" height=\"582\"></strong></span></p><p> </p><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">1 major + 4 minor = Fat embolism</span></li></ul><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Treatment:</strong></span><ul><li><span style=\"font-size:12.0pt;\">The aim of treatment is <strong>maintaining adequate oxygen level in the blood</strong>.</span></li><li><span style=\"font-size:12.0pt;\">If necessary, by using intermittent positive pressure ventilation.</span></li><li><span style=\"font-size:12.0pt;\">Oxygen is the only therapeutic tool of proven use.</span></li><li><span style=\"font-size:12.0pt;\">It should be administered in sufficient amount to maintain arterial PO2 > 80 mm Hg.</span></li><li><span style=\"font-size:12.0pt;\">O<sub>2</sub> toxicity (pneumonitis) is avoided by using O2 conc. below 40%.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Steroids are given to Avoid Pneumonitis.</strong></span></li></ul></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Pneumothorax</strong>. A pneumothorax is a collection of air outside the lung but within the pleural cavity. It occurs when air accumulates between the parietal and visceral pleurae inside the chest. The air accumulation can apply pressure on the lung and make it collapse. Causes of traumatic pneumothorax are penetrating or blunt trauma, rib fracture, diving or flying. While it can cause shortness of breath, it is less likely to occur specifically after femur fracture fixation unless there was a procedure complication.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Pleural effusion</strong>. Pleural effusion is the accumulation of fluid in between the parietal and visceral pleura, called the pleural cavity. It can occur by itself or can be the result of surrounding parenchymal disease like infection, malignancy, or inflammatory conditions. While it can cause respiratory symptoms, it is less likely to occur suddenly after femur fracture fixation unless there are other complicating factors.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Congestive cardiac failure</strong>. Congestive heart failure (CHF) is a complex clinical syndrome characterized by inefficient myocardial performance, resulting in compromised blood supply to the body. CHF results from any disorder that impairs ventricular filling or ejection of blood to the systemic circulation. Patients usually present with fatigue and dyspnea, reduced exercise tolerance, and systemic or pulmonary congestion. While congestive heart failure can cause shortness of breath, it is less likely to occur suddenly after a femur fracture fixation unless the patient has pre-existing heart conditions.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Fat embolism is the most common complication of femur fracture.</span></li><li><span style=\"font-size:12.0pt;\">It usually presents 48 hours after the injury with breathlessness and low grade fever.</span></li><li><span style=\"font-size:12.0pt;\">The patient  remains asymptomatic in the initial 12-48 hours.</span></li></ul><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/15/screenshot-2024-05-15-103933.JPG\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200234,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50059,
      "choices": [
        {
          "id": 200236,
          "text": "<p><span style=\"font-size:12.0pt;\">Entropion of right eye</span></p>"
        },
        {
          "id": 200237,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Lagophthalmos of right eye</span></p>"
        },
        {
          "id": 200238,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Ptosis of right eye</span></p>"
        },
        {
          "id": 200239,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Exophthalmos of left eye</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">The physician noticed the following finding in a patient that came to the OPD for an eye exam. What is the most likely diagnosis?</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture1_ZFZHZMG.jpg\" alt=\"\" width=\"400\" height=\"176\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture1_ZFZHZMG.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q7510091",
      "question_audio": null,
      "question_video": null,
      "map_id": 34928336,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C)</strong> </span><span style=\"font-size:12.0pt;\"><strong>Ptosis of right eye</strong></span></p><p><span style=\"font-size:10.5pt;\"> </span></p><p><span style=\"font-size:12.0pt;\">The patient has ptosis of the right eye. Ptosis is abnormal drooping of the upper eyelid to a level that covers more than 2mm of the superior cornea. Ptosis is generally unilateral, in over 70% of individuals. The drooping in this case is significant enough to cover a portion of the pupil, thereby obstructing part of the visual field, which is characteristic of ptosis.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Entropion of right eye:</strong> This condition involves the inward turning of the eyelid margin, not observed in the provided image.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Lagophthalmos of right eye:</strong> Refers to the inability to close the eyelids completely, not evident here.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Exophthalmos of left eye:</strong> Characterized by the protrusion of the eyeball, which is not depicted in the image.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Ptosis, particularly of the type seen in this patient, is typically caused by a dysfunction or disconnection of the levator muscle or its aponeurosis, either congenital or acquired.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Types:</strong></span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/04/screenshot-2024-07-04-131205.png\" alt=\"\" width=\"1000\" height=\"302\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Note:</strong> Pseudoptosis is apparent but not true drooping of the eyelid. Causes include lack of support of the lids by the globe (orbital volume deficit like an artificial eye, microphthalmos, or enophthalmos), contralateral lid retraction, ipsilateral hypotropia, brow ptosis, or dermatochalasis.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/04/screenshot-2024-07-04-131205.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200238,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50060,
      "choices": [
        {
          "id": 200240,
          "text": "<p><span style=\"font-size:12.0pt;\">Blastomycosis</span></p>"
        },
        {
          "id": 200241,
          "text": "<p><span style=\"font-size:12.0pt;\">Pheohyphomycosis</span></p>"
        },
        {
          "id": 200242,
          "text": "<p><span style=\"font-size:12.0pt;\">Chromoblastomycosis</span></p>"
        },
        {
          "id": 200243,
          "text": "<p><span style=\"font-size:12.0pt;\">Sporotrichosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A female from Himachal Pradesh presented with H/O thorn prick, a year back has a verrucous lesion in the skin with the following microscopic findings. Identify the agent? (INICET MAY 2017)</span></p><p style=\"text-align:justify;\"> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/30/untitled-284.jpg\" alt=\"\" width=\"300\" height=\"197\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/30/untitled-284.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q2745952",
      "question_audio": null,
      "question_video": null,
      "map_id": 34378278,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Chromoblastomycosis</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The given clinical history and histopathological image are suggestive of Chromoblastomycosis</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Chromoblastomycosis (chromomycosis) is <strong>a subcutaneous mycotic infection</strong> that is usually caused by traumatic inoculation.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Over months to years, <strong>the primary lesion becomes <u>verrucous and wart-like</u> with extension along the draining lymphatics.</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Histologically, the lesions are <strong>granulomatous and the dark sclerotic bodies </strong>may be seen within leukocytes or giant cells (medlar/copper penny bodies)</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The following are the various dematiaceous species of fungi</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Phialophora verrucosa</span></li><li><span style=\"font-size:12.0pt;\">Fonsecaea pedrosoi</span></li><li><span style=\"font-size:12.0pt;\">Fonsecaea compacta</span></li><li><span style=\"font-size:12.0pt;\">Rhinocladiella aquaspersa</span></li><li><span style=\"font-size:12.0pt;\">Cladophialophora carrionii</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Treatment:</strong> </span><span style=\"font-size:12.0pt;\"><strong><u>Surgical excision with wide margins</u></strong><u> is the treatment of choice</u> for small lesions. Chemotherapy with <u>flucytosine or </u><strong><u>itraconazole</u></strong> may be efficacious for larger lesions. The application of local heat is also beneficial.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">MEDLAR/ SCLEROTIC BODIES</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/22/untitled-178.jpg\" alt=\"\" width=\"400\" height=\"279\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Blastomycosis: </strong>Blastomycosis is a systemic fungal infection caused by Blastomyces dermatitidis. It does not typically present with the sclerotic bodies seen in Chromoblastomycosis.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Pheohyphomycosis:</strong> Pheohyphomycosis is a broad term for infections caused by dematiaceous fungi but lacks the characteristic sclerotic bodies seen in Chromoblastomycosis.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Sporotrichosis:</strong> Sporotrichosis, caused by Sporothrix schenckii, typically presents with lymphocutaneous lesions but does not show the sclerotic bodies characteristic of Chromoblastomycosis.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Chromoblastomycosis is identified by its characteristic histopathological features, including granulomatous lesions with dark sclerotic bodies (Medlar or copper penny bodies), and is caused by various dematiaceous fungi. The clinical history of a thorn prick and the verrucous lesion further support this diagnosis.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/22/untitled-178.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200242,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50061,
      "choices": [
        {
          "id": 200244,
          "text": "<p><span style=\"font-size:12pt;\">Orbicularis oculi, facial muscles, thorax, upper limb</span></p>"
        },
        {
          "id": 200245,
          "text": "<p><span style=\"font-size:12pt;\">Orbicularis oculi, neck, facial muscles, upper limb, thorax</span></p>"
        },
        {
          "id": 200246,
          "text": "<p><span style=\"font-size:12pt;\">Neck, muscles of eyelid, upper limb, thorax</span></p>"
        },
        {
          "id": 200247,
          "text": "<p><span style=\"font-size:12pt;\">Neck, muscles of eyelid, facial muscles, thorax, upper limb</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12pt;\">In what sequence do muscles develop rigor mortis, progressing from early to late? (</span>AIIMS Nov 2017)</p>",
      "unique_key": "Q3217176",
      "question_audio": null,
      "question_video": null,
      "map_id": 34144858,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A. Orbicularis oculi, facial muscles, thorax, upper limb</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Nysten's rule describes the sequential onset of rigor mortis in various muscle groups.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Rigor mortis begins from the head and progresses down the body. The order of appearance of rigor mortis is:</span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\">Myocardium</span></li><li><span style=\"font-size:12.0pt;\">Eyelids</span></li><li><span style=\"font-size:12.0pt;\">Neck and lower jaw</span></li><li><span style=\"font-size:12.0pt;\">Face</span></li><li><span style=\"font-size:12.0pt;\">Chest</span></li><li><span style=\"font-size:12.0pt;\">Upper extremities</span></li><li><span style=\"font-size:12.0pt;\">Abdomen</span></li><li><span style=\"font-size:12.0pt;\">Legs</span></li><li><span style=\"font-size:12.0pt;\">Fingers and toes</span></li></ol><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Rigor mortis</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">Rigor mortis is the post-mortem stiffening and contraction of muscles in the body, resulting from the depletion of energy stores, usually becoming noticeable a few hours after death and gradually resolving over time.”</span></p><p> </p><ul><li><span style=\"font-size:12pt;\">It first affects the involuntary muscles first starting with the myocardium</span></li><li><span style=\"font-size:12pt;\">Nysten’s law deals with the progression of rigor mortis in voluntary muscles</span></li><li><span style=\"font-size:12pt;\">Order of appearance of Rigor mortis in different organs:</span></li></ul>",
      "correct_choice_id": 200244,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50062,
      "choices": [
        {
          "id": 200248,
          "text": "<p><span style=\"font-size:12.0pt;\">Antibodies against desmoglein 3</span></p>"
        },
        {
          "id": 200249,
          "text": "<p><span style=\"font-size:12.0pt;\">Antibodies against desmoglein 1</span></p>"
        },
        {
          "id": 200250,
          "text": "<p><span style=\"font-size:12.0pt;\">Suprabasal acantholytic blister is a characteristic feature</span></p>"
        },
        {
          "id": 200251,
          "text": "<p><span style=\"font-size:12.0pt;\">Antibodies against hemidesmosomes</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old woman presented with painful blisters on the skin and oral mucosa. Direct immunofluorescence is given below. Which of the following is false regarding the same?</span> (AIIMS MAY 2017)</p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/30.jpg\" alt=\"\" width=\"422\" height=\"392\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/30.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q2098681",
      "question_audio": null,
      "question_video": null,
      "map_id": 34638326,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Antibiotics against hemidesmosomes</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The given image shows a characteristic fish-net appearance on direct immunofluorescence, which is diagnostic of pemphigus vulgaris.</span></p><p> </p><p>The question talking about the false statement.</p><p> </p><p><span style=\"font-size:12.0pt;\">In direct immunofluorescence testing for pemphigus vulgaris, the immunoglobulin deposition is observed along the plasma membranes of epidermal keratinocytes in a <strong>reticular or fishnet-like pattern</strong>, indicating an autoantibody attack against desmosomal adhesion proteins. This results in early <strong>suprabasal separation</strong> and loss of cell-to-cell adhesion (acantholysis). The severity and position of the blisters are related to the distribution <strong>of desmoglein 1 and 3 in the epidermis</strong> and the presence of autoantibodies to one or both proteins. The antibodies primarily disrupt the intercellular adhesive function of the desmosomes and may activate intercellular proteases. The observed pattern is due to the interepidermal <strong>intercellular deposition of IgG and C3</strong>. The <strong>Tzanck smear is the preferred initial test</strong>, which involves collecting material from the floor of a fresh blister for microscopic examination, <strong>using Giemsa or Romanowsky stain</strong>. The presence of <strong>Tzank cells confirms the diagnosis.</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">This is incorrect and hence the false statement. Hemidesmosomes are associated with a different condition called <strong>bullous pemphigoid</strong>, where autoantibodies target components of the basement membrane, not the desmosomes as in pemphigus vulgaris.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Antibodies against desmoglein 3</strong>: This statement is true, as pemphigus vulgaris involves antibodies against desmoglein 3, particularly in mucosal lesions.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Antibodies against desmoglein 1</strong>: This statement is also true. Pemphigus vulgaris can involve antibodies against desmoglein 1, which is primarily found in the superficial layers of the skin.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Suprabasal acantholytic blister is a characteristic feature</strong>: This is correct, as pemphigus vulgaris is characterized by suprabasal blisters formed due to acantholysis, resulting from the disruption of desmosomes.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Pemphigus vulgaris is characterized by autoantibodies against desmosomal proteins (desmoglein 1 and 3), leading to a suprabasal acantholytic blister and a diagnostic fish-net appearance on direct immunofluorescence.</span></p>",
      "correct_choice_id": 200251,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50063,
      "choices": [
        {
          "id": 200252,
          "text": "<p><span style=\"font-size:12.0pt;\">Alert, pulse, grimace, activity, respiration</span></p>"
        },
        {
          "id": 200253,
          "text": "<p><span style=\"font-size:12.0pt;\">Assessment, pulse, grimace, alive, respiration</span></p>"
        },
        {
          "id": 200254,
          "text": "<p><span style=\"font-size:12.0pt;\">Appearance, pulse, grimace, activity, respiration</span></p>"
        },
        {
          "id": 200255,
          "text": "<p><span style=\"font-size:12.0pt;\">Appearance, pressure, grimace, activity, respiration</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The most appropriate expansion of Apgar is: (AIIMS MAY 2017)</span></p>",
      "unique_key": "Q4468907",
      "question_audio": null,
      "question_video": null,
      "map_id": 34107413,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Appearance, pulse, grimace, activity, respiration</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The expansion of Apgar is appearance, pulse, grimace, activity and respiration.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-155857.png\" alt=\"\" width=\"1000\" height=\"454\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/picture4_ZuwodDk.jpg\" alt=\"\" width=\"700\" height=\"468\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The APGAR score is a quick assessment of a newborn's overall health and well-being immediately after birth. The score is based on a five-point scale that evaluates the newborn's appearance, pulse, grimace, activity, and respiration. Each category is scored from 0-2, and the total score ranges from 0-10. A score of 7 or above is considered normal, while a score of 4-6 indicates that the newborn may require some medical attention, and a score of 3 or below indicates that the newborn requires immediate medical attention. The APGAR score is typically assessed at 1 and 5 minutes after birth and may be repeated if necessary.Top of FormBottom of Form</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">The Apgar score assesses a newborn's health based on five criteria: Appearance, Pulse, Grimace, Activity, and Respiration.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-155857.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200254,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50064,
      "choices": [
        {
          "id": 200256,
          "text": "<p><span style=\"font-size:12.0pt;\">Abdominal pain</span></p>"
        },
        {
          "id": 200257,
          "text": "<p><span style=\"font-size:12.0pt;\">Abdominal mass</span></p>"
        },
        {
          "id": 200258,
          "text": "<p><span style=\"font-size:12.0pt;\">Fever</span></p>"
        },
        {
          "id": 200259,
          "text": "<p><span style=\"font-size:12.0pt;\">Rectal prolapse</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is the most frequent presentation of an abdominal desmoid tumor? (AIIMS MAY 2017)</span></p>",
      "unique_key": "Q1290670",
      "question_audio": null,
      "question_video": null,
      "map_id": 34927872,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Abdominal mass</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The most common presentation of abdominal desmoid tumor is as an abdominal mass.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Abdominal mass is the most common presentation of abdominal desmoid tumors. These tumors are characterized by the development of firm, palpable masses in the abdominal wall or other abdominal structures. This is the hallmark sign of these tumors.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Abdominal pain</strong>: While abdominal pain can be a symptom of abdominal desmoid tumors, it is not the most frequent presentation. These tumors often manifest as painless masses in the abdominal area.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Fever</strong>: Fever is generally not a primary symptom of abdominal desmoid tumors. These tumors are primarily associated with the formation of masses rather than systemic symptoms like fever.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Rectal prolapse</strong>: Rectal prolapse is not a common presentation of abdominal desmoid tumors.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">An abdominal desmoid tumor is a tumor that arises from fibro-aponeurotic tissue in the musculoaponeurotic structures of the abdominal wall, especially below the level of the umbilicus.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Desmoid tumors are frequently seen to be associated with Familial Adenomatous Polyposis (FAP) syndrome.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">It commonly presents as a slow-growing mass and tends to infiltrate muscle in the immediate area. Eventually, it can undergo a myxomatous change and then shows an increase in size more rapidly.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The investigation of choice for desmoid tumor is MRI. Biopsy with immunohistochemistry can help in establishing the diagnosis. The tumors typically stain positive for</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">3-catenin</span></li><li><span style=\"font-size:12.0pt;\">Actin and</span></li><li><span style=\"font-size:12.0pt;\">Vimentin.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\">It stains negative for cytokeratin and S-100.</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Treatment includes wide excision with a margin clearance of 2.5cm to avoid recurrence. It is a completely unencapsulated fibroma and is hard to cut. The defect then requires repair using mesh to prevent hernia in the future.</span></li><li><span style=\"font-size:12.0pt;\">Radiotherapy alone is an acceptable treatment option for patients with unresectable desmoid tumors</span></li><li><span style=\"font-size:12.0pt;\">Prognosis is good, with no metastasis or sarcomatous change. Although they lack metastatic potential, they can be multifocal as well as locally aggressive and invasive, with a high propensity for recurrence.</span></li></ul>",
      "correct_choice_id": 200257,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50065,
      "choices": [
        {
          "id": 200260,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Aminoglycoside and colistin</span></p>"
        },
        {
          "id": 200261,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Cotrimoxazole with 3rd generation cephalosporin</span></p>"
        },
        {
          "id": 200262,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Carbapenems and 3rd generation cephalosporin</span></p>"
        },
        {
          "id": 200263,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Cefepime and tigecycline</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\">A 43-year-old patient presented with spikes of fever and difficulty in breathing. Transesophageal echo revealed vegetations in the heart. The culture was positive for Burkholderia cepacia. Which of the following is the first line of management? (AIIMS MAY 2017)</span></p>",
      "unique_key": "Q3879932",
      "question_audio": null,
      "question_video": null,
      "map_id": 34039648,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Cotrimoxazole with 3rd generation cephalosporins</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The correct answer is B, Cotrimoxazole with 3rd generation cephalosporins. This combination is effective against Burkholderia cepacia, a pathogen known for its resistance to many standard antibiotics. The standard regimen includes Cotrimoxazole (trimethoprim-sulfamethoxazole), which has broad-spectrum bacterial coverage, combined with a 3rd generation cephalosporin such as ceftazidime or cefoperazone-sulbactam to cover for the pathogen's unique resistance profiles and aggressive infection nature, especially in immunocompromised patients or those with existing cardiac issues.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Aminoglycoside and colistin:</strong> This option is incorrect due to the intrinsic resistance of Burkholderia cepacia to aminoglycosides. While colistin could still be effective, the resistance to aminoglycosides limits this combination's usefulness.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Carbapenems and 3rd generation cephalosporin:</strong> Incorrect because the combination of carbapenems with cephalosporins is generally not recommended. They both share a similar mechanism of action, inhibiting bacterial cell wall synthesis, and could potentially compete for the same binding sites, thus reducing their effectiveness.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Cefepime and tigecycline:</strong> Incorrect because tigecycline is not particularly effective against Burkholderia cepacia. Cefepime alone would not sufficiently manage the infection due to the bacteria's robust resistance profile.</span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The standard regimen for Burkholderia cepacia is cotrimoxazole with ceftazidime /cefoperazone-sulbactam.</span></p>",
      "correct_choice_id": 200261,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50066,
      "choices": [
        {
          "id": 200264,
          "text": "<p><span style=\"font-size:12pt;\">Wertheim's hysterectomy</span></p>"
        },
        {
          "id": 200265,
          "text": "<p><span style=\"font-size:12pt;\">Abdominal hysterectomy</span></p>"
        },
        {
          "id": 200266,
          "text": "<p><span style=\"font-size:12pt;\">Vaginal hysterectomy</span></p>"
        },
        {
          "id": 200267,
          "text": "<p><span style=\"font-size:12pt;\">Anterior colporrhaphy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which procedure amongst the following has the highest probability of ureteric injury? (INICET MAY 2017)</span></p>",
      "unique_key": "Q7240851",
      "question_audio": null,
      "question_video": null,
      "map_id": 34787852,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Wertheim's hysterectomy</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">Ureteric injury is most associated with Wertheim's hysterectomy due to the radical nature of the procedure. Wertheim's hysterectomy, also known as radical hysterectomy, involves extensive dissection and removal of not only the uterus but also the surrounding tissues, including the parametria and the upper part of the vagina. This extensive dissection increases the risk of ureteric injury.</span></p><p> </p><p><span style=\"font-size:12pt;\">However, it's important to note that while Wertheim's hysterectomy carries a higher individual risk for ureteric injury due to its radical nature, the most common cause of ureteric injury overall is abdominal hysterectomy, simply because it is the most commonly performed type of hysterectomy.</span></p><p> </p><p><span style=\"font-size:12pt;\">The overall incidence of ureteric injury in all pelvic operations is about 0.5-1%.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option B. Abdominal hysterectomy:</strong> Although it is the most common cause of ureteric injury due to its high frequency, the individual risk per procedure is lower than that of Wertheim's hysterectomy.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C. Vaginal hysterectomy:</strong> This procedure has a lower risk of ureteric injury compared to abdominal and Wertheim's hysterectomy.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D. Anterior colporrhaphy:</strong> This procedure, which is used to repair the anterior vaginal wall, has a much lower risk of ureteric injury compared to hysterectomy procedures.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">Ureteric injury is most associated with Wertheim's hysterectomy due to the extensive dissection involved in the procedure.</span></p><p> </p><p><span style=\"font-size:16px;\">The risk of ureteric injury is highest with a radical hysterectomy followed laparoscopic or robotic hysterectomy followed by abdominal hysterectomy and least risk is with vaginal hysterectomy</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Ref: TeLinde’s Operative gynecology 12<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 200264,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50067,
      "choices": [
        {
          "id": 200268,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">60</span></p>"
        },
        {
          "id": 200269,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">80</span></p>"
        },
        {
          "id": 200270,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">100</span></p>"
        },
        {
          "id": 200271,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">110</span></p>"
        }
      ],
      "text": "<p><span style=\"color:black;font-size:12.0pt;\">Dr. Radhika, the district health officer, is evaluating the efficiency of a subcenter in a rural region of India. This subcenter services a population of 5,000 people, and it has been reported that the crude birth rate (CBR) in this region stands at 20 per 1,000 people. Dr. Radhika wants to ensure that every pregnant woman receives antenatal care (ANC) to promote healthy pregnancies and reduce complications. With the current CBR, how many ANC registrations should the village health nurse (VHN) expect to handle annually? (AIIMS MAY 2017)</span></p>",
      "unique_key": "Q9276314",
      "question_audio": null,
      "question_video": null,
      "map_id": 34418955,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. A) 60</strong></span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Calculation </strong></span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\">A subcentre serves a population of 5000 in plains.</span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\">CBR given is 20.</span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\">Expected number of pregnancies can be calculated by: Birth rate x population of the area / 1000 = 20 × 5000/1000 = 100.</span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\">A correction factor of 10% is added to adjust for pregnancy wastage in the form of abortions or stillbirths.</span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\">Hence, total number of expected pregnancies = Expected number of pregnancies + 10% of the same = 100 + 10 = 110</span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\"> Since not all pregnancies are officially registered, an Auxiliary Nurse Midwife (ANM) is typically expected to have at least half of the anticipated pregnancies under her care registered at any point in time. Therefore, the count of Antenatal Care (ANC) registrations is calculated as 50% of the projected pregnancies.</span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\">Therefore, Total ANC registrations expected = total number of expected pregnancies/2 = 55</span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\">The closest answer is 60.</span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">In assessing ANC needs based on CBR in a rural health setting, it's crucial to accurately apply demographic statistics to the actual population size.</span></li><li><span style=\"font-size:12.0pt;\">Expectations should align with direct calculations unless specific adjustments are warranted by local conditions or policies.</span></li></ul>",
      "correct_choice_id": 200268,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50068,
      "choices": [
        {
          "id": 200272,
          "text": "<p><span style=\"font-size:12.0pt;\">Pyelonephritis</span></p>"
        },
        {
          "id": 200273,
          "text": "<p><span style=\"font-size:12.0pt;\">Psoas abscess</span></p>"
        },
        {
          "id": 200274,
          "text": "<p><span style=\"font-size:12.0pt;\">Appendicitis</span></p>"
        },
        {
          "id": 200275,
          "text": "<p><span style=\"font-size:12.0pt;\">Torsion of right undescended testis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 10-year-old child came with complaints of pain over the right lower quadrant and lower back pain. On examination, he had pain over the right side of the hip on passive extension along with a mass in the right lumbar region pointing towards the groin. What is the most likely diagnosis? (AIIMS MAY 2017)</span></p>",
      "unique_key": "Q2643035",
      "question_audio": null,
      "question_video": null,
      "map_id": 34831191,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Psoas abscess</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The given clinical finding of pain on hip extension is “psoas sign” which is seen in inflammation of psoas like abscess or appendicitis. However, presence of mass in right lumbar makes psoas abscess more likely.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Psoas abscess is an infection that occurs in the psoas muscle, which is located in the lower back and can extend into the right lower quadrant. It can cause lower back pain, hip pain on passive extension, and the presence of a mass in the lumbar region, making it a likely diagnosis based on the symptoms described.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Pyelonephritis</strong>: Pyelonephritis is an infection of the kidneys and typically presents with symptoms such as fever, flank pain, and urinary symptoms. While it can cause lower back pain, it doesn't typically result in a palpable mass in the lumbar region.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Appendicitis</strong>: Appendicitis usually presents with pain in the right lower quadrant, but it doesn't typically involve lower back pain or the presence of a palpable mass in the lumbar region.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Torsion of right undescended testis</strong>: Testicular torsion is a condition involving the twisting of the spermatic cord, which leads to severe testicular pain and swelling. It does not typically cause lower back pain or a palpable mass in the lumbar region.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">History of abdominal pain and mass in the right lumbar region, with pain on passive extension of the right hip (psoas sign), points towards the diagnosis of psoas abscess.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The history of lower back pain needs to be evaluated with the possibility of <strong>tubercular origin</strong> to be kept in mind in this patient.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Treatment is usually by percutaneous CT-guided drainage and appropriate antibiotic therapy.</span></p>",
      "correct_choice_id": 200273,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50069,
      "choices": [
        {
          "id": 200276,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">50 mg</span></span></span></p>"
        },
        {
          "id": 200277,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">30.5 mg</span></span></span></p>"
        },
        {
          "id": 200278,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">12.5 mg</span></span></span></p>"
        },
        {
          "id": 200279,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">6.25 mg</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">How much drug will be left after 6 hours if a patient is given a dose of 200 mg and 75 mg is excreted in 90 minutes. (Assume that the drug follows first-order kinetics)?  (AIIMS MAY 2017)</span></span></p>",
      "unique_key": "Q4747432",
      "question_audio": null,
      "question_video": null,
      "map_id": 34061866,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:16px\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\">Ans. B. 30.5 mg</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:16px\">This question can be solved by two methods.</span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:16px\"><strong>Method 1: Using the fraction method</strong></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:16px\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\">In 1<sup>st</sup> order kinetics, a constant fraction of the drug is excreted in a given time.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:16px\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\">75 mg is excreted in 90 mins. </span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:16px\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\">Therefore 75/200 = 3/8<sup>th</sup> of the drug is eliminated in 90 minutes.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:16px\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\">Thus after 90 minutes, 1-3/8 = 5/8<sup>th</sup> portion of the drug is left behind.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:16px\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\">6 hours = 4 * 90 minutes.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:16px\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\">Or, in 6 hrs = (5/8) * (5/8) *(5/8)*(5/8)* 200 mg will be left behind</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:16px\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\">= 30.518 mg will be left behind.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:16px\"><strong><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\">Method 2: Using the formula</span></span></strong></span></p>\r\n\r\n<p><span style=\"font-size:16px\">First we need to determine the elimination rate constant (k) and the half-life (t1/2) of the drug. </span></p>\r\n\r\n<p><span style=\"font-size:16px\">We know that 75 mg of the drug is excreted in 90 minutes (1.5 hours). This means that the amount remaining after 1.5 hours is 200 mg - 75 mg = 125 mg.</span></p>\r\n\r\n<p><span style=\"font-size:16px\">First, we can use the formula for first-order kinetics to find k:</span></p>\r\n\r\n<p><span style=\"font-size:16px\">k = {log (C0/Ct)} / t​</span></p>\r\n\r\n<p><span style=\"font-size:16px\">Where:</span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:16px\">C0 ​is the initial concentration (200 mg)</span></li>\r\n\t<li><span style=\"font-size:16px\">Ct ​is the concentration after time t (125 mg)</span></li>\r\n\t<li><span style=\"font-size:16px\">t is the time in hours (1.5 hours)</span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:16px\">k = {log⁡ (200/125)} / 1.5</span></p>\r\n\r\n<p><span style=\"font-size:16px\">k={log⁡(1.6)} / 1.5</span></p>\r\n\r\n<p><span style=\"font-size:16px\">k ≈ 0.470/1.5</span></p>\r\n\r\n<p><span style=\"font-size:16px\">k ≈ 0.313 hr<sup>−1</sup></span></p>\r\n\r\n<p><span style=\"font-size:16px\">Next, we find the half-life using the relationship between k and t1/2:</span></p>\r\n\r\n<p><span style=\"font-size:16px\">t1/2 = 0.693 /k </span></p>\r\n\r\n<p><span style=\"font-size:16px\">t1/2 ​= 0.693​/0.313</span></p>\r\n\r\n<p><span style=\"font-size:16px\">t1/2 = 2.21 hours</span></p>\r\n\r\n<p><span style=\"font-size:16px\">Now, we need to determine the amount of drug left after 6 hours. We use the first-order kinetics formula:</span></p>\r\n\r\n<p><span style=\"font-size:16px\">Ct = C0 × e<sup>−kt</sup></span></p>\r\n\r\n<p><span style=\"font-size:16px\">Where:</span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:16px\">C0 is the initial concentration (200 mg)</span></li>\r\n\t<li><span style=\"font-size:16px\">k is the elimination rate constant (0.313 hr^-1)</span></li>\r\n\t<li><span style=\"font-size:16px\">t is the time (6 hours)</span></li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:16px\">Ct = 200 × e<sup>−0.313×6</sup></span></p>\r\n\r\n<p><span style=\"font-size:16px\">Ct = 200 × e<sup>−1.878</sup></span></p>\r\n\r\n<p><span style=\"font-size:16px\">Ct = 200 × 0.153 </span></p>\r\n\r\n<p><span style=\"font-size:16px\">Ct ≈ 30.5 mg</span></p>\r\n\r\n<p style=\"text-align:left\"> </p>",
      "correct_choice_id": 200277,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50070,
      "choices": [
        {
          "id": 200280,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Abducens nerve</span></p>"
        },
        {
          "id": 200281,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Spinal accessory nerve</span></p>"
        },
        {
          "id": 200282,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Ophthalmic artery</span></p>"
        },
        {
          "id": 200283,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Middle meningeal artery</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11.0pt;\">Identify the structure passing through the foramen marked 2? (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">AIIMS May 2017)</span></p><p> </p><p><span style=\"color:black;font-size:10.5pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/25/inicet-anat-2017-4_HhoLlFM.jpg\" alt=\"\" width=\"300\" height=\"293\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/25/inicet-anat-2017-4_HhoLlFM.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q8388586",
      "question_audio": null,
      "question_video": null,
      "map_id": 34715969,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt;\"><strong>Ans. A. Abducens nerve</strong></span></p><p> </p><p><span style=\"font-size:11pt;\">The foramen marked as 2 in the given image is the superior orbital fissure and the abducens nerve passes through it.</span></p><p> </p><p><span style=\"font-size:11pt;\">Superior ophthalmic fissure is divided into 3 parts by annulus of zinn, parts of fissure and structures passing via each part are listed below:</span></p><ol><li><span style=\"font-size:11pt;\">Superior -lateral part - Lacrimal nerve, frontal nerve, trochlear nerve, superior opthalmic vein, lacrimal artery, meningeal branch of lacrimal artery. (Lacrimal nerve, frontal nerve and trochlear nerve are the branches of ophthalmic division of trigeminal nerve.</span></li><li><span style=\"font-size:11pt;\">Middle/ Intermediate part - Nasocillary nerve (branch of ophthalmic division of trigeminal), occulomotor nerve (CN 3), abducens nerve (CN - 6) </span></li><li><span style=\"font-size:11pt;\">Infero - medial part - Inferior opthalmic vein.</span></li></ol><p><br><span style=\"font-size:11pt;\"><strong>Note </strong>- Opthalmic vein passes via superior orbital fissure and not artery. Opthalmic artery passes via optic canal.</span><br> </p><p><span style=\"font-size:11pt;\">Brief summary about important structures passing via superior ophthalmic fissure is given below</span><br> </p><p><span style=\"font-size:11pt;\"><strong>Abducens Nerve (Cranial Nerve VI): </strong>The abducens nerve is responsible for controlling the lateral rectus muscle of the eye, which is essential for eye abduction (outward movement). Damage to the abducens nerve can result in difficulty moving the affected eye outward, leading to diplopia (double vision) when looking toward the affected side.</span></p><p> </p><p><span style=\"font-size:11pt;\"><strong>Ophthalmic Division of Trigeminal Nerve (Cranial Nerve V1)</strong>: The ophthalmic division (V1) of the trigeminal nerve carries sensory information from the upper face, including the forehead, scalp, and anterior part of the scalp. It also provides sensory innervation to the cornea, conjunctiva, and other structures within the orbit.</span></p><p> </p><p><span style=\"font-size:11pt;\"><strong>Trochlear Nerve (Cranial Nerve IV):</strong> The trochlear nerve controls the superior oblique muscle of the eye, which is responsible for rotating the eye downward and laterally. Damage to the trochlear nerve can lead to difficulty moving the affected eye downward and inward, causing vertical diplopia.</span></p><p> </p><p><span style=\"font-size:11pt;\"><strong>Superior ophthalmic vein</strong></span></p><p> </p><p><span style=\"font-size:11pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:11pt;\"><strong>Option B. Spinal Accessory Nerve: </strong>This nerve does not pass through the superior orbital fissure. It primarily traverses the jugular foramen and is involved in motor functions, particularly in controlling the sternocleidomastoid and trapezius muscles.</span></p><p> </p><p><span style=\"font-size:11pt;\"><strong>Option C. Ophthalmic Artery: </strong>Although the ophthalmic artery passes through the orbit, it is not transmitted through the foramen marked 2 but accompanies the optic nerve through the optic canal.</span></p><p> </p><p><span style=\"font-size:11pt;\"><strong>Option D. Middle Meningeal Artery: </strong>The middle meningeal artery enters the cranial cavity through the foramen spinosum, not the superior orbital fissure.</span></p><p> </p><p><span style=\"font-size:11.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:11pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/25/untitled-86_jZv9jmH.jpg\" alt=\"\" width=\"500\" height=\"534\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/25/untitled-86_jZv9jmH.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200280,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50071,
      "choices": [
        {
          "id": 200284,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Fever persisting for more than 3 weeks</span></p>"
        },
        {
          "id": 200285,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Immunocompromised status should be ruled out</span></p>"
        },
        {
          "id": 200286,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Undiagnosed after one week of investigation</span></p>"
        },
        {
          "id": 200287,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Temperature more than 38.3° C</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\">Definition of PUO includes all of the following except? (AIIMS MAY 2017)</span></p>",
      "unique_key": "Q7902477",
      "question_audio": null,
      "question_video": null,
      "map_id": 34135889,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Undiagnosed after one week of investigation</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The correct answer is C because the definition of Pyrexia of Unknown Origin (PUO) does not specify that the fever must remain undiagnosed for only one week. According to the established criteria for diagnosing PUO, the investigation can be longer and more thorough before labeling a fever as PUO. The criteria include a fever exceeding 38.3°C on at least two occasions, persisting for more than three weeks, and a diagnosis that remains uncertain after comprehensive history taking, physical examinations, and routine investigations.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Fever persisting for more than 3 weeks:</strong> This is incorrect because it is a part of the definition of PUO, where the fever must last for more than three weeks.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Immunocompromised status should be ruled out:</strong> This is incorrect  as a choice because being non-immunocompromised is a criterion in the diagnosis of PUO, which means any immunocompromised status should indeed be ruled out.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Temperature more than 38.3°C:</strong> This is also incorrect as it is part of the criteria, where the temperature must be more than 38.3°C on multiple occasions to consider it as PUO.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Criteria for diagnosis of PUO:</strong></span></p><p> </p><ul><li><span style=\"color:black;font-size:12.0pt;\">Fever > 38.3 degrees C (101° F) on 2 occasions.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Duration > 3 weeks.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Not immunocompromised state.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Diagnosis not certain after history, physical examination and routine and obligatory investigations.</span></li></ul>",
      "correct_choice_id": 200286,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50072,
      "choices": [
        {
          "id": 200288,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">22</span></span></span></p>"
        },
        {
          "id": 200289,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">16</span></span></span></p>"
        },
        {
          "id": 200290,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">14</span></span></span></p>"
        },
        {
          "id": 200291,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">18</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">What is the oxygen carrying capacity of 18-year-old boy with Hb of 14g/dl? (</span></span></span>AIIMS May 2017)</p>",
      "unique_key": "Q1503332",
      "question_audio": null,
      "question_video": null,
      "map_id": 34968533,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) 18</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The oxygen carrying capacity of blood is determined by the haemoglobin (Hb) concentration. </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The average oxygen carrying capacity of haemoglobin is approximately 1.34 mL of oxygen per gram of haemoglobin. </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Oxygen carrying capacity formula:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Oxygen Carrying Capacity = Hb (g/dL) × 1.34 mL/g</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:48px\"> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Substituting the given value:</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Oxygen Carrying Capacity = 14 g/dL × 1.34 mL/g</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Oxygen Carrying Capacity = 18.76 mL/dL</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Therefore, the estimated oxygen carrying capacity for an 18-year-old boy with a haemoglobin concentration of 14 g/dL is approximately 18.76 mL/dL.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective </span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><span style=\"background-color:white\"><span style=\"color:#0d0d0d\">The oxygen carrying capacity of blood is approximately 1.34 mL of oxygen per gram of hemoglobin, a crucial metric in assessing the oxygenation potential of blood in clinical settings.</span></span></span></span></p>",
      "correct_choice_id": 200291,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50073,
      "choices": [
        {
          "id": 200292,
          "text": "<p><span style=\"font-size:12.0pt;\">Give oral fluids and zinc supplementation only and ask mother to come back if danger sign develops.</span></p>"
        },
        {
          "id": 200293,
          "text": "<p><span style=\"font-size:12.0pt;\">Give oral fluids and ask mother to continue the same and visit again the next day.</span></p>"
        },
        {
          "id": 200294,
          "text": "<p><span style=\"font-size:12.0pt;\">Consider severe dehydration start IV fluids, IV antibiotics, and refer to higher centre.</span></p>"
        },
        {
          "id": 200295,
          "text": "<p><span style=\"font-size:12.0pt;\">Wait and observe.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 4-year-old child was brought to the hospital with a history of loose stools. No history of fever or blood in stools. The mother says he is irritable and eagerly drinks water if given. On examination, eyes are sunken and in the skin pinch test, the skin retracted within two seconds but not immediately. What treatment is advised for the child? (AIIMS MAY 2017)</span></p>",
      "unique_key": "Q7841359",
      "question_audio": null,
      "question_video": null,
      "map_id": 34245530,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Give oral fluids and zinc supplementation only and ask mother to come back if danger sign develops</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">In this question, the child has some dehydration because he or she is restless and irritable, drinks water freely, has sluggish skin retraction (2 seconds) on skin pinch test, and has sunken eyes.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Treatment according to the WHO Integrated Management of Neonatal and Childhood Diseases (IMNCI) guideline plan B.</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Oral rehydration therapy</span></li><li><span style=\"font-size:12.0pt;\">Zinc supplements,</span></li><li><span style=\"font-size:12.0pt;\">Sustained breastfeeding</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/signs_page_1.jpg\" alt=\"\" width=\"1000\" height=\"1601\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Give oral fluids and ask mother to continue the same and visit again the next day</strong>: Zinc supplementation is an important treatment protocol for diarrhea. In this option that point was missing, therefore this is not the right option.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C.</strong> <strong>Consider severe dehydration start IV fluids, IV antibiotics, and refer to higher centre</strong>: If the child was having refusal to drink with skin pinch more than 2 seconds, we could have thought of severe dehydration. Therefore this is not the right option.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Wait and observe</strong>: Child is eagerly drinking which is a feature of some dehydration, therefore, wait and observe is not the right option.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">In a child with some dehydration, the recommended treatment includes oral rehydration therapy, zinc supplementation, and continued breastfeeding, with instructions to return if danger signs develop.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/signs_page_1.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200292,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50074,
      "choices": [
        {
          "id": 200296,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">300-400</span></p>"
        },
        {
          "id": 200297,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">200-300</span></p>"
        },
        {
          "id": 200298,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Below 250</span></p>"
        },
        {
          "id": 200299,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Above 350</span></p>"
        }
      ],
      "text": "<p style=\"margin-left:-9px;\"><span style=\"color:black;font-size:12.0pt;\">An esteemed research institute recently conducted a comprehensive study on individuals diagnosed with HIV to understand the progression and current health status of the participants. As a part of this study, the CD4 count, which plays a critical role in assessing the immune status of these individuals, was meticulously measured. Given the graphical representation provided that depicts the distribution of CD4 counts, can you infer the average CD4 count range that can be derived from this graph? (AIIMS MAY 2017)</span></p><p> </p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/22/ip2.jpg\" alt=\"\" width=\"300\" height=\"253\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/22/ip2.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q4818494",
      "question_audio": null,
      "question_video": null,
      "map_id": 34651889,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. A) 300-400</strong></span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\">If we convert the given graph data into a table, it will be as follows:</span></p><p><br><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/18/screenshot-2023-10-18-113657_rVUMCJ4.jpg\" alt=\"\" width=\"778\" height=\"589\"></span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\">To determine the midpoint of each provided interval, it is necessary to calculate the midpoint for each interval individually. Following this, the resulting midpoints should be multiplied by the corresponding interval frequencies.</span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\">Mean = Sum of all observations / number of observations.</span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/18/screenshot-2023-10-18-114014.jpg\" alt=\"\" width=\"800\" height=\"445\"></span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\">Mean = 34500/100 = 345.</span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\">Hence, 300 -400 is the answer.</span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">When interpreting a frequency distribution graph like this for CD4 counts in HIV-positive individuals, it's essential to compute the weighted average based on the midpoint of each interval and the frequency of observations within each interval.</span></li><li><span style=\"font-size:12.0pt;\">This provides a more accurate assessment of the overall average CD4 count, crucial for understanding the immune status in a clinical setting.</span></li></ul><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/18/screenshot-2023-10-18-113657_rVUMCJ4.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200296,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50075,
      "choices": [
        {
          "id": 200300,
          "text": "<p><span style=\"font-size:12.0pt;\">Ceruloplasmin</span></p>"
        },
        {
          "id": 200301,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepcidin</span></p>"
        },
        {
          "id": 200302,
          "text": "<p><span style=\"font-size:12.0pt;\">Transthyretin</span></p>"
        },
        {
          "id": 200303,
          "text": "<p><span style=\"font-size:12.0pt;\">Transferrin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which one of the following is not involved in iron metabolism? (</span>AIIMS May 2017)</p>",
      "unique_key": "Q3603111",
      "question_audio": null,
      "question_video": null,
      "map_id": 34351582,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Transthyretin</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Transthyretin is not involved in iron metabolism. <strong>It transports thyroxine</strong>.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Hepcidin, a 25-amino-acid (aa) peptide, is the principal regulator of iron absorption and its distribution to tissues.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Ceruloplasmin:</strong> Functions as a ferroxidase, converting Fe2+ (ferrous iron) to Fe3+ (ferric iron), which is essential for iron binding to transferrin for transport.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Hepcidin:</strong> A 25-amino-acid peptide that is the principal regulator of iron absorption and its distribution to tissues. It inhibits iron release from enterocytes, macrophages, and hepatocytes by binding to ferroportin, leading to its degradation.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Transferrin:</strong> The main iron transport protein in the blood. It binds and transports iron to various tissues, including the bone marrow for erythropoiesis and the liver for storage.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/05/screenshot-2024-06-05-180255.jpg\" alt=\"\" width=\"1000\" height=\"684\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/05/screenshot-2024-06-05-180255.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200302,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50076,
      "choices": [
        {
          "id": 200304,
          "text": "<p><span style=\"font-size:12pt;\">Conization</span></p>"
        },
        {
          "id": 200305,
          "text": "<p><span style=\"font-size:12pt;\">Hysterectomy</span></p>"
        },
        {
          "id": 200306,
          "text": "<p><span style=\"font-size:12pt;\">Repeat Colposcopy and biopsy after 6 months</span></p>"
        },
        {
          "id": 200307,
          "text": "<p><span style=\"font-size:12pt;\">HPV DNA testing</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old female came for routine PAP smear testing. The report came as HSIL. On colposcopy and biopsy, it was confirmed to be carcinoma in situ. What is the next step? (INICET MAY 2017)</span></p>",
      "unique_key": "Q1479627",
      "question_audio": null,
      "question_video": null,
      "map_id": 34728367,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Conization</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">Carcinoma in situ (CIS) of the cervix is classified as Stage 0 cancer. In a young woman with stage 0 cervical cancer, the management of choice is conization. Conization involves the removal of a cone-shaped section of the cervix, including the transformation zone and part of the endocervix. This procedure serves both diagnostic and therapeutic purposes:</span></p><p> </p><ul><li><span style=\"font-size:12pt;\"><strong>Diagnostic:</strong> Conization provides a tissue specimen for histopathological examination, which is more definitive compared to a cytological specimen obtained from a Pap smear.</span></li><li><span style=\"font-size:12pt;\"><strong>Therapeutic:</strong> If the histopathology shows clear margins, conization can be curative for carcinoma in situ.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option B. Hysterectomy:</strong> This is a more radical treatment and is generally reserved for cases where there is invasive cancer or other indications. It is not the first-line treatment for CIS in a young woman.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C. Repeat colposcopy and biopsy after 6 months:</strong> In the case of confirmed carcinoma in situ, conization is preferred. There is no need of repeat colpobiopsy </span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D. HPV DNA testing:</strong> This test is used for screening and risk assessment but is not a treatment for confirmed carcinoma in situ.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">Conization, which involves the removal of a cone-shaped section of the cervix including the transformation zone and part of the endocervix, is the management of choice for carcinoma in situ in young women. It is both diagnostic and therapeutic if histopathology shows clear margins.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/18/picture2_ByHlD4H.jpg\" alt=\"\" width=\"500\" height=\"354\"></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 992, Williams Gynecology 3<sup>rd</sup> edition</strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/18/picture2_ByHlD4H.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200304,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50077,
      "choices": [
        {
          "id": 200308,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Pubococcygeus</span></span></span></p>"
        },
        {
          "id": 200309,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Bulbospongiosus</span></span></span></p>"
        },
        {
          "id": 200310,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">ischiocavernosus </span></span></span></p>"
        },
        {
          "id": 200311,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Superficial transverse perineal</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">The deepest part of perineal body injury, which causes cystocele, enterocoele and urethral descent is? (INICET MAY 2017)</span></span></p>",
      "unique_key": "Q3859328",
      "question_audio": null,
      "question_video": null,
      "map_id": 34357111,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. A) Pubococcygeus</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Pubococcygeus is the deepest part of the levator ani muscle. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Injury to it can cause enterocele, cystocele, and urethral descent.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The levator ani muscles are the most important muscles in the pelvic floor and maintain a constant state of contraction. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Weakening of this muscle decreases support for the vagina, bladder, uterus, or rectum or alter the position of the neck of the bladder and urethra.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other Options: </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. Bulbospongiosus, Option C. ischiocavernosus </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">and </span><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. superficial transverse perineal</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> are all superficial muscles and their damage does not result in uterovaginal descent</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Supports of the vagal have been described by Delancey as shown below and defects in these lead to different levels of uterovaginal prolapse</span></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Defect in Level 1 support: Vaginal apical prolapse and uterine prolapse</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Defect in level 2 support: Cystocele and Rectocele</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Defect in level 3 support: urethrocele and deficient perineal body</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/18/screenshot-2023-11-18-174103.jpg\" style=\"height:427px; width:1000px\" /></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ref: Page no 544, Williams Gynecology 3<sup>rd</sup> edition</span></strong></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/18/screenshot-2023-11-18-174103.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200308,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50078,
      "choices": [
        {
          "id": 200312,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">6, 11, 16, 18, 20, 23, 35, 42, 52</span></span></span></p>"
        },
        {
          "id": 200313,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">6, 11, 16, 19, 23, 33, 45, 58</span></span></span></p>"
        },
        {
          "id": 200314,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">6, 11, 16, 18, 32, 34, 45, 52, 58</span></span></span></p>"
        },
        {
          "id": 200315,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">6, 11, 16, 18, 31, 33, 45, 52, 58</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">HPV Nonavalent vaccine is active against which of the following serotypes? (INICET MAY 2017)</span></span></p>",
      "unique_key": "Q3481814",
      "question_audio": null,
      "question_video": null,
      "map_id": 34058180,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. D) 6, 11, 16, 18, 31, 33, 45, 52, 58</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">HPV Vaccines available are</span></span></span>:</p>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Cervarix (Bivalent): 16, 18</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Gardasil (Quadrivalent): 6, 11, 16, 18</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Nonavalent: (Gardasil 9 or HPV9): 6, 11, 16, 18, 31, 33, 45, 52, 58.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Cervavac (India’s indigenous HPV vaccine): Quadrivalent: 6, 11, 16, 18</span></span></span></li>\r\n</ol>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Gardasil 9 is a nonavalent HPV vaccine effective against 9 serotypes of the virus </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">These include: 6, 11, 16, 18, 31, 33, 45, 52, 58.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ref: </span></strong><a href=\"https://www.merckvaccines.com/gardasil9/\" style=\"color:#0563c1; text-decoration:underline\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">https://www.merckvaccines.com/gardasil9/</span></strong></a></span></span></p>",
      "correct_choice_id": 200315,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50079,
      "choices": [
        {
          "id": 200316,
          "text": "<p><span style=\"font-size:12.0pt;\">Aspartate aminotransferases /platelet ratio</span></p>"
        },
        {
          "id": 200317,
          "text": "<p><span style=\"font-size:12.0pt;\">Fibro test</span></p>"
        },
        {
          "id": 200318,
          "text": "<p><span style=\"font-size:12.0pt;\">Forns index</span></p>"
        },
        {
          "id": 200319,
          "text": "<p><span style=\"font-size:12.0pt;\">Serum laminin & serum hyaluronidase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Noninvasive test to detect hepatic fibrosis include?</span><span style=\"color:black;font-size:12.0pt;\"> (AIIMS MAY 2017)</span></p>",
      "unique_key": "Q1323560",
      "question_audio": null,
      "question_video": null,
      "map_id": 34610215,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Fibro test</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The FibroTest, also known as the Fibro test, is a noninvasive, blood-based test designed specifically to detect hepatic fibrosis. This test calculates the degree of liver fibrosis using a combination of several serum biochemical markers including haptoglobin, bilirubin, gamma-glutamyl transpeptidase (GGT), apolipoprotein A1, and alpha-2 macroglobulin. It evaluates liver damage and fibrosis by measuring these markers, which are affected by liver function and architecture changes.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Aspartate aminotransferases /platelet ratio (APRI):</strong> Incorrect as it is primarily used to estimate the likelihood or severity of fibrosis rather than to directly detect it. It correlates with the degree of liver fibrosis but is less specific.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Forns index:</strong> Incorrect for the same reason as APRI. The Forns index is used to assess the risk of developing liver fibrosis based on variables including age, platelet count, cholesterol levels, and GGT, but it does not directly measure fibrosis.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Serum laminin & serum hyaluronidase:</strong> Incorrect as these are not standard tests for directly detecting hepatic fibrosis; they can indicate changes in extracellular matrix turnover but are less specific and commonly used compared to the FibroTest.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Fibro test is a sensitive test to detect hepatic fibrosis. It is a <strong>multiparameter blood test</strong> which incorporate haptoglobin, bilirubin, GGT, apolipoprotein A1, and alpha-2 macroglobulin.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Test for estimating risk developing hepatic fibrosis:</strong></span></p><p> </p><ol style=\"list-style-type:lower-alpha;\"><li><span style=\"font-size:12.0pt;\">AST/platelet ratio</span></li><li><span style=\"font-size:12.0pt;\">Forns index</span></li><li><span style=\"font-size:12.0pt;\">Fib-4</span></li><li><span style=\"font-size:12.0pt;\">Cirrhosis determinant score.</span></li></ol><p> </p><p><span style=\"font-size:12.0pt;\">Test for detecting hepatic fibrosis: <strong>Fibro test</strong>.</span></p>",
      "correct_choice_id": 200317,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50080,
      "choices": [
        {
          "id": 200320,
          "text": "<p><span style=\"font-size:12.0pt;\">Ferritin mRNA concentration iron-responsive element increases and ferritin synthesis decreases</span></p>"
        },
        {
          "id": 200321,
          "text": "<p><span style=\"font-size:12.0pt;\">Transferrin receptor 1 iron-responsive elements increases transferrin receptor mRNA concentration and synthesis</span></p>"
        },
        {
          "id": 200322,
          "text": "<p><span style=\"font-size:12.0pt;\">Transferrin receptor 1 iron responsive elements decreases transferrin receptor mRNA concentration and synthesis</span></p>"
        },
        {
          "id": 200323,
          "text": "<p><span style=\"font-size:12.0pt;\">Ferritin mRNA concentration iron responsive element decreases and ferritin synthesis increases</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is true regarding the internal iron homeostasis in iron-deficiency anemia? </span>(AIIMS MAY 2017)</p>",
      "unique_key": "Q5197653",
      "question_audio": null,
      "question_video": null,
      "map_id": 34604578,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B)</strong> <strong>Transferrin receptor 1 iron-responsive elements increases transferrin receptor mRNA concentration and synthesis</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">In iron deficiency anemia, there is an increase in transferrin receptor mRNA concentration and synthesis.</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/04/screenshot-2024-09-04-102155.png\" alt=\"\" width=\"1000\" height=\"277\"></p><p> </p><p><span style=\"font-size:12.0pt;\">Progressive depletion of iron reserves first lowers serum iron and transferrin saturation levels without producing anemia. In this early stage there is increased erythroid activity in the bone marrow.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Anemia appears only when iron stores are completely depleted and is accompanied by low serum iron, ferritin, and transferrin saturation levels.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The serum iron and ferritin are low, and the total plasma iron-binding capacity (reflecting elevated transferrin levels) is high. Low serum iron with increased iron-binding capacity results in a reduction of transferrin saturation to below 15%. Reduced iron stores inhibit hepcidin synthesis, and its serum levels fall and this in turn facilitates iron absorption.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Ferritin mRNA concentration iron-responsive element increases and ferritin synthesis decreases</strong>: This statement is incorrect. In iron deficiency, ferritin synthesis decreases as the body conserves iron, but the ferritin mRNA concentration does not increase.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Transferrin receptor 1 iron-responsive elements decreases transferrin receptor mRNA concentration and synthesis</strong>: This is incorrect because in iron deficiency, transferrin receptor 1 expression increases to maximize iron uptake.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Ferritin mRNA concentration iron-responsive element decreases and ferritin synthesis increases</strong>: This is also incorrect. In iron deficiency, both ferritin mRNA levels and ferritin synthesis decrease.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">In iron-deficiency anemia, transferrin receptor 1 iron-responsive elements increase mRNA concentration and synthesis to enhance iron uptake, while ferritin levels decrease as the body attempts to conserve iron.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbins and Cotran Pathologic basis of disease, 8th edition, pg 1231-1234</strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/04/screenshot-2024-09-04-102155.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200321,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50081,
      "choices": [
        {
          "id": 200324,
          "text": "<p><span style=\"font-size:12pt;\">Epidermal verrucous nevus</span></p>"
        },
        {
          "id": 200325,
          "text": "<p><span style=\"font-size:12pt;\">Congenital melanocytic nevus</span></p>"
        },
        {
          "id": 200326,
          "text": "<p><span style=\"font-size:12pt;\">Melanoacanthoma</span></p>"
        },
        {
          "id": 200327,
          "text": "<p><span style=\"font-size:12pt;\">Malignant melanoma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the condition shown in image below? (</span>AIIMS May 2017)</p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/picture3.jpg\" alt=\"\" width=\"298\" height=\"397\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/picture3.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q7600625",
      "question_audio": null,
      "question_video": null,
      "map_id": 34911569,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Congenital melanocytic nevus</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">The Picture shown above depicts a child with a <strong>well circumscribed, black, heterogenous lesion covered with hair</strong>. This is a characteristic lesion of congenital melanocytic nevus (CMN).</span></p><p> </p><p><span style=\"font-size:12pt;\">CMNs are benign proliferations of nevus cells that are present at birth or develop shortly after. They are known for their variable pigmentation and the presence of terminal hair.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A. Epidermal verrucous nevus:</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">Description: A type of <strong>epidermal nevus </strong>(skin lesion) that is characterized by a <strong>warty or rough </strong>appearance as seen in the below image.</span></li></ul><p> </p><p><span style=\"color:#374151;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/20/picture333335.jpg\" alt=\"\" width=\"300\" height=\"164\"></span></p><p> </p><ul><li><span style=\"font-size:12pt;\"><strong>Why it's not the answer</strong>: While these can be present at birth or appear later in life, they don't typically present as deeply pigmented lesions with dense hair.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C. Melanoacanthoma:</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">Description: A rare, <strong>benign</strong> skin lesion that typically presents as a <strong>rapidly growing, hyperpigmented patch or plaque as shown in the image below</strong>.</span></li></ul><p> </p><p><span style=\"color:#374151;font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/20/picture422.jpg\" alt=\"\" width=\"300\" height=\"199\"></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">It has a combination of <strong>melanocytes and keratinocytes.</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Why it's not the answer</strong>: Although melanoacanthomas are pigmented lesions, they <strong>don't</strong> typically have <strong>dense hair</strong> growth, making it less consistent with the provided description.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D. Malignant melanoma:</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">Description: A type of skin <strong>cancer</strong> that arises from <strong>melanocytes</strong>. It can appear as a new, <strong>irregularly-shaped mole </strong>with <strong>uneven color </strong>or a mole that changes in size, shape, or color.</span></li><li><span style=\"font-size:12pt;\"><strong>Why it's not the answer</strong>: While malignant melanoma is a pigmented lesion, the hallmark features include <strong>asymmetry, border irregularity, color variation, and diameter enlargement</strong> (often referred to by the mnemonic ABCD) as seen in the image below.</span></li></ul><p> </p><p><span style=\"color:#374151;font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/20/picture5666.jpg\" alt=\"\" width=\"300\" height=\"209\"></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">The presence of dense hair is not a characteristic feature of <strong>melanoma.</strong></span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Congenital Melanocytic Nevus (CMN):</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\"><strong>Presentation:</strong> These nevi are typically pigmented and hairy and may vary in size. The presence of hair is a distinguishing feature that often helps differentiate them from other pigmented lesions.</span></li><li><span style=\"font-size:12pt;\"><strong>Risk Factors:</strong> Larger nevi have a higher risk of developing malignant melanoma later in life, but this is rare with smaller nevi.</span></li><li><span style=\"font-size:12pt;\"><strong>Management:</strong> Monitoring is essential, and in some cases, surgical removal may be considered for aesthetic reasons or to reduce melanoma risk, particularly in larger lesions.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Ref: Rook's Textbook of Dermatology - 9th Edition Chapter 75 Page no 75.14</strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/20/picture333335.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200325,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50082,
      "choices": [
        {
          "id": 200328,
          "text": "<p><span style=\"font-size:12.0pt;\">Hopping on one foot</span></p>"
        },
        {
          "id": 200329,
          "text": "<p><span style=\"font-size:12.0pt;\">Spoon handling</span></p>"
        },
        {
          "id": 200330,
          "text": "<p><span style=\"font-size:12.0pt;\">Copying a triangle</span></p>"
        },
        {
          "id": 200331,
          "text": "<p><span style=\"font-size:12.0pt;\">Repeats sentence of 10 syllables</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following milestones would you generally expect a 3-year-old child to display? (AIIMS MAY 2017)</span></p>",
      "unique_key": "Q2384717",
      "question_audio": null,
      "question_video": null,
      "map_id": 34771335,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Spoon handling</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">By the age of 24 months (2 years), most children develop the ability to use a spoon and feed themselves, which is a key fine motor skill. By the age of 3 years, this skill is typically well established, allowing the child to handle a spoon with greater proficiency.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Hopping on one foot</strong>: Hopping on one foot is a motor milestone that typically develops around the age of 4 years. Skipping usually comes later, around 5 years.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Copying a triangle</strong>: The ability to copy shapes such as a triangle is generally seen around 5 years of age. More complex shapes like a diamond are usually copied around 7 years of age.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Repeats sentences of 10 syllables</strong>: A child's ability to repeat longer sentences, including those with 10 syllables, generally develops around 4 to 5 years of age.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">By the age of 3 years, a child is typically expected to handle a spoon and feed themselves, while more complex motor and language skills develop later.</span></p>",
      "correct_choice_id": 200329,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50083,
      "choices": [
        {
          "id": 200332,
          "text": "<p><span style=\"font-size:12.0pt;\">Selenocysteine</span></p>"
        },
        {
          "id": 200333,
          "text": "<p><span style=\"font-size:12.0pt;\">Triiodothyronine</span></p>"
        },
        {
          "id": 200334,
          "text": "<p><span style=\"font-size:12.0pt;\">Hydroxy proline</span></p>"
        },
        {
          "id": 200335,
          "text": "<p><span style=\"font-size:12.0pt;\">Hydroxylysine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following amino acids is not formed after post-translational modification? (</span>AIIMS May 2017)</p>",
      "unique_key": "Q9535540",
      "question_audio": null,
      "question_video": null,
      "map_id": 34645494,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Selenocysteine</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Selenocysteine is abbreviated as SeCys is the <strong>21<sup>st</sup> human amino acid.</strong></span></p><p><span style=\"font-size:12.0pt;\">It is formed by <strong>co-translational modification.</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>It is seen at the active site of the following enzymes:</strong></span></p><p> </p><ol style=\"list-style-type:upper-alpha;\"><li><span style=\"font-size:12.0pt;\"><strong>Thioredoxin reductase</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Glutathione peroxidase</strong>, which scavenges peroxides;</span></li><li><span style=\"font-size:12.0pt;\"><strong>De-iodinase</strong> that removes iodine from thyroxine to make triiodothyronine</span></li><li><span style=\"font-size:12.0pt;\">Selenoprotein P, a glycoprotein seen in mammalian blood.</span></li></ol><p> </p><p><span style=\"font-size:12.0pt;\">Replacement of Secys by Cys will lead to decreased activity of these enzymes.</span></p><p><span style=\"font-size:12.0pt;\">Deficiency of these enzymes may be related with <strong>atherosclerosis,</strong> as these enzymes have an antioxidant function. Their concentration falls in selenium deficiency.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Its structure is COOH–CHNH2–CH2–SeH. It is incorporated into protein during translation process. <strong>There is a tRNA, specific to carry Secys</strong>. The <strong>codon is</strong> <strong>UGA</strong>. Biosynthesis of selenocysteine is by replacing the oxygen of serine by selenium; this is <strong>done by two steps:</strong></span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\">Se + ATP → Se-P + AMP + Pi</span></li><li><span style=\"font-size:12.0pt;\">Serine + Se-P → SeCys + Pi</span></li></ol><p> </p><p><span style=\"font-size:12.0pt;\">The code for SeCys is UGA, which is identified by a SeCys insertion element in the mRNA, with the help of a specific elongation factor. The tRNA-Sec is first charged with serine, then it is converted into SeCys. This is then inserted into the correct position, when protein is synthesized.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Triiodothyronine (T3): </strong>Formed by post-translational modification of thyroxine (T4) through the enzymatic removal of an iodine atom.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Hydroxyproline: </strong>Formed by post-translational hydroxylation of proline, a process critical for the stability of collagen.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Hydroxylysine: </strong>Formed by post-translational hydroxylation of lysine, also important in collagen stability.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/05/screenshot-2024-06-05-180619.jpg\" alt=\"\" width=\"1000\" height=\"618\"></strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/05/screenshot-2024-06-05-180619.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200332,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50084,
      "choices": [
        {
          "id": 200336,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Alpha error</span></p>"
        },
        {
          "id": 200337,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Beta error</span></p>"
        },
        {
          "id": 200338,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">1-α</span></p>"
        },
        {
          "id": 200339,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">1-β</span></p>"
        }
      ],
      "text": "<p><span style=\"color:black;font-size:12.0pt;\">Dr. Sharma was enthusiastically reviewing the results of a randomized controlled trial (RCT) that aimed to compare the therapeutic benefits of Drug A and Drug B. To her surprise, the data suggested a statistically significant difference between the two medications, indicated by a p-value of <0.005. However, after a comprehensive review and collaboration with other experts, it was established that in real-world settings, both drugs had essentially equivalent therapeutic outcomes. This error in interpretation, where a difference was falsely identified when none existed in reality, is best described by which of the following statistical terms? (AIIMS MAY 2017)</span></p>",
      "unique_key": "Q9096904",
      "question_audio": null,
      "question_video": null,
      "map_id": 34108250,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. A) Alpha error</strong></span></p><p> </p><ul><li><span style=\"color:black;font-size:12.0pt;\">In the given scenario, null hypothesis (H<sub>0</sub>) can be that the two drugs being the same in effectiveness is true in reality.</span></li><li><span style=\"color:black;font-size:12.0pt;\">The alternative hypothesis will be that both drugs are different.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Since P-value was found to be < 0.005, means that data is statistically significant and thus, null hypothesis is rejected.</span></li><li><span style=\"color:black;font-size:12.0pt;\">But it is already established that the null hypothesis is true and now if we accept the alternative hypothesis even though it is false, this will be a type I error or alpha error.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Hypothesis (H): Is an assumption about the status of a phenomenon</span></li><li><span style=\"color:black;font-size:12.0pt;\">Null Hypothesis (H<sub>0</sub>): In Biostatistics, when we have to prove a particular hypothesis about difference between 2 regimens, we make Null Hypothesis (For examples, If we have to prove that new treatment is better than older treatment, H<sub>0</sub> = new treatment is not better than older treatment).</span></li></ul><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Statistical errors:</strong></span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/18/screenshot-2023-10-18-114514.jpg\" alt=\"\" width=\"800\" height=\"183\"></strong></span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Type I Error (Alpha Error):</strong></span></p><p> </p><ul><li><span style=\"color:black;font-size:12.0pt;\">Null hypothesis is true but rejected</span></li><li><span style=\"color:black;font-size:12.0pt;\">Probability of Type I error is given by ‘P – value’ (probability of declaring a significant difference when actually it is not present)</span></li><li><span style=\"color:black;font-size:12.0pt;\">Significance (a) level: is the maximum tolerable probability of Type I error</span></li><li><span style=\"color:black;font-size:12.0pt;\">Alpha is fixed in advance: P – value calculated can be less than, equal to or greater than alpha (a)</span></li><li><span style=\"color:black;font-size:12.0pt;\">Keep Type I error to be minimum (P < a): Then results are declared statistically significant</span></li></ul><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Type II Error (Beta Error):</strong></span></p><p> </p><ul><li><span style=\"color:black;font-size:12.0pt;\">Null hypothesis is false but not rejected (or accepted)</span></li><li><span style=\"color:black;font-size:12.0pt;\">Probability of Type II error is given by beta (b) (probability of declaring no significant difference when actually it is present)</span></li></ul><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/18/screenshot-2023-10-18-114514.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200336,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50085,
      "choices": [
        {
          "id": 200340,
          "text": "<p><span style=\"font-size:12.0pt;\">Stargardt's disease</span></p>"
        },
        {
          "id": 200341,
          "text": "<p><span style=\"font-size:12.0pt;\">Best's disease</span></p>"
        },
        {
          "id": 200342,
          "text": "<p><span style=\"font-size:12.0pt;\">Age related macular degeneration</span></p>"
        },
        {
          "id": 200343,
          "text": "<p><span style=\"font-size:12.0pt;\">Cystoid macular edema</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Silent choroid on FFA is a feature of which of the following disorders?</span></p>",
      "unique_key": "Q1912678",
      "question_audio": null,
      "question_video": null,
      "map_id": 34477383,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Stargardt's disease</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Silent choroid / Dark choroid on FFA is a feature of Stargardt's disease.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture2_zKs31Lw.jpg\" alt=\"\" width=\"300\" height=\"289\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The 'silent choroid' or 'dark choroid' phenomenon is caused by the obscuration of the background choroidal fluorescence due to diffuse abnormalities in the retinal epithelium (RE). The accumulation of lipofuscin within the RE is a hallmark feature of Stargardt disease / Fundus flavimaculatus (FFM), which is the most prevalent type of macular dystrophy.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Signs:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The macula may initially be normal, later progressing to an oval 'snail slime' or 'beaten bronze appearance and subsequently to geographic atrophy.</span></li><li><span style=\"font-size:12.0pt;\">Numerous yellow-white round, oval or fish-shaped lesions are seen at the level of the RPE.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Investigations:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Visual fields show central loss</span></li><li><span style=\"font-size:12.0pt;\">FFA - Dark choroid, the macula shows mixed hyper and hypofluorescence. Indocyanine green angiography (ICGA). shows hypofluorescent spots.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Best's disease:</strong> This condition is characterized by the accumulation of lipofuscin-like material within the RPE but does not typically feature a silent choroid on FFA.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Age-related macular degeneration (AMD):</strong> AMD is associated with drusen and neovascular changes rather than a silent choroid.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Cystoid macular edema:</strong> This involves swelling of the macular region of the retina due to fluid accumulation in the cystoid spaces, not linked with the silent choroid phenomenon.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The silent choroid or dark choroid on FFA is a distinctive feature of Stargardt's disease, caused by lipofuscin accumulation in the retinal pigment epithelium, which blocks the normal choroidal fluorescence. Recognizing this feature is crucial in diagnosing and differentiating Stargardt’s disease from other macular disorders.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture2_zKs31Lw.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200340,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50086,
      "choices": [
        {
          "id": 200344,
          "text": "<p><span style=\"font-size:12pt;\">Ligaments</span></p>"
        },
        {
          "id": 200345,
          "text": "<p><span style=\"font-size:12pt;\">Dermis</span></p>"
        },
        {
          "id": 200346,
          "text": "<p><span style=\"font-size:12pt;\">Tendons</span></p>"
        },
        {
          "id": 200347,
          "text": "<p><span style=\"font-size:12pt;\">Bones</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Structure made up of dense irregular collagen is? (</span>AIIMS May 2017)</p>",
      "unique_key": "Q6569401",
      "question_audio": null,
      "question_video": null,
      "map_id": 34049370,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Dermis</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Dermis (precisely Reticular dermis) </strong>is made up of <strong>dense irregular connective tissue. </strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Irregular connective tissue, </strong>is characterized by <strong>collagen fibers</strong> that are <strong>randomly oriented</strong> in multiple directions.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Irregular connective tissue </strong>is of three types: <strong>Loose, Dense & Adipose</strong>.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Dense </strong>connective tissue can be found in areas where <strong>unsheathed organs </strong>are protected and where there is significant <strong>mechanical stress.</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">This arrangement of fibers provides <strong>strength and elasticity </strong>in multiple directions, allowing the skin to <strong>resist tearing.</strong></span></li></ul><p> </p><p><span style=\"font-size:12pt;\">Function: Provides <strong>structural integrity </strong>and <strong>support</strong> for the skin.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Dense connective tissue:</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">It typically exists in the <strong>reticular dermis</strong>.</span></li><li><span style=\"font-size:12pt;\"><strong>Muscle and nerve sheaths </strong>made of the <strong>superficial</strong> connective tissue</span></li><li><span style=\"font-size:12pt;\">Adventitia of <strong>large vessels</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Capsules</strong> of various organs & glands (e.g.: testis sclera, periosteum, perichondrium)</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A. Ligaments:</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">Composition: Primarily made up of <strong>dense regular</strong> connective tissue, which contains <strong>tightly packed collagen</strong> fibers that run in <strong>parallel</strong> directions.</span></li><li><span style=\"font-size:12pt;\">Function: Connect <strong>bones to other bones</strong>.</span></li><li><span style=\"font-size:12pt;\"><strong>Why it's not the answer</strong>: Ligaments have a more organized structure with the collagen fibers aligned in the same direction, which classifies them as dense regular connective tissue.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C. Tendons:</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">Composition: Made up of <strong>dense regular</strong> connective tissue, with collagen fibers that are closely packed and align in the <strong>same direction.</strong></span></li><li><span style=\"font-size:12pt;\">Function: Connect <strong>muscles to bones</strong>, aiding in the <strong>transmission</strong> of <strong>forces and movement.</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Why it's not the answer</strong>: Like ligaments, tendons have collagen fibers that are organized in a parallel manner, making them dense regular connective tissue.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D. Bones:</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">Composition: <strong>Hard, dense </strong>connective tissue made up of cells (like <strong>osteocytes</strong>), as well as <strong>mineralized extracellular </strong>matrix containing <strong>collagen fibers </strong>and calcium phosphate.</span></li><li><span style=\"font-size:12pt;\">Function: Provide <strong>structural support</strong>, protect vital organs, aid in <strong>movement</strong>, and <strong>store minerals.</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Why it's not the answer</strong>: While bones do contain collagen, their primary <strong>structural</strong> component is the <strong>mineralized matrix </strong>which provides <strong>rigidity</strong>, distinguishing them from the dense irregular connective tissue of the dermis.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Reticular dermis </strong>is comprised of the <strong>dense irregular</strong> connective tissue, that plays a crucial role in providing <strong>structural support</strong> and integrity to the skin due to its <strong>randomly oriented collagen</strong> fibers, allowing the skin to resist tearing.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Ref: Rooks textbook of dermatology- 9<sup>th</sup> Edition: Volume 1 Chapter 2, Page no 2.34</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Grays Anatomy: The anatomical basis of clinical practice- 42<sup>nd</sup> edition- page no 40, 41</strong></span></p>",
      "correct_choice_id": 200345,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50087,
      "choices": [
        {
          "id": 200348,
          "text": "<p><span style=\"font-size:12.0pt;\">No additional treatment</span></p>"
        },
        {
          "id": 200349,
          "text": "<p><span style=\"font-size:12.0pt;\">Adjuvant radiotherapy</span></p>"
        },
        {
          "id": 200350,
          "text": "<p><span style=\"font-size:12.0pt;\">Adjuvant chemotherapy</span></p>"
        },
        {
          "id": 200351,
          "text": "<p><span style=\"font-size:12.0pt;\">Adjuvant chemoradiotherapy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 43-year-old woman presented with a painless breast lump measuring 6.2 X 4.5 cm in the left upper outer quadrant and no axillary nodes. Core cut biopsy showed ductal carcinoma in situ. She underwent tumor resection with adequate margins and postoperative H&E showed DCIS with intermediate-grade necrosis and with 6-mm clearance on margins. What would be the next step in treatment? (AIIMS MAY 2017)</span></p>",
      "unique_key": "Q8808098",
      "question_audio": null,
      "question_video": null,
      "map_id": 34067845,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Adjuvant radiotherapy</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">According to Silverstein Van Nuys prognostic index which is used for DCIS, the total score is 9, and the patient would require adjuvant radiotherapy.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Age: 43 years (score 2), size: 62mm (score 3), clearance margin: 6mm (score 2) with intermediate-grade necrosis (score 2).</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The Silverstein Van Nuys Prognostic Index (VNPI) is a prognostic tool used in the management of ductal carcinoma in situ (DCIS) of the breast. DCIS is a non-invasive form of breast cancer, and the VNPI helps guide treatment decisions by assessing the risk of local recurrence.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The VNPI combines three significant predictors of local recurrence:</span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\">Tumor size: The size of the DCIS lesion.</span></li><li><span style=\"font-size:12.0pt;\">Margin width: The width of clear tissue margins around the tumor after surgical resection.</span></li><li><span style=\"font-size:12.0pt;\">Pathologic classification: The histopathological characteristics of the DCIS, including features like grade and necrosis.</span></li></ol><p> </p><p><span style=\"font-size:12.0pt;\">Scores on the VNPI typically range from 1 (best prognosis) to 3 (worst prognosis), with higher scores indicating a higher risk of local recurrence</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The VNPI assists oncologists and surgeons in determining the appropriate treatment approach for patients with DCIS. For example, patients with a lower VNPI score may be candidates for less aggressive treatment, while those with a higher score may require more intensive therapies such as radiation therapy or mastectomy.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Score <7: No further treatment</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Score 7-9: Adjuvant radiotherapy</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Score >9: Simple mastectomy</span></p>",
      "correct_choice_id": 200349,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50088,
      "choices": [
        {
          "id": 200352,
          "text": "<p><span style=\"font-size:12pt;\">Thinning of corpus callosum</span></p>"
        },
        {
          "id": 200353,
          "text": "<p><span style=\"font-size:12pt;\">Microcephaly</span></p>"
        },
        {
          "id": 200354,
          "text": "<p><span style=\"font-size:12pt;\">Holoprosencephaly</span></p>"
        },
        {
          "id": 200355,
          "text": "<p><span style=\"font-size:12pt;\">Macrocephaly</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">In fetal alcohol syndrome, which of the following is not seen? (INICET MAY 2017)</span></p>",
      "unique_key": "Q5571202",
      "question_audio": null,
      "question_video": null,
      "map_id": 34277718,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Macrocephaly</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">Fetal alcohol syndrome (FAS) is associated with various structural, behavioral, and developmental anomalies due to prenatal alcohol exposure. One of the key features of FAS is microcephaly, not macrocephaly. High levels of alcohol ingestion during pregnancy can severely impact embryonic and fetal development.</span></p><p> </p><p><span style=\"font-size:12pt;\">The presence of at least one of the following characteristics is indicative of fetal alcohol syndrome:</span></p><p> </p><ul><li><span style=\"font-size:12pt;\"><strong>Growth restriction:</strong> Can occur before and/or after birth.</span></li><li><span style=\"font-size:12pt;\"><strong>Facial anomalies:</strong> These include small palpebral fissures, indistinct or absent philtrum, epicanthic folds, flattened nasal bridge, short length of nose, thin upper lip, low-set and unparallel ears, and retarded midfacial development.</span></li><li><span style=\"font-size:12pt;\"><strong>CNS dysfunction:</strong> Includes microcephaly, mental retardation, and abnormal neurobehavioral development such as attention deficit with hyperactivity.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\">Other features that may be seen in FAS include:</span></p><p> </p><ul><li><span style=\"font-size:12pt;\"><strong>Incomplete holoprosencephaly:</strong> A condition where the forebrain does not completely divide into two hemispheres.</span></li><li><span style=\"font-size:12pt;\"><strong>Agenesis of the corpus callosum and cerebellar vermis:</strong> Developmental anomalies where these brain structures are partially or completely absent.</span></li><li><span style=\"font-size:12pt;\"><strong>Cardiac anomalies:</strong> Such as ventricular septal defect (VSD), atrial septal defect (ASD), and tetralogy of Fallot.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Macrocephaly</strong> is not seen in fetal alcohol syndrome; instead, microcephaly is characteristic.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A. Thinning of corpus callosum:</strong> This is a characteristic finding in fetal alcohol syndrome due to developmental anomalies.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option B. Microcephaly:</strong> This is commonly seen in fetal alcohol syndrome and is one of the diagnostic features.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C. Holoprosencephaly:</strong> Incomplete holoprosencephaly can be seen in fetal alcohol syndrome as a result of severe midline developmental anomalies.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">Fetal alcohol syndrome is associated with microcephaly, not macrocephaly.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 397, Williams Obstetrics 26<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 200355,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50089,
      "choices": [
        {
          "id": 200356,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Decrease in GFR</span></span></span></p>"
        },
        {
          "id": 200357,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Decreases renal blood flow</span></span></p>"
        },
        {
          "id": 200358,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Decreases oncotic pressure in glomerular capillaries</span></span></span></p>"
        },
        {
          "id": 200359,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increases hydrostatic pressure in glomerular capillaries</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Efferent arteriolar constriction causes all except? (</span></span>AIIMS May 2017)</p>",
      "unique_key": "Q7831640",
      "question_audio": null,
      "question_video": null,
      "map_id": 34865939,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Decreases oncotic pressure in glomerular capillaries</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Explanation </span></span></strong></p>\r\n\r\n<p> </p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/28/screenshot-2024-05-28-180328.png\" style=\"height:265px; width:400px\" /></span></span></strong></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Efferent arteriolar constriction <strong>increases</strong> oncotic pressure in glomerular capillaries.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Constriction of the efferent arterioles:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increases the resistance to outflow from the glomerular capillaries raising the glomerular hydrostatic pressure</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Reduces renal blood flow</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increase in filtration fraction and glomerular colloid osmotic pressure (oncotic pressure) </span></span></span></li>\r\n</ol>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Therefore, if the constriction of efferent arterioles is severe (more than about a threefold increase in efferent arteriolar resistance), the rise in colloid osmotic pressure (oncotic pressure) exceeds the increase in glomerular capillary hydrostatic pressure caused by efferent arteriolar constriction. When this occurs, the net force for filtration actually decreases, causing a reduction in GFR.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Decrease in GFR: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Incorrect in this context as initial efferent arteriolar constriction might actually increase GFR by raising hydrostatic pressure, though severe constriction can eventually decrease it.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Decreases renal blood flow: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Incorrect as this is a direct effect of efferent arteriolar constriction.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Increases hydrostatic pressure in glomerular capillaries: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Incorrect as this is indeed a result of efferent arteriolar constriction.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Efferent arteriolar constriction leads to an increase in both hydrostatic and oncotic pressures within the glomerular capillaries, which can modify renal blood flow and the dynamics of glomerular filtration. It does not decrease the oncotic pressure in the glomerular capillaries.</span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/28/screenshot-2024-05-28-180328.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200358,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50090,
      "choices": [
        {
          "id": 200360,
          "text": "<p><span style=\"font-size:12.0pt;\">Superior olivary</span></p>"
        },
        {
          "id": 200361,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Inferior colliculus</span></p>"
        },
        {
          "id": 200362,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Superior colliculus</span></p>"
        },
        {
          "id": 200363,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Fascial colliculus</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Name the location of the nucleus supplying the muscle marked with the question mark in the image given below: (</span>AIIMS May 2017)</p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/04/screenshot-2024-07-04-130522.png\" alt=\"\" width=\"400\" height=\"390\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/04/screenshot-2024-07-04-130522.png\" alt=\"Question Image\"></p>",
      "unique_key": "Q4310230",
      "question_audio": null,
      "question_video": null,
      "map_id": 34794237,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Superior colliculus</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The highlighted muscle is the medial rectus, which is supplied by the oculomotor nerve. The nucleus of the oculomotor nerve is situated at the level of the superior colliculus. The oculomotor nerve arises from a nuclear complex that includes the oculomotor nucleus and Edinger-Westphal preganglionic nucleus. The oculomotor nucleus is comprised of several groups of large motor neurons that innervate the ipsilateral inferior rectus, inferior oblique, and medial rectus in dorsoventral order. Additionally, a column of cells located medially innervates the contralateral superior rectus.</span></p><p> </p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture4_OfVnNKz.jpg\" alt=\"\" width=\"500\" height=\"296\"></span></p><p style=\"text-align:justify;\"> </p><p style=\"text-align:justify;\"> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Superior olivary:</strong> This is part of the auditory pathway and has no involvement in eye muscle control.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Inferior colliculus:</strong> Also part of the auditory pathway, located in the midbrain but not involved in motor control of eye movements.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Fascial colliculus:</strong> This term is likely a typographical error for \"facial colliculus,\" which refers to a structure in the brainstem associated with the facial nerve, not the oculomotor nerve.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The nucleus of the oculomotor nerve, responsible for innervating the medial rectus muscle among others, is located at the level of the superior colliculus in the midbrain. This is crucial for understanding the neural control of eye movements, particularly in how various components of the eye are coordinated for proper visual alignment and focus.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture4_OfVnNKz.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200362,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50091,
      "choices": [
        {
          "id": 200364,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Subclinical hypothyroidism</span></span></span></span></p>"
        },
        {
          "id": 200365,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Hyperthyroidism</span></span></span></span></p>"
        },
        {
          "id": 200366,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Secondary hypothyroidism</span></span></span></span></p>"
        },
        {
          "id": 200367,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Primary hypothyroidism</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:black\">On thyroid function test analysis, TSH value was much higher than normal with low free T4. What is the diagnosis? (AIIMS MAY 2017)</span></span></span></p>",
      "unique_key": "Q1246473",
      "question_audio": null,
      "question_video": null,
      "map_id": 34787439,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Primary hypothyroidism</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">HYPOTHYROIDISM</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Types:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Primary Hypothyroidism</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> - Increased TSH with low T4 levels. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Secondary hypothyroidism </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">- TSH can be low, normal or elevated slightly. The latter is due to secretion of immune-active but bio-active forms of TSH. Confirmation of diagnosis is done by detecting low levels of unbound T4. </span></span></span></li>\r\n</ol>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Evaluation of Hypothyroidism:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/picture30.jpg\" style=\"height:362px; width:500px\" /></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Subclinical hypothyroidism:</span></strong><span style=\"font-size:12.0pt\"> Incorrect because subclinical hypothyroidism would show an elevated TSH but normal free T4 levels.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Hyperthyroidism:</span></strong><span style=\"font-size:12.0pt\"> Incorrect as hyperthyroidism would typically present with low TSH and high free T4 levels.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Secondary hypothyroidism:</span></strong><span style=\"font-size:12.0pt\"> Incorrect for this scenario because secondary hypothyroidism involves a problem with pituitary TSH production, which does not typically result in a significantly elevated TSH.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The primary hypothyroidism is characterized by high TSH and low free T4 levels, indicating a failure of the thyroid gland itself to produce sufficient hormones.</span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/picture30.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200367,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50092,
      "choices": [
        {
          "id": 200368,
          "text": "<p><span style=\"font-size:12.0pt;\">One set from each parent</span></p>"
        },
        {
          "id": 200369,
          "text": "<p><span style=\"font-size:12.0pt;\">It has a higher mutation rate than nuclear DNA</span></p>"
        },
        {
          "id": 200370,
          "text": "<p><span style=\"font-size:12.0pt;\">It codes for more than 25% of oxidative phosphorylation proteins</span></p>"
        },
        {
          "id": 200371,
          "text": "<p><span style=\"font-size:12.0pt;\">It has 3 X 10<sup>9</sup> base pairs</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">True regarding Mitochondrial DNA is? (</span>AIIMS May 2017)</p>",
      "unique_key": "Q7974963",
      "question_audio": null,
      "question_video": null,
      "map_id": 34759871,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) It has a higher mutation rate than nuclear DNA</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Mitochondrial DNA and RNA</strong></span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\">There is a dichotomy on the mitochondrial metabolism. Some of the mitochondrial protein synthesis is under the control of mitochondrial DNA; but <strong>important proteins of the outer membrane of the mitochondria are synthesized under the influence of nuclear DNA.</strong></span></li><li><span style=\"font-size:12.0pt;\">The <strong>mitochondrial DNA (mtDNA) is circular, has about 16,500 nucleotides</strong>. The mtDNA has information for <strong>synthesis of 2 ribosomal RNAs, 22 tRNAs and 13 proteins</strong>. All of them are components of electron transport chain. <strong>It has 37 genes that encode 13 protein subunits of the respiratory chain (total of 67 i.e., about 20%).</strong> However, most of mitochondrial proteins are encoded by nuclear DNA and synthesized in the cytoplasm.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Maternal inheritance:</strong> Since, the mitochondria are inherited cytoplasmically, the mtDNA is inherited from the mother. Mother transmits mtDNA through oocyte.</span></li><li><span style=\"font-size:12.0pt;\">There are hundreds of copies of mtDNA in each cell (nuclear DNA has only 2 copies).</span></li><li><span style=\"font-size:12.0pt;\">Heteroplasmy is defined as the presence of normal and mutant mtDNA in different proportions in different cells. During cell division, mtDNA replicates and they segregate to the daughter cells. If a mutation occurs in mtDNA, the daughter cells may inherit the mutant or normal mtDNA.</span></li><li><span style=\"font-size:12.0pt;\"><strong>High mutation rate:</strong> 5-10 times that of nuclear DNA</span></li><li><span style=\"font-size:12.0pt;\">Age-related accumulation of mutations in mtDNA may be responsible for <strong>age-related decrease in cellular OXPHOS function</strong>, and progression of other degenerative diseases.</span></li><li><span style=\"font-size:12.0pt;\">Defects in mitochondrial genome will lead to mitochondrial myopathies.</span></li></ol><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. One set from each parent:</strong> Incorrect. mtDNA is inherited only from the mother.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. It codes for more than 25% of oxidative phosphorylation proteins:</strong> Incorrect. mtDNA encodes about 13 protein subunits of the respiratory chain, approximately 20% of the total, not more than 25%.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. It has 3 X 10^9 base pairs:</strong> Incorrect. mtDNA is much smaller, with about 16,500 base pairs.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Mitochondrial DNA has a higher mutation rate than nuclear DNA, is maternally inherited, and contains 37 genes encoding essential components of the electron transport chain.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Ref - Textbook of Biochemistry for Medical Students 7<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 200369,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50093,
      "choices": [
        {
          "id": 200372,
          "text": "<p><span style=\"font-size:12.0pt;\">Liver biopsy</span></p>"
        },
        {
          "id": 200373,
          "text": "<p><span style=\"font-size:12.0pt;\">CSF</span></p>"
        },
        {
          "id": 200374,
          "text": "<p><span style=\"font-size:12.0pt;\">Blood</span></p>"
        },
        {
          "id": 200375,
          "text": "<p><span style=\"font-size:12.0pt;\">Urine</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A baby in the NICU is being evaluated for his features of microcephaly and hepatomegaly. CT scan revealed nodular periventricular calcifications. Congenital CMV infection is suspected. Which of the following samples is the best to detect the organism using PCR? (AIIMS MAY 2017)</span></p>",
      "unique_key": "Q5585230",
      "question_audio": null,
      "question_video": null,
      "map_id": 34787485,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Urine</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Urine is the best sample</strong> to send for the diagnosis of congenital cytomegalovirus infection among the following options.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">CMV can be detected using <strong>either PCR or culture</strong>. <u>Saliva, urine, or blood can be used </u>to collect the sample.</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Clinical features:</strong></span><ol style=\"list-style-type:lower-alpha;\"><li><span style=\"font-size:12.0pt;\">Intrauterine growth retardation (IUGR)</span></li><li><span style=\"font-size:12.0pt;\">Prematurity</span></li><li><span style=\"font-size:12.0pt;\">Microcephaly</span></li><li><span style=\"font-size:12.0pt;\">Intracranial calcifications (Periventricular)</span></li><li><span style=\"font-size:12.0pt;\">Chorioretinitis</span></li><li><span style=\"font-size:12.0pt;\">Sensorineural hearing loss (SNHL)</span></li><li><span style=\"font-size:12.0pt;\">Hepatosplenomegaly</span></li><li><span style=\"font-size:12.0pt;\">Jaundice</span></li><li><span style=\"font-size:12.0pt;\">Blueberry-muffin-like rash</span></li><li><span style=\"font-size:12.0pt;\">Thrombocytopenia, purpura</span></li><li><span style=\"font-size:12.0pt;\">Mild increases in CSF protein</span></li></ol></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/picture2_v6gG1Oj.jpg\" alt=\"\" width=\"300\" height=\"361\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Liver biopsy:</strong> In any of the TORCH infection, liver biopsy is not the investigation of choice. Live biopsy is the gold standard investigation of choice in Wilson disease.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. CSF</strong>: In case of suspected meningitis we do CSF, not in TORCH profile</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Blood</strong>: In this question blood sample is not the right option. If the question was regarding diagnosing of congenital varicella infection, then the right choice would be ANTI – VZV – ANTIBODY</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Urine is the most appropriate sample for the detection of congenital cytomegalovirus (CMV) infection using PCR, particularly in the neonatal period.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/picture2_v6gG1Oj.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200375,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50094,
      "choices": [
        {
          "id": 200376,
          "text": "<p><span style=\"font-size:12.0pt;\">Brachial artery</span></p>"
        },
        {
          "id": 200377,
          "text": "<p><span style=\"font-size:12.0pt;\">Radial artery</span></p>"
        },
        {
          "id": 200378,
          "text": "<p><span style=\"font-size:12.0pt;\">Ulnar artery</span></p>"
        },
        {
          "id": 200379,
          "text": "<p><span style=\"font-size:12.0pt;\">Cubital vein</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In the fracture seen in the X-ray below, what is the most commonly expected vascular injury?(AIIMS MAY 2017)</span></p><p style=\"text-align:justify;\"> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/02/untitled-597.jpg\" alt=\"\" width=\"309\" height=\"219\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/02/untitled-597.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q4869584",
      "question_audio": null,
      "question_video": null,
      "map_id": 34067846,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Brachial artery</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The given image shows the <strong>supracondylar fracture of the humerus</strong>.</span></li><li><span style=\"font-size:12.0pt;\">Fracture supracondylar humerus is:</span><ul><li><span style=\"font-size:12.0pt;\">Most common fracture <strong>associated with vascular injury</strong>.</span></li><li><span style=\"font-size:12.0pt;\">Most common fracture to <strong>involve brachial artery</strong> (10% cases).</span></li><li><span style=\"font-size:12.0pt;\">Most common <strong>cause of volkmann's ischemia and compartment syndrome</strong> in children.</span></li><li><span style=\"font-size:12.0pt;\">Most common cause of volkmann's ischemic contracture.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Non-union is unknown</strong>.</span></li></ul></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Radial artery</strong>. It can be associated with the fracture of the distal radius.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Ulnar artery</strong>. It can be associated with the comminuted fracture of the distal radius.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The given image shows the supracondylar humerus fracture which is mostly associated with the brachial artery injury.</span></li></ul>",
      "correct_choice_id": 200376,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50095,
      "choices": [
        {
          "id": 200380,
          "text": "<p><span style=\"font-size:12.0pt;\">HIV</span></p>"
        },
        {
          "id": 200381,
          "text": "<p><span style=\"font-size:12.0pt;\">Hepatitis B</span></p>"
        },
        {
          "id": 200382,
          "text": "<p><span style=\"font-size:12.0pt;\">Influenza</span></p>"
        },
        {
          "id": 200383,
          "text": "<p><span style=\"font-size:12.0pt;\">Herpes simplex</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The given life cycle is suggestive of which of the following viruses? (INICET MAY 2017)</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/30/1-micro-4.jpg\" alt=\"\" width=\"400\" height=\"292\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/30/1-micro-4.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q4465797",
      "question_audio": null,
      "question_video": null,
      "map_id": 34917352,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Hepatitis B</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The given life cycle is of the hepatitis B virus.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Steps:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The infectious <u>virion attaches</u> to cells and uncoating occurs.</span></li><li><span style=\"font-size:12.0pt;\">Cell enzymes in the hepatocytes convert dsDNA to covalently closed circular double-stranded DNA (cccDNA)</span></li><li><span style=\"font-size:12.0pt;\">HBV mRNA and pre-genome <u>RNA is synthesized</u> using cDNA as a template.</span></li><li><span style=\"font-size:12.0pt;\">pre-genome RNA is encapsidated by packaging signal into new core particles.</span></li><li><span style=\"font-size:12.0pt;\">These new core particles are templates for HBV reverse transcriptase.</span></li><li><span style=\"font-size:12.0pt;\">Negative-strand DNA is synthesized by viral polymerase by reverse transcription.</span></li><li><span style=\"font-size:12.0pt;\">The cores bud from the pre-Golgi membranes, acquiring HBAg-containing envelopes.</span></li><li><span style=\"font-size:12.0pt;\">Once viral particles are assembled, they either exit the cell or cause reinfection of the same cell.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. HIV: </strong>HIV is an RNA virus with a life cycle that involves reverse transcription of RNA into DNA, integration into the host genome, and the production of new virions. The depicted life cycle does not match HIV's replication cycle.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Influenza: </strong>Influenza is an RNA virus with a replication cycle involving the nuclear replication of viral RNA and budding from the plasma membrane. Its life cycle does not involve cccDNA or reverse transcription.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Herpes simplex: </strong>Herpes simplex virus (HSV) is a DNA virus that also forms episomal DNA in the nucleus, but its replication and assembly processes differ from those of HBV, particularly in the use of the Golgi for envelopment.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Hepatitis B virus is characterized by the formation of cccDNA in the nucleus, reverse transcription of RNA to DNA within the core particles, and budding from the pre-Golgi membranes.</span></p>",
      "correct_choice_id": 200381,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50096,
      "choices": [
        {
          "id": 200384,
          "text": "<p><span style=\"font-size:12.0pt;\">High fat diet</span></p>"
        },
        {
          "id": 200385,
          "text": "<p><span style=\"font-size:12.0pt;\">It does not depend on the macronutrients</span></p>"
        },
        {
          "id": 200386,
          "text": "<p><span style=\"font-size:12.0pt;\">High protein diet</span></p>"
        },
        {
          "id": 200387,
          "text": "<p><span style=\"font-size:12.0pt;\">High carbohydrate diet</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is Thermogenic food? (</span>AIIMS May 2017)</p>",
      "unique_key": "Q7965982",
      "question_audio": null,
      "question_video": null,
      "map_id": 34349837,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) High protein diet</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Increased heat production or increased metabolic rate following the intake of food </strong>is called as thermogenic effect of food or diet-induced thermogenesis or <strong>specific dynamic action (SDA) of food </strong>(non-shivering thermogenesis).</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Part of this is due to the expenditure of energy for digestion; absorption and active transport of products of the digestion. Another reason for this expenditure of energy is that reserve materials, such as glycogen, triacyl glycerol, protein, etc. are synthesized from small molecules available after digestion.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>A high protein diet leads to higher protein turnover resulting in increased diet induced thermogenesis</strong>.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The values of <strong>SDA are: for proteins 30%, for lipids 15%, and for carbohydrates 5%</strong>. This means that out of every 100 grams of proteins consumed, the energy available for doing useful work is 30% less than the calculated value.</span></p><p><span style=\"font-size:12.0pt;\">Thermogenesis results from the presence of an uncoupling protein, <strong>thermogenin</strong>, <strong>in the inner mitochondrial membrane.</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">It is a common experience that during hot weather following the consumption of a protein rich meal, one feels hot and humid for a while. On the other hand, in cold weather, the same would provide a comfortable feeling.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. High fat diet:</strong> While fats do contribute to thermogenesis, their specific dynamic action (SDA) is lower (15%) compared to proteins (30%).</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. It does not depend on the macronutrients:</strong> This statement is incorrect, as the thermogenic effect of food does depend on the type of macronutrient consumed.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. High carbohydrate diet:</strong> Carbohydrates have a lower thermogenic effect (5%) compared to proteins (30%).</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">A high protein diet has the highest thermogenic effect compared to fats and carbohydrates, leading to increased energy expenditure during digestion and metabolism.</span></p>",
      "correct_choice_id": 200386,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50097,
      "choices": [
        {
          "id": 200388,
          "text": "<p><span style=\"font-size:12.0pt;\">Ferritin</span></p>"
        },
        {
          "id": 200389,
          "text": "<p><span style=\"font-size:12.0pt;\">TIBC</span></p>"
        },
        {
          "id": 200390,
          "text": "<p><span style=\"font-size:12.0pt;\">Iron</span></p>"
        },
        {
          "id": 200391,
          "text": "<p><span style=\"font-size:12.0pt;\">Transferrin saturation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All are reduced in Iron Deficiency Anemia except? </span>(AIIMS MAY 2017)</p>",
      "unique_key": "Q3418316",
      "question_audio": null,
      "question_video": null,
      "map_id": 34924502,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) TIBC</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">In Iron Deficiency Anemia, Total Iron Binding Capacity (TIBC) is increased in order to compensate to the deficient state.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Iron deficiency anemia –</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Progressive depletion of iron reserves first lowers serum iron and transferrin saturation levels without producing anemia. In this early stage there is increased erythroid activity in the bone marrow.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Anemia appears only when iron stores are completely depleted and is accompanied by low serum iron, ferritin, and transferrin saturation levels.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>The serum iron and ferritin are low, and the total plasma iron-binding capacity (reflecting elevated transferrin levels) is high</strong>. Low serum iron with increased iron-binding capacity results in a reduction of transferrin saturation to below 15%. Reduced iron stores inhibit hepcidin synthesis, and its serum levels fall and this in turn facilitates iron absorption.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Ferritin</strong>: Ferritin is an intracellular protein that stores iron and releases it in a controlled fashion. In IDA, ferritin levels drop as iron stores are exhausted.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Iron</strong>: Serum Iron reflects the amount of circulating iron bound to transferrin. In IDA, serum iron levels are reduced because iron stores are depleted.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Transferrin Saturation</strong>: This is the percentage of transferrin that is saturated with iron. In IDA, it is reduced because there is less iron available to bind to transferrin.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>DDs of microcytic anemia</strong>:-</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/04/screenshot-2024-09-04-102155_0hAIFjo.png\" alt=\"\" width=\"1000\" height=\"277\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbins and Cotran Pathologic basis of disease, 8th edition, Page No. 1231-1234</strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/04/screenshot-2024-09-04-102155_0hAIFjo.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200389,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50098,
      "choices": [
        {
          "id": 200392,
          "text": "<p><span style=\"font-size:12.0pt;\">Causes metabolic and enzymatic activity to stop</span></p>"
        },
        {
          "id": 200393,
          "text": "<p><span style=\"font-size:12.0pt;\">Prevents the cells from sticking to the slide surface</span></p>"
        },
        {
          "id": 200394,
          "text": "<p><span style=\"font-size:12.0pt;\">Colors the red cells</span></p>"
        },
        {
          "id": 200395,
          "text": "<p><span style=\"font-size:12.0pt;\">Fixes cells to slide</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the function of Acetone Free Methanol in Leishman stain? (AIIMS MAY 2017)</span></p>",
      "unique_key": "Q7326593",
      "question_audio": null,
      "question_video": null,
      "map_id": 34709730,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Causes metabolic and enzymatic activity to stop</strong></span><br><br><span style=\"font-size:12.0pt;\">Acetone-free methanol serves as a fixing agent in the Leishman stain process. Its primary function is to cause metabolic and enzymatic activity to stop, which preserves cellular architecture. This fixation occurs through protein denaturation and halts all biological processes, maintaining the cellular structure for microscopic examination. Therefore, the correct choice would be: \"Causes metabolic and enzymatic activity to stop.\"</span><br><br> </p><p><span style=\"font-size:12.0pt;\">The procedure of Leishman stain:</span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Freshly prepare and rapidly air-dry blood film.</span></li><li><span style=\"font-size:12.0pt;\">Cover the film with Leishman's Stain (S018S) and allow it to act for 1 minute. Methanol in the stain fixes the preparation.</span></li><li><span style=\"font-size:12.0pt;\">Add double the volume of distilled water to the slide and mix.</span></li><li><span style=\"font-size:12.0pt;\">Allow the diluted stain to act for 10-12 minutes.</span></li><li><span style=\"font-size:12.0pt;\">Wash the film with distilled water or phosphate buffer of pH 7.0, drain and dry in air and examine</span></li></ul><p><span style=\"font-size:12.0pt;\"> </span></p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span><br><br><span style=\"font-size:12.0pt;\"><strong>Option B. Prevents the cells from sticking to the slide surface:</strong> This is incorrect because methanol doesn't prevent adhesion; rather, it preserves cellular structure through protein denaturation.</span><br><br> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Colors the red cells:</strong> This is not the role of acetone-free methanol. The actual coloring of the cells is performed by the dye components in the Leishman stain (methylene blue and eosin).</span><br><br> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Fixes cells to slide:</strong> While methanol is a fixative, its primary mechanism is stopping metabolic activity, not adhering cells to the slide. As previously noted, adhesion to the slide surface is the function of substances like albumin.</span><br><span style=\"font-size:12.0pt;\"> </span></p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Acetone-free methanol in the Leishman stain primarily functions by causing metabolic and enzymatic activity to stop through protein denaturation, which preserves cellular architecture and enables proper staining and microscopic examination.</span></p>",
      "correct_choice_id": 200392,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50099,
      "choices": [
        {
          "id": 200396,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Growth hormone</span></span></span></p>"
        },
        {
          "id": 200397,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Cortisol</span></span></p>"
        },
        {
          "id": 200398,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Estrogen</span></span></p>"
        },
        {
          "id": 200399,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Insulin</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Identify the hormone from the picture?</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/28/screenshot-2024-05-28-175415.png\" style=\"height:269px; width:700px\" /></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/28/screenshot-2024-05-28-175415.png\" alt=\"Question Image\"></p>",
      "unique_key": "Q3304754",
      "question_audio": null,
      "question_video": null,
      "map_id": 34316817,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Growth Hormone</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The above image shows variations in growth hormone levels through the day.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The level is low during the day and is around 5 ng/mL (another reference says <2 ng/mL) increasing in response to specific stimuli like:</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Exercise.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Physical and emotional stress.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ingestion of protein.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In hypoglycaemia (Starvation, Fasting)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Spike occurs after 3 hours of meals or exercise.</span></span></span></li>\r\n</ol>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In adults and children in the evening, it shows the highest level.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The secretion of GH is episodic and variable; sometimes, the level may reach 40 ng/ml in a healthy subject.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The highest values are noted during the deepest sleep level. So, its level is increased during sleep.</span> <span style=\"font-size:12.0pt\">The GH may increase ten times the normal level during sleep.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">So, the best time to for growth hormone is 60 to 90 minutes after deep sleep. Or do the exercise for 30 minutes and get the GH sample, which will be at the highest level.</span></span></span></p>\r\n\r\n<p style=\"margin-left:24px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">            </span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Cortisol: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Incorrect. Cortisol typically peaks in the early morning and lowers throughout the day, not in response to meals or exercise in this marked pattern.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Estrogen: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Incorrect. Estrogen levels do not show such acute changes in response to daily activities like meals or exercise.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Insulin: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Incorrect. Insulin spikes are typically observed post-meal but would not show the pattern of peaks associated with exercise or sleep as depicted.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Growth hormone levels exhibit significant variability, influenced by factors such as time of day, meals, exercise, and sleep, with the highest levels occurring during deep sleep. This pattern underlines the hormone's critical roles in growth, metabolism, and recovery processes.</span></span></p>",
      "correct_choice_id": 200396,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50100,
      "choices": [
        {
          "id": 200400,
          "text": "<p><span style=\"font-size:18px;\">Malaria</span></p>"
        },
        {
          "id": 200401,
          "text": "<p><span style=\"font-size:18px;\">Dengue</span></p>"
        },
        {
          "id": 200402,
          "text": "<p><span style=\"font-size:18px;\">Chikungunya</span></p>"
        },
        {
          "id": 200403,
          "text": "<p><span style=\"font-size:18px;\">Fixed drug eruption</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:18px;\">A male patient complained of bone and joint pain and was prescribed NSAIDs. After a few days, he returned with vesiculo-bullous lesions that subsequently healed, leaving a brownish discoloration on his face (particularly in the upper lip area), as shown in the image. Based on these symptoms, what is the most likely diagnosis?</span></p><p style=\"text-align:justify;\"> </p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/picture1.jpg\" alt=\"\" width=\"300\" height=\"282\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/11/picture1.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q1556436",
      "question_audio": null,
      "question_video": null,
      "map_id": 34843505,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:18px;\"><strong>Ans. D) Fixed drug eruption</strong></span></p><p> </p><p><span style=\"font-size:18px;\">The given clinical situation suggests a diagnosis of a Fixed drug eruption. <strong>Fixed drug eruption</strong> is one of the <strong>most common</strong> forms of <strong>drug induced exanthems</strong>.</span></p><p> </p><p><span style=\"font-size:18px;\">A <strong>fixed drug eruption</strong> is a known adverse <strong>drug reaction</strong> characterized by r<strong>ecurrent</strong> skin eruptions at the <strong>same location</strong> upon <strong>re-exposure</strong> to a specific drug. The <strong>vesiculo-bullous lesions</strong> followed by <strong>brownish discoloration</strong> can be seen in <strong>fixed drug eruptions</strong>, making it the most likely diagnosis given the patient's <strong>history of NSAID use.</strong></span></p><p> </p><p><span style=\"font-size:18px;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:18px;\"><strong>Option A</strong>. <strong>Malaria</strong>:</span></p><p> </p><ul><li><span style=\"font-size:18px;\">Etiology: Caused by the <strong>Plasmodium parasite</strong>, which is transmitted to humans via the bites of infected <strong>Anopheles mosquitoes</strong>.</span></li><li><span style=\"font-size:18px;\">Clinical Features: <strong>Fever (often cyclic), chills, sweating, headaches, muscle pains, fatigue, anemia</strong>, jaundice due to hemolysis, and enlargement of the spleen.</span></li><li><span style=\"font-size:18px;\"><strong>Why it's not the likely diagnosis</strong>: Malaria does not typically cause vesico-bullous lesions or discoloration of the face.</span></li></ul><p> </p><p><span style=\"font-size:18px;\"><strong>Option B.</strong> <strong>Dengue</strong>:</span></p><p> </p><ul><li><span style=\"font-size:18px;\">Etiology: Caused by the dengue virus, which is transmitted through the bite of <strong>Aedes</strong> mosquitoes.</span></li><li><span style=\"font-size:18px;\">Clinical Features: High fever, <strong>severe headache</strong>, <strong>pain behind the eyes, joint and muscle pain, rash, and mild bleeding</strong> (e.g., nose or gum bleed, or easy bruising).</span></li><li><span style=\"font-size:18px;\"><strong>Why it's not the likely diagnosis</strong>: While dengue can cause rashes, it does not usually result in vesico-bullous lesions or leave a persistent brownish discoloration on the skin.</span></li></ul><p> </p><p><span style=\"font-size:18px;\"><strong>Option C.</strong> <strong>Chikungunya fever:</strong></span></p><p> </p><p><span style=\"font-size:18px;\">A strong differential diagnosis is <strong>post chikungunya pigmentation</strong> (PCP) of the face seen on the <strong>nose & cheeks (Chik Sign</strong>) as shown in the below image.</span></p><p> </p><p><span style=\"font-size:18px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/20/picture2666.jpg\" alt=\"\" width=\"300\" height=\"290\"></span></p><p> </p><p><span style=\"font-size:18px;\"><strong>Why it's not the likely diagnosis</strong>: However, this is not the answer because there is <strong>no</strong> antecedent history of <strong>fever</strong>, <strong>myalgia</strong>, or other symptoms suggestive of chikungunya. PCP often appears as the fever subsides and may persist for about <strong>three to six months.</strong> PCP <strong>mimics melasma</strong> & may be misdiagnosed If proper history is not taken.</span></p><p> </p><p><span style=\"font-size:18px;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:18px;\"><strong>Fixed drug eruption (FDE)</strong></span></p><p> </p><p><span style=\"font-size:18px;\">FDE is a drug eruption distinguished by its <strong>recurrence at the same sites</strong> on <strong>re‐challenge with the same drug</strong>, hence their site on the skin is <strong>fixed</strong>, it has a <strong>short latency</strong> and is <strong>benign</strong> in nature.</span></p><p> </p><p><span style=\"font-size:18px;\">FDE typically presents <strong>30 min to 8 h</strong> after <strong>drug exposure</strong>.</span></p><p> </p><ul><li><span style=\"font-size:18px;\">Typically, FDE presents as a sharply‐defined, round or oval <strong>erythematous and edematous</strong> plaque which evolves to become dusky, violaceous and occasionally <strong>vesicular or bullous</strong>.</span></li><li><span style=\"font-size:18px;\">Classically <strong>hyperpigmentation</strong> occurs after lesions <strong>heal.</strong> Most common cause:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:18px;\"><strong>NSAIDs - On Lips</strong></span></li><li><span style=\"font-size:18px;\"><strong>Cotrimoxazole - On Genitals</strong></span></li></ul></li></ul><p> </p><p><span style=\"font-size:18px;\">Acute onset pigmentary changes after <strong>NSAID</strong> use point toward the diagnosis of <strong>FDE</strong>. NSAID's are one of the most common drugs causing FDE.</span></p><p> </p><p><span style=\"font-size:18px;\"><strong>Ref: Rooks textbook of dermatology, 9<sup>th</sup> edition, Chapter 118 page no 118.11, 118.12</strong></span></p><p><span style=\"font-size:18px;\"><strong>Harrisons principles of internal medicine 21<sup>st</sup> edition pages 141-142, 1633</strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/20/picture2666.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200403,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50101,
      "choices": [
        {
          "id": 200404,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">0.66/10,000 population</span></p>"
        },
        {
          "id": 200405,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">0.66/1 lakh population</span></p>"
        },
        {
          "id": 200406,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">9.7/10,000 population</span></p>"
        },
        {
          "id": 200407,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">9.7/1 lakh population</span></p>"
        }
      ],
      "text": "<p><span style=\"color:black;font-size:12.0pt;\">Dr. Mehta, Public health expert who works extensively with the National Leprosy Eradication Programme (NLEP) in India. In a meeting with local health workers in 2017, he has shared the data and progress made in controlling leprosy. He mentions the crucial statistic of the Annual New Case Detection Rate (ANCDR) as of March 31, 2016, to give a snapshot of the magnitude of new leprosy cases detected. This rate helps in understanding the effectiveness of ongoing programs and strategies. What value did Dr. Mehta share as the ANCDR for leprosy for that specific year? (AIIMS MAY 2017)</span></p>",
      "unique_key": "Q3065900",
      "question_audio": null,
      "question_video": null,
      "map_id": 34760626,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. D) 9.7/1 lakh population</strong></span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\">During the 2015-2016 period, India recorded an annual new case detection rate (ANCDR) for leprosy at 9.7 per 100,000 people.</span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Annual New Case Detection Rate (ANCDR):</strong></span></p><p> </p><ul><li><span style=\"color:black;font-size:12.0pt;\">An important Indicator being used under the National Leprosy Eradication Program </span></li><li><span style=\"color:black;font-size:12.0pt;\">Indicator is calculated at the end of March every year, wherein New Cases detected during the</span><span style=\"font-size:12.0pt;\"> </span><span style=\"color:black;font-size:12.0pt;\">period April (Previous Calendar year) and March (current year) is used</span></li><li><span style=\"color:black;font-size:12.0pt;\">ANCDR - 2015-16: 9.71 per 100,000 population</span></li><li><span style=\"color:black;font-size:12.0pt;\"><strong>ANCDR - 2021-22: 5.52 per 100,000 population</strong></span></li></ul><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The ANCDR is a pivotal indicator in disease surveillance and control programs, helping public health officials and stakeholders understand the scale of new cases and the impact of interventions.</span></li><li><span style=\"font-size:12.0pt;\">For leprosy in India, maintaining a keen understanding of this rate is essential for achieving the goals of the National Leprosy Eradication Programme.</span></li></ul>",
      "correct_choice_id": 200407,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50102,
      "choices": [
        {
          "id": 200408,
          "text": "<p><span style=\"font-size:12.0pt;\">Warthin starry stain</span></p>"
        },
        {
          "id": 200409,
          "text": "<p><span style=\"font-size:12.0pt;\">Steiner silver stain</span></p>"
        },
        {
          "id": 200410,
          "text": "<p><span style=\"font-size:12.0pt;\">Sweet's reticulin stain</span></p>"
        },
        {
          "id": 200411,
          "text": "<p><span style=\"font-size:12.0pt;\">Grimelius silver stain</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The stain done on a section of liver shown below is:</span> (AIIMS MAY 2017)</p><p> </p><p style=\"text-align:center;\"><img src=\"https://iqmstore.com/wp-content/uploads/2020/06/Reticulin-Stain-Kit-Gordon-Sweets-1936-with-Gold-Chloride-min.jpg\" alt=\"Reticulin Stain Kit (Gordon & Sweets 1936) (with Gold Chloride) - iqmstore\"></p><p><img src=\"https://iqmstore.com/wp-content/uploads/2020/06/Reticulin-Stain-Kit-Gordon-Sweets-1936-with-Gold-Chloride-min.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q9611936",
      "question_audio": null,
      "question_video": null,
      "map_id": 34286512,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Sweet’s reticulin stain</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Stain demonstrates reticular fibers of the liver and hence has to be <strong>reticulin stain.</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">On microscope - plump hepatocytes are surrounded by rims of atrophic hepatocytes. The variation in parenchymal architecture is not easily seen on an H&E stain, and reticulin staining is required to appreciate the changes in hepatocellular architecture.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Warthin starry stain</strong>: This stain is typically used to identify organisms such as <strong>Helicobacter pylori</strong> or <strong>spirochetes</strong> and is not used for reticulin fibers.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Steiner silver stain</strong>: Steiner silver stain is used for the detection of certain microorganisms, like <strong>Legionella</strong> and <strong>Treponema</strong>, and is not related to reticulin fibers.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Grimelius silver stain</strong>: This stain is used for the detection of <strong>neuroendocrine cells</strong> by highlighting granules within these cells, and again, it is not related to the reticulin fibers of the liver.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Sweet’s reticulin stain is specifically used to demonstrate reticular fibers in the liver, allowing for the visualization of changes in hepatocellular architecture that are not apparent with H&E staining.</span></p>",
      "correct_choice_id": 200410,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50103,
      "choices": [
        {
          "id": 200412,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Azithromycin + Metronidazole</span></p>"
        },
        {
          "id": 200413,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Cefixime + Azithromycin</span></p>"
        },
        {
          "id": 200414,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Azithromycin + Doxycycline</span></p>"
        },
        {
          "id": 200415,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Doxycycline + Cefixime</span></p>"
        }
      ],
      "text": "<p><span style=\"color:black;font-size:12.0pt;\">Dr. Rajan is a consultant at a primary health center, frequently encountering cases of sexually transmitted infections (STIs) and reproductive tract infections (RTIs). He usually prefers syndromic approach for managing these conditions due to limited diagnostic facilities. A 28-year-old male patient walks in, presenting with discharge from his urethra, indicating a possible urethritis. The patient is unaware of the specific causative organism. Given the syndromic management approach, which combination of medications would Dr. Rajan most likely prescribe to effectively treat both gonococcal and non-gonococcal urethritis? (AIIMS MAY 2017)</span></p>",
      "unique_key": "Q9342031",
      "question_audio": null,
      "question_video": null,
      "map_id": 34443564,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. B) Cefixime + Azithromycin</strong></span></p><p> </p><ul><li><span style=\"color:black;font-size:12.0pt;\"> According to the syndromic approach for managing STIs/RTIs, the preferred treatment for both gonococcal and non-gonococcal urethritis involves a combination of Azithromycin and Cefixime.</span></li></ul><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Educational Objective: </strong></span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/20/screenshot-2024-09-20-114908.png\" alt=\"\" width=\"1000\" height=\"514\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/20/screenshot-2024-09-20-114908.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200413,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50104,
      "choices": [
        {
          "id": 200416,
          "text": "<p><span style=\"font-size:12pt;\">Subarachnoid hemorrhage</span></p>"
        },
        {
          "id": 200417,
          "text": "<p><span style=\"font-size:12pt;\">Meningitis</span></p>"
        },
        {
          "id": 200418,
          "text": "<p><span style=\"font-size:12pt;\">Acute migraine</span></p>"
        },
        {
          "id": 200419,
          "text": "<p><span style=\"font-size:12pt;\">Cortical vein thrombosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A lady was discharged after a normal vaginal delivery. On the third day she came back with fever, tachycardia and seizures. Fundus showed papilledema with no focal deficits. Diagnosis is? (INICET MAY 2017)</span></p>",
      "unique_key": "Q1693349",
      "question_audio": null,
      "question_video": null,
      "map_id": 34736706,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Cortical vein thrombosis</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">The given clinical situation likely suggests Cortical Vein Thrombosis.</span></li><li><span style=\"font-size:12pt;\">Cortical Vein thrombosis</span><ul><li><span style=\"font-size:12pt;\">Risk factors:</span><ul><li><span style=\"font-size:12pt;\">Pregnancy and puerperium</span></li><li><span style=\"font-size:12pt;\">Oral contraceptives</span></li><li><span style=\"font-size:12pt;\">Pro thrombotic conditions</span></li></ul></li><li><span style=\"font-size:12pt;\">Clinical presentation</span><ul><li><span style=\"font-size:12pt;\">Highly variable</span></li><li><span style=\"font-size:12pt;\">Headache is the most common symptom.</span></li><li><span style=\"font-size:12pt;\">With or without</span></li><li><span style=\"font-size:12pt;\">Vomiting</span></li><li><span style=\"font-size:12pt;\">Papilledema</span></li><li><span style=\"font-size:12pt;\">Focal deficits</span></li></ul></li><li><span style=\"font-size:12pt;\">Investigation</span><ul><li><span style=\"font-size:12pt;\">Brain MRI with MR venography - most sensitive</span></li><li><span style=\"font-size:12pt;\">CT - normal in 30 % of cases.</span></li></ul></li></ul></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A. Subarachnoid hemorrhage:</strong> Subarachnoid hemorrhage unlikely as there are no focal deficits</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option B. Meningitis:</strong> Meningitis would have presented with neck rigidity / photophobia and early papilledema goes against acute meningitis.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C. Acute Migraine:</strong> Acute Migraine does not present with seizures.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\"><strong>Cortical/ Cerebral vein thrombosis should be thought of in a patient with headache and seizures/ other neurological deficits following delivery</strong></span></li></ul>",
      "correct_choice_id": 200419,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50105,
      "choices": [
        {
          "id": 200420,
          "text": "<p><span style=\"font-size:12pt;\">Wedging</span></p>"
        },
        {
          "id": 200421,
          "text": "<p><span style=\"font-size:12pt;\">Burking</span></p>"
        },
        {
          "id": 200422,
          "text": "<p><span style=\"font-size:12pt;\">Positional asphyxia</span></p>"
        },
        {
          "id": 200423,
          "text": "<p><span style=\"font-size:12pt;\">Traumatic asphyxia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Cause of death in the position shown in the image below is: (</span>AIIMS Nov 2017)</p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/18/screenshot-2023-11-18-104356.png\" alt=\"\" width=\"300\" height=\"159\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/18/screenshot-2023-11-18-104356.png\" alt=\"Question Image\"></p>",
      "unique_key": "Q1503794",
      "question_audio": null,
      "question_video": null,
      "map_id": 34443046,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C. Positional asphyxia</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The position shown is Jack-knife position that leads to positional asphyxia (Restriction of lung expansion d/t abnormal position of the body). It is a position where the victim's thighs and knees are driven against the chest causing indirect compression of the chest and restriction of breathing movements.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A) Wedging:</strong></span><span style=\"font-size:9pt;\"> </span><span style=\"font-size:12.0pt;\">Infant falls in the small gap between wall & bed and getting wedged there.</span><span style=\"font-size:9pt;\"> </span><span style=\"font-size:12.0pt;\">It is a type of traumatic asphyxia.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B) Burking: </strong>Accused sits on chest of victim & closes mouth/ nostril as well. Its Mechanism is smothering combined with traumatic asphyxia.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D) Traumatic asphyxia: </strong>it is asphyxia due to restriction of lung expansion as a result of mechanical fixation of chest and not due to abnormal body position hence this option is incorrect.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Classification of Mechanical Asphyxia</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>1. Suffocation Asphyxia</strong></span></p><ul><li><span style=\"font-size:12.0pt;\">Smothering</span></li><li><span style=\"font-size:12.0pt;\">Gagging</span></li><li><span style=\"font-size:12.0pt;\">Traumatic Asphyxia (Crush Asphyxia)</span></li><li><span style=\"font-size:12.0pt;\">Positional Asphyxia (Postural Asphyxia)</span></li><li><span style=\"font-size:12.0pt;\">Burking</span></li><li><span style=\"font-size:12.0pt;\">Overlaying</span></li><li><span style=\"font-size:12.0pt;\">Choking (Café Coronary)</span></li></ul><p style=\"margin-left:48px;\"> </p><p><span style=\"font-size:12.0pt;\"><strong>2. Compression of neck</strong></span></p><ul><li><span style=\"font-size:12.0pt;\">Hanging – force is body weight / body is suspended</span></li><li><span style=\"font-size:12.0pt;\">Strangulation – force is anything other than body weight / no suspension.</span></li></ul><p style=\"margin-left:48px;\"> </p><p><span style=\"font-size:12.0pt;\"><strong>3. Drowning</strong></span></p>",
      "correct_choice_id": 200422,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50106,
      "choices": [
        {
          "id": 200424,
          "text": "<p><span style=\"font-size:12.0pt;\">Fibromatosis</span></p>"
        },
        {
          "id": 200425,
          "text": "<p><span style=\"font-size:12.0pt;\">Synovial sarcoma</span></p>"
        },
        {
          "id": 200426,
          "text": "<p><span style=\"font-size:12.0pt;\">Ewing sarcoma</span></p>"
        },
        {
          "id": 200427,
          "text": "<p><span style=\"font-size:12.0pt;\">Inflammatory myofibroblastic tumour</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">ALK positivity is seen in which of the following neoplasms: </span>(AIIMS MAY 2017)</p>",
      "unique_key": "Q2562124",
      "question_audio": null,
      "question_video": null,
      "map_id": 34540963,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Inflammatory myofibroblastic tumor</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">ALK (anaplastic lymphoma kinase) is seen in Inflammatory myofibroblastic tumor of lung.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">(ALK) Anaplastic lymphoma kinase {<strong>CD246</strong>} is a tyrosine kinase receptor encoded by the ALK gene located on <strong>chromosome 2p</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">ALK positive tumors respond to ALK kinase inhibitors, therefore it has an <strong>excellent prognosis.</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Fibromatosis</strong>: ALK positivity is not associated with fibromatosis. This condition is characterized by fibroblastic proliferation, and ALK is not typically involved.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Synovial sarcoma</strong>: Synovial sarcoma does not show ALK positivity. It is more often associated with specific translocations, such as <strong>t(X;18)(p11;q11)</strong>, resulting in SS18-SSX fusion genes.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Ewing sarcoma</strong>: Ewing sarcoma is characterized by a specific <strong>EWSR1-FLI1 fusion gene</strong> due to a translocation involving chromosomes 11 and 22. ALK positivity is not seen in Ewing sarcoma.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>ALK positivity is seen in:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Lung Cancers – Adenocarcinoma</strong>, small cell cancer, anaplastic cancer</span></li><li><span style=\"font-size:12.0pt;\"><strong>Inflammatory myofibroblastic tumor</strong></span></li><li><span style=\"font-size:12.0pt;\">Neuroblastoma</span></li><li><span style=\"font-size:12.0pt;\">Renal cell carcinomas</span></li><li><span style=\"font-size:12.0pt;\">Esophageal squamous cell carcinoma</span></li><li><span style=\"font-size:12.0pt;\">Breast cancer notably the inflammatory subtype</span></li><li><span style=\"font-size:12.0pt;\">Colonic adenocarcinoma</span></li><li><span style=\"font-size:12.0pt;\">Glioblastoma multiforme</span></li><li><span style=\"font-size:12.0pt;\">Anaplastic thyroid cancer</span></li></ul>",
      "correct_choice_id": 200427,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50107,
      "choices": [
        {
          "id": 200428,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Amoxicillin</span></span></span></p>"
        },
        {
          "id": 200429,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ciprofloxacin</span></span></span></p>"
        },
        {
          "id": 200430,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ofloxacin</span></span></span></p>"
        },
        {
          "id": 200431,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Erythromycin</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">What is the most bactericidal anti leprotic drug amongst the given drugs? (AIIMS MAY 2017)</span></span></p>",
      "unique_key": "Q3869206",
      "question_audio": null,
      "question_video": null,
      "map_id": 34349160,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C. Ofloxacin</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In general, Rifampicin is the most potent bactericidal anti leprotic drug.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">But in cases of Rifampicin resistance, we use regimens consisting of Ofloxacin+ Clofazimine + Clarithromycin/Minocycline are used for 24 months.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Out of these, the fluoroquinolone Ofloxacin is the most bactericidal anti leprotic drug.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option</span></strong><span style=\"font-size:12.0pt\"> <strong>A</strong>. <strong>Amoxicillin</strong>: Amoxicillin is a broad-spectrum antibiotic effective against a variety of bacterial infections but is not typically used or effective against Mycobacterium leprae, the bacterium that causes leprosy.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Ciprofloxacin</span></strong><span style=\"font-size:12.0pt\">: Ciprofloxacin is another fluoroquinolone that has broad antibacterial activity, including some activity against Mycobacterium species. However, it is not as potent as Ofloxacin in the treatment of leprosy.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D</span></strong><span style=\"font-size:12.0pt\">. <strong>Erythromycin</strong>: Erythromycin is a macrolide antibiotic that has some activity against Mycobacterium species but is less effective and less commonly used in the treatment of leprosy compared to Other Options: like Rifampicin and Ofloxacin.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Ofloxacin is the most bactericidal anti-leprotic drug among the given options, especially used in cases where there is resistance to the standard first-line treatment with Rifampicin.</span></span></p>",
      "correct_choice_id": 200430,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50108,
      "choices": [
        {
          "id": 200432,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">a</span></p>"
        },
        {
          "id": 200433,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">b</span></p>"
        },
        {
          "id": 200434,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">c</span></p>"
        },
        {
          "id": 200435,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">d</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11.0pt;\">In the image given below, identify the muscle responsible for the opening of the mouth? (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">AIIMS May 2017)</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/25/inicet-anat-2017-7.jpg\" alt=\"\" width=\"300\" height=\"297\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/25/inicet-anat-2017-7.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q3594231",
      "question_audio": null,
      "question_video": null,
      "map_id": 34941395,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt;\"><strong>Ans. B. b</strong></span></p><p> </p><p><span style=\"font-size:11pt;\">In the above image the structure marked ‘b’ represents the lateral pterygoid muscle which is responsible for opening the mouth.</span></p><p> </p><p><span style=\"font-size:11pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:11pt;\"><strong>Option A. a-Temporalis:</strong> This muscle is responsible for Elevation and retraction of mandible.</span></p><p> </p><p><span style=\"font-size:11pt;\"><strong>Option C. c – Medial pterygoid:</strong> This muscle is responsible for Elevation and ‘side-to-side’ movements of the mandible.</span></p><p> </p><p><span style=\"font-size:11pt;\"><strong>Option D. d –Buccinator:</strong> This muscle is responsible for compresses cheek against molar teeth</span><br> </p><p> </p><p><span style=\"font-size:11pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:11.0pt;\"><strong>Muscles of mastication </strong></span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/08/screenshot-2023-11-08-172431_qv8tx2u.jpg\" alt=\"\" width=\"1000\" height=\"837\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/08/screenshot-2023-11-08-172431_qv8tx2u.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200433,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50109,
      "choices": [
        {
          "id": 200436,
          "text": "<p>A</p>"
        },
        {
          "id": 200437,
          "text": "<p>B</p>"
        },
        {
          "id": 200438,
          "text": "<p>C</p>"
        },
        {
          "id": 200439,
          "text": "<p>D</p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The provided picture shows a patient who has undergone mastoidectomy. Identify the lateral semicircular canal in the image. (</span>AIIMS May 2017)</p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/29/picture9.jpg\" alt=\"\" width=\"300\" height=\"218\"></span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/29/picture9.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q5310733",
      "question_audio": null,
      "question_video": null,
      "map_id": 34687915,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) A</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">In the given image of a post-mastoidectomy surgical field, label A corresponds to the lateral semicircular canal. The lateral semicircular canal is a crucial component of the inner ear's vestibular system, involved in maintaining balance and spatial orientation. It can be identified by its specific location relative to other anatomical landmarks visible in the image, such as the tympanic bone, mastoid tip, and the spine of Henle.</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/29/picture10.jpg\" alt=\"\" width=\"500\" height=\"281\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B: </strong>This label points to the posterior semicircular canal, which is a bony protrusion in the mastoid portion of the temporal bone, serving as an important landmark during mastoid surgery.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C: </strong>This indicates the sigmoid sinus, a dural venous sinus within the skull, lying beneath the cranial bone and above the structures of the middle and inner ear.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D:</strong> Labelled as the Tegmen, which is part of the temporal bone that forms the roof over the middle ear and mastoid antrum, shielding these structures from the intracranial contents.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span><br> </p><p><span style=\"font-size:12.0pt;\">The lateral semicircular canal, identified at label A, is part of the vestibular system, crucial for balance and orientation.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/29/picture10.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200436,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50110,
      "choices": [
        {
          "id": 200440,
          "text": "<p><span style=\"color:black;font-size:16px;\">Orbital cortex</span></p>"
        },
        {
          "id": 200441,
          "text": "<p><span style=\"color:black;font-size:16px;\">Hippocampus</span></p>"
        },
        {
          "id": 200442,
          "text": "<p><span style=\"color:black;font-size:16px;\">Striate cortex</span></p>"
        },
        {
          "id": 200443,
          "text": "<p><span style=\"color:black;font-size:16px;\">Optic chiasma</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:16px;\">Which of the following is connected to the structure marked as A in the image below?</span></p><p> </p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/25/inicet-anat-2017-9.jpg\" alt=\"\" width=\"300\" height=\"224\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/25/inicet-anat-2017-9.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q6140545",
      "question_audio": null,
      "question_video": null,
      "map_id": 34684666,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C. Striate cortex</strong></span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Explanation:</strong></span></p><p> </p><ul><li><span style=\"font-size:16px;\">The structure marked A in the above image is the splenium of the corpus callosum and it is connected to the striate cortex.</span></li><li><span style=\"font-size:16px;\">The striate cortex, also known as the primary visual cortex or V1, is involved in early visual processing, such as processing basic features of visual stimuli like edges, orientation, and motion. It does have connections to the splenium of the corpus callosum, especially for the transfer of visual information between the hemispheres. This connection allows the brain to process visual information from both eyes and integrate it into a cohesive visual experience.</span></li><li><span style=\"font-size:16px;\">The splenium of the corpus callosum primarily connects various regions of the cerebral hemispheres, facilitating communication between the left and right cerebral hemispheres<strong>.</strong></span></li></ul><p> </p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Option A. Orbital Cortex:</strong> The orbital cortex is involved in various aspects of emotional processing and decision-making. It is not directly connected to the splenium of the corpus callosum.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Option B. Hippocampus: </strong>The hippocampus is a crucial structure for memory formation and spatial navigation. While it has connections to other parts of the brain, its primary connection to the corpus callosum is through the more anterior parts, not the splenium.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Option D. Optic Chiasma:</strong> The optic chiasma is not directly connected to the splenium of the corpus callosum. It is a structure located at the base of the brain where some of the optic nerve fibers from each eye cross over to the opposite side of the brain. This crossover allows for the integration of visual input from both eyes, but it occurs before the information reaches the corpus callosum.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:16px;\">The corpus callosum is divided into four parts: </span><ul><li><span style=\"font-size:16px;\">The <strong>rostrum</strong> is continuous with the lamina terminalis and connects the orbital surfaces of the frontal lobes.</span></li><li><span style=\"font-size:16px;\">The <strong>genu </strong>is the bend of the anterior corpus callosum and the forceps minor is a tract that projects fibres from the genu to connect the medial and lateral surfaces of the frontal lobes.</span></li><li><span style=\"font-size:16px;\">The <strong>body </strong>forms the long central section and its fibres pass through the corona radiata to reach the surface of the hemispheres. </span></li><li><span style=\"font-size:16px;\">The <strong>splenium </strong>tapers away at the posterior section, with the forceps major projecting fibres from the splenium to connect the two occipital lobes. Striate cortex (visual area) is located in occupital lobe.</span></li></ul></li><li><span style=\"color:black;font-size:16px;\">The hippocampus is not connected directly to the splenium, but situated inferior to the splenium.</span></li></ul><p> </p><p><span style=\"color:black;font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/08/picture6_Ya7jOMP.jpg\" alt=\"\" width=\"400\" height=\"367\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/08/picture6_Ya7jOMP.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200442,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50111,
      "choices": [
        {
          "id": 200444,
          "text": "<p><span style=\"font-size:12.0pt;\">Fasciola hepatica</span></p>"
        },
        {
          "id": 200445,
          "text": "<p><span style=\"font-size:12.0pt;\">Fasciolopsis buski</span></p>"
        },
        {
          "id": 200446,
          "text": "<p><span style=\"font-size:12.0pt;\">Pargaonimus westermani</span></p>"
        },
        {
          "id": 200447,
          "text": "<p><span style=\"font-size:12.0pt;\">Clonorchis sinensus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old male presents to the clinic with complaints of abdominal pain, fatigue, and weight loss and looked jaundiced. Upon further investigation, you suspect a parasitic infection. You obtain a stool sample and operculated eggs in the feces. Further examination reveals the presence of a parasite with a complex life cycle with snail and plants as the intermediate host. Which parasite is most likely responsible for the above symptoms? (INICET MAY 2017)</span></p>",
      "unique_key": "Q3451612",
      "question_audio": null,
      "question_video": null,
      "map_id": 34410287,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Fasciola hepatica</strong></span></p><p><span style=\"font-size:12.0pt;\"> </span></p><p><span style=\"font-size:12.0pt;\">Fasciola hepatica (sheep liver fluke) causes disease primarily in sheep and other domestic animals.</span></p><p><span style=\"font-size:12.0pt;\"> </span></p><p><span style=\"font-size:12.0pt;\">Humans are <strong>infected by eating watercress</strong> (or other aquatic plants) contaminated by larvae <strong>(metacercariae</strong>) that excyst in the duodenum, penetrate the gut wall, and reach the liver, where they mature into adults.</span></p><p><span style=\"font-size:12.0pt;\"> </span></p><p><span style=\"font-size:12.0pt;\">The adult flukes in the bile ducts produce eggs, which are excreted in the feces. The eggs hatch in freshwater and miracidia enter the snails. Miracidia develop into cercariae, which then encyst on aquatic vegetation.</span></p><p><span style=\"font-size:12.0pt;\"> </span></p><p><span style=\"font-size:12.0pt;\">Sheep and humans eat the plants, thus completing the life cycle.</span></p><p><span style=\"font-size:12.0pt;\"> </span></p><p><span style=\"font-size:12.0pt;\"><strong>Diagnosis is made by identification of the eggs in the feces.</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/22/untitled-175.jpg\" alt=\"\" width=\"600\" height=\"451\"></strong></span></p><p> </p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options</strong></span></p><p><span style=\"font-size:12.0pt;\"> </span></p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Fasciolopsis buski: </strong>Fasciolopsis buski is an intestinal fluke, and while it also involves snails as intermediate hosts, it does not primarily target the liver. Infection typically occurs through ingestion of aquatic plants, but the symptoms and life cycle do not match those described.</span></p><p><span style=\"font-size:12.0pt;\"> </span></p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Paragonimus westermani: </strong>Paragonimus westermani, the lung fluke, has a complex life cycle involving snails and crustaceans. It primarily causes pulmonary symptoms rather than abdominal pain, fatigue, and weight loss. Eggs are typically found in sputum, not feces.</span></p><p><span style=\"font-size:12.0pt;\"> </span></p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Clonorchis sinensis: </strong>Clonorchis sinensis, the Chinese liver fluke, also involves snails as intermediate hosts and can cause liver-related symptoms. However, the life cycle and specific hosts differ slightly from Fasciola hepatica. It primarily affects the liver and bile ducts but is more common in certain geographic regions.</span></p><p><span style=\"font-size:12.0pt;\"> </span></p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong></span></p><p><span style=\"font-size:12.0pt;\"> </span></p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Fasciola hepatica, the sheep liver fluke, is diagnosed by identifying eggs in the feces, and it has a complex life cycle involving snails and aquatic vegetation, making it the most likely cause of the described symptoms.</span></li></ul><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/22/untitled-175.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200444,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50112,
      "choices": [
        {
          "id": 200448,
          "text": "<p><span style=\"font-size:12.0pt;\">Capgras syndrome</span></p>"
        },
        {
          "id": 200449,
          "text": "<p><span style=\"font-size:12.0pt;\">Fregoli syndrome</span></p>"
        },
        {
          "id": 200450,
          "text": "<p><span style=\"font-size:12.0pt;\">Delusion of subjective doubles</span></p>"
        },
        {
          "id": 200451,
          "text": "<p><span style=\"font-size:12.0pt;\">Othello syndrome</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"color:#374151;font-size:12.0pt;\">A young patient with acute psychosis is admitted to the hospital. He wakes up and asks for his wife, even though she is in the same room as him. When she is pointed out, he claims that she is not his wife and that she is being impersonated by someone else. What is the most likely diagnosis? (</span>AIIMS May 2017)</p>",
      "unique_key": "Q1853963",
      "question_audio": null,
      "question_video": null,
      "map_id": 34148078,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"color:#374151;font-size:12.0pt;\"><strong>Ans. A) Capgras syndrome</strong></span></p><p> </p><p><span style=\"color:#374151;font-size:12.0pt;\">The described scenario involves the patient's belief that a familiar person, in this case his wife, has been replaced by an imposter. This specific delusion is characteristic of <strong>Capgras syndrome</strong>.</span></p><p> </p><p><span style=\"color:#374151;font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"color:#374151;font-size:12.0pt;\"><strong>Option B. </strong></span><span style=\"font-size:12.0pt;\"><strong>Fregoli syndrome:</strong></span><span style=\"color:#374151;font-size:12.0pt;\"> Fregoli syndrome is a delusional misidentification syndrome where the patient believes that a familiar persons can change his physical appearance and disguise as a stranger, and that he can take multiple different appearances.</span></p><p> </p><p><span style=\"color:#374151;font-size:12.0pt;\"><strong>Option C. Delusion of subjective doubles: </strong>Delusion of subjective doubles refers to the patient's belief that he or she has many doubles who are living life of their own.</span></p><p> </p><p><span style=\"color:#374151;font-size:12.0pt;\"><strong>Option D. Othello syndrome: </strong>Othello syndrome pertains to the delusional belief that one's partner is unfaithful.</span></p><p> </p><p><span style=\"color:#374151;font-size:12.0pt;\"><strong>Educational Objective: </strong></span></p><p> </p><p><span style=\"color:#374151;font-size:12.0pt;\">Delusional misidentification syndromes include Capgras syndrome, Fregoli’s syndrome, syndrome of intermetamorphosis and syndrome of subjective doubles.</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/11/screenshot-2023-10-11-173832.jpg\" alt=\"\" width=\"1000\" height=\"667\"></p><p> </p><p><span style=\"color:#374151;font-size:12.0pt;\"><strong>Reference: Sim’s Symptoms in the Mind, 7th edition, Page No 124-125.</strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/11/screenshot-2023-10-11-173832.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200448,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50113,
      "choices": [
        {
          "id": 200452,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Confused state</span></p>"
        },
        {
          "id": 200453,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Respiratory rate >30/min</span></p>"
        },
        {
          "id": 200454,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Blood urea nitrogen greater than 7mmol/L</span></p>"
        },
        {
          "id": 200455,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Systolic blood pressure less than 100 mm Hg</span></p>"
        }
      ],
      "text": "<p><span style=\"color:black;font-size:12.0pt;\">All are components of CURB65 except? (AIIMS MAY 2017)</span></p>",
      "unique_key": "Q4136906",
      "question_audio": null,
      "question_video": null,
      "map_id": 34403765,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Systolic blood pressure less than 10mm Hg</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The correct answer, D, specifies a systolic blood pressure less than 100 mm Hg, which is not part of the CURB-65 criteria. The specified threshold for blood pressure in the CURB-65 is ≤90 mm Hg systolic or ≤60 mm Hg diastolic.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">CURB-65 criteria is <strong>used to assess the severity of illness in case of pneumonia</strong>, especially community acquired pneumonia. It includes 5 variables -</span></p><p> </p><p><span style=\"color:red;font-size:12.0pt;\"><strong>C - C</strong></span><span style=\"font-size:12.0pt;\">onfusion</span></p><p> </p><p><span style=\"color:red;font-size:12.0pt;\"><strong>U - U</strong></span><span style=\"font-size:12.0pt;\">rea>7mmol/L</span></p><p> </p><p><span style=\"color:red;font-size:12.0pt;\"><strong>R - R</strong></span><span style=\"font-size:12.0pt;\">espiratory rate >30/mins</span></p><p> </p><p><span style=\"color:red;font-size:12.0pt;\"><strong>B - B</strong></span><span style=\"font-size:12.0pt;\">lood pressure, SBP </=90 mmHg or diastolic </= 60 mmHg</span></p><p> </p><p><span style=\"color:red;font-size:12.0pt;\"><strong>65 - </strong></span><span style=\"font-size:12.0pt;\">Age >/= </span><span style=\"color:red;font-size:12.0pt;\"><strong>65</strong></span><span style=\"font-size:12.0pt;\"> years</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Management</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/picture29.jpg\" alt=\"\" width=\"1000\" height=\"193\"></strong></span></p><p> </p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">CURB-65 scoring system is used to evaluate pneumonia severity, which does not include systolic blood pressure less than 100 mm Hg but instead sets the threshold at ≤90 mm Hg systolic or ≤60 mm Hg diastolic.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/picture29.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200455,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50114,
      "choices": [
        {
          "id": 200456,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Yellow – least priority</span></p>"
        },
        {
          "id": 200457,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Red – mortality</span></p>"
        },
        {
          "id": 200458,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Green – ambulatory</span></p>"
        },
        {
          "id": 200459,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Blue – ambulatory</span></p>"
        }
      ],
      "text": "<p><span style=\"color:black;font-size:12.0pt;\">During a major disaster response, the medical team in an emergency department needs to prioritize patients based on the severity of their injuries and their medical needs. This prioritization process is known as triage. Each patient is assigned a specific color code representing their current state and the urgency of their medical attention. Which of the following correctly matches the color designation with its corresponding level of patient priority in the triage process? (AIIMS MAY 2017)</span></p>",
      "unique_key": "Q3181720",
      "question_audio": null,
      "question_video": null,
      "map_id": 34096397,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. C) Green – ambulatory</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Triage is a critical process used in emergency medicine to quickly classify patients according to the severity of their health condition and the urgency of their need for care.</span></li><li><span style=\"font-size:12.0pt;\">The color-coding system is a standardized approach used globally, with each color representing a specific category of priority:</span></li><li><span style=\"font-size:12.0pt;\"><strong>Green</strong> indicates \"ambulatory\" patients, who are those with relatively minor injuries or conditions that do not require immediate, life-saving intervention.</span></li><li><span style=\"font-size:12.0pt;\">These patients can often walk and may have injuries such as infections, closed fractures, minor abrasions, and lacerations.</span></li></ul><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/18/screenshot-2023-10-18-114302.jpg\" alt=\"\" width=\"800\" height=\"417\"></strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/18/screenshot-2023-10-18-114302.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200458,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50115,
      "choices": [
        {
          "id": 200460,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Zonula occludens</span></span></span></p>"
        },
        {
          "id": 200461,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Fascia adherens</span></span></span></p>"
        },
        {
          "id": 200462,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Gap junctions</span></span></span></p>"
        },
        {
          "id": 200463,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Macula adherens</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Cellular junctions present in a cardiac muscle are all except? (</span></span>AIIMS May 2017)</p>",
      "unique_key": "Q3313637",
      "question_audio": null,
      "question_video": null,
      "map_id": 34651096,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Zonula occludens</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Zonula occludens is the other name for the tight junction. It is absent in a cardiac muscle.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cardiac muscle fibers are striated bound by sarcolemma with a centrally placed nucleus.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Myofibrils are embedded in the sarcoplasm.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sarcomere of the cardiac muscle has all the contractile proteins, namely actin, myosin, troponin and tropomyosin. Cardiac muscle fiber is branched.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Intercalated disk - formed by the fusion of the membrane of the cardiac muscle branches.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/28/screenshot-2024-05-28-175907.png\" style=\"height:335px; width:400px\" /></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Fascia adherens</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> - broad intercellular junction both of sarcolemma and intercalated disc of cardiac muscle fibers that anchors actin filaments.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Gap junction - </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">fused membranes adjacent muscle fibers form gap junctions. It is permeable to ions and it facilitates the rapid conduction of action potential from one fiber to another.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Macula adherens</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> - Also called as desmosomes are intercellular junctions specialized for strong adhesion. They prevent the separation of cardiac myocytes during individual fiber contraction by binding to intracellular intermediate filaments (cytoskeleton), which joins cells together.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"background-color:white\"><span style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:#0d0d0d\">Zonula occludens are absent in cardiac muscle; instead, this muscle type prominently features fascia adherens, gap junctions, and macula adherens, which are essential for mechanical stability and coordinated contraction.</span></span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/28/screenshot-2024-05-28-175907.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200460,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50116,
      "choices": [
        {
          "id": 200464,
          "text": "<p><span style=\"font-size:12.0pt;\">Tension band wiring</span></p>"
        },
        {
          "id": 200465,
          "text": "<p><span style=\"font-size:12.0pt;\">Compression plating</span></p>"
        },
        {
          "id": 200466,
          "text": "<p><span style=\"font-size:12.0pt;\">Internal fixation</span></p>"
        },
        {
          "id": 200467,
          "text": "<p><span style=\"font-size:12.0pt;\">K-wire fixation</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">An athlete suffers a fracture as shown in the knee X-ray below. How is this fracture managed? (AIIMS MAY 2018)</span></p><p style=\"text-align:justify;\"> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/15/screenshot-2024-05-15-110859.JPG\" alt=\"\" width=\"250\" height=\"421\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/15/screenshot-2024-05-15-110859.JPG\" alt=\"Question Image\"></p>",
      "unique_key": "Q7615026",
      "question_audio": null,
      "question_video": null,
      "map_id": 34732211,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Tension band wiring</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>PATELLA FRACTURE TREATMENT</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The image displays a displaced patellar fracture, and the treatment of choice is <strong>Tension Band Wiring</strong>.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Tension Band Wiring (TBW)</strong> is a surgical method to secure the bones in place which are subjected to tension forces.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Wires</strong> and <strong>Screws</strong> or <strong>Pins</strong> are used to create this tension band effect.</span></li><li><span style=\"font-size:12.0pt;\">In <strong>two-part fracture of Patella</strong>, the <strong>pull of Quadriceps</strong> on the proximal fragment keeps them apart.</span></li><li><span style=\"font-size:12.0pt;\">In the operation, first the fractured <strong>fragments are reduced, fixed with TBW</strong> and then the <strong>extensor retinacula are repaired</strong>.</span></li><li><span style=\"font-size:12.0pt;\"><strong>TBW converts distractive forces into compressive forces.</strong></span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/15/screenshot-2024-05-15-110958.JPG\" alt=\"\" width=\"500\" height=\"313\"></strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>In case if there is comminuted fracture where accurate reduction is not possible, patellectomy is done.</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Tension band wiring is done using: </strong></span><ul><li><span style=\"font-size:12.0pt;\">Cancellous screws for fracture of Olecranon process</span></li><li><span style=\"font-size:12.0pt;\">K-wires and stainless steel wires for fracture of Patella</span></li></ul></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Tension band wiring is the gold standard treatment for the two-part patella fracture.</span></li></ul><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/15/screenshot-2024-05-15-110958.JPG\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200464,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50117,
      "choices": [
        {
          "id": 200468,
          "text": "<p><span style=\"font-size:12.0pt;\">Signature of the Doctor</span></p>"
        },
        {
          "id": 200469,
          "text": "<p><span style=\"font-size:12.0pt;\">Consent</span></p>"
        },
        {
          "id": 200470,
          "text": "<p><span style=\"font-size:12.0pt;\">Functioning pulse oximeter</span></p>"
        },
        {
          "id": 200471,
          "text": "<p><span style=\"font-size:12.0pt;\">Sterility of instruments</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In a Preoperative surgical safety Checklist, which of the following is not a component? (AIIMS MAY 2017)</span></p>",
      "unique_key": "Q6693819",
      "question_audio": null,
      "question_video": null,
      "map_id": 34235923,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Signature of the doctor</strong></span></p><p><span style=\"font-size:11pt;\"><strong> </strong></span></p><p><span style=\"font-size:12.0pt;\">In a preoperative patient surgical safety checklist, doctor's signature is not needed.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">the signature of the doctor, is not typically a component of the surgical safety checklist. Instead, the checklist focuses on verifying critical safety elements like patient consent, equipment functionality, and instrument sterility.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Consent</strong>: Ensuring that informed consent has been obtained from the patient is a crucial component of preoperative safety checklists. It confirms that the patient has been informed about the procedure, risks, and alternatives and has given their consent for the surgery.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Functioning</strong> <strong>pulse</strong> <strong>oximeter</strong>: Checking the functioning of medical equipment like a pulse oximeter is an important step in preoperative safety. It ensures that necessary monitoring devices are in working order to monitor the patient's vital signs during surgery.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Sterility of instruments</strong>: Verifying the sterility of surgical instruments is essential to prevent infections during surgery. It ensures that all instruments that will come into contact with the patient are properly sterilized and safe for use.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/09/screenshot-2024-09-09-171218.png\" alt=\"\" width=\"600\" height=\"253\"></strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/09/screenshot-2024-09-09-171218.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200468,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50118,
      "choices": [
        {
          "id": 200472,
          "text": "<p><span style=\"font-size:12.0pt;\">Rheumatic valvular disease</span></p>"
        },
        {
          "id": 200473,
          "text": "<p><span style=\"font-size:12.0pt;\">Infective endocarditis</span></p>"
        },
        {
          "id": 200474,
          "text": "<p><span style=\"font-size:12.0pt;\">Myxoma</span></p>"
        },
        {
          "id": 200475,
          "text": "<p><span style=\"font-size:12.0pt;\">Sarcoidosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old male patient presents with severe dyspnea. Mitral stenosis with left atrial hypertrophy is seen. Vegetations present on the mitral valve were excised. What is the most likely diagnosis based on the given HE image? </span>(AIIMS MAY 2017)</p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/43.jpg\" alt=\"\" width=\"300\" height=\"200\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/43.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q4539933",
      "question_audio": null,
      "question_video": null,
      "map_id": 34331406,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Rheumatic valvular disease</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The given image depicts Aschoff's body, which is suggestive of rheumatic valvular disease. During acute Rheumatic Fever (RF), focal inflammatory lesions are found in various tissues. Distinctive lesions occur in the heart, called Aschoff bodies, which consist of foci of lymphocytes (<strong>primarily T cells</strong>), occasional plasma cells, and plump <strong>activated macrophages called Anitschkow</strong> cells (pathognomonic for RF). These macrophages have abundant cytoplasm and central round-to ovoid nuclei in which the chromatin is disposed in a central, slender, wavy ribbon (hence the designation <strong>“caterpillar cells</strong>”) and may become multinucleated.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/44.jpg\" alt=\"\" width=\"500\" height=\"395\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Infective endocarditis</strong>: Infective endocarditis is characterized by large, friable vegetations composed of fibrin, inflammatory cells, and microorganisms, which would not exhibit the Aschoff bodies seen in rheumatic fever.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Myxoma</strong>: Myxomas are benign tumors of the heart that typically present as a gelatinous mass, and they do not feature Aschoff bodies or the inflammatory response seen in rheumatic fever.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Sarcoidosis</strong>: Sarcoidosis is a granulomatous disease that can affect the heart but does not produce the Aschoff bodies characteristic of rheumatic fever.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The presence of Aschoff bodies, characterized by foci of lymphocytes, plasma cells, and Anitschkow cells, is pathognomonic for rheumatic valvular disease and indicates a history of acute rheumatic fever.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbins and Cortans pathologic basis of disease, 8<sup>th</sup> edition, Page no – 1044</strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/44.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200472,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50119,
      "choices": [
        {
          "id": 200476,
          "text": "<p><span style=\"font-size:12.0pt;\">Frozen shoulder</span></p>"
        },
        {
          "id": 200477,
          "text": "<p><span style=\"font-size:12.0pt;\">Recurrent shoulder dislocation</span></p>"
        },
        {
          "id": 200478,
          "text": "<p><span style=\"font-size:12.0pt;\">Normal shoulder healing and movements</span></p>"
        },
        {
          "id": 200479,
          "text": "<p><span style=\"font-size:12.0pt;\">Subscapular tendinitis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the most common sequelae of traumatic shoulder dislocation in young adults?(AIIMS MAY 2017)</span></p>",
      "unique_key": "Q8753361",
      "question_audio": null,
      "question_video": null,
      "map_id": 34784420,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Recurrent shoulder dislocation</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>SEQUELAE OF TRAUMATIC SHOULDER DISLOCATION</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Recurrent dislocation is most common in shoulder joint, accounting for nearly 50% of all dislocations.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Most commonly it is subcoracoid type</strong>.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Other complications include</strong>:</span><ul><li><span style=\"font-size:12.0pt;\">Muscle, ligament or tendon rupture</span></li><li><span style=\"font-size:12.0pt;\">Nerve or blood vessel damage around the joint</span></li><li><span style=\"font-size:12.0pt;\">Shoulder instability</span></li></ul></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Frozen shoulder</strong>. Following dislocation, the shoulder shows some degree of limited motion owing to pain or apprehension for some time, which usually spontaneously recovers. However, some patients experience continuous stiffness after dislocation. This may lead to frozen shoulder if not mobilized early.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Normal shoulder healing and movements</strong>. The healing after the shoulder dislocation takes around 12-16 weeks. The movements are started slowly under the rehabilitation process.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Subscapular tendinitis</strong>. It is a rare complication of shoulder dislocation.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The most common sequealae of the shoulder dislocation is the recurrence of the shoulder dislocation due to instability of the shoulder joint tissues.</span></li></ul>",
      "correct_choice_id": 200477,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50120,
      "choices": [
        {
          "id": 200480,
          "text": "<p><span style=\"font-size:12.0pt;\">Epidermis</span></p>"
        },
        {
          "id": 200481,
          "text": "<p><span style=\"font-size:12.0pt;\">Subcutaneous tissue</span></p>"
        },
        {
          "id": 200482,
          "text": "<p><span style=\"font-size:12.0pt;\">Papillary dermis</span></p>"
        },
        {
          "id": 200483,
          "text": "<p><span style=\"font-size:12.0pt;\">Reticular dermis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following layers is involved in blister formation in a superficial partial thickness burn? (AIIMS MAY 2017)</span></p>",
      "unique_key": "Q3343656",
      "question_audio": null,
      "question_video": null,
      "map_id": 34619972,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Papillary dermis</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The papillary dermis is a layer of the skin that lies just below the epidermis. Blister formation in superficial partial thickness burns occurs within this layer, as it is the point where the burn has affected both the epidermis and the upper portion of the dermis.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Epidermis</strong>: The epidermis is the outermost layer of the skin. In superficial partial thickness burns, this layer is typically damaged, but blister formation occurs slightly deeper within the skin.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Subcutaneous tissue</strong>: The subcutaneous tissue is located beneath the dermis and is not typically involved in blister formation in superficial partial thickness burns.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Reticular dermis</strong>: The reticular dermis is located deeper in the skin and is not primarily associated with blister formation in superficial partial thickness burns. Blister formation occurs closer to the surface.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The papillary dermis is involved in blister formation in a superficial partial-thickness burn.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>First-degree burns </strong>involve only the epidermis, with pain, redness, and mild swelling.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Second-degree burns </strong>involve the epidermis and some parts of the dermis (also known as partial-thickness burns). Further classified as-</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Superficial second degree or superficial partial-thickness burn - involves the upper part of the dermis (papillary) and shows pain, blisters, and severe swelling.</span></li><li><span style=\"font-size:12.0pt;\">Deep second degree or deep partial-thickness burn - extends deeper up to the reticular layer of the dermis and appears paler and more mottled, does not blanch to touch, but remains painful to pinprick.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Third-degree or full-thickness burns </strong>involve the complete thickness of the dermis and subcutaneous tissue.</span></p>",
      "correct_choice_id": 200482,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50121,
      "choices": [
        {
          "id": 200484,
          "text": "<p><span style=\"font-size:12.0pt;\">SIADH</span></p>"
        },
        {
          "id": 200485,
          "text": "<p><span style=\"font-size:12.0pt;\">Diuretic induced hyponatremia</span></p>"
        },
        {
          "id": 200486,
          "text": "<p><span style=\"font-size:12.0pt;\">Cerebral salt wasting syndrome</span></p>"
        },
        {
          "id": 200487,
          "text": "<p><span style=\"font-size:12.0pt;\">Pseudohyponatremia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 40-year-old smoker who is a known case of hypertension was on enalapril and hydrochlorothiazide. He had an episode of hemoptysis and on evaluation, he was found to have bronchogenic carcinoma with brain metastasis. His lab values were Na-124mg/dL, creatinine - 2.8mg%, blood sugar 112mg/dL, blood urea - 24mg/dL, serum osmolality 255mosm, urine osmolality - 110 mosm, 24-hour urinary sodium - 110 and BP - 150/90 mmHg.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Which of the following is the most probable diagnosis of the low sodium values in him? (AIIMS MAY 2018)</span></p>",
      "unique_key": "Q8622876",
      "question_audio": null,
      "question_video": null,
      "map_id": 34451859,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) SIADH</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH) is the most probable diagnosis in this patient. The diagnostic criteria and the patient's clinical presentation support this conclusion:</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/picture31.jpg\" alt=\"\" width=\"1000\" height=\"267\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Additionally, lung cancer (specifically bronchogenic carcinoma) can often cause SIADH, either through ectopic production of antidiuretic hormone (ADH) or related paraneoplastic syndromes.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Diuretic induced hyponatremia:</strong> Incorrect because the pattern of serum and urine osmolality does not align solely with diuretic use; the high urine sodium and euvolemia are more indicative of SIADH.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Cerebral salt wasting syndrome:</strong> Incorrect as this condition typically presents with hypovolemia and low blood pressure due to significant sodium and fluid loss, which is not evident in this patient who maintains a normal blood pressure.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Pseudohyponatremia:</strong> Incorrect because the reduced serum osmolality directly indicates true hyponatremia, not a distortion caused by high levels of lipids or proteins in the blood.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">SIADH can be associated with malignancies like lung cancer, presenting with hyponatremia, low serum osmolality, and inappropriately concentrated urine despite the presence of low plasma osmolality. This clinical scenario should prompt consideration of SIADH, particularly in patients with known malignancies and typical lab findings.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/20/picture31.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200484,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50122,
      "choices": [
        {
          "id": 200488,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Mitochondria</span></p>"
        },
        {
          "id": 200489,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Golgi bodies</span></p>"
        },
        {
          "id": 200490,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Secretory vesicles</span></p>"
        },
        {
          "id": 200491,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Ribosomes</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11.0pt;\">The structure marked with the asterisk in the electron micrograph indicates? (</span>AIIMS May 2017)</p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/09/picture2_Uz5q5Z3.jpg\" alt=\"\" width=\"300\" height=\"343\"></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/09/picture2_Uz5q5Z3.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q7367541",
      "question_audio": null,
      "question_video": null,
      "map_id": 34205308,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt;\"><strong>Ans. C. Secretory vesicles</strong></span></p><p> </p><p><span style=\"font-size:11pt;\"><strong>Explanation</strong></span></p><p> </p><ul><li><span style=\"font-size:11pt;\">The structure marked with the asterisk in the electron micrograph indicates presynaptic secretory vesicles.</span></li><li><span style=\"font-size:11pt;\">The structure marked with the arrowhead is postsynaptic density.</span></li><li><span style=\"font-size:11pt;\">The secretory vesicles are synthesized by the neurons and are involved in electrochemical signalling in the brain and neuromuscular junctions.</span></li><li><span style=\"color:black;font-size:11.0pt;\">In the synaptic region, the plasma membrane of the presynaptic cell is specialized for vesicle exocytosis; synaptic vesicles, which contain a neurotransmitter, are clustered in these regions. The opposing membrane of the postsynaptic cell (in this case, a neuron) contains receptors for the neurotransmitter.</span></li></ul><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/25/untitled-88.jpg\" alt=\"\" width=\"400\" height=\"400\"></span></p><p> </p><p><span style=\"font-size:11pt;\"><strong>On electron microscopy</strong></span></p><p> </p><p><span style=\"font-size:11pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:11.0pt;\"><strong>Option A . Mitochondria </strong></span><span style=\"font-size:11pt;\">appear as round or elliptical bodies of 0.5-2.0 micron long on an electron microscope, consisting of an outer and an inner mitochondrial membrane, cristae, and mitochondrial matrix.</span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/25/inicet-anat-2017-5.jpg\" alt=\"\" width=\"500\" height=\"597\"></span></p><p> </p><p><span style=\"font-size:11pt;\"><strong>Option B. Golgi bodies (</strong>or Golgi apparatus) appear as stacks of flattened membranous cisternae surrounded by clusters of vesicles.</span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/25/inicet-anat-2017-6.jpg\" alt=\"\" width=\"700\" height=\"213\"></span></p><p> </p><p><span style=\"font-size:11pt;\"><strong>Option D. Ribosomes</strong> may be attached to the membrane of the rough endoplasmic reticulum (as shown in the image below), or else, they may exist as monosomes or as a chain of granular structures called polyribosomes associated with mRNA</span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/25/untitled-89.jpg\" alt=\"\" width=\"637\" height=\"325\"></span></p><p> </p><p><span style=\"font-size:11pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:11pt;\">The structure marked with the asterisk in the electron micrograph represents presynaptic secretory vesicles, essential for neurotransmitter storage and release during synaptic transmission, highlighting their role in neuronal communication.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/25/untitled-88.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200490,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50123,
      "choices": [
        {
          "id": 200492,
          "text": "<p><span style=\"font-size:12pt;\">G4P2 L1 A2</span></p>"
        },
        {
          "id": 200493,
          "text": "<p><span style=\"font-size:12pt;\">G4P1 A2 L1</span></p>"
        },
        {
          "id": 200494,
          "text": "<p><span style=\"font-size:12pt;\">G5PO L1 A2</span></p>"
        },
        {
          "id": 200495,
          "text": "<p><span style=\"font-size:12pt;\">G5P1 A2 L1</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old woman came to OPD with a twin pregnancy at 10 weeks of gestation. She has a 3-year-old female child who was born at term and had 2 first trimester abortions previously. Which of the following is the correct representation of her obstetric score/formula? (INICET MAY 2017)</span></p>",
      "unique_key": "Q8092985",
      "question_audio": null,
      "question_video": null,
      "map_id": 34948490,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) G4P1 A2 L1</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Determining the Parity Index/ Obstetric Formula</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>2 formulas</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>1. G __ P __ L __ A ___</strong></span></p><p> </p><ul style=\"list-style-type:square;\"><li><span style=\"font-size:12pt;\">Gravida (G): The number of times a woman has conceived including the present pregnancy irrespective of the gestational age or the outcome.</span></li><li><span style=\"font-size:12pt;\">Para (P): The number of times a pregnancy has crossed the period of viability (taken as 28 weeks for all practical purposes) EXCLUDING the present pregnancy.</span></li><li><span style=\"font-size:12pt;\">Living (L): The total number of living children the woman has.</span></li><li><span style=\"font-size:12pt;\">Abortion (A): The total number of times the pregnancy has resulted in an abortion/ pregnancy has not crossed the period of viability.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>The obstetric score here is G4P1A2L1.</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>2. P A-B-C-D (A: term; B: preterm; C: abortions; D: Living)</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">This is another way to write the formula.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong><u>IMPORTANT</u>: A Twin pregnancy which has crossed the period of viability is considered as Para 1 NOT Para 2. But if it results in 2 living children it will be Live 2.</strong></span></p>",
      "correct_choice_id": 200493,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50124,
      "choices": [
        {
          "id": 200496,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Doxycycline</span></span></span></p>"
        },
        {
          "id": 200497,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:\"Calibri\",sans-serif\">Amoxicillin</span></span></span></p>"
        },
        {
          "id": 200498,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:\"Calibri\",sans-serif\">Fluconazole</span></span></span></p>"
        },
        {
          "id": 200499,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:\"Calibri\",sans-serif\">Metronidazole</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A 25-year-old female came with complaints of greenish discharge per vagina and on examination she had a strawberry cervix. Which of the following is the treatment for her? (INICET MAY 2017)</span></span></p>",
      "unique_key": "Q1340802",
      "question_audio": null,
      "question_video": null,
      "map_id": 34211235,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-family:\"Calibri\",sans-serif\">Ans. D) Metronidazole</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The clinical presentation of greenish-yellow discharge and a strawberry cervix is characteristic of trichomoniasis. Trichomoniasis is a sexually transmitted infection caused by the protozoan Trichomonas vaginalis. The diagnostic feature of trichomoniasis includes the presence of motile flagellate organisms on a wet mount microscopy.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Characteristic findings:</span></strong></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Colour of discharge:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> Greenish yellow</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">On examination:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> Strawberry cervix and vagina</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">pH:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> >5</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Diagnosis (Wet mount):</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> Motile flagellate organism</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Treatment:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The recommended treatment for trichomoniasis is metronidazole. It can be administered as a single dose of 2g or 200mg TDS for 7 days.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A. Doxycycline:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> This antibiotic is used to treat various bacterial infections, including some sexually transmitted infections, but it is not the treatment of choice for trichomoniasis.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. Amoxicillin:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> This antibiotic is used for bacterial infections but is not effective against trichomoniasis.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. Fluconazole:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> This antifungal medication is used to treat candidiasis, not trichomoniasis.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Strawberry cervix and greenish-yellow vaginal discharge are characteristic of trichomoniasis, which is treated with metronidazole.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/03/screenshot-2024-08-03-154323.png\" style=\"height:447px; width:1000px\" /></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Strawberry cervix and vagina are characteristic of Trichomoniasis</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ref: Page no 164, DC Dutta’s Textbook of Gynecology 6<sup>th</sup> edition</span></strong></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/08/03/screenshot-2024-08-03-154323.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200499,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50125,
      "choices": [
        {
          "id": 200500,
          "text": "<p><span style=\"font-size:12.0pt;\">Suprachoroidal hemorrhage</span></p>"
        },
        {
          "id": 200501,
          "text": "<p><span style=\"font-size:12.0pt;\">Cyclodialysis of uvea</span></p>"
        },
        {
          "id": 200502,
          "text": "<p><span style=\"font-size:12.0pt;\">Corneal perforation</span></p>"
        },
        {
          "id": 200503,
          "text": "<p><span style=\"font-size:12.0pt;\">Filtration site leak</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient came to the ophthalmology OPD with corneal abrasion, corneal ulcer, corneal perforation and foreign body. Which of the following will not cause hypotonic maculopathy in this patient? (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">AIIMS May 2017)</span></p>",
      "unique_key": "Q4164521",
      "question_audio": null,
      "question_video": null,
      "map_id": 34622594,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Suprachoroidal hemorrhage</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Suprachoroidal hemorrhage does not cause hypotonic maculopathy in this patient.</span></li><li><span style=\"font-size:12.0pt;\">Signs of Suprachoroidal hemorrhage include the following:</span></li><li> <ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">Anterior chamber shallowing</span></li><li><span style=\"font-size:12.0pt;\">Loss of the red reflex</span></li><li><span style=\"font-size:12.0pt;\">Increased IOP, with firming of the eye</span></li><li><span style=\"font-size:12.0pt;\">Wrinkling and bulging of the posterior capsule</span></li><li><span style=\"font-size:12.0pt;\">Extrusion of intraocular contents: spontaneous nuclear expression, iris prolapse, vitreous prolapse</span></li></ul></li><li><span style=\"font-size:12.0pt;\">Maculopathy is a common consequence of hypotony, defined as IOP less than 5 mmHg.</span></li><li><span style=\"font-size:12.0pt;\">Excessive drainage following glaucoma filtration surgery is the most common cause of hypotonic maculopathy.</span></li><li><span style=\"font-size:12.0pt;\">Other causes include trauma (cyclodialysis cleft, penetrating injury), chronic uveitis, retinal detachment.</span></li><li><span style=\"font-size:12.0pt;\">Systemic causes of hypotony, usually bilateral, include dehydration, uncontrolled diabetes with hyperglycaemia, uraemia, and treatment with hyperosmotic agents or carbonic anhydrase inhibitors<strong>.</strong></span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Cyclodialysis of uvea:</strong> This refers to the disinsertion of the ciliary body from the scleral spur, a trauma-related occurrence that can lead to a direct decrease in IOP, potentially causing hypotonic maculopathy.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Corneal perforation:</strong> Severe enough corneal damage, such as perforation, can lead to loss of aqueous humor and a subsequent decrease in IOP, posing a risk for hypotonic maculopathy.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Filtration site leak:</strong> This condition is specifically associated with glaucoma surgery where a leak at the filtration site can lead to a significant reduction in IOP, making it a direct cause of hypotonic maculopathy.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Suprachoroidal hemorrhage does not lead to hypotonic maculopathy because it typically causes an increase in intraocular pressure, not a decrease. Understanding the distinction between conditions that increase versus those that decrease IOP is critical in the management of eye conditions and their potential complications.</span></p>",
      "correct_choice_id": 200500,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50126,
      "choices": [
        {
          "id": 200504,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Urine bag</span></span></span></span></p>"
        },
        {
          "id": 200505,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Anatomical waste</span></span></span></span></p>"
        },
        {
          "id": 200506,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Soiled waste</span></span></span></span></p>"
        },
        {
          "id": 200507,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"color:black\">Sharp waste</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><span style=\"color:black\">A 56-year-old woman was admitted to a tertiary care hospital in New Delhi following a fall at home. During her stay, the nursing staff consistently followed protocols for waste segregation. Based on the guidelines for biomedical waste management, which type of waste should be correctly disposed of in the following mentioned bag? (AIIMS MAY 2017)</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/22/ip1.jpg\" style=\"height:325px; width:300px\" /></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/22/ip1.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q2628242",
      "question_audio": null,
      "question_video": null,
      "map_id": 34725173,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"FR\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ans. A) Urine Bag</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/20/screenshot-2024-09-20-111930.png\" style=\"height:741px; width:1000px\" /></p>\r\n\r\n<p> </p>\r\n\r\n<p style=\"margin-right:-3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:-3px\"> </p>\r\n\r\n<p style=\"margin-right:63px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Option B. Anatomical waste: </span></span></strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Anatomical wastes is disposed in yellow bin.</span></span></span></span></p>\r\n\r\n<p style=\"margin-right:63px\"> </p>\r\n\r\n<p style=\"margin-right:63px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Option C. Soiled waste: </span></span></strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Soiled wastes are disposed in yellow bin.</span></span></span></span></p>\r\n\r\n<p style=\"margin-right:63px\"> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Option D. Sharp waste: </span></span></strong><span style=\"font-size:12.0pt\"><span style=\"color:black\">Sharp wastes are disposed in white puncture proof, leak-proof, tamper-proof white containers.</span></span></span></span></p>\r\n\r\n<p style=\"margin-right:-3px\"> </p>\r\n\r\n<p style=\"margin-right:-3px\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"FR\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"margin-right:-3px\"> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The red biohazard bag is used for the disposal of </span><span style=\"font-size:12.0pt\"><span style=\"color:black\">Contaminated plastic recyclable waste like tubing, bottles, intravenous tubes and sets, catheters, urine bags, syringes (without needles) and gloves</span></span></span></span></li>\r\n</ul><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/20/screenshot-2024-09-20-111930.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200504,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50127,
      "choices": [
        {
          "id": 200508,
          "text": "<p><span style=\"font-size:12.0pt;\">Internal rotation</span></p>"
        },
        {
          "id": 200509,
          "text": "<p><span style=\"font-size:12.0pt;\">External rotation</span></p>"
        },
        {
          "id": 200510,
          "text": "<p><span style=\"font-size:12.0pt;\">Adduction</span></p>"
        },
        {
          "id": 200511,
          "text": "<p><span style=\"font-size:12.0pt;\">Abduction</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which movement of the hip is being demonstrated by the examiner in the following diagram?(AIIMS MAY 2017)</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/02/untitled-604.jpg\" alt=\"\" width=\"190\" height=\"301\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/02/untitled-604.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q8113595",
      "question_audio": null,
      "question_video": null,
      "map_id": 34113518,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Internal rotation</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>HIP MOVEMENTS</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The given image shows the <strong>internal rotation </strong>movement of the hip.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/15/screenshot-2024-05-15-112419.JPG\" alt=\"\" width=\"250\" height=\"286\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. External rotation.</strong></span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/15/screenshot-2024-05-15-112429.JPG\" alt=\"\" width=\"250\" height=\"254\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Adduction.</strong></span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/15/screenshot-2024-05-15-112438.JPG\" alt=\"\" width=\"250\" height=\"289\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Abduction.</strong></span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/15/screenshot-2024-05-15-112448.JPG\" alt=\"\" width=\"250\" height=\"233\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The given image shows internal rotation of hip.</span></li></ul><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/15/screenshot-2024-05-15-112419.JPG\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200508,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50128,
      "choices": [
        {
          "id": 200512,
          "text": "<p><span style=\"font-size:12pt;\">At the perineum</span></p>"
        },
        {
          "id": 200513,
          "text": "<p><span style=\"font-size:12pt;\">Just below ischial spine</span></p>"
        },
        {
          "id": 200514,
          "text": "<p><span style=\"font-size:12pt;\">Just above ischial spine</span></p>"
        },
        {
          "id": 200515,
          "text": "<p><span style=\"font-size:12pt;\">High up in the false pelvis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 32-year-old lady nearing her due date has been admitted following regular contractions. The resident doctor did an examination and told the intern that the head is at +1 station. Where is the exact position of head? (INICET MAY 2017)</span></p>",
      "unique_key": "Q8068690",
      "question_audio": null,
      "question_video": null,
      "map_id": 34647069,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Just below ischial spine</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">In obstetrics, the station of the fetal head during labor is measured relative to the ischial spines of the maternal pelvis. The ischial spines are bony landmarks that serve as reference points.</span></p><p> </p><ul><li><span style=\"font-size:12pt;\"><strong>0 Station:</strong> The presenting part of the fetus is at the level of the ischial spines.</span></li><li><span style=\"font-size:12pt;\"><strong>Positive Stations (+1 to +5):</strong> These indicate the presenting part is below the ischial spines. For example, +1 station means the presenting part is 1 cm below the ischial spines.</span></li><li><span style=\"font-size:12pt;\"><strong>Negative Stations (-1 to -5):</strong> These indicate the presenting part is above the ischial spines.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\">At +1 station, the fetal head is just below the ischial spine by 1 cm.</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_muEd4bX.png\" width=\"405\" height=\"273\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A. At the perineum:</strong> This would indicate a more advanced station, such as +4 or +5.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C. Just above the ischial spine:</strong> This would be a negative station (e.g., -1 or -2).</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D. High up in the false pelvis:</strong> This would correspond to a much higher, negative station.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">When the station of the head is described during a vaginal exam, it is with respect to the ischial spine:</span></p><p> </p><ul><li><span style=\"font-size:12pt;\">The ischial spine is taken as 0 station.</span></li><li><span style=\"font-size:12pt;\">Anything above the ischial spine is denoted as a negative station (-).</span></li><li><span style=\"font-size:12pt;\">Anything below the ischial spine is denoted as a positive station (+).</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 153, DC Dutta’s Textbook of Obstetrics 8<sup>th</sup> edition</strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_muEd4bX.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200513,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50129,
      "choices": [
        {
          "id": 200516,
          "text": "<p><span style=\"font-size:12.0pt;\">Osteoporosis</span></p>"
        },
        {
          "id": 200517,
          "text": "<p><span style=\"font-size:12.0pt;\">Ankylosing spondylitis</span></p>"
        },
        {
          "id": 200518,
          "text": "<p><span style=\"font-size:12.0pt;\">PIVD</span></p>"
        },
        {
          "id": 200519,
          "text": "<p><span style=\"font-size:12.0pt;\">Osteoarthritis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 21-year-old male presented in clinic with low back pain & stiffness since 2 months. Modified Schober's test done was positive. An X-ray was done as shown in the image. Most likely diagnosis is:(AIIMS MAY 2017)</span></p><p style=\"text-align:justify;\"> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/02/untitled-602.jpg\" alt=\"\" width=\"256\" height=\"329\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/02/untitled-602.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q5092717",
      "question_audio": null,
      "question_video": null,
      "map_id": 34534070,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Ankylosing spondylitis</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>ANKYLOSING SPONDYLITIS</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Also known as <strong>Marie-Strumpell or Bechterew’s disease</strong>.</span><ul><li><span style=\"font-size:12.0pt;\">It is a chronic inflammatory disease <strong>affecting the spine and sacroiliac joints</strong>.</span></li><li><span style=\"font-size:12.0pt;\"><strong>HLA B27 is positive</strong> in 90% patients.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Sacroiliitis is the earliest manifestation</strong> with features of both enthesitis & synovitis.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Clinical Presentation:</strong></span><ul><li><span style=\"font-size:12.0pt;\">It is most commonly seen in young males aged 15 - 25 years.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Most common symptom is dull backache</strong>, insidious in onset, associated with morning stiffness and improves with activity.</span></li><li><span style=\"font-size:12.0pt;\">Hip and shoulder joint arthritis may occur. Peripheral joints may also be involved in some.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Anterior uveitis is the most common extra-articular manifestation</strong>.</span></li></ul></li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Diagnostic Criteria: Modified New York Criterion:</strong></span><ul><li><span style=\"font-size:12.0pt;\"><strong>Essential criteria </strong>is definite<strong> radiographic sacroiliitis</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Supporting criteria</strong>: one of these three:</span><ul><li><span style=\"font-size:12.0pt;\">Inflammatory back pain</span></li><li><span style=\"font-size:12.0pt;\">Limited chest expansion (<5 cm at 4th ICS) {not a reliable criterion in elderly because of pulmonary disorders}</span></li><li><span style=\"font-size:12.0pt;\">Limited lumbar spine motion in both sagittal and frontal plane (Schober test/Modified Schober test).</span></li></ul></li><li><span style=\"font-size:12.0pt;\">Inflammatory back pain is classified if <strong>4/5 are present</strong></span><ol><li><span style=\"font-size:12.0pt;\">Pain for > 3 months</span></li><li><span style=\"font-size:12.0pt;\"><40 years age</span></li><li><span style=\"font-size:12.0pt;\">Insidious onset</span></li><li><span style=\"font-size:12.0pt;\">Pain improves with exercise</span></li><li><span style=\"font-size:12.0pt;\">Pain at night</span></li></ol></li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Spine radiograph shows:</strong></span><ul><li><span style=\"font-size:12.0pt;\"><strong>Haziness of sacroiliac (SI) joint margins is the earliest change</strong>.</span></li><li><span style=\"font-size:12.0pt;\">Later on, SI joints show irregular subchondral erosions in, sclerotic articular margins, joint space widening and eventually bony ankylosis.</span></li><li><span style=\"font-size:12.0pt;\">Calcification of supraspinous & interspinous ligaments <strong>(Dagger sign)</strong> and that of sacroiliac and sacrotuberous ligaments.</span></li></ul></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/15/screenshot-2024-05-15-111356.JPG\" alt=\"\" width=\"200\" height=\"258\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Dagger sign</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Enthesopathy:</strong> Calcification at the attachment of muscles, tendons & ligaments.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Trolley/Tram-track sign</strong><i><strong>: </strong></i>Three linear radiopaque lines due to ligament calcification.</span></li><li><span style=\"font-size:12.0pt;\">Squaring of vertebra, loss of lumbar lordosis and bridging osteophytes (syndesmophytes) are seen.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/15/screenshot-2024-05-15-111407.JPG\" alt=\"\" width=\"200\" height=\"473\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Trolley track sign</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Bamboo spine  appearance due to syndesmophytes</strong>.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/15/screenshot-2024-05-15-111417.JPG\" alt=\"\" width=\"250\" height=\"335\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Bamboo spine</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Osteoporosis. </strong>Osteoporosis is reduction in bone mass (density) i.e. there is quantitative decrease of units of bone formation but each unit has qualitatively normal configuration. So, osteoporosis characteristically has normal calcium, phosphate and alkaline phoshatase levels. Bone Mineral Density is measured by DEXA (Dual Emission X-ray Absorptiometry) Scan and it is matched to Dexa scan of 30 year old individual and T score is calculated. WHO classification of values in a DEXA scan are T score 0 to –1 is normal,<strong> </strong>T score –1 to –2.5 is osteopenia, and T score less than –2.5 is osteoporosis. The patient is usually asymptomatic until a vertebral fracture occurs. The x-ray of the spine shows codfish vertebrae.</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/15/screenshot-2024-05-15-111429.JPG\" alt=\"\" width=\"250\" height=\"324\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. PIVD. </strong>Lumbar Disc Herniation is a very common cause of low back pain and unilateral leg pain, known as radiculopathy. The patient usually presents with decreased lumbar movement, paraspinal muscle spasm. The provocative tests like straight leg raise is positive. The x-ray shows decreased space between the affected vertebrae due to disc prolapse.</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/15/screenshot-2024-05-15-111438.JPG\" alt=\"\" width=\"250\" height=\"404\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Osteoarthritis. </strong>Spine osteoarthritis is the presence of disc degeneration and osteophyte formation<strong>. </strong>The typical presentation of patients with symptomatic osteoarthritis of the spine is pain, stiffness, and motion restriction, which is commonly accompanied by referred pain. The lumbar spine provides pain located in the buttock and thigh region. Lumbar spine osteoarthritis can be associated with radicular pain above the knee.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/15/screenshot-2024-05-15-111448.JPG\" alt=\"\" width=\"250\" height=\"416\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The given image in the question shows the bamboo spine appearance which is characteristic of ankylosing spondylitis.</span></li><li><span style=\"font-size:12.0pt;\">Out of the diagnostic criterias for ankylosing spondylitis, one of the criteria is the positive modified Schober’s test i.e., limited lumbar spine movement in saggital and frontal planes.</span></li></ul><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/15/screenshot-2024-05-15-111356.JPG\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200517,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50130,
      "choices": [
        {
          "id": 200520,
          "text": "<p><span style=\"font-size:12.0pt;\">Sense changes in muscle direction</span></p>"
        },
        {
          "id": 200521,
          "text": "<p><span style=\"font-size:12.0pt;\">Sense changes in muscle tension</span></p>"
        },
        {
          "id": 200522,
          "text": "<p><span style=\"font-size:12.0pt;\">Sense changes in position of the muscle</span></p>"
        },
        {
          "id": 200523,
          "text": "<p><span style=\"font-size:12.0pt;\">Sense changes in length of the muscle</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The function of the Golgi tendon organ is to? (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">AIIMS May 2017)</span></p>",
      "unique_key": "Q5985035",
      "question_audio": null,
      "question_video": null,
      "map_id": 34188101,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Sense changes in muscle tension</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The Golgi tendon organ functions as a crucial sensory receptor that provides important feedback to the central nervous system, contributing to muscle control, injury prevention, and maintaining appropriate muscle tension during various activities.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The Golgi tendon organ is an encapsulated sensory receptor through which muscle tendon fibers pass. About 10 to 15 muscle fibers are usually connected to each Golgi tendon organ, and the organ is stimulated when this small bundle of muscle fibers is “tensed” by Excessive contraction or stretching the muscle.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The major difference in excitation of the Golgi tendon organ versus the <strong>muscle spindle is that the spindle detects muscle length and changes in muscle length,</strong> whereas the tendon organ detects muscle tension as reflected by the tension in itself.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Golgi tendon reflex (Inverse myotatic/ Inverse stretch reflex)</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/28/screenshot-2024-05-28-174058.png\" alt=\"\" width=\"600\" height=\"395\"></strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Sense changes in muscle direction: </strong>Incorrect because muscle direction is not detected by GTOs but rather involves the coordinated action of multiple muscles and joints.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Sense changes in the position of the muscle: </strong>Incorrect because muscle position is generally sensed by muscle spindles, not GTOs.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Sense changes in the length of the muscle: </strong>Incorrect because muscle length changes are detected by muscle spindles.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The Golgi tendon organ primarily functions to monitor and respond to changes in muscle tension, helping to prevent muscle damage from excessive force during activities.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/28/screenshot-2024-05-28-174058.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200521,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50131,
      "choices": [
        {
          "id": 200524,
          "text": "<p><span style=\"font-size:12.0pt;\">Peripheral smear</span></p>"
        },
        {
          "id": 200525,
          "text": "<p><span style=\"font-size:12.0pt;\">Platelets</span></p>"
        },
        {
          "id": 200526,
          "text": "<p><span style=\"font-size:12.0pt;\">Hb concentration</span></p>"
        },
        {
          "id": 200527,
          "text": "<p><span style=\"font-size:12.0pt;\">Leucocytic count</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A child presents with bilateral proptosis. Which investigation will help you in arriving at a diagnosis of chloroma? </span>(AIIMS MAY 2017)</p>",
      "unique_key": "Q1638870",
      "question_audio": null,
      "question_video": null,
      "map_id": 34049287,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Peripheral smear</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Chloroma or granulocytic sarcoma is an extramedullary manifestation of acute myeloid leukemia (AML</strong>). It is a localized tumor forming mass occurring in the skin or orbit due to local infiltration of the tissues by leukemic cells. The <strong>tumor is greenish in appearance due to the presence of myeloperoxidase.</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The diagnosis of AML is made by a combination of routine blood picture and bone marrow examination, coupled with cytochemical stains and other special laboratory investigations.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The best investigation among the given options would be a peripheral blood smear which shows the following-</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/45.jpg\" alt=\"\" width=\"500\" height=\"403\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Platelets:</strong> While platelet count can be abnormal in AML, it is not the primary diagnostic tool for chloroma.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Hb concentration:</strong> Hemoglobin concentration might be reduced in AML due to anemia, but it is not specific for diagnosing chloroma.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Leucocytic count:</strong> Leukocyte count can be elevated, normal, or low in AML, but it does not specifically help diagnose chloroma.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The peripheral blood smear is the key investigation to diagnose chloroma, revealing the presence of myeloblasts, which are indicative of acute myeloid leukemia.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Ref: Robbins and Cortan pathologic basis of disease, 8<sup>th</sup> edition, page no - 1154</strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/45.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200524,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50132,
      "choices": [
        {
          "id": 200528,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Adrenaline 0.5 mg 1/1000 IM</span></span></span></p>"
        },
        {
          "id": 200529,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Adrenaline 1 mg 1/10000 IV</span></span></span></p>"
        },
        {
          "id": 200530,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Atropine 3 mg</span></span></span></p>"
        },
        {
          "id": 200531,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Adenosine 6 mg followed by 12 mg IV</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">The drug of choice in Anaphylactic Shock is? (AIIMS MAY 2017)</span></span></p>",
      "unique_key": "Q6134749",
      "question_audio": null,
      "question_video": null,
      "map_id": 34804545,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Adrenaline 0.5 mg 1/1000 IM</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Anaphylactic shock is a severe, life-threatening allergic reaction that requires immediate treatment. The first-line treatment for anaphylactic shock is the administration of adrenaline (epinephrine). Adrenaline works by counteracting the severe hypotension, bronchospasm, and edema that occur during anaphylactic reactions.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Adrenaline 0.5 mg 1/1000 IM</span></strong><span style=\"font-size:12.0pt\"> is the recommended dose for the treatment of anaphylaxis. This intramuscular injection provides rapid absorption and action, which is critical in managing the symptoms of anaphylaxis effectively.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\">Option </span></strong><strong><span style=\"font-family:\"Calibri\",sans-serif\">B. <strong><span style=\"font-family:\"Calibri\",sans-serif\">Adrenaline 1 mg 1/10000 IV</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: This dose and concentration of adrenaline are typically used in cardiac arrest scenarios, not for initial treatment of anaphylactic shock.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\">Option </span></strong><strong><span style=\"font-family:\"Calibri\",sans-serif\">C. <strong><span style=\"font-family:\"Calibri\",sans-serif\">Atropine 3 mg</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Atropine is used primarily to treat bradycardia (slow heart rate) and is not effective in managing anaphylactic shock.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\">Option </span></strong><strong><span style=\"font-family:\"Calibri\",sans-serif\">D. <strong><span style=\"font-family:\"Calibri\",sans-serif\">Adenosine 6 mg followed by 12 mg IV</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Adenosine is used to treat certain types of supraventricular tachycardia (SVT) and is not relevant for the treatment of anaphylactic shock.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/30/screenshot-2024-09-30-145658.jpg\" style=\"height:429px; width:1000px\" /></span></strong></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/30/screenshot-2024-09-30-145658.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200528,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50133,
      "choices": [
        {
          "id": 200532,
          "text": "<p><span style=\"font-size:12pt;\">Formaldehyde</span></p>"
        },
        {
          "id": 200533,
          "text": "<p><span style=\"font-size:12pt;\">Ethylene glycol</span></p>"
        },
        {
          "id": 200534,
          "text": "<p><span style=\"font-size:12pt;\">Paraldehyde</span></p>"
        },
        {
          "id": 200535,
          "text": "<p><span style=\"font-size:12pt;\">Methyl alcohol</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 33-year-old male with attempted poisoning was brought to the casualty in a drowsy state. His pulse was 140/min, respiratory rate -30/min. His ABG showed metabolic acidosis. Urine analysis showed Calcium oxalate crystals. Identify the likely poison?</span></p>",
      "unique_key": "Q1714403",
      "question_audio": null,
      "question_video": null,
      "map_id": 34997947,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B. Ethylene glycol</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">The presence of calcium oxalate crystals in the urine is a key diagnostic sign of ethylene glycol poisoning. Metabolic acidosis and drowsiness is also indicating towards ethylene glycol poisoning.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A. Formaldehyde </strong>is ruled out because the patient’s symptoms like, metabolic acidosis, and the presence of calcium oxalate crystals in the urine, do not align with the typical effects of formaldehyde poisoning, which usually involves respiratory and mucous membrane irritation.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C. Paraldehyde </strong>While drowsiness and metabolic acidosis can be associated with paraldehyde poisoning, the presence of calcium oxalate crystals in the urine is a characteristic feature of ethylene glycol poisoning.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D. Methyl alcohol (methanol) </strong>While drowsiness and metabolic acidosis can be associated with methyl alcohol poisoning, the presence of calcium oxalate crystals in the urine is a characteristic feature of glycol poisoning.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Ethylene glycol poisoning</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">Ethylene glycol is the major constituent of antifreeze solutions. It is a clear, colorless, odorless, non-volatile liquid with a bitter-sweet taste.</span></p><p> </p><p><span style=\"font-size:12pt;\">Action: Ethylene glycol itself is not toxic, but the toxicity is due to metabolites glycolic and oxalic acids which inhibits oxidative phosphorylation.</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Oxalic acid combines with calcium to form calcium oxalate crystals which accumulates in the proximal convoluted tubules causing renal failure.</span></li><li><span style=\"font-size:12.0pt;\">Metabolic acidosis occurs from glycolic acid.</span></li><li><span style=\"background-color:white;color:#202124;font-size:12.0pt;\">Ingestion of ethylene glycol produces <strong>CNS depression which may be accompanied by nausea, vomiting, and abdominal cramps</strong>. Metabolites of ethylene glycol produce severe metabolic acidosis and damage to the brain, heart, and kidneys</span></li></ul><p> </p><p><span style=\"font-size:12pt;\">Treatment - Sodium bicarbonate, calcium gluconate, and 4-methyl pyrazole.</span></p>",
      "correct_choice_id": 200533,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50134,
      "choices": [
        {
          "id": 200536,
          "text": "<p><span style=\"font-size:12.0pt;\">Radial fracture with disruption of triangular fibrocartilage complex and lower radio-ulnar joint</span></p>"
        },
        {
          "id": 200537,
          "text": "<p><span style=\"font-size:12.0pt;\">Ulnar fracture with disruption of triangular fibrocartilage complex and lower radio-ulnar joint</span></p>"
        },
        {
          "id": 200538,
          "text": "<p><span style=\"font-size:12.0pt;\">Ulnar shaft fracture and disruption of superior radio-ulnar joint</span></p>"
        },
        {
          "id": 200539,
          "text": "<p><span style=\"font-size:12.0pt;\">Radial collateral ligament tear with interosseous membrane tear and radial shaft fracture</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements correctly defines Galeazzi fracture-dislocation?(AIIMS MAY 2017)</span></p>",
      "unique_key": "Q7734129",
      "question_audio": null,
      "question_video": null,
      "map_id": 34532245,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Radial fracture with disruption of triangular fibrocartilage complex and lower radio-ulnar joint</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>GALEAZZI FRACTURE</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The combination of <strong>fracture of the distal third of the shaft of the radius and dislocation of the distal radioulnar joint</strong>, along with <strong>damage to interosseous membrane and Triangular Fibro Cartilage complex</strong>, is called Galeazzi Fracture-dislocation.</span></li><li><span style=\"font-size:12.0pt;\">It is the <strong>fracture of necessity</strong>.</span></li><li><span style=\"font-size:12.0pt;\">A treatment regimen of <strong>closed reduction and cast immobilization</strong> has a high rate of unsatisfactory results.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Open reduction and internal fixation with plate</strong> is the treatment of choice in adult.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Monteggia and Galeazzi Fractures:</strong></span></li></ul><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/09/screenshot-2024-10-09-120346.jpg\" alt=\"\" width=\"1000\" height=\"603\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Galeazzi fracture is the fracture of the distal 1/3rd shaft of the radius with disruption of triangular fibrocartilage complex and distal radioulnar joint.</span></li></ul><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/09/screenshot-2024-10-09-120346.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200536,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50135,
      "choices": [
        {
          "id": 200540,
          "text": "<p><span style=\"font-size:11.0pt;\">Re-intubate</span></p>"
        },
        {
          "id": 200541,
          "text": "<p><span style=\"font-size:11.0pt;\">Oxygenate and re-intubate</span></p>"
        },
        {
          "id": 200542,
          "text": "<p><span style=\"font-size:11.0pt;\">Start CPR</span></p>"
        },
        {
          "id": 200543,
          "text": "<p><span style=\"font-size:12pt;\">Watch for spontaneous breaths and re-intubate if needed</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">A patient who was on a ventilator for one week suddenly gets agitated and self-extubates himself. What is the next step of management? (</span>AIIMS May 2017)</p>",
      "unique_key": "Q3319056",
      "question_audio": null,
      "question_video": null,
      "map_id": 34312284,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<h3><span style=\"color:#434343;font-size:16px;\"><strong>Ans. D) Watch for spontaneous breaths and re-intubate if needed</strong></span></h3><p> </p><ul><li><span style=\"font-size:16px;\">This is the most logical and safest immediate action. By observing the patient's spontaneous breathing, clinicians can gauge whether the patient is in distress or if they're maintaining their airway and oxygenating adequately. Self-extubation doesn't automatically necessitate re-intubation. If the patient is breathing well and does not desaturate, self-extubated patients may not require re-intubation. This can be confirmed by doing an arterial blood gas of the patient and checking his PaO2/FiO2 ratio and also watching for spontaneous breathing.</span></li></ul><h3> </h3><p><span style=\"color:#434343;font-size:16px;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Option A. Re-intubate:</strong> Simply re-intubating without assessment can be a precipitous action. It might be unnecessary if the patient can maintain their airway and oxygenation without assistance. Additionally, re-intubation has its own set of risks, including injury to the airway, so it's not a decision to be taken lightly.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Option B. Oxygenate and re-intubate:</strong> While it's always important to ensure a patient is well-oxygenated, especially if there's potential for re-intubation, the decision to re-intubate should be based on the patient's clinical status and not solely on the fact that they've self-extubated.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Option C. Start CPR:</strong> Cardiopulmonary resuscitation (CPR) is initiated in situations of cardiac arrest. There's no indication in the scenario that the patient's heart has stopped. Starting CPR without evidence of cardiac arrest can cause harm, including broken ribs and internal injury.</span></p><p> </p><p><span style=\"color:#434343;font-size:16px;\"><strong>Educational Objective :</strong></span></p><p> </p><ul><li><span style=\"font-size:16px;\">Self-extubation requires careful assessment to determine if re-intubation is necessary. Observing the patient's spontaneous breathing and oxygenation status is crucial before making the decision to re-intubate.</span></li></ul>",
      "correct_choice_id": 200543,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50136,
      "choices": [
        {
          "id": 200544,
          "text": "<p><span style=\"color:#374151;font-size:12.0pt;\">Digit span forward up to 7 digits with 2 skips allowed</span></p>"
        },
        {
          "id": 200545,
          "text": "<p><span style=\"color:#374151;font-size:12.0pt;\">Serial (100-7) subtraction test up to 5 steps</span></p>"
        },
        {
          "id": 200546,
          "text": "<p><span style=\"color:#374151;font-size:12.0pt;\">Digit span backwards up to 5 digits with 2 skips allowed</span></p>"
        },
        {
          "id": 200547,
          "text": "<p><span style=\"color:#374151;font-size:12.0pt;\">Serial (20-1) subtraction test up to 5 steps</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"color:#374151;font-size:12.0pt;\">Which of the following is the test for immediate memory? (</span>AIIMS May 2017)</p>",
      "unique_key": "Q5958038",
      "question_audio": null,
      "question_video": null,
      "map_id": 34747484,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"color:#374151;font-size:12.0pt;\"><strong>Ans. A) Digit span forward up to 7 digits with 2 skips allowed</strong></span></p><p> </p><p><span style=\"color:#374151;font-size:12.0pt;\">This is the classic test for immediate memory. The patient is asked to repeat a sequence of digits (usually ranging from 5 to 9 numbers), and it tests the capacity of one's immediate memory.</span></p><p> </p><p><span style=\"color:#374151;font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"color:#374151;font-size:12.0pt;\"><strong>Option B. Serial (100-7) subtraction test up to 5 steps:</strong> This tests concentration.</span></p><p> </p><p><span style=\"color:#374151;font-size:12.0pt;\"><strong>Option C. Digit span backwards up to 5 digits with 2 skips allowed:</strong> This is more challenging than the forward span and is used to assess working memory.</span></p><p> </p><p><span style=\"color:#374151;font-size:12.0pt;\"><strong>Option D. Serial (20-1) subtraction test up to 5 steps</strong>: Like the serial (100-7) test, it's more of an assessment for concentration.</span></p><p> </p><p><span style=\"color:#374151;font-size:12.0pt;\"><strong>Educational Objective: </strong></span></p><p> </p><p><span style=\"color:#374151;font-size:12.0pt;\">The digit span forward test, which involves repeating a sequence of numbers, is a measure of immediate memory and is a fundamental aspect of cognitive assessments.</span></p><p> </p><p><span style=\"color:#374151;font-size:12.0pt;\"><strong>Reference: Kaplan & Sadock’s Synopsis of Psychiatry, 12th edition, Page No 13.</strong></span></p>",
      "correct_choice_id": 200544,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50137,
      "choices": [
        {
          "id": 200548,
          "text": "<p><span style=\"font-size:12.0pt;\">Difference in alveolar pressure during inspiration and expiration</span></p>"
        },
        {
          "id": 200549,
          "text": "<p><span style=\"font-size:16px;\">Difference in concentration of surfactant during inspiration and expiration</span></p>"
        },
        {
          "id": 200550,
          "text": "<p><span style=\"font-size:12.0pt;\">Difference in airway resistance during inspiration and expiration</span></p>"
        },
        {
          "id": 200551,
          "text": "<p><span style=\"font-size:12.0pt;\">Inspiration is active and expiration is passive</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Difference in trajectory between inspiratory loop and the expiratory loop in the curve is due to: (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">AIIMS May 2017)</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/28/screenshot-2024-05-28-174628.png\" alt=\"\" width=\"400\" height=\"352\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/28/screenshot-2024-05-28-174628.png\" alt=\"Question Image\"></p>",
      "unique_key": "Q2942548",
      "question_audio": null,
      "question_video": null,
      "map_id": 34769812,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. B) Difference in concentration of surfactant during inspiration and expiration</strong></span></p><p> </p><p><span style=\"font-size:16px;\">The above shows the compliance diagram of lung</span></p><p> </p><p><span style=\"font-size:16px;\">Compliance Diagram of the Lungs </span></p><p> </p><p><span style=\"font-size:16px;\">It is a diagram relating lung volume changes to changes in transpulmonary pressure. </span></p><p> </p><p><span style=\"font-size:16px;\"><strong>The characteristics of the compliance diagram are determined</strong></span></p><p> </p><ol><li><span style=\"font-size:16px;\">Elastic forces of the lung tissue itself due to elastin and collagen fibres</span></li><li><span style=\"font-size:16px;\">Elastic forces caused by surface tension of the fluid that lines the inside walls of the alveoli and other lung air spaces which exerts a collapsing force on the alveolus contributes to elastic recoil of lung</span></li></ol><p> </p><p><span style=\"font-size:16px;\">The tissue elastic forces tending to cause collapse of the air-filled lung represent only about one third of the total lung elasticity, whereas the fluid-air surface tension forces in the alveoli represent about two thirds.</span></p><p> </p><p><span style=\"font-size:16px;\">Thus, a greater transpulmonary pressure is required to open a previously closed airway due to surface tension at the air-water interface due to surfactant deficit, than to keep an open airway from closing, reflecting abundant surfactant.</span></p><p> </p><p><span style=\"font-size:16px;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_KaAUiVc.png\" width=\"372\" height=\"207\"></span></p><p><span style=\"font-size:16px;\"><strong>Kindly add the diagram</strong></span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Surfactant concentration increases during expiration (smaller alveoli → surfactant molecules closer), lowering surface tension and making expiration easier compared to inspiration. This is the correct cause of hysteresis</strong></span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Option A. Difference in alveolar pressure during inspiration and expiration:</strong> Incorrect, as this refers to the pressure gradients that drive airflow but does not directly cause the loop shape differences seen in the compliance graph.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Option C. Difference in airway resistance during inspiration and expiration</strong></span></p><p><span style=\"font-size:16px;\">Airway resistance may vary slightly, but this difference is important in flow–volume loops, especially in obstructive diseases. However, it does not account for the hysteresis seen in the pressure–volume curve, which is mainly due to change in surfactant concentration.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Option D. Inspiration is active and expiration is passive:</strong> Partially correct but does not specifically address the mechanical difference seen in the trajectory of the loops on a compliance graph.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Educational Objective: </strong></span></p><p> </p><p><span style=\"font-size:16px;\">The difference between inspiratory and expiratory pressure-volume loops (hysteresis) is primarily due to dynamic changes in surfactant concentration, which alters surface tension between inspiration and expiration. Understanding this helps explain lung compliance behavior and the role of surfactant in stabilizing alveoli.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_KaAUiVc.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200549,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50138,
      "choices": [
        {
          "id": 200552,
          "text": "<p><span style=\"font-size:12.0pt;\">Pachymetry</span></p>"
        },
        {
          "id": 200553,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Tonometry</span></p>"
        },
        {
          "id": 200554,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿Auto Refractometry</span></p>"
        },
        {
          "id": 200555,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿A Scan</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient recently underwent LASIK surgery for her myopia. She is now complaining of headaches and eye pain. Identify the test being performed on her: (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">AIIMS May 2017)</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture5_JhAIxJm.jpg\" alt=\"\" width=\"300\" height=\"231\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture5_JhAIxJm.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q2316407",
      "question_audio": null,
      "question_video": null,
      "map_id": 34867469,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Tonometry</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The image depicts the use of an Applanation tonometry. It is based on the applanation principle described by Imbert and Fick. With regards to applanation tonometry, the law states that pressure (P) can be approximated by the force (F) necessary to flatten the cornea in a fixed area, divided by the surface (S) of the flattened area. The Imbert-Fick law is defined as P=F/S.</span></li><li><span style=\"font-size:12.0pt;\">The dynamic contour tonometer (Pascal) for tonometry looks as</span></li></ul><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/09/whatsapp-image-2024-07-09-at-32321-pm.jpeg\" alt=\"\" width=\"300\" height=\"250\"></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Intraocular pressure (IOP) readings obtained with this tonometer are not influenced by central corneal thickness.</span></li><li><span style=\"font-size:12.0pt;\">The Pascal tonometer is the preferred tonometer for measuring IOP in post-LASIK corneas.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span><br> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Pachymetry</strong>: This test measures the thickness of the cornea. It is important for assessing the cornea pre-LASIK but is not depicted in the image nor directly associated with measuring IOP.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/22/whatsapp-image-2023-06-12-at-190121011010201026_page_68_page_262_page_47.jpg\" alt=\"\" width=\"300\" height=\"202\"></span></p><p style=\"text-align:center;\"> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Autorefractometry</strong>: This procedure determines the refractive error and prescription for glasses or contact lenses. It does not involve contact with the eye as depicted and is unrelated to IOP measurement.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/22/whatsapp-image-2023-06-12-at-190121011010201026_page_68_page_262_page_48.jpg\" alt=\"\" width=\"300\" height=\"200\"></span></p><p style=\"margin-left:48px;text-align:center;\"> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. A scan</strong>: This ultrasound test measures the length of the eye and is primarily used in cataract surgery planning. It does not involve the measurement of IOP.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/22/whatsapp-image-2023-06-12-at-190121011010201026_page_68_page_262_page_49.jpg\" alt=\"\" width=\"300\" height=\"238\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Tonometry, especially applanation tonometry, is crucial for monitoring intraocular pressure post-LASIK surgery to ensure no adverse effects on eye pressure, which could lead to symptoms like headaches and eye pain as described. This test is essential for the ongoing evaluation of patients' eye health following refractive surgery.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/09/whatsapp-image-2024-07-09-at-32321-pm.jpeg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200553,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50139,
      "choices": [
        {
          "id": 200556,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Cytarabine</span></p>"
        },
        {
          "id": 200557,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Dexamethasone</span></p>"
        },
        {
          "id": 200558,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Doxorubicin</span></p>"
        },
        {
          "id": 200559,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Methotrexate</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\">An 18-year-old girl with the diagnosis of acute promyelocytic leukemia was treated medically. She developed fever and tachypnea and a chest X-ray showed pulmonary infiltrates. What drug should she be given next? (AIIMS MAY 2017)</span></p>",
      "unique_key": "Q9860668",
      "question_audio": null,
      "question_video": null,
      "map_id": 34807731,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. B) Dexamethasone</strong></span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\">APML is a leukemia with excellent prognosis managed with Arsenic trioxide and All-Trans retinoic acid. Differentiation syndrome is characterized by <strong>infiltrates, pleural effusion after treatment and improves with Dexamethasone</strong>. Used Intrathecally in children for AML.</span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Option A</strong>. Cytarabine is used in the treatment of acute myeloid leukemia.</span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Option C</strong>. Doxorubicin is a cardiotoxic drug used in Hodgkin, CA breast, thyroid.</span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Option D</strong>. Methotrexate is not recommended in APML treatment.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Dexamethasone is used to manage differentiation syndrome in patients with acute promyelocytic leukemia, characterized by symptoms like fever, tachypnea, and pulmonary infiltrates following treatment with specific leukemia drugs.</span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Reference -Harrison/Oncology/Acute leukemia/chap100-743</strong></span></p>",
      "correct_choice_id": 200557,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50140,
      "choices": [
        {
          "id": 200560,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">10% buffered formalin</span></span></span></p>"
        },
        {
          "id": 200561,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">95% ethyl alcohol</span></span></span></p>"
        },
        {
          "id": 200562,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Air dried</span></span></span></p>"
        },
        {
          "id": 200563,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">None of the above</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Fixative for PAP smear: (INICET MAY 2017)</span></span></p>",
      "unique_key": "Q7065932",
      "question_audio": null,
      "question_video": null,
      "map_id": 34243719,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. B) 95% ethyl alcohol</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The most commonly used fixative for a Pap smear is 95% ethyl alcohol. This fixative preserves the cellular detail necessary for accurate cytological evaluation by preventing cellular autolysis and degradation. The use of 95% ethyl alcohol ensures that the cells maintain their morphology, which is critical for detecting abnormalities such as dysplasia or carcinoma.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">95% Ethyl Alcohol:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> This is the standard fixative for Pap smears, ensuring optimal preservation of cellular details.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ethanol Spray:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> In modern practice, an ethanol spray fixative is available, which can be conveniently used in an office setting to fix the smear immediately after it is taken.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A. 10% buffered formalin:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> This fixative is typically used for histological specimens rather than cytological smears like the Pap test.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. Air dried:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> Air drying is not recommended for Pap smears as it can cause cellular distortion and artifacts, which complicate the interpretation of the smear.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. None of the above:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> This is incorrect as 95% ethyl alcohol is the correct fixative.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The most commonly used fixative for a Pap smear is 95% ethyl alcohol, which preserves cellular morphology necessary for accurate cytological evaluation.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ref: Page no 271, DC Dutta’s Textbook of Gynecology 8<sup>th</sup> edition</span></strong></span></span></p>",
      "correct_choice_id": 200561,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50141,
      "choices": [
        {
          "id": 200564,
          "text": "<p><span style=\"font-size:12.0pt;\">DISH</span></p>"
        },
        {
          "id": 200565,
          "text": "<p><span style=\"font-size:12.0pt;\">Fluorosis</span></p>"
        },
        {
          "id": 200566,
          "text": "<p><span style=\"font-size:12.0pt;\">Alkaptonuria</span></p>"
        },
        {
          "id": 200567,
          "text": "<p><span style=\"font-size:12.0pt;\">Ankylosing spondylitis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 30-year-old female came to the OPD with complaints of backache. On examination, her eyes and pinna revealed blackish discoloration. What is the likely diagnosis? (AIIMS 2017)</span></p><p style=\"text-align:justify;\"> </p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/26/untitled-117.jpg\" alt=\"\" width=\"250\" height=\"328\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/26/untitled-117.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q6496997",
      "question_audio": null,
      "question_video": null,
      "map_id": 34198374,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Alkaptonuria</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Intervertebral disc calcification is seen in the image suggestive of alkaptonuria.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Deficiency: Homogentisic oxidase</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Hyperpigmentation of ears and eyes suggestive of ochronosis is a clue. It is seen due to excessive build-up of homogentisic acid.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. DISH (Diffuse Idiopathic Skeletal Hyperostosis):</strong> Features ossification along the anterolateral aspect of at least four contiguous vertebral bodies, often with a \"candle wax dripping\" appearance, distinct from the findings in alkaptonuria.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Fluorosis:</strong> Typically presents with increased bone density and ossification of interosseous ligaments, not specifically associated with hyperpigmentation or the disc calcifications shown.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Ankylosing Spondylitis:</strong> Characterized by a \"bamboo spine\" appearance due to bony fusion, seen in younger patients (less than 50 years old), which does not typically include hyperpigmentation or the type of disc calcification seen in alkaptonuria.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Alkaptonuria - Is characterized by a deficiency of the enzyme homogentisic oxidase</span></li><li><span style=\"font-size:12.0pt;\">Fluorosis – Increased bone density with interosseous ligament ossification </span></li><li><span style=\"color:black;font-size:12.0pt;\"><strong>DISH VS   Ankylosing spondylitis</strong></span></li></ul><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/26/untitled-118.jpg\" alt=\"\" width=\"572\" height=\"247\"></strong></span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/23/screenshot-2024-05-23-093829.png\" alt=\"\" width=\"689\" height=\"265\"></strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/26/untitled-118.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200566,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50142,
      "choices": [
        {
          "id": 200568,
          "text": "<p><span style=\"font-size:12.0pt;\">Outer Diameter</span></p>"
        },
        {
          "id": 200569,
          "text": "<p><span style=\"font-size:12.0pt;\">Inner Diameter</span></p>"
        },
        {
          "id": 200570,
          "text": "<p><span style=\"font-size:12.0pt;\">Inner Circumference</span></p>"
        },
        {
          "id": 200571,
          "text": "<p><span style=\"font-size:12.0pt;\">Radius</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Fr with respect to size of Foley's catheter refers to: (AIIMS MAY 2017)</span></p>",
      "unique_key": "Q9774167",
      "question_audio": null,
      "question_video": null,
      "map_id": 34365948,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Outer Diameter</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Fr, short for French, is a unit of measurement used for the outer diameter of a Foley catheter. It is a common way to denote the size of the catheter, especially in medical and healthcare settings. The French scale is based on a 3:1 ratio, where one French unit (Fr) is approximately equal to 0.33 millimeters in outer diameter. For example, a Foley catheter with a size of 16 Fr has an outer diameter of approximately 5.3 millimeters.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Therefore, the diameter of a catheter in millimeters can be determined by dividing the French size by 3.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/09/screenshot-2024-09-09-164749.png\" alt=\"\" width=\"400\" height=\"321\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/09/screenshot-2024-09-09-164749.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200568,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50143,
      "choices": [
        {
          "id": 200572,
          "text": "<p><span style=\"font-size:12pt;\">Tzanck smear</span></p>"
        },
        {
          "id": 200573,
          "text": "<p><span style=\"font-size:12pt;\">Gram stain</span></p>"
        },
        {
          "id": 200574,
          "text": "<p><span style=\"font-size:12pt;\">Slit skin smear</span></p>"
        },
        {
          "id": 200575,
          "text": "<p><span style=\"font-size:12pt;\">KOH mount</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What would be a useful diagnostic tool to consider for a patient who presented with symptoms of hair loss, itching of the scalp, and a mild discharge? (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">AIIMS May 2017)</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/17/untitled-1347.jpg\" alt=\"\" width=\"300\" height=\"377\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/17/untitled-1347.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q3528997",
      "question_audio": null,
      "question_video": null,
      "map_id": 34288441,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) KOH mount</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">The above image shows <strong>tinea capitis</strong>, which presents with a <strong>well-demarcated scaly patch in which hair shafts are broken off just above the skin</strong> resulting in alopecia / hair loss. KOH mount is useful for the depicted condition.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Tinea capitis variants:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/14/screenshot-2024-06-14-121155.png\" alt=\"\" width=\"900\" height=\"125\"></strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\"><strong>Ectothrix - </strong>Spores & fungus present outside the hair shaft.</span></li><li><span style=\"font-size:12pt;\"><strong>Endothrix -</strong> Spores & fungi present inside the hair shaft.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/17/untitled-13489.jpg\" alt=\"\" width=\"300\" height=\"297\"></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Kerion</strong>:</span></p><p> </p><ul><li><span style=\"font-size:12pt;\">Presents in Children with <strong>boggy swelling, easily pluckable hair, with regional lymphadenopathy.</strong></span></li><li><span style=\"font-size:12pt;\">It is a severe inflammatory type of tinea capitis.</span></li><li><span style=\"font-size:12pt;\">The <strong>most common causative organisms of kerion are Zoophilic dermatophytes</strong>, T. verrucosum and T. mentagrophytes. In severe cases, there may be pus along with sinus formation.</span></li></ul><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/14/screenshot-2024-06-14-121613.png\" alt=\"\" width=\"300\" height=\"259\"></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Fig: Lesion:</strong> Boggy indurated scalp swelling</span></p><p> </p><ul><li><span style=\"font-size:12pt;\"><strong>Investigation:</strong> 10% KOH mount</span></li><li><span style=\"font-size:12pt;\"><strong>Treatment:</strong> DOC overall and for Microsporum is Griseofulvin</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Note:</strong> DOC for Trichophyton associated Tinea capitis specifically is Terbinafine.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A. Tzanck smear:</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">Use: It is a <strong>microscopic</strong> examination used to identify <strong>cells</strong> from <strong>blistering</strong> skin conditions. It's especially useful in detecting <strong>herpes simplex, herpes zoster, and pemphigus vulgaris.</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Why it's not the answer</strong>: The presented symptoms are not typical of blistering skin conditions or herpetic infections, which is where a Tzanck smear would be most useful.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Option B. Gram stain:</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">Use: This is a staining technique used to <strong>classify bacterial</strong> species into two groups (<strong>Gram-positive and Gram-negative</strong>) based on the chemical and physical properties of their <strong>cell walls</strong>.</span></li><li><span style=\"font-size:12pt;\"><strong>Why it's not the answer</strong>: While a bacterial infection could lead to scalp discharge, the combination of <strong>hair loss and itching</strong> specifically <strong>suggests a fungal</strong> etiology over a bacterial one.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C. Slit skin smear:</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">Use: This test is primarily used for diagnosing <strong>leprosy</strong> by detecting <strong>Mycobacterium leprae</strong> in skin lesions.</span></li><li><span style=\"font-size:12pt;\"><strong>Why it's not the answer</strong>: The symptoms described are not indicative of leprosy, which generally presents as skin patches with <strong>sensory loss</strong> or <strong>nerve enlargement</strong>.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/14/screenshot-2024-06-14-121841.png\" alt=\"\" width=\"1000\" height=\"429\"></strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Ref: Rook's Textbook of Dermatology - Volume II-9th Edition Chapter 32 Page no 32.39</strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/14/screenshot-2024-06-14-121155.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200575,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50144,
      "choices": [
        {
          "id": 200576,
          "text": "<p><span style=\"font-size:12.0pt;\">Frankfurt line</span></p>"
        },
        {
          "id": 200577,
          "text": "<p><span style=\"font-size:12.0pt;\">Donaldson line</span></p>"
        },
        {
          "id": 200578,
          "text": "<p><span style=\"font-size:12.0pt;\">Line of Sebileau</span></p>"
        },
        {
          "id": 200579,
          "text": "<p><span style=\"font-size:12.0pt;\">Ohngren's line</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the blue line shown in the below picture:(</span>AIIMS May 2017)</p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/29/picture4.jpg\" alt=\"\" width=\"300\" height=\"365\"></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/29/picture4.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q5405344",
      "question_audio": null,
      "question_video": null,
      "map_id": 34001656,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Ohngren's line</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Ohngren's line is an imaginary line passing through the medial canthus of the eye and angle of mandible.</span></li><li><span style=\"font-size:12.0pt;\">It is used for classification of maxillary carcinoma.</span></li><li><span style=\"font-size:12.0pt;\">Growth situated above the plane - Suprastructure - Poor Prognosis</span></li><li><span style=\"font-size:12.0pt;\">Growth situated below the plane - Infrastructure - Good Prognosis</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Frankfurt horizontal line</strong>, the line passing through the inferior border of infraorbital rim and superior border of external auditory canal, is one of the most widely used intracranial landmarks in cephalometric analysis.</span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/29/picture5.jpg\" alt=\"\" width=\"400\" height=\"355\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Donaldson line</strong> is an imaginary line drawn posteriorly from the course of the horizontal semicircular canal, used to identify endolymphatic sac during endolymphatic sac decompression surgery for meniere’s disease.</span></p><p> </p><p><span style=\"color:#385623;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/29/picture6.jpg\" alt=\"\" width=\"400\" height=\"260\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. </strong>According to Lederman’s classification, 2 horizontal lines called <strong>lines of Sebileau</strong> pass through orbit floor and maxillary sinus, producing Suprastructure, mesostructure and infrastructure.</span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/29/picture7.jpg\" alt=\"\" width=\"400\" height=\"302\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Ohngren's line is used to classify maxillary carcinomas into suprastructure and infrastructure based on their location relative to the line, which is critical for determining the prognosis and approach for surgical intervention.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/29/picture5.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200579,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50145,
      "choices": [
        {
          "id": 200580,
          "text": "<p><span style=\"font-size:12.0pt;\">Hemodynamically unstable patient should not be sent for CT scan</span></p>"
        },
        {
          "id": 200581,
          "text": "<p><span style=\"font-size:12.0pt;\">All patients should have chest X-ray PA view only</span></p>"
        },
        {
          "id": 200582,
          "text": "<p><span style=\"font-size:12.0pt;\">X-ray of the pelvis is done in primary survey</span></p>"
        },
        {
          "id": 200583,
          "text": "<p><span style=\"font-size:12.0pt;\">X-rays in primary survey may also be done in pregnant women</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">All of the following are true regarding imaging in the primary survey of a trauma patient except? (AIIMS MAY 2017)</span></p>",
      "unique_key": "Q7117933",
      "question_audio": null,
      "question_video": null,
      "map_id": 34876760,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) All patients should have chest X-ray PA view only</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Chest X-ray and X-ray pelvis are taken in AP view in the adjuncts to the primary survey of a trauma patient.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">This statement is false. Chest X-rays are often a standard part of the primary survey to assess for chest injuries and potential life-threatening conditions like pneumothorax or hemothorax, however AP view is commonly used in the primary survey. PA view requires patient to be standing, which is usually not possible.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Hemodynamically unstable patients should not be sent for CT scans</strong>: This statement is true. Hemodynamically unstable patients are in a critical condition, and their immediate management should prioritize stabilizing their condition.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. X-ray of the pelvis is done in the primary survey</strong>: This statement is true. Pelvic X-rays may be performed if pelvic injury is suspected based on clinical assessment, however they are not universally conducted in all trauma patients during the primary survey, hence considered as “adjuncts”.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. X-rays in the primary survey may be done in pregnant women: </strong>This statement is generally true. Pregnant trauma patients should undergo imaging as needed during the primary survey to assess for injuries. However, the choice of imaging modalities and the use of shielding techniques should consider the safety of the fetus.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>The steps in the ATLS (Advanced Trauma Life Support) include:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Primary survey and simultaneous resuscitation - in order to identify and treat what is killing the patient</span></li><li><span style=\"font-size:12.0pt;\">Secondary survey - proceeding to identify all other injuries</span></li><li><span style=\"font-size:12.0pt;\">Definitive care - developing a definitive management plan</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>ABCDE of trauma care:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Airway assessment and protection (maintain cervical spine stabilization when appropriate)</span></li><li><span style=\"font-size:12.0pt;\">Breathing and ventilation assessment (maintain adequate oxygenation)</span></li><li><span style=\"font-size:12.0pt;\">Circulation assessment (control hemorrhage and maintain adequate end-organ perfusion)</span></li><li><span style=\"font-size:12.0pt;\">Disability assessment (perform basic neurologic evaluation)</span></li><li><span style=\"font-size:12.0pt;\">Exposure, with environmental control (undress patient and search everywhere for possible injury, while preventing hypothermia)</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Adjuncts to the primary survey are-</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Blood - CBC, urea and electrolytes, clotting screen, glucose, toxicology, cross-match</span></li><li><span style=\"font-size:12.0pt;\">ECG, pulse oximetry, ventilatory rate, capnography, ABG analysis</span></li><li><span style=\"font-size:12.0pt;\">Two wide-bore cannulae for intravenous fluids</span></li><li><span style=\"font-size:12.0pt;\">Urinary and gastric catheterization</span></li><li><span style=\"font-size:12.0pt;\">Radiographs of the chest and pelvis are done as a part of the primary survey preferably with a portable x-ray unit. When required, all these x rays must also be done in pregnant women.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\">Other more specialized forms of imaging, such as ultrasound, computerized tomography, angiography, and diagnostic peritoneal lavage, should be considered after the secondary survey and only in a patient stable after initial resuscitation.</span></p>",
      "correct_choice_id": 200581,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50146,
      "choices": [
        {
          "id": 200584,
          "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Cell wall synthesis inhibition</span></span></p>"
        },
        {
          "id": 200585,
          "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Cell membrane inhibition</span></span></p>"
        },
        {
          "id": 200586,
          "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Peptide synthesis inhibition</span></span></p>"
        },
        {
          "id": 200587,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">50S ribosome inhibition</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">What is the mechanism of action of vancomycin? (AIIMS MAY 2017)</span></span></p>",
      "unique_key": "Q3583459",
      "question_audio": null,
      "question_video": null,
      "map_id": 34433528,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Cell wall synthesis inhibition</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Vancomycin binds to the D-Ala-D-Ala terminus of the newly formed peptidoglycan pentapeptide. This prevents further elongation of the peptidoglycan and its cross-linking by inhibiting transglycolase. </span></span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Vancomycin is a bactericidal agent used against gram positive agent like MRSA.</span></span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\">Option </span></strong><strong><span style=\"font-family:\"Calibri\",sans-serif\">B. <strong><span style=\"font-family:\"Calibri\",sans-serif\">Cell membrane inhibition</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: This is not the mechanism of action of vancomycin. Drugs like polymyxins target the cell membrane.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\">Option </span></strong><strong><span style=\"font-family:\"Calibri\",sans-serif\">C. <strong><span style=\"font-family:\"Calibri\",sans-serif\">Peptide synthesis inhibition</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: This option is incorrect. Peptide synthesis inhibition is typically the mechanism of action for drugs like tetracyclines and macrolides that interfere with ribosomal function.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\">Option </span></strong><strong><span style=\"font-family:\"Calibri\",sans-serif\">D. <strong><span style=\"font-family:\"Calibri\",sans-serif\">50S ribosome inhibition</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: This is not the mechanism of action of vancomycin. Drugs like macrolides (e.g., erythromycin), chloramphenicol, and clindamycin inhibit the 50S ribosomal subunit.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Vancomycin inhibits bacterial cell wall synthesis by binding to the D-Ala-D-Ala terminus of peptidoglycan precursors, preventing peptidoglycan elongation and cross-linking, leading to cell lysis and death. It is especially effective against gram-positive bacteria like MRSA.</span></span></p>",
      "correct_choice_id": 200584,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50147,
      "choices": [
        {
          "id": 200588,
          "text": "<p><span style=\"font-size:12pt;\">Estimate serum estradiol values</span></p>"
        },
        {
          "id": 200589,
          "text": "<p><span style=\"font-size:12pt;\">Give progesterone and stop after 10 days for withdrawal bleeding</span></p>"
        },
        {
          "id": 200590,
          "text": "<p><span style=\"font-size:12pt;\">Check USG for polycystic ovaries</span></p>"
        },
        {
          "id": 200591,
          "text": "<p><span style=\"font-size:12pt;\">Do a urine pregnancy test</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 25-year-old female came with complaints of 4 months amenorrhea. Her FSH and LH were elevated above the normal value, thyroid function tests were normal. Which is the next step in management? (INICET MAY 2017)</span></p>",
      "unique_key": "Q1696436",
      "question_audio": null,
      "question_video": null,
      "map_id": 34224180,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Give progesterone and stop after 10 days for withdrawal bleeding</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Explanation</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">Since LH and FSH are elevated above the normal value, the possibility of a pregnancy can be ruled out as FSH and LH levels fall to very low levels in pregnancy</span></li><li><span style=\"font-size:12pt;\">The first step in evaluation of secondary amenorrhoea after ruling out pregnancy is to do a progesterone challenge test i.e. to see if she bleeds after a challenge of progesterone.</span></li><li><span style=\"font-size:12pt;\">If she bleeds, the diagnosis is anovulation like in PCOS</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A. Estimate serum estradiol values</strong>: Serum estradiol level measurement has no role in evaluation of secondary amenorrhoea</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D. Do a urine pregnancy test</strong>: FSH levels in pregnancy are very very low so pregnancy is unlikely; otherwise the most common cause of secondary amenorrhoea is pregnancy</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C. Check USG for Polycystic ovaries</strong>: This is done if the patient bleeds following progesterone withdrawal as it determines the cause of anovular cycles</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">Secondary amenorrhea is defined as a period of amenorrhoea of 6 months</span></li><li><span style=\"font-size:12pt;\">Pregnancy needs to be ruled out</span></li><li><span style=\"font-size:12pt;\">The most common cause of secondary amenorrhea after ruling out pregnancy is anovulation (PCOS) which can be determined by the progesterone withdrawal test</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Ref: Page no 457, DC Dutta’s Textbook of Gynecology 6<sup>th</sup> edition</strong></span></p>",
      "correct_choice_id": 200589,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50148,
      "choices": [
        {
          "id": 200592,
          "text": "<p><span style=\"font-size:12.0pt;\">Base excision repair</span></p>"
        },
        {
          "id": 200593,
          "text": "<p><span style=\"font-size:12.0pt;\">Nucleotide excision repair</span></p>"
        },
        {
          "id": 200594,
          "text": "<p><span style=\"font-size:12.0pt;\">Mismatch Repair</span></p>"
        },
        {
          "id": 200595,
          "text": "<p><span style=\"font-size:12.0pt;\">Non-homologous end joining repair</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In SCID, what type of DNA repair is defective? (AIIMS May 2017)</span></p>",
      "unique_key": "Q5875518",
      "question_audio": null,
      "question_video": null,
      "map_id": 34780555,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Non-homologous end joining repair</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Human severe combined immune deficiency (SCID) is the most serious inherited immunological deficit which is caused due to <strong>defects in the predominant pathway for double-strand break repair</strong> called <strong>nonhomologous DNA end joining, or NHEJ</strong>.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Defects in DNA Repair:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/28/1-bio-29-2.jpg\" alt=\"\" width=\"700\" height=\"383\"></strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong> </span></p><p> </p><p><span style=\"font-size:12.0pt;\">The table in the provided image highlights various DNA repair pathways and the associated cancer syndromes when these pathways are defective:</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Base excision repair (BER):</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">DNA Lesion: Base modifications, abasic sites</span></li><li><span style=\"font-size:12.0pt;\">Cancer Syndromes: Not yet reported</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Nucleotide excision repair (NER):</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">DNA Lesion: Intra-strand crosslinks, bulky adducts</span></li><li><span style=\"font-size:12.0pt;\">Cancer Syndromes: Xeroderma pigmentosum, ERCC6L2 deficiency</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Mismatch repair (MMR):</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">DNA Lesion: Mismatches, indels</span></li><li><span style=\"font-size:12.0pt;\">Cancer Syndromes: Constitutional MMR syndrome</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">SCID is caused by defects in the NHEJ pathway, which is responsible for repairing double-strand breaks in DNA. This defect impairs the immune system, leading to severe immunodeficiency.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Non-homologous end joining (NHEJ):</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">DNA Lesion: Double-strand breaks (DSBs)</span></li><li><span style=\"font-size:12.0pt;\">Cancer Syndromes: Ligase IV deficiency, XLF/NHEJ1 deficiency, Rothmund-Thompson syndrome, Werner syndrome</span></li></ul><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/28/1-bio-29-2.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200595,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50149,
      "choices": [
        {
          "id": 200596,
          "text": "<p><span style=\"font-size:12pt;\">Arsenic</span></p>"
        },
        {
          "id": 200597,
          "text": "<p><span style=\"font-size:12pt;\">Lead</span></p>"
        },
        {
          "id": 200598,
          "text": "<p><span style=\"font-size:12pt;\">Mercury</span></p>"
        },
        {
          "id": 200599,
          "text": "<p><span style=\"font-size:12pt;\">Phosphorus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Black foot is seen in which poisoning: (</span>AIIMS Nov 2017)</p>",
      "unique_key": "Q6780418",
      "question_audio": null,
      "question_video": null,
      "map_id": 34675728,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A. Arsenic</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">Blackfoot disease is an endemic peripheral vascular disease found among the inhabitants of a limited area on the southwest coast of Taiwan, where well water with a high concentration of arsenic causes peripheral vascular disease resulting in gangrene.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Other options are incorrect as the term Blackfoot disease is used only for arsenic</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">Arsenic, cadmium, lead and mercury are the heavy metals which can cause peripheral vascular disease due to chronic poisoning. This leads to general clinical features of peripheral vascular disease (numbness in feet, rest pain etc.).</span></li><li><span style=\"font-size:12pt;\">Blackfoot disease is a unique term given to peripheral vascular disease produced by chronic Arsenic poisoning. The name \"Blackfoot\" refers to the characteristic darkening and gangrene of the feet and lower legs. This ultimately leads to amputation.</span></li><li><span style=\"font-size:12pt;\">In peripheral vascular disease caused by other heavy metals, gangrene is not a common manifestation</span></li></ul><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/18/picture133334.jpg\" alt=\"\" width=\"400\" height=\"249\"></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Above picture shows Blackfoot disease:</span></li></ul><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/18/picture133334.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200596,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50150,
      "choices": [
        {
          "id": 200600,
          "text": "<p><span style=\"font-size:12.0pt;\">Plasmodium vivax and falciparum</span></p>"
        },
        {
          "id": 200601,
          "text": "<p><span style=\"font-size:12.0pt;\">Plasmodium ovale and falciparum</span></p>"
        },
        {
          "id": 200602,
          "text": "<p><span style=\"font-size:12.0pt;\">Plasmodium vivax and ovale</span></p>"
        },
        {
          "id": 200603,
          "text": "<p><span style=\"font-size:12.0pt;\">Plasmodium vivax and malariae</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Relapse is seen in? (INICET MAY 2017)</span></p>",
      "unique_key": "Q4713352",
      "question_audio": null,
      "question_video": null,
      "map_id": 34098672,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Plasmodium viva and ovale</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Malaria relapse:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">In case of Plasmodium vivax and ovale two kinds of sporozoites are seen, some of which multiply inside hepatic cells to form schizonts and others persist and remain dormant as hypnozoites.</span></li><li><span style=\"font-size:12.0pt;\">True relapse is caused due to hypnozoites (resting forms). Some get activated to become schizonts and release merozoites, which go on infecting RBCs producing clinical relapse.</span></li><li><span style=\"font-size:12.0pt;\">In case of Plasmodium falciparum and malaria, the initial tissue phase disappears completely and no hypnozoites are found, hence relapse is not seen.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Plasmodium vivax and falciparum:</strong> While P. vivax can cause relapse, P. falciparum does not form hypnozoites and therefore does not cause relapse.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Plasmodium ovale and falciparum:</strong> P. ovale can cause relapse due to hypnozoites, but P. falciparum does not form hypnozoites.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Plasmodium vivax and malariae:</strong> P. vivax causes relapse due to hypnozoites, but P. malariae does not form hypnozoites and does not cause relapse.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Relapse in malaria is seen in cases of Plasmodium vivax and Plasmodium ovale due to the presence of hypnozoites, the dormant liver stages that can reactivate and cause renewed infection.</span></p>",
      "correct_choice_id": 200602,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50151,
      "choices": [
        {
          "id": 200604,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Serum Potassium</span></p>"
        },
        {
          "id": 200605,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Serum Magnesium</span></p>"
        },
        {
          "id": 200606,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Serum Sodium</span></p>"
        },
        {
          "id": 200607,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Serum Calcium</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\">A 36-year-old male came with complaints of ascending weakness in both lower limb and upper body. There was no history of trauma. Which of the following is the next investigation? (AIIMS MAY 2017)</span></p>",
      "unique_key": "Q6703508",
      "question_audio": null,
      "question_video": null,
      "map_id": 34588523,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Serum Potassium</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Disturbance in serum potassium levels (hypokalemia or hyperkalemia) present with ascending muscle weakness.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Serum Magnesium:</strong> Incorrect for this scenario as disturbances in magnesium typically cause tetany (muscle spasms) when low and generalized weakness when high, but are less directly linked to the type of ascending muscle weakness described.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Serum Sodium:</strong> Incorrect because changes in serum sodium levels generally affect neurological function but do not typically cause muscular weakness.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Serum Calcium:</strong> Incorrect as calcium imbalances would more likely cause tetany (from hypocalcemia) or symptoms like fatigue, depression, and cardiac arrhythmias (from hypercalcemia), rather than ascending muscle weakness.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span><br> </p><p><span style=\"font-size:12.0pt;\">The disturbances in serum potassium levels can manifest as muscle weakness, making it a vital test in cases of unexplained, ascending muscle weakness without trauma.</span></p>",
      "correct_choice_id": 200604,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50152,
      "choices": [
        {
          "id": 200608,
          "text": "<p><span style=\"font-size:12pt;\">In Africanoids the cusps of molars are wide and deep with shovel shaped cusps in incisors</span></p>"
        },
        {
          "id": 200609,
          "text": "<p><span style=\"font-size:12pt;\">Caucasians have carabelli cusps</span></p>"
        },
        {
          "id": 200610,
          "text": "<p><span style=\"font-size:12pt;\">Upper third molar is most commonly absent in Mongolians</span></p>"
        },
        {
          "id": 200611,
          "text": "<p><span style=\"font-size:12pt;\">Prominent lingual ridge and labial ridge in mongols</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Identify the false statement regarding teeth and ethnicity?</span></p>",
      "unique_key": "Q3882003",
      "question_audio": null,
      "question_video": null,
      "map_id": 34869899,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A. In Africanoids the cusps of molars are wide and deep with shovel shaped cusps in incisors</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The</span><span style=\"font-size:9pt;\"> </span><span style=\"font-size:12.0pt;\">cusps of molars are wide and deep and cusps of incisors are shovel-shaped is typically seen in Mongoloid races not in Africanoids hence the statement is incorrect. In Africanoids there is presence of large teeth and often have more cusps on their molars, even up to eight, with two lingual cusps on the mandibular first premolars as an additional common finding.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B), Option C), Option D): </strong>these statements are correct as explained in the core concept above. The question is asking for the wrong statement.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Key differences between race</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/11/screenshot-2024-06-11-142652.png\" alt=\"\" width=\"1000\" height=\"719\"></strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/11/screenshot-2024-06-11-142652.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200608,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50153,
      "choices": [
        {
          "id": 200612,
          "text": "<p><span style=\"font-size:12.0pt;\">Complement mediated cell damage</span></p>"
        },
        {
          "id": 200613,
          "text": "<p><span style=\"font-size:12.0pt;\">Precipitation reaction</span></p>"
        },
        {
          "id": 200614,
          "text": "<p><span style=\"font-size:12.0pt;\">Heterophile antibody test</span></p>"
        },
        {
          "id": 200615,
          "text": "<p><span style=\"font-size:12.0pt;\">Neutralisation reaction</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 25-year-old male with history of fever and enlarged lymph nodes and sore throat was suspected to have infectious mono-nucleosis and was ordered a Paul Bunnel test. Which of the following is the principle of the test? (INICET MAY 2017)</span></p>",
      "unique_key": "Q9351452",
      "question_audio": null,
      "question_video": null,
      "map_id": 34435835,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Heterophile antibody test</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Paul Bunnell test is a heterophile antibody reaction test and is used in glandular fever like Infectious mononucleosis.</span></li><li><span style=\"font-size:12.0pt;\">Heterophile antibodies have the ability to <strong>agglutinate RBCs</strong> of different animal species.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Paul Bunnell test uses sheep erythrocytes</strong> for agglutination and Monospot test uses horse erythrocytes for agglutination.</span></li><li><span style=\"font-size:12.0pt;\">In Infectious Mononucleosis<u>, </u><strong><u>IgM heterophile</u> antibodies are detectable for the first 3 months</strong> of infection and they can agglutinate sheep erythrocytes.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Complement mediated cell damage: </strong>This refers to a different mechanism where the complement system causes lysis of cells. It is not related to the principle of the Paul Bunnell test.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Precipitation reaction </strong>uses a soluble antigen to form a precipitate in a solid media when combined with an antibody.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Neutralisation reaction: </strong>Neutralization reactions involve antibodies that neutralize the pathogen, preventing it from infecting cells. This principle does not apply to the Paul Bunnell test.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The Paul Bunnell test is a heterophile antibody test used to diagnose infectious mononucleosis. It detects IgM heterophile antibodies that can agglutinate sheep erythrocytes, which are present during the early stages of the infection.</span></p>",
      "correct_choice_id": 200614,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50154,
      "choices": [
        {
          "id": 200616,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Blood volume</span></span></span></p>"
        },
        {
          "id": 200617,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">pH</span></span></span></p>"
        },
        {
          "id": 200618,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Temperature</span></span></span></p>"
        },
        {
          "id": 200619,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Blood pressure</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Feed forward control system is employed during the regulation of</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">? (</span></span>AIIMS May 2017)</p>",
      "unique_key": "Q9920042",
      "question_audio": null,
      "question_video": null,
      "map_id": 34865156,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Temperature</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Feed forward control system is employed during regulation of temperature.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This is the control system of our body that anticipates and makes corrective changes without any stimulus. Such a system is called <strong>Feed forward or Anticipatory or Adaptive Control</strong>.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">For instance, some movements of the body occur so rapidly that there is not enough time for nerve signals to travel from the peripheral parts of the body all the way to the brain and then back to the periphery again to control the movement. Therefore, the brain uses a principle called feed-forward control to cause required muscle contractions wherein sensory nerve signals from the moving parts inform the brain whether the movement is performed correctly. If not, the brain corrects the feed-forward signals that it sends to the muscles the next time the movement is required. Then, if still further correction is needed, this will be done again for subsequent movements. This is called adaptive control.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Examples include:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Thermoregulation by hypothalamus BEFORE the changes in environmental temperature changes the body's core body temperature</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cephalic phase of gastric secretion- Increase in gastric acid secretion on thinking about food</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Thinking about exercise leading to increase heart rate & respiratory rate</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Motor coordination by cerebellum</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Blood volume: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Incorrect. The regulation of blood volume is primarily a feedback mechanism based on circulating blood volume and blood pressure.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. pH: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Incorrect. pH regulation in the body involves feedback mechanisms that monitor and adjust to changes in hydrogen ion concentration.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Blood pressure: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Incorrect. While there are anticipatory aspects in blood pressure regulation during activities like exercise, it's primarily governed by feedback mechanisms responding to changes in blood pressure.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The feed forward control system is a preemptive regulatory mechanism employed notably in temperature regulation, allowing the body to anticipate environmental changes and adjust physiological responses in advance to maintain homeostasis.</span></span></span></p>",
      "correct_choice_id": 200618,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50155,
      "choices": [
        {
          "id": 200620,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Vaginoplasty</span></span></span></p>"
        },
        {
          "id": 200621,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Bilateral gonadectomy</span></span></span></p>"
        },
        {
          "id": 200622,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">HRT to induce puberty</span></span></span></p>"
        },
        {
          "id": 200623,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Clitoroplasty</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A 18-year-old girl with primary amenorrhea, no breast development and Prader 3 genitalia was found to have raised FSH. Her karyotype revealed 45 X0/46 XY and an ultrasound revealed Mullerian structures with poorly visualized gonads. What would be the next line of management? (INICET MAY 2017)</span></span></p>",
      "unique_key": "Q3151693",
      "question_audio": null,
      "question_video": null,
      "map_id": 34908233,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. B) Bilateral gonadectomy</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">This patient has gonadal dysgenesis with virilization (Prader 3 classification is used to describe the degree of virilization of external genitalia)</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/18/screenshot-2023-11-18-111404.jpg\" style=\"height:922px; width:1000px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">If a Y-chromosome is identified during evaluation of primary amenorrhoea, laparoscopic prophylactic gonadectomy is recommended at the time of diagnosis to eliminate the risk of malignancy as dysgenetic gonads have a very high risk of malignancy</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other Options: </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. HRT to induce puberty</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: After gonadectomy, then HRT can be given for secondary sexual development</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. Clitoroplasty </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">and<strong> Option A. vaginoplasty</strong> and other surgeries to correct the virilization may be required but the immediate next step would be to do gonadectomy</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Whenever there is 46XY with primary amenorrhoea, always gonadectomy needs to be done in view of high risk of malignancy in dysgenetic gonads</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ref: Speroff’s Textbook of Reproductive Medicine </span></strong></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/18/screenshot-2023-11-18-111404.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200621,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50156,
      "choices": [
        {
          "id": 200624,
          "text": "<p><span style=\"font-size:12.0pt;\">Elbow</span></p>"
        },
        {
          "id": 200625,
          "text": "<p><span style=\"font-size:12.0pt;\">Knee</span></p>"
        },
        {
          "id": 200626,
          "text": "<p><span style=\"font-size:12.0pt;\">Wrist</span></p>"
        },
        {
          "id": 200627,
          "text": "<p><span style=\"font-size:12.0pt;\">Ankle</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Haglund’s deformity is seen in which joint?(AIIMS MAY 2017)</span></p>",
      "unique_key": "Q2453469",
      "question_audio": null,
      "question_video": null,
      "map_id": 34169969,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Ankle</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>HAGLUND DEFORMITY</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Haglund deformity is prominent Calcaneal tuberosity and overlying bursitis (retro-calcaneal).</span></li><li><span style=\"font-size:12.0pt;\">It is a bony enlargement formed at posterosuperior aspect of calcaneum along with retrocalcaneal bursitis.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/15/screenshot-2024-05-15-112245.JPG\" alt=\"\" width=\"700\" height=\"210\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Haglund deformity is seen at the ankle joint.</span></li></ul><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/15/screenshot-2024-05-15-112245.JPG\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200627,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50157,
      "choices": [
        {
          "id": 200628,
          "text": "<p><span style=\"font-size:12pt;\">Hanging</span></p>"
        },
        {
          "id": 200629,
          "text": "<p><span style=\"font-size:12pt;\">Throttling</span></p>"
        },
        {
          "id": 200630,
          "text": "<p><span style=\"font-size:12pt;\">Strangulation</span></p>"
        },
        {
          "id": 200631,
          "text": "<p><span style=\"font-size:12pt;\">Mugging</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">An autopsy was performed to find the cause of death of a person brought dead to the casualty. It showed abrasions on the neck, fracture of the thyroid cartilage and contused tissues in the neck. The cause of death is? (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">AIIMS May 2017)</span></p>",
      "unique_key": "Q1909926",
      "question_audio": null,
      "question_video": null,
      "map_id": 34901786,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B. Throttling</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">The description of the autopsy findings, including abrasions on the neck, fracture of the thyroid cartilage, and contused tissues in the neck, typically indicates death resulting from external pressure on the neck. Throttling is the act of applying pressure to the neck, often by external force or someone’s hands, which can lead to these specific injuries.</span></p><p> </p><p><span style=\"font-size:12pt;\">Manual strangulation, also known as <strong>throttling</strong>, is a type of asphyxial death where the perpetrator uses his hand to encircle and compress the front and side of the neck.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Autopsy finding</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">External Findings:</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Neck abrasions and bruises, often near the laryngeal prominence and jawline.</span></li><li><span style=\"font-size:12.0pt;\">Signs of asphyxia: cyanosis, facial swelling, Tardieu’s spot, and bleeding from the nose and ears.</span></li><li><span style=\"font-size:12.0pt;\">Finger bruises, usually 1.5–2 cm in size.</span></li><li><span style=\"font-size:12.0pt;\">Extent depends on factors like pressure, assailant’s nails, and victim’s resistance.</span></li><li><span style=\"font-size:12.0pt;\">Thumb marks are more prominent, and multiple abrasions may result from victim’s struggle.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\">Internal Findings:</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Muscle tears.</span></li><li><span style=\"font-size:12.0pt;\">Tongue damage.</span></li><li><span style=\"font-size:12.0pt;\">Inward hyoid bone fracture.</span></li><li><span style=\"font-size:12.0pt;\">Thyroid cartilage fracture.</span></li><li><span style=\"font-size:12.0pt;\">Carotid sheath laceration and carotid artery damage.</span></li></ul><p><span style=\"font-size:12pt;\"> </span></p><p><span style=\"font-size:12.0pt;\">The given autopsy images are suggestive of throttling as bruises and abrasions on the neck is seen.</span></p><p><span style=\"font-size:12pt;\"> </span></p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Hanging:</strong> In the case of hanging, there will be a ligature mark, which is not mentioned in the question.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Strangulation: </strong>Strangulation is a very generalized term used to describe deaths due to violent asphyxia. Eg- ligature strangulation, throttling etc. Since Throttling is already given in option B we can consider option C strangulation as ligature strangulation. It cannot be the answer as ligature mark is not seen.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Mugging: </strong>In mugging cases, the assailant typically compresses or squeezes the victim’s neck by using the crook of their elbow or knee. While a victim killed by this method may exhibit signs of asphyxia, a neck examination may not reveal any signs of violence because the compression is applied using the soft muscles of the arm or leg.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">Throttling involves manual strangulation by applying pressure to the neck, causing abrasions, contusions, and fractures in the neck structures.</span></p>",
      "correct_choice_id": 200629,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50158,
      "choices": [
        {
          "id": 200632,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">1/3 of the total protein requirement + ½ of total energy requirement</span></p>"
        },
        {
          "id": 200633,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">2/3 of the total protein requirement + ½ of total energy requirement</span></p>"
        },
        {
          "id": 200634,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">½ of the total protein requirement + 1/3 of total energy requirement</span></p>"
        },
        {
          "id": 200635,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">½ of the total protein requirement + 2/3 of total energy requirement</span></p>"
        }
      ],
      "text": "<p><span style=\"color:black;font-size:12.0pt;\">Dr. Anil, working as a nutritional consultant with the government of India, is reviewing the Mid-Day Meal (MDM) scheme, an initiative to enhance the nutritional intake among school-going children. He emphasizes that the nutritional component of the meals should not just be about filling stomachs but ensuring that children get adequate protein and energy to support their growth and learning. Given the constraints and the need to ensure minimal nutritional adequacy, what should the minimum supplementation be in the Mid-Day Meal to support the children's needs? (AIIMS MAY 2017)</span></p>",
      "unique_key": "Q7482586",
      "question_audio": null,
      "question_video": null,
      "map_id": 34730444,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. C) ½ of the total protein requirement + 1/3 of total energy requirement</strong></span></p><p> </p><ul><li><span style=\"color:black;font-size:12.0pt;\">The meal should supplement 1/3 of the total energy requirement and 1/2 of the total protein requirement.</span></li><li><span style=\"color:black;font-size:12.0pt;\"><strong>Mid-day meal programme (MDMP): </strong>Also known as ‘School Lunch Programme’, it has been in operation since 1961.</span></li><li><span style=\"color:black;font-size:12.0pt;\">The <strong>major objective </strong>of MDMP: To attract more children for admission to schools and retain them so that literacy improvement of children could be brought about.</span></li><li><span style=\"color:black;font-size:12.0pt;\">The meal is a supplement and not a substitute to the home diet</span></li><li><span style=\"color:black;font-size:12.0pt;\">The meal should supply 1/3 of the total energy requirement and 1/2 of the total protein requirement</span></li><li><span style=\"color:black;font-size:12.0pt;\">MDMP is being operationalised under the Ministry of Human Resource & Development </span></li><li><span style=\"color:black;font-size:12.0pt;\">National Institute of Nutrition, Hyderabad is of the view that minimum number of feeding days in year be 250 to have the desired impact on children</span></li></ul><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Mid-day meal scheme (MDMS) (National Programme of Nutritional Support to Primary Education):</strong></span></p><p> </p><ul><li><span style=\"color:black;font-size:12.0pt;\">Launched in 1995</span></li><li><span style=\"color:black;font-size:12.0pt;\">Main objective: Universalisation of primary education by increasing enrolment, retention and attendance and simultaneously impacting on nutrition of students in primary classes</span></li><li><span style=\"color:black;font-size:12.0pt;\">The mid-day meal should supply 1/3 of the total energy requirement and 1/2 of the total protein requirement</span></li><li><span style=\"color:black;font-size:12.0pt;\">A model menu for mid-day school meal</span></li></ul><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/18/whatsapp-image-2023-10-18-at-122126.jpeg\" alt=\"\" width=\"800\" height=\"294\"></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Principles for formulating mid-day meals:</strong></span></p><p> </p><ul><li><span style=\"color:black;font-size:12.0pt;\">Meal should be a supplement only not a substitute for home diet</span></li><li><span style=\"color:black;font-size:12.0pt;\">Meal should provide 1/3 calories and 1/2 proteins</span></li><li><span style=\"color:black;font-size:12.0pt;\">Meal cost should be low</span></li><li><span style=\"color:black;font-size:12.0pt;\">Complicated cooking process must not be involved</span></li><li><span style=\"color:black;font-size:12.0pt;\">Use locally available foods</span></li><li><span style=\"color:black;font-size:12.0pt;\">Keep changing menu frequently</span></li></ul><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Mid-Day Meal Scheme is now renamed as PM POSHAN or Pradhan Mantri Poshan Shakti Nirman.</strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/18/whatsapp-image-2023-10-18-at-122126.jpeg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200634,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50159,
      "choices": [
        {
          "id": 200636,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">600 kcal/day</span></p>"
        },
        {
          "id": 200637,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">520 kcal/day</span></p>"
        },
        {
          "id": 200638,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">450 kcal/day</span></p>"
        },
        {
          "id": 200639,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">350 kcal/day</span></p>"
        }
      ],
      "text": "<p><span style=\"color:black;font-size:12.0pt;\">Dr. Rathi, an obstetrician in a suburban Indian clinic, was counseling Mrs. Mehta, a software engineer, on nutritional needs during pregnancy. Mrs. Mehta has a sedentary desk job and is entering her second trimester. The doctor emphasized the significance of an appropriate caloric intake to ensure both maternal and fetal health. Given her lifestyle and the stage of pregnancy, by how much should Mrs. Mehta ideally increase her daily caloric consumption? (AIIMS MAY 2017)</span></p>",
      "unique_key": "Q4376922",
      "question_audio": null,
      "question_video": null,
      "map_id": 34096672,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"color:black;font-size:12.0pt;\"><strong>Ans. D) 350 kcal/day</strong></span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\">The suggested daily calorie intake for a pregnant woman in a sedentary occupation should be raised by approximately 350 calories.</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/18/whatsapp-image-2023-10-18-at-122347.jpeg\" alt=\"\" width=\"800\" height=\"183\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"color:black;font-size:12.0pt;\"><strong>Pregnancy Additional Energy Requirements:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"color:black;font-size:12.0pt;\">+350 kcal/day</span></li></ul></li><li><span style=\"color:black;font-size:12.0pt;\"><strong>Lactation Additional Energy Requirements:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"color:black;font-size:12.0pt;\">0-6 m: +600 kcal/day</span></li><li><span style=\"color:black;font-size:12.0pt;\">6-12 m: +520 kcal/day</span></li></ul></li></ul><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/18/whatsapp-image-2023-10-18-at-122347.jpeg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200639,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50160,
      "choices": [
        {
          "id": 200640,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">1<sup>1/2 </sup>hours</span></p>"
        },
        {
          "id": 200641,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">2<sup>1/2 </sup>hours</span></p>"
        },
        {
          "id": 200642,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">3<sup>1/2 </sup>hours</span></p>"
        },
        {
          "id": 200643,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">4<sup>1/2 </sup>hours</span></p>"
        }
      ],
      "text": "<p><span style=\"color:black;font-size:12.0pt;\">What is the window period for thrombolysis in case of stroke? (AIIMS MAY 2017)</span></p>",
      "unique_key": "Q5376211",
      "question_audio": null,
      "question_video": null,
      "map_id": 34891091,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) 4<sup>1/2</sup> hours</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The window period for the administration of intravenous recombinant tissue plasminogen activator (rtPA) in the case of an acute ischemic stroke is 4½ hours from the onset of symptoms. This time frame is critical as rtPA is most effective when administered early, aiming to dissolve the blood clot and restore blood flow to the affected part of the brain, thus minimizing or reversing the damage caused by the stroke.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Indications:</strong></span></p><p> </p><ul><li><span style=\"color:black;font-size:12.0pt;\">After Clinical diagnosis of stroke established</span></li><li><span style=\"color:black;font-size:12.0pt;\">If onset of symptoms to time of drug administration </= 4.5 hours</span></li><li><span style=\"color:black;font-size:12.0pt;\">If age >/= 18 years</span></li><li><span style=\"color:black;font-size:12.0pt;\">CT scan showing no hemorrhage or edema of >1/3<sup>rd</sup> of the MCA territory</span></li><li><span style=\"color:black;font-size:12.0pt;\">Consent given by patient or surrogate</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Contraindications:</strong></span></p><p> </p><ul><li><span style=\"color:black;font-size:12.0pt;\">Coma/stupor/ recent MI.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Major surgery in last 14 days/ GI bleeding in last 21 days/ minor stroke symptoms.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Rapidly improving symptoms.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Sustained BP > 185/110 mmHg despite treatment.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Platelets < 100,000; HCT < 25%; glucose < 50 or > 400 mg/dL.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Use of heparin within 48hrs and prolonged PTT or elevated INR.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Prior stroke or head injury within 3 months; prior intracranial hemorrhage.</span></li></ul><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The therapeutic window for thrombolysis in acute ischemic stroke using rtPA is up to 4½ hours from symptom onset, and strict criteria must be met to ensure the safety and efficacy of treatment. This timeframe is crucial for maximizing the potential benefits of the treatment while minimizing risks.</span></p>",
      "correct_choice_id": 200643,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50161,
      "choices": [
        {
          "id": 200644,
          "text": "<p style=\"margin-left:3px;\"><span style=\"color:black;font-size:12.0pt;\">Paralysis agitans</span></p>"
        },
        {
          "id": 200645,
          "text": "<p style=\"margin-left:3px;\"><span style=\"color:black;font-size:12.0pt;\">Depression</span></p>"
        },
        {
          "id": 200646,
          "text": "<p style=\"margin-left:3px;\"><span style=\"color:black;font-size:12.0pt;\">Alzheimer’s disease</span></p>"
        },
        {
          "id": 200647,
          "text": "<p style=\"margin-left:3px;\"><span style=\"color:black;font-size:12.0pt;\">Huntington chorea</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\">Which of the following disease pathogenesis primarily involves the marked structure: (AIIMS MAY 2017)</span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/26/nm57.jpg\" alt=\"\" width=\"300\" height=\"188\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/26/nm57.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q9486826",
      "question_audio": null,
      "question_video": null,
      "map_id": 34050957,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Paralysis agitans</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The <strong>substantia nigra is the marked structure in the transverse section</strong> of the brain that is shown. Degeneration of the substantia nigra is observed in Parkinson's disease, commonly referred to as paralysis agitans.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Due to the <strong>presence of neuromelanin granules</strong>, which aid in the manufacture of dopamine, <strong>the substantia nigra is pigmented</strong>. The substantia nigra lacks or has less pigmentation in Parkinson's disease.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Parkinson's disease is characterized by bradykinesia, stiffness, and resting tremors. It's also known as paralysis agitans due to the motor dysfunction.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Depression:</strong> Incorrect because depression is typically associated with dysfunctions in other brain regions such as the prefrontal cortex and limbic system, not specifically the substantia nigra.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Alzheimer’s disease:</strong> Incorrect as Alzheimer's disease primarily involves the cerebral cortex and hippocampus, leading to amyloid plaques and neurofibrillary tangles, rather than specific damage to the substantia nigra.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Huntington chorea:</strong> Incorrect because Huntington’s disease involves degeneration of the striatum and other parts of the brain but does not primarily affect the substantia nigra.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The substantia nigra's degeneration is central to the pathogenesis of Parkinson's disease, manifesting as motor symptoms like bradykinesia, stiffness, and resting tremors.</span></p>",
      "correct_choice_id": 200644,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50162,
      "choices": [
        {
          "id": 200648,
          "text": "<p><span style=\"font-size:12.0pt;\">M. tuberculosis</span></p>"
        },
        {
          "id": 200649,
          "text": "<p><span style=\"font-size:12.0pt;\">M. leprae</span></p>"
        },
        {
          "id": 200650,
          "text": "<p><span style=\"font-size:12.0pt;\">Mycoplasma</span></p>"
        },
        {
          "id": 200651,
          "text": "<p><span style=\"font-size:12.0pt;\">Listeria monocyogenes</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Urine LAM is used for the diagnosis of? (INICET MAY 2017)</span></p>",
      "unique_key": "Q8173866",
      "question_audio": null,
      "question_video": null,
      "map_id": 34998472,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) M. tuberculosis</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Urine lipoarabinomannan (LAM) assay is used for the diagnosis of tuberculosis.</span></li><li><span style=\"font-size:12.0pt;\">Lipoarabinomannan (LAM) antigen is a lipopolysaccharide present in mycobacterial cell wall.</span></li><li><span style=\"font-size:12.0pt;\">It is released from metabolically active cells or degenerating cells of patients having tuberculosis<strong>.</strong></span></li><li><span style=\"font-size:12.0pt;\"><strong>Urine LAM testing is especially useful in diagnosing TB in patients with HIV and low CD 4 counts.</strong></span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. M. leprae: </strong>Mycobacterium leprae causes leprosy, and its diagnosis is typically made through skin biopsy and slit-skin smear. Urine LAM is not used for diagnosing leprosy.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Mycoplasma: </strong>Mycoplasma species cause respiratory and urogenital infections. They lack a cell wall and, therefore, LAM is not relevant to their diagnosis.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Listeria monocytogenes: </strong>Listeria monocytogenes is a bacterial pathogen causing listeriosis, diagnosed typically through blood culture or cerebrospinal fluid analysis. Urine LAM is not applicable.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Urine LAM assay is a diagnostic tool for tuberculosis, particularly useful for patients with HIV and low CD4 counts due to the detection of the LAM antigen from mycobacterial cell walls in urine.</span></li></ul>",
      "correct_choice_id": 200648,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50163,
      "choices": [
        {
          "id": 200652,
          "text": "<p><span style=\"font-size:12.0pt;\">Airway Obstruction</span></p>"
        },
        {
          "id": 200653,
          "text": "<p><span style=\"font-size:12.0pt;\">Grade 4 Shock</span></p>"
        },
        {
          "id": 200654,
          "text": "<p><span style=\"font-size:12.0pt;\">Flail Chest</span></p>"
        },
        {
          "id": 200655,
          "text": "<p><span style=\"font-size:12.0pt;\">Severe head injury</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">While performing triage of children who are victims of a school bus accident, which one will you attend to first? (AIIMS MAY 2017)</span></p>",
      "unique_key": "Q8644554",
      "question_audio": null,
      "question_video": null,
      "map_id": 34956937,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Airway Obstruction</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The most appropriate answer is airway obstruction.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Maintaining a patent airway is crucial for the survival of any trauma patient, especially children. An airway obstruction can quickly lead to severe respiratory distress and, if left untreated, can result in death.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Grade 4 Shock</strong>: While shock is a critical condition, attending to airway obstruction takes precedence because it directly impacts oxygenation, which is vital for life. Treating shock without addressing airway obstruction may not be effective.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Flail Chest</strong>: Flail chest is a serious chest injury, but it may not be an immediate threat to the airway. It should be assessed and treated promptly but is not the first priority compared to airway obstruction.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Severe head injury</strong>: Head injuries are also critical, but immediate attention to airway obstruction is necessary to ensure the child's ability to breathe and maintain oxygenation. Head injuries can be assessed and managed after ensuring a clear airway.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Triage decisions are to be made by deciding which injuries constitute the greatest immediate threat to life.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">In general, airway problems are more rapidly lethal than breathing problems › circulation problems > neurologic injuries.</span></p>",
      "correct_choice_id": 200652,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50164,
      "choices": [
        {
          "id": 200656,
          "text": "<p><span style=\"font-size:12.0pt;\">CVP (central venous pressure)</span></p>"
        },
        {
          "id": 200657,
          "text": "<p><span style=\"font-size:12.0pt;\">Urine Output</span></p>"
        },
        {
          "id": 200658,
          "text": "<p><span style=\"font-size:12.0pt;\">Blood pressure</span></p>"
        },
        {
          "id": 200659,
          "text": "<p><span style=\"font-size:12.0pt;\">Oxygen saturation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which parameter is best used to monitor the adequacy of and guide fluid resuscitation in a patient? (AIIMS MAY 2017)</span></p>",
      "unique_key": "Q2221366",
      "question_audio": null,
      "question_video": null,
      "map_id": 34724568,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Urine Output</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Urine output is the best measure of organ perfusion and the best monitor for adequacy of fluid resuscitation.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Adequate end-organ perfusion is best indicated by urine output of >0.5 to 1 mL/kg/h. However, it does not give minute-to-minute values.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. CVP (central venous pressure)</strong>: CVP is a poor reflector of preload. Central venous pressure (CVP) is the mean pressure in the superior vena cava, indicating right ventricular end-diastolic pressure or preload. Normal CVP ranges from 2 to 7 mm Hg (3 to 9 cm H20). A sick or injured patient with a CVP <3 mm Hg is presumed to be volume depleted and maybe given fluids with relative safety. However, CVP is unreliable for assessment of volume status or left ventricular function.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Blood pressure</strong>: Blood pressure is an important vital sign, but it alone may not provide a complete picture of a patient's fluid status. Hypotension (low blood pressure) can be a late sign of inadequate fluid resuscitation, and normotension (normal blood pressure) does not guarantee adequate tissue perfusion. The level of consciousness is an important marker for cerebral perfusion.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Oxygen saturation</strong>: Oxygen saturation (SpO2) measures the amount of oxygen in the blood, and while it is essential for assessing respiratory status, it is not a direct indicator of fluid balance or adequacy of fluid resuscitation</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Urine output is a valuable and non-invasive parameter for assessing fluid resuscitation. Adequate urine output indicates that the patient's kidneys are functioning well and that they are likely receiving an appropriate amount of fluids. It is a practical and real-time measure of the patient's response to fluid therapy.</span></p>",
      "correct_choice_id": 200657,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50165,
      "choices": [
        {
          "id": 200660,
          "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">PGP stands for permeability glycoprotein</span></span></p>"
        },
        {
          "id": 200661,
          "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Also known as CD243</span></span></p>"
        },
        {
          "id": 200662,
          "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Also known as ABCB1</span></span></p>"
        },
        {
          "id": 200663,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Also known as MDR2</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Which of the following is not true about P-glycoprotein? (AIIMS MAY 2017)</span></span></p>",
      "unique_key": "Q6385594",
      "question_audio": null,
      "question_video": null,
      "map_id": 34773595,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D. Also known as MDR2 </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Also known as MDR2 is not true about P-glycoprotein. P-glycoprotein is also known as permeability glycoprotein (PGP), CD243, and ATP-binding cassette sub-family B member 1 (ABCB1). MDR2, on the other hand, is a different protein called multidrug resistance protein 2, which is also involved in drug transport.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">P-glycoprotein (PGP) is a well-known membrane protein that functions as a drug transporter. It is involved in the efflux of drugs and other substances from cells, contributing to multidrug resistance.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. PGP stands for permeability glycoprotein</span></strong><span style=\"font-size:12.0pt\">: This is true. P-glycoprotein is indeed referred to as permeability glycoprotein.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Also known as CD243</span></strong><span style=\"font-size:12.0pt\">: This is true. P-glycoprotein is identified as CD243 in the cluster of differentiation nomenclature.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Also known as ABCB1</span></strong><span style=\"font-size:12.0pt\">: This is true. P-glycoprotein is also known as ATP-binding cassette sub-family B member 1 (ABCB1).</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">P-glycoprotein is known as permeability glycoprotein (PGP), CD243, and ABCB1, but it is not referred to as MDR2. MDR2 is a separate protein involved in drug transport.</span></span></p>",
      "correct_choice_id": 200663,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50166,
      "choices": [
        {
          "id": 200664,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Griseofulvin</span></span></span></p>"
        },
        {
          "id": 200665,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Amphotericin B</span></span></span></p>"
        },
        {
          "id": 200666,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ampicillin</span></span></span></p>"
        },
        {
          "id": 200667,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Aspirin</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">For which of the following drugs, absorption is increased after a fatty meal? (AIIMS MAY 2017)</span></span></p>",
      "unique_key": "Q2293156",
      "question_audio": null,
      "question_video": null,
      "map_id": 34013022,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Griseofulvin</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Griseofulvin is an antifungal drug that acts by blocking the microtubules. It is given orally, preferably with a fatty meal, which has been found to increase its absorption. This enhancement in absorption is due to the lipophilic nature of griseofulvin, which allows it to dissolve better in the presence of dietary fats, facilitating its uptake in the gastrointestinal tract.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\">Option </span></strong><strong><span style=\"font-family:\"Calibri\",sans-serif\">B.</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> <strong><span style=\"font-family:\"Calibri\",sans-serif\">Amphotericin B</span></strong>: Amphotericin B is an antifungal medication primarily administered intravenously due to poor oral absorption. Its absorption is not significantly affected by meals.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\">Option </span></strong><strong><span style=\"font-family:\"Calibri\",sans-serif\">C. <strong><span style=\"font-family:\"Calibri\",sans-serif\">Ampicillin</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Ampicillin is an antibiotic that is generally well absorbed on an empty stomach. Food can actually reduce the absorption of ampicillin.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\">Option </span></strong><strong><span style=\"font-family:\"Calibri\",sans-serif\">D. <strong><span style=\"font-family:\"Calibri\",sans-serif\">Aspirin</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Aspirin is an anti-inflammatory and antipyretic drug. Its absorption is not significantly increased by fatty meals, although taking it with food can help minimize gastrointestinal side effects.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Drugs whose absorption increase with meals</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Griseofulvin</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Statins</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Halofantrine</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Erlotinib</span></span></span></p>",
      "correct_choice_id": 200664,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50167,
      "choices": [
        {
          "id": 200668,
          "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">No advice as most of drug are not present in breast milk</span></span></p>"
        },
        {
          "id": 200669,
          "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Give longer half-life drugs</span></span></p>"
        },
        {
          "id": 200670,
          "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Tell the mother to feed when it is least efficacious</span></span></p>"
        },
        {
          "id": 200671,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">To feed just before the next dose, when the plasma concentration of the drug would be the least</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">What advice do you give to a mother who is using medications during lactation? (AIIMS MAY 2017)</span></span></p>",
      "unique_key": "Q3598090",
      "question_audio": null,
      "question_video": null,
      "map_id": 34414530,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D. To feed just before the next dose, when the plasma concentration of the drug would be the least</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">When administering medications to a lactating mother, the timing of breast feeding is very important. It is advised to feed the baby just before the intake of the drug, as at that time the plasma concentration of the drug would be least. Then after feeding the drug is taken.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. No advice as most of the drug are not present in breast milk</span></strong><span style=\"font-size:12.0pt\">: This is incorrect. Many drugs can pass into breast milk to varying degrees. Therefore, careful consideration and advice are needed to minimize infant exposure.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Give longer half-life drugs</span></strong><span style=\"font-size:12.0pt\">: This is not a general recommendation. Drugs with longer half-lives stay in the body longer and can potentially accumulate in the breast milk, increasing exposure to the infant.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Tell the mother to feed when it is least efficacious</span></strong><span style=\"font-size:12.0pt\">: This advice is not clear or practical. The key is to time breastfeeding relative to the dosing schedule to minimize drug transfer to the breast milk.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">The best advice for a lactating mother using medications is to breastfeed just before taking her next dose of medication. This practice ensures that the drug's plasma concentration is at its lowest during breastfeeding, thereby reducing the amount of drug that passes into the breast milk and minimizing exposure to the infant.</span></span></p>",
      "correct_choice_id": 200671,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50168,
      "choices": [
        {
          "id": 200672,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Corticosteroids increase bronchial responsiveness to salbutamol</span></span></span></p>"
        },
        {
          "id": 200673,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Corticosteroids cause direct bronchodilatation when used with xanthine</span></span></span></p>"
        },
        {
          "id": 200674,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Corticosteroids indirectly increase the effect of xanthine on adenosine receptor</span></span></span></p>"
        },
        {
          "id": 200675,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Corticosteroids increase mucous secretion.</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Acute exacerbation of asthma was comprehended, salbutamol was prescribed, however, no improvement was noticed. Intravenous corticosteroids and aminophylline were given and the condition improved. What is the probable mechanism by which the corticosteroids would have improved the condition? (AIIMS MAY 2017)</span></span></p>",
      "unique_key": "Q7347791",
      "question_audio": null,
      "question_video": null,
      "map_id": 34581454,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Corticosteroids increase bronchial responsiveness to salbutamol</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Corticosteroids are not bronchodilators by itself, but they are used in acute exacerbation of asthma because they decrease the secretion of mucous, decrease the inflammatory mediators and also increase the responsiveness of the β receptors to the action of the β2 agonists. Therefore, it can be said that Corticosteroids improved the condition by increasing the airway responsiveness to salbutamol.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\">Option </span></strong><strong><span style=\"font-family:\"Calibri\",sans-serif\">B. <strong><span style=\"font-family:\"Calibri\",sans-serif\">Corticosteroids cause direct bronchodilatation when used with xanthine</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: This is incorrect. Corticosteroids do not cause direct bronchodilation. Their primary role is to reduce inflammation and enhance the effects of bronchodilators.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\">Option </span></strong><strong><span style=\"font-family:\"Calibri\",sans-serif\">C. <strong><span style=\"font-family:\"Calibri\",sans-serif\">Corticosteroids indirectly increase the effect of xanthine on adenosine receptor</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: This is incorrect. Corticosteroids do not have a direct or indirect effect on the xanthine (aminophylline) action on adenosine receptors.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\">Option </span></strong><strong><span style=\"font-family:\"Calibri\",sans-serif\">D. <strong><span style=\"font-family:\"Calibri\",sans-serif\">Corticosteroids increase mucous secretion</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: This is incorrect. Corticosteroids actually decrease mucus secretion, which helps to clear the airways and improve airflow during an asthma exacerbation.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Corticosteroids improve the condition of patients with acute asthma exacerbation by increasing the bronchial responsiveness to β2 agonists like salbutamol, reducing inflammation, and decreasing mucus secretion.</span></span></p>",
      "correct_choice_id": 200672,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50169,
      "choices": [
        {
          "id": 200676,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pentazocine</span></span></span></p>"
        },
        {
          "id": 200677,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Buprenorphine</span></span></span></p>"
        },
        {
          "id": 200678,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tramadol</span></span></span></p>"
        },
        {
          "id": 200679,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Fentanyl</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Which of the following opioids is an antagonist at ‘µ’ and a complete agonist at ‘k’ receptors? (AIIMS MAY 2017)</span></span></p>",
      "unique_key": "Q6409564",
      "question_audio": null,
      "question_video": null,
      "map_id": 34036181,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Pentazocine</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pentazocine is an opioid agonist-antagonist agent, which acts as a full agonist at the Kappa receptors but as a partial agonist or antagonist at the mu receptors. It is used as an analgesic, but contraindicated in myocardial infarction due to its potential to increase heart rate and blood pressure.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\">Option </span></strong><strong><span style=\"font-family:\"Calibri\",sans-serif\">B. <strong><span style=\"font-family:\"Calibri\",sans-serif\">Buprenorphine</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Buprenorphine is a partial agonist at mu (μ) receptors and an antagonist at kappa (κ) receptors. It is used for pain management and in the treatment of opioid dependence.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\">Option </span></strong><strong><span style=\"font-family:\"Calibri\",sans-serif\">C. <strong><span style=\"font-family:\"Calibri\",sans-serif\">Tramadol</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Tramadol is a weak agonist at mu (μ) receptors and also inhibits the reuptake of norepinephrine and serotonin. It does not have significant kappa (κ) receptor activity.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\">Option </span></strong><strong><span style=\"font-family:\"Calibri\",sans-serif\">D. <strong><span style=\"font-family:\"Calibri\",sans-serif\">Fentanyl</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Fentanyl is a potent full agonist at mu (μ) receptors with no significant activity at kappa (κ) receptors. It is used for severe pain management, particularly in surgical settings.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Pentazocine is an opioid that acts as an antagonist at mu (μ) receptors and a full agonist at kappa (κ) receptors. This unique profile allows it to serve as an analgesic with a potentially lower risk of certain side effects, although it is contraindicated in myocardial infarction.</span></span></p>",
      "correct_choice_id": 200676,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50170,
      "choices": [
        {
          "id": 200680,
          "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Latanoprostene</span></span></p>"
        },
        {
          "id": 200681,
          "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Zerviate</span></span></p>"
        },
        {
          "id": 200682,
          "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Tasimelteon</span></span></p>"
        },
        {
          "id": 200683,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Ramelteon</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">The drug of choice for insomnia in blind people is? (AIIMS MAY 2017)</span></span></p>",
      "unique_key": "Q4778980",
      "question_audio": null,
      "question_video": null,
      "map_id": 34908420,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C. Tasimelteon</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tasimelteon and Ramelteon are melatonin agonists. Tasimelteon is used for the treatment of insomnia in blind persons, whereas Ramelteon is used for the treatment of jet lag and also used for sleep induction.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\">Option </span></strong><strong><span style=\"font-family:\"Calibri\",sans-serif\">A. <strong><span style=\"font-family:\"Calibri\",sans-serif\">Latanoprostene:</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> Is not relevant to the treatment of insomnia. It is a medication used to reduce intraocular pressure in patients with glaucoma or ocular hypertension.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\">Option </span></strong><strong><span style=\"font-family:\"Calibri\",sans-serif\">B. <strong><span style=\"font-family:\"Calibri\",sans-serif\">Zerviate: </span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">Is an antihistamine eye drop used for the treatment of ocular itching associated with allergic conjunctivitis, not for insomnia.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\">Option </span></strong><strong><span style=\"font-family:\"Calibri\",sans-serif\">D.</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> <strong><span style=\"font-family:\"Calibri\",sans-serif\">Ramelteon:</span></strong> Is also a melatonin receptor agonist used for the treatment of insomnia, specifically for difficulties with sleep onset. It is not specifically indicated for Non-24-Hour Sleep-Wake Disorder in blind individuals.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Tasimelteon is the drug of choice for treating insomnia in blind individuals due to its effectiveness in regulating the sleep-wake cycle by acting as a melatonin receptor agonist, particularly in those with Non-24-Hour Sleep-Wake Disorder.</span></span></span></p>",
      "correct_choice_id": 200682,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50171,
      "choices": [
        {
          "id": 200684,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Class I</span></span></span></p>"
        },
        {
          "id": 200685,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Class II</span></span></span></p>"
        },
        {
          "id": 200686,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Class III</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>"
        },
        {
          "id": 200687,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Class IV</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Dofetilide belongs to which class of anti-arrhythmic drugs? (AIIMS MAY 2017)</span></span></p>",
      "unique_key": "Q4661134",
      "question_audio": null,
      "question_video": null,
      "map_id": 34484832,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C. Class III</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Dofetilide is a class III anti arrhythmic drug that works by blocking K+ channels. The other class III anti arrhythmic include Amiodarone, Ibutilide, Sotalol and bretylium.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The side effect is QT prolongation/Torsades de pointes.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\">Option </span></strong><strong><span style=\"font-family:\"Calibri\",sans-serif\">A. <strong><span style=\"font-family:\"Calibri\",sans-serif\">Class I</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: These are sodium channel blockers. </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\">Option </span></strong><strong><span style=\"font-family:\"Calibri\",sans-serif\">B. <strong><span style=\"font-family:\"Calibri\",sans-serif\">Class II</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: These are beta-blockers. </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\">Option </span></strong><strong><span style=\"font-family:\"Calibri\",sans-serif\">D. <strong><span style=\"font-family:\"Calibri\",sans-serif\">Class IV</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: These are calcium channel blockers.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Class III drugs include:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">B: Bretylium</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">I: Ibutilide</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">N</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">D: Dofetilide</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A: Amiodarone</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">S: Sotalol</span></span></span></p>",
      "correct_choice_id": 200686,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50172,
      "choices": [
        {
          "id": 200688,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">α1 agonist and β1 agonist</span></span></span></span></span></p>"
        },
        {
          "id": 200689,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">﻿﻿﻿M2 agonist and M3 agonist</span></span></span></span></span></p>"
        },
        {
          "id": 200690,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">﻿﻿﻿α 1 antagonist and β2 agonist</span></span></span></span></span></p>"
        },
        {
          "id": 200691,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\">﻿﻿﻿<span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">β1 agonist and β2 agonist</span></span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-family:Helvetica,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">The following table gives BP values before and after administration of drug 'X'. What would be the probable mechanism of action of drug 'X'?</span></span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"> (AIIMS MAY 2017)</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/30/screenshot-2024-09-30-150657.jpg\" style=\"height:296px; width:687px\" /></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/30/screenshot-2024-09-30-150657.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q7025284",
      "question_audio": null,
      "question_video": null,
      "map_id": 34926670,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Ans. D. <span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">β1 agonist and β2 agonist</span></strong></span></span></span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The drug's likely mechanism of action is β1 and β2 agonism.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Due to its action on β1 receptors, there is an increase in the HR of the patient and also of the SBP (Increase in HR leads to an increase in the CO upto a certain extent). The agonistic action on the β2 receptors causes vasodilation and leads to a fall in the DBP.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\">Option </span></strong><strong><span style=\"font-family:\"Calibri\",sans-serif\">A.</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> <strong><span style=\"font-family:\"Calibri\",sans-serif\">α1 agonist and β1 agonist</span></strong>: α1 agonists typically cause vasoconstriction, which would increase both SBP and DBP. This does not align with the observed decrease in DBP.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\">Option </span></strong><strong><span style=\"font-family:\"Calibri\",sans-serif\">B. <strong><span style=\"font-family:\"Calibri\",sans-serif\">M2 agonist and M3 agonist</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: M2 and M3 receptor agonism would likely lead to bradycardia and increased gastrointestinal motility, respectively. They do not explain the observed increase in HR and SBP, nor the decrease in DBP.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\">Option </span></strong><strong><span style=\"font-family:\"Calibri\",sans-serif\">C. <strong><span style=\"font-family:\"Calibri\",sans-serif\">α1 antagonist and β2 agonist</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: While α1 antagonism could contribute to a decrease in DBP through vasodilation, it would not typically cause an increase in SBP and HR, which are more specifically associated with β1 agonism.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">The combination of increased systolic blood pressure, decreased diastolic blood pressure, and increased heart rate suggests that drug 'X' acts as a β1 and β2 agonist, leading to increased cardiac output and vasodilation.</span></span></p>",
      "correct_choice_id": 200691,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50173,
      "choices": [
        {
          "id": 200692,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">18</span></span></span></p>"
        },
        {
          "id": 200693,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1.8</span></span></span></p>"
        },
        {
          "id": 200694,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">20</span></span></span></p>"
        },
        {
          "id": 200695,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">2</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Ceftriaxone 180 mg is required for a patient. You're using a 2 mL syringe with 10 divisions per ml. Ceftriaxone 500 mg/5ml is contained in the vial. How many divisions will you fill in the 2 mL syringe to give 180 mg ceftriaxone? (AIIMS MAY 2017)</span></span></p>",
      "unique_key": "Q8913737",
      "question_audio": null,
      "question_video": null,
      "map_id": 34221320,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. 18</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In a vial of Ceftriaxone, it is given than 500mg is there in 5ml.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Therefore 180 mg will be present in 1.8 ml.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In the 2ml syringe there are 10 divisions per ml.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Thus, to take 1.8ml, we need to fill 10*1.8 = 18 divisions.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">To administer 180 mg of ceftriaxone using a 2 mL syringe with 10 divisions per ml, you need to fill the syringe to 18 divisions.</span></span></p>",
      "correct_choice_id": 200692,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50174,
      "choices": [
        {
          "id": 200696,
          "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Tamsulosin</span></span></p>"
        },
        {
          "id": 200697,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Sildenafil</span></span></p>"
        },
        {
          "id": 200698,
          "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Finasteride</span></span></p>"
        },
        {
          "id": 200699,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Flutamide</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">The drug that decreases the size of prostate is? (AIIMS MAY 2017)</span></span></p>",
      "unique_key": "Q6731210",
      "question_audio": null,
      "question_video": null,
      "map_id": 34197690,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C. Finasteride</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Finasteride: It inhibits the conversion of testosterone into its active form, DHT (dihydrotestosterone), by acting as a competitive inhibitor of the 5-reductase enzyme. It has a long-term effect of reducing prostatic epithelial cell proliferation, which reduces the size of the prostate and improves urine flow.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tamsulosin is a Selective α1A Antagonist which dilates prostatic urethra and hence produces immediate symptom relief in BPH. It has no effect on reducing size of the prostate.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Flutamide is a Androgen Receptor antagonist with no hormonal activity. It is used for the treatment of metastatic prostatic cancer in conjunction with GnRH agonists.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\">Option </span></strong><strong><span style=\"font-family:\"Calibri\",sans-serif\">A.</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> <strong><span style=\"font-family:\"Calibri\",sans-serif\">Tamsulosin</span></strong>: Tamsulosin is a selective alpha-1A adrenergic receptor antagonist. It works by relaxing the muscles in the prostate and bladder neck, making it easier to urinate. While it provides symptomatic relief for BPH, it does not reduce the size of the prostate.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\">Option </span></strong><strong><span style=\"font-family:\"Calibri\",sans-serif\">B. <strong><span style=\"font-family:\"Calibri\",sans-serif\">Sildenafil</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Sildenafil is a phosphodiesterase type 5 (PDE5) inhibitor used primarily for the treatment of erectile dysfunction. It has no effect on prostate size.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\">Option </span></strong><strong><span style=\"font-family:\"Calibri\",sans-serif\">D.</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> <strong><span style=\"font-family:\"Calibri\",sans-serif\">Flutamide</span></strong>: Flutamide is an androgen receptor antagonist that is used in the treatment of metastatic prostate cancer. It does not reduce the size of the prostate but works by blocking the effects of androgens (male hormones).</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Finasteride decreases the size of the prostate by inhibiting the conversion of testosterone to dihydrotestosterone (DHT), thereby reducing prostatic cell proliferation and improving urinary symptoms in patients with benign prostatic hyperplasia.</span></span></p>",
      "correct_choice_id": 200698,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50175,
      "choices": [
        {
          "id": 200700,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Herbal medication with no effect known</span></span></span></p>"
        },
        {
          "id": 200701,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Physiotherapy</span></span></span></p>"
        },
        {
          "id": 200702,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sham surgery</span></span></span></p>"
        },
        {
          "id": 200703,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cognitive behavioral therapy</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Which one of the following is a placebo? (AIIMS MAY 2017)</span></span></p>",
      "unique_key": "Q9043501",
      "question_audio": null,
      "question_video": null,
      "map_id": 34402905,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C. Sham surgery</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sham surgery (placebo surgery) is a fictitious surgical intervention when the actual step that is of therapeutic benefit is omitted. For example, opening the abdomen and then again suturing it without any sort of intervention done on the viscera.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\">Option </span></strong><strong><span style=\"font-family:\"Calibri\",sans-serif\">A. <strong><span style=\"font-family:\"Calibri\",sans-serif\">Herbal medication with no effect known</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: While an herbal medication with no known effect might be considered a placebo in certain contexts, it is not specifically designed as a placebo. It could contain active ingredients with unknown effects.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\">Option </span></strong><strong><span style=\"font-family:\"Calibri\",sans-serif\">B. <strong><span style=\"font-family:\"Calibri\",sans-serif\">Physiotherapy</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Physiotherapy is an established therapeutic practice with known benefits for various conditions. It is not a placebo.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:\"Calibri\",sans-serif\">Option </span></strong><strong><span style=\"font-family:\"Calibri\",sans-serif\">D. <strong><span style=\"font-family:\"Calibri\",sans-serif\">Cognitive behavioral therapy</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Cognitive behavioral therapy (CBT) is a well-established psychological treatment for a variety of mental health conditions. It is not a placebo, as it involves specific therapeutic techniques aimed at changing maladaptive thinking and behavior patterns.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Sham surgery is a type of placebo where the therapeutic intervention is omitted, used primarily in clinical trials to control for the placebo effect and test the efficacy of surgical procedures.</span></span></span></p>",
      "correct_choice_id": 200702,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50176,
      "choices": [
        {
          "id": 200704,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2 and 3</span></p>"
        },
        {
          "id": 200705,
          "text": "<p><span style=\"font-size:12.0pt;\">1 and 2</span></p>"
        },
        {
          "id": 200706,
          "text": "<p><span style=\"font-size:12.0pt;\">2 and 3</span></p>"
        },
        {
          "id": 200707,
          "text": "<p><span style=\"font-size:12.0pt;\">1 and 3</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient has a HbA2 of 3% and HbF of 97%. A peripheral blood smear is taken. Which of the following blood pictures will be seen in this patient? </span>(AIIMS MAY 2017)</p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/40.jpg\" alt=\"\" width=\"699\" height=\"228\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/40.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q9656844",
      "question_audio": null,
      "question_video": null,
      "map_id": 34493661,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. </strong></span><span style=\"background-color:transparent;font-size:11pt;\"><strong>A) 1, 2 and 3</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Based on the patient's HbA2 and HbF levels, this patient likely has beta thalassemia major, a condition where the body produces less than normal amounts of hemoglobin beta chains. This results in a decrease in HbA, and an increase in HbF and HbA2.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Beta thalassemia will have high HbA2 levels (>3.5%) and slightly increased HbF</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The peripheral blood smear of a patient with beta thalassemia major will show hypochromic microcytic red blood cells (Image 1), which are smaller and paler than normal. Howell-jolly bodies (image 2) will also be seen. These cells may also be more variable in size and shape, and may have a target cell appearance (Image 3) due to increased membrane-to-cytoplasm ratio.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Other possible findings on the blood smear may include anisocytosis (variation in cell size), poikilocytosis (variation in cell shape), and nucleated red blood cells (if the patient has severe anemia).</span></p><p> </p><p><span style=\"font-size:12.0pt;\">It's important to note that the blood smear alone is not sufficient to diagnose beta thalassemia major, and additional laboratory tests and genetic testing may be necessary for confirmation.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Image 2 shows Howell–Jolly bodies, which are small, round, dark purple inclusions within red blood cells (RBCs), representing residual nuclear DNA fragments. These inclusions are typically removed by a healthy spleen; their presence often indicates splenic dysfunction or absence.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Conditions Associated with Howell–Jolly Bodies</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The presence of Howell–Jolly bodies is commonly associated with:</span></p><p> </p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">Post-splenectomy: Following surgical removal of the spleen</span></li><li><span style=\"font-size:12.0pt;\">Functional asplenia or hyposplenism: Conditions like sickle cell disease can lead to spleen dysfunction</span></li><li><span style=\"font-size:12.0pt;\">Megaloblastic anemia: Due to vitamin B12 or folate deficiency</span></li><li><span style=\"font-size:12.0pt;\">Severe hemolytic anemia: Where rapid RBC destruction overwhelms the spleen's filtering capacity</span></li><li><span style=\"font-size:12.0pt;\">Myelodysplastic syndromes: Bone marrow disorders affecting blood cell production</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">In beta thalassemia major, the peripheral blood smear typically shows hypochromic microcytic red blood cells and target cells, which are best represented by Image 1 and Image 3.</span></p>",
      "correct_choice_id": 200704,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50177,
      "choices": [
        {
          "id": 200708,
          "text": "<p><span style=\"font-size:12.0pt;\">1+</span></p>"
        },
        {
          "id": 200709,
          "text": "<p><span style=\"font-size:12.0pt;\">2+</span></p>"
        },
        {
          "id": 200710,
          "text": "<p><span style=\"font-size:12.0pt;\">3+</span></p>"
        },
        {
          "id": 200711,
          "text": "<p><span style=\"font-size:12.0pt;\">Gene Amplification is done irrespective of Her 2 Neu status</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In breast cancer, FISH for gene amplification will be done based on which of the following IHC staining for Her-2/neu? </span>(AIIMS MAY 2017)</p>",
      "unique_key": "Q6617366",
      "question_audio": null,
      "question_video": null,
      "map_id": 34251401,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 2+</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">In the context of breast cancer, the <strong>Her-2/neu</strong> status is typically assessed by <strong>Immunohistochemistry (IHC)</strong>. The Her-2/neu protein overexpression is graded on a scale of 0 to 3+ based on the intensity and completeness of membrane staining. This grading is crucial in guiding further testing and treatment decisions.</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>IHC 0 or 1+</strong>: These scores indicate no or low levels of Her-2/neu expression, respectively. Tumors with these scores are considered Her-2 negative, and no further testing for gene amplification is typically needed.</span></li><li><span style=\"font-size:12.0pt;\"><strong>IHC 2+</strong>: This score is considered <strong>equivocal</strong>. When a tumor shows a 2+ result on IHC, it suggests an intermediate level of Her-2/neu expression. Because this result is not definitively positive or negative, <strong>Fluorescence in Situ Hybridization (FISH)</strong> testing is recommended to assess for <strong>gene amplification</strong> of Her-2/neu. FISH is a more sensitive and specific test that directly detects the amplification of the Her-2/neu gene, providing definitive information about the tumor's status.</span></li><li><span style=\"font-size:12.0pt;\"><strong>IHC 3+</strong>: A score of 3+ indicates a high level of Her-2/neu protein overexpression. Tumors with this score are considered <strong>Her-2 positive</strong> and typically do not require further FISH testing, as the overexpression is sufficient to warrant Herceptin (trastuzumab) therapy.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Herceptin</strong> is a targeted therapy that specifically inhibits the Her-2/neu receptor, which is overexpressed in some breast cancers, leading to more aggressive tumor behavior. Therefore, determining the correct Her-2/neu status through IHC and, if necessary, confirming with FISH is crucial in selecting the appropriate treatment.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. 1+:</strong> IHC 1+ is considered Her-2/neu negative, and FISH testing is generally not indicated in these cases.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. 3+:</strong> IHC 3+ is strongly positive for Her-2/neu, making FISH testing unnecessary since the high expression level is sufficient to guide treatment decisions.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Gene Amplification is done irrespective of Her 2 Neu status:</strong> This option is incorrect because FISH testing for gene amplification is specifically indicated in cases with an equivocal IHC result (2+), not irrespective of Her-2/neu status.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">FISH for Her-2/neu gene amplification is performed when the IHC result is 2+, as this score is considered equivocal, requiring further testing to determine the appropriate therapeutic approach.</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/14/untitled-367.jpg\" alt=\"\" width=\"500\" height=\"791\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/42.jpg\" alt=\"\" width=\"406\" height=\"445\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/14/untitled-367.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200709,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50178,
      "choices": [
        {
          "id": 200712,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Necrotizing TB granuloma</span></span></span></p>"
        },
        {
          "id": 200713,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Vegetative matter aspiration pneumonia</span></span></span></p>"
        },
        {
          "id": 200714,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sarcoid granuloma</span></span></span></p>"
        },
        {
          "id": 200715,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Severe fungal pneumonia</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A 35-year-old depressed man came with complaints of sudden onset breathlessness, with desaturation. Chest x-ray showed bilateral diffuse infiltrates with predominant involvement of right middle and lower lobes. The patient could not be revived despite treatment. On autopsy, the lungs, appeared grossly normal. The histopathology image of the lung is as shown below. Which among the following is the appropriate cause?</span></span> (AIIMS MAY 2017)</p>\r\n\r\n<p style=\"text-align:justify\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/47.jpg\" style=\"height:267px; width:300px\" /></span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/47.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q5785857",
      "question_audio": null,
      "question_video": null,
      "map_id": 34314463,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Vegetative matter aspiration pneumonia </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The above image shows a <strong>foreign body granuloma</strong>. Foreign bodies are surrounded by macrophages and lymphocytes. This change results from aspiration of stomach contents or food particles in this case probably vegetative matter.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Aspiration pneumonia </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">occurs in markedly debilitated patients or those who aspirate gastric contents either while unconscious (e.g., <strong>after a stroke</strong>) or during repeated vomiting. These patients have <strong>abnormal gag and swallowing reflexes</strong> that predispose to aspiration. The resultant pneumonia is partly chemical because of the extremely irritating effects of the gastric acid, and partly bacterial (from the oral flora). Typically, more than one organism is recovered on culture, aerobes being more common than anaerobes. This type of pneumonia is often necrotizing, pursues a fulminant clinical course, and is a frequent cause of death. </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The most commonly affected lobes in Necrotizing pneumonia are the right middle and lower lobes, consistent with the findings in this case.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Necrotizing TB granuloma</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Tuberculosis typically presents with caseating granulomas, not foreign body granulomas as seen in this image. The clinical scenario also does not support TB.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Sarcoid granuloma</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Sarcoidosis is characterized by non-caseating granulomas, which differ from the foreign body granuloma seen in the provided image.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Severe fungal pneumonia</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Fungal infections can cause granulomatous inflammation, but they typically present with necrotizing granulomas or other distinct histological features. The presence of foreign material is more indicative of aspiration pneumonia.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Vegetative matter aspiration pneumonia can lead to the formation of foreign body granulomas, characterized by macrophages and lymphocytes surrounding the aspirated material. This condition is often associated with severe clinical outcomes, especially in debilitated patients.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ref: Robbins and Cotran Pathologic basis of disease, 8th edition, Page No 1344</span></strong></span></span></p>",
      "correct_choice_id": 200713,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50179,
      "choices": [
        {
          "id": 200716,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Acid Citrate dextrose</span></span></span></p>"
        },
        {
          "id": 200717,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Citrate phosphate dextrose</span></span></span></p>"
        },
        {
          "id": 200718,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Citrate phosphate 2 dextrose</span></span></span></p>"
        },
        {
          "id": 200719,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Citrate phosphate dextrose adenine – 1</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Which of the following can be used to store blood for up to 35 days? </span></span></span>(AIIMS MAY 2017)</p>",
      "unique_key": "Q4572483",
      "question_audio": null,
      "question_video": null,
      "map_id": 34475044,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Citrate phosphate dextrose adenine – 1 </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Citrate-phosphate-dextrose solution with adenine (CPDA) is an anticoagulant and preservative for storage of blood. It can prolong red blood cell storage life up to 35 days. It <strong>maintains platelet viability</strong>. Usage of <strong>CPDA improves post-transfusion visibility and improves glucose and ATP levels in blood. CPDA can increase serum uric acid levels (due to adenine component).</strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The shelf life of storage of other options:</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Acid Citrate dextrose - 21 days</span></strong></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Citrate-phosphate dextrose - 21 days</span></strong></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Citrate Phosphate 2 Dextrose (CP2D):</span></strong><span style=\"font-size:12.0pt\"> 21 days</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Citrate Phosphate Dextrose Adenine (CPDA-1) can be used to store blood for up to 35 days, making it the solution with the longest preservation capability among the options provided.</span></span></span></p>",
      "correct_choice_id": 200719,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50180,
      "choices": [
        {
          "id": 200720,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Bedside blood collection, label the samples, fill the laboratory requisition forms, Identify the patient</span></span></span></p>"
        },
        {
          "id": 200721,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Fill the laboratory requisition forms, Identify the Patient, Bedside blood collection, label the samples</span></span></span></p>"
        },
        {
          "id": 200722,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Label the sample tubes, Bedside blood collection, fill the laboratory requisition forms, Identify the patient</span></span></span></p>"
        },
        {
          "id": 200723,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Identify the Patient, Fill the laboratory requisition forms, Bedside blood collection, label the samples</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Identify the correct sequence: </span></span>(AIIMS MAY 2017)</p>",
      "unique_key": "Q5537252",
      "question_audio": null,
      "question_video": null,
      "map_id": 34751252,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Ans. B)</strong> </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Fill the laboratory requisition forms, Identify the Patient, Bedside blood collection, label the samples</strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The correct sequence for blood collection and sample handling in a clinical setting involves several critical steps to ensure patient safety and accurate test results. The sequence is as follows:</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Provisional diagnosis by the physician</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This initial step involves the physician evaluating the patient and determining the necessary diagnostic tests.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Fill the laboratory requisition forms</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: The healthcare staff or laboratory personnel must fill out the requisition forms based on the physician's diagnosis. This step is crucial because it ensures that the correct tests are requested and that the laboratory has all the necessary information to process the samples.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Identify the Patient</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Before collecting any samples, the healthcare staff must properly identify the patient. This step is vital to prevent any mix-up of samples, which could lead to incorrect diagnosis and treatment.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Bedside blood collection</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: After confirming the patient's identity, the blood sample is collected at the bedside. Proper collection technique is essential to avoid contamination or sample degradation.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Label the samples</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Finally, the collected samples must be labeled accurately and immediately to ensure that they are correctly matched with the patient and the requested tests.</span></span></span></li>\r\n</ol>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This sequence ensures that the right patient receives the correct test, and the results are reliable and accurate.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sequence:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Provisional diagnosis by the physician > Requisition forms are filled accordingly for test to the lab > patient is identified by the laboratory personnel/ health care staff > samples are collected and labeled appropriately.</span></span></span></p>",
      "correct_choice_id": 200721,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50181,
      "choices": [
        {
          "id": 200724,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">EDTA</span></span></span></p>"
        },
        {
          "id": 200725,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Citrate</span></span></span></p>"
        },
        {
          "id": 200726,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Sodium Fluoride</span></span></span></p>"
        },
        {
          "id": 200727,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lithium Heparin</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Which anticoagulant is used for electrolyte estimation?</span></span> (AIIMS MAY 2017)</p>",
      "unique_key": "Q7979173",
      "question_audio": null,
      "question_video": null,
      "map_id": 34959903,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) Lithium Heparin</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Lithium Heparin </span></strong><span style=\"font-size:12.0pt\">is preferred for electrolyte testing because it does not interfere with the measurement of most electrolytes, such as sodium, potassium, and chloride. It is also the best anticoagulant for tests that require accurate <strong>pH</strong>, <strong>blood gases</strong>, <strong>electrolytes</strong>, and <strong>ionized calcium</strong> levels.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. EDTA:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> While EDTA is widely used for hematological examinations, it is not suitable for electrolyte estimation because it can chelate calcium and interfere with other ion measurements.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Citrate:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Sodium citrate is primarily used for coagulation studies (e.g., PT, PTT) because it binds calcium ions to prevent clotting, but it is not ideal for electrolyte estimation.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Sodium Fluoride:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Sodium fluoride is used primarily for glucose and lactate testing because it inhibits glycolysis, but it is not appropriate for electrolyte testing as it can interfere with the results.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/04/screenshot-2024-09-04-112143.png\" style=\"height:680px; width:1000px\" /></span></strong></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/04/screenshot-2024-09-04-112143.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200727,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50182,
      "choices": [
        {
          "id": 200728,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Extrinsic</span></span></span></p>"
        },
        {
          "id": 200729,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Intrinsic</span></span></span></p>"
        },
        {
          "id": 200730,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Fibrinolysis</span></span></span></p>"
        },
        {
          "id": 200731,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Common</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">When you add calcium and thromboplastin to platelet poor plasma which pathway is assessed?</span></span> (AIIMS MAY 2017)</p>",
      "unique_key": "Q4281050",
      "question_audio": null,
      "question_video": null,
      "map_id": 34418453,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Extrinsic </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Thromboplastin (Factor III) binds with Factor VII. When calcium is added, it activates extrinsic pathway. </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/14/untitled-370.jpg\" style=\"height:500px; width:500px\" /></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Activated Prothrombin Time (aPTT) measures the integrity of the intrinsic system (Factors XII, XI, VIII, IX) and common clotting pathways. Calcium and activating substances (kaolin) are added to the plasma- </span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/14/untitled-371.jpg\" style=\"height:500px; width:500px\" /></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Intrinsic: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The intrinsic pathway is assessed using the <strong>Activated Partial Thromboplastin Time (aPTT)</strong> test, where calcium and an activating substance like kaolin (not thromboplastin) are added to the plasma to measure the activity of Factors XII, XI, IX, and VIII.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Fibrinolysis:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Fibrinolysis is the process of breaking down fibrin clots, which is not directly assessed by adding thromboplastin and calcium. It is evaluated by other means, such as measuring fibrin degradation products (FDPs) or D-dimer levels.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Common:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> While the extrinsic pathway feeds into the common pathway (Factors X, V, II, and I), the specific test described (PT) is primarily assessing the extrinsic pathway, though it also gives some information about the common pathway.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Adding calcium and thromboplastin to platelet-poor plasma assesses the extrinsic pathway of coagulation, which is the basis for the Prothrombin Time (PT) test.</span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/14/untitled-370.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200728,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50183,
      "choices": [
        {
          "id": 200732,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Pectoral myocutaneous flap</span></span></p>"
        },
        {
          "id": 200733,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Serratus anterior flap</span></span></p>"
        },
        {
          "id": 200734,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">TRAM flap</span></span></p>"
        },
        {
          "id": 200735,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">VRAM flap</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A 34-year-old male is undergoing reconstructive surgery after trauma to the chest wall. During the procedure, the surgeon uses a muscle flap to cover a defect as shown in the image. Which flap is most likely being used in this reconstruction? (AIIMS MAY 2017) </span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/19/screenshot-2024-10-19-162508.jpg\" style=\"height:301px; width:400px\" /></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/19/screenshot-2024-10-19-162508.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q7387309",
      "question_audio": null,
      "question_video": null,
      "map_id": 34073743,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Serratus anterior flap</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>Serratus anterior flap</strong> is a widely used option for chest wall reconstruction, especially in cases involving trauma or oncologic resection. The muscle originates from the lateral surfaces of the upper 8–9 ribs and is inserted into the medial border of the scapula. It is innervated by the <strong>long thoracic nerve (C5, C6, C7)</strong> and supplied by the <strong>lateral thoracic artery</strong> (upper part) and the <strong>thoracodorsal artery</strong> (lower part). This flap can be rotated medially to cover large defects in the pectoral region, making it the flap of choice for lateral chest wall reconstruction in the described case.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Pectoral myocutaneous flap</span></strong><span style=\"font-size:12.0pt\">: This flap is also used in chest wall reconstruction, but it primarily covers anterior chest defects. The described rotation pattern (lateral to medial) is more characteristic of the serratus anterior flap.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. TRAM flap</span></strong><span style=\"font-size:12.0pt\">: The Transverse Rectus Abdominis Myocutaneous (TRAM) flap is usually employed in breast reconstruction, not chest wall defects, making it less relevant to this scenario.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. VRAM flap</span></strong><span style=\"font-size:12.0pt\">: The Vertical Rectus Abdominis Myocutaneous (VRAM) flap is also used for breast or abdominal wall reconstruction and is not typically used for the chest wall, as suggested in this case.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The <strong>Serratus anterior flap</strong> is a versatile muscle flap used for chest wall reconstruction. It is often rotated medially to cover lateral or pectoral defects due to its excellent blood supply and robust arc of rotation.</span></span></span></p>",
      "correct_choice_id": 200733,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50184,
      "choices": [
        {
          "id": 200736,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Incidence increases and prevalence reduces</span></span></p>"
        },
        {
          "id": 200737,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Incidence reduces and prevalence remains the same</span></span></p>"
        },
        {
          "id": 200738,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Incidence remains the same and prevalence increases</span></span></p>"
        },
        {
          "id": 200739,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Incidence reduces and prevalence increases</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A 55-year-old man is diagnosed with metastatic melanoma and begins a newly developed combination of chemotherapy and immunotherapy. His oncologist explains that this treatment significantly prolongs survival. Which of the following statements best describes the expected impact of this treatment on the epidemiological metrics of melanoma? (AIIMS MAY 2017)</span></span></p>",
      "unique_key": "Q5122012",
      "question_audio": null,
      "question_video": null,
      "map_id": 34658511,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Incidence remains the same and prevalence increases</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The introduction of the new drug combination improves survival in patients with metastatic melanoma. This means that more people will live longer with the disease, which directly increases <strong>prevalence</strong>—the total number of people living with the disease at a given time.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Since the treatment does not prevent the disease from occurring, the <strong>incidence</strong>—the rate of new cases—remains unchanged. Therefore, with longer survival but no change in the rate of new cases, the overall prevalence will rise.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Incidence: Is defined as the ‘no. of new cases’ occurring in a defined population during a specified period of time</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Prevalence: Is total current (Old + New) cases in a given population over a point or period of time</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Relationship between Incidence and Prevalence: Given the assumption that population is stable AND incidence & duration are unchanging, </span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Prevalence = Incidence × Mean duration of the disease </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">P = I × d</span></span></span></p>",
      "correct_choice_id": 200738,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50185,
      "choices": [
        {
          "id": 200740,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">SOX11</span></span></p>"
        },
        {
          "id": 200741,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">ITRA 1</span></span></p>"
        },
        {
          "id": 200742,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">MYD88</span></span></p>"
        },
        {
          "id": 200743,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Annexin V</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A 62-year-old man presents with generalized lymphadenopathy and fatigue. A biopsy of one of the lymph nodes reveals features suggestive of mantle cell lymphoma. Immunohistochemical staining shows the tumor cells are negative for Cyclin D1 expression. Which of the following immunohistochemical markers would be most helpful in confirming the diagnosis of Cyclin D1 negative mantle cell lymphoma? (AIIMS MAY 2017)</span></span></p>",
      "unique_key": "Q7914285",
      "question_audio": null,
      "question_video": null,
      "map_id": 34801980,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) SOX11</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Mantle cell lymphoma (MCL) is typically characterized by the overexpression of Cyclin D1 due to the t(11;14) chromosomal translocation. However, a subset of mantle cell lymphomas are Cyclin D1-negative. In these cases, the SOX11 marker is often used for diagnosis. SOX11 is a transcription factor expressed in the majority of mantle cell lymphomas, including those that are negative for Cyclin D1. The presence of SOX11 helps distinguish mantle cell lymphoma from other lymphomas when Cyclin D1 is absent.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. ITRA 1:</span></strong><span style=\"font-size:12.0pt\"> ITRA 1 (Interferon-Inducible Transmembrane Protein 1) is not associated with mantle cell lymphoma. It has no diagnostic relevance in distinguishing Cyclin D1-negative mantle cell lymphoma.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. MYD88:</span></strong><span style=\"font-size:12.0pt\"> MYD88 mutations are most commonly associated with Waldenström's macroglobulinemia and certain types of diffuse large B-cell lymphoma (DLBCL), not mantle cell lymphoma.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Annexin V:</span></strong><span style=\"font-size:12.0pt\"> Annexin V is commonly used in studies of apoptosis (programmed cell death) but is not specific to mantle cell lymphoma and does not play a role in the diagnosis of Cyclin D1-negative cases.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">SOX11 is an important immunohistochemical marker used to diagnose <strong>Cyclin D1-negative mantle cell lymphoma</strong> and has significant clinical relevance in confirming the diagnosis in the absence of Cyclin D1 expression.</span></span></span></p>",
      "correct_choice_id": 200740,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50186,
      "choices": [
        {
          "id": 200744,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">2 Fc and 1 Fab fragments</span></span></p>"
        },
        {
          "id": 200745,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">1 Variable chain and 1 constant chain</span></span></p>"
        },
        {
          "id": 200746,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">1 Fc and 2 Fab fragments</span></span></p>"
        },
        {
          "id": 200747,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">1 Fab and 1 hypervariable region</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A 25-year-old immunology student is studying the effects of enzymatic digestion on immunoglobulins. She uses papain to cleave the immunoglobulin molecule. What are the resulting products after papain acts on an immunoglobulin? (AIIMS MAY 2017)</span></span></p>",
      "unique_key": "Q3049870",
      "question_audio": null,
      "question_video": null,
      "map_id": 34789428,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) 1 Fc and 2 Fab fragments</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Papain is a proteolytic enzyme that cleaves immunoglobulin (Ig) molecules into specific fragments. When papain acts on an Ig molecule, it cleaves the Ig at a site above the hinge region, resulting in two Fab (Fragment antigen-binding) fragments and one Fc (Fragment crystallizable) fragment. The two Fab fragments retain the antigen-binding regions of the antibody, while the Fc fragment is responsible for effector functions such as binding to Fc receptors or activating complement. This cleavage results in the separation of the antigen-binding and effector regions of the antibody.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Papain cleaves immunoglobulins to produce <strong>2 Fab fragments</strong> and <strong>1 Fc fragment</strong>, effectively separating the antigen-binding sites from the effector region of the antibody.</span></span></span></p>",
      "correct_choice_id": 200746,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50187,
      "choices": [
        {
          "id": 200748,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Do a routine episiotomy</span></span></p>"
        },
        {
          "id": 200749,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Manual support to the perineum to maintain flexion of the head</span></span></p>"
        },
        {
          "id": 200750,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Never give warm compress to the perineum</span></span></p>"
        },
        {
          "id": 200751,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Perform labor in lithotomy position</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Which of the following is part of the WHO recommendations for managing the second stage of labor?</span></span> <span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">(AIIMS MAY 2017)</span></span></p>",
      "unique_key": "Q4458910",
      "question_audio": null,
      "question_video": null,
      "map_id": 34472172,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Manual support to the perineum to maintain flexion of the head</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The WHO guidelines for the management of the second stage of labor recommend <strong>manual support to the perineum and controlled delivery of the fetal head</strong>. This method, also known as <strong>guarding the perineum</strong>, reduces the risk of perineal trauma by preventing rapid delivery of the head. Gentle downward pressure is applied on the occiput to control the speed of delivery, and once the occiput is born, the rest of the head is delivered with gentle assistance.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Do a routine episiotomy</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Routine episiotomy is <strong>not recommended</strong> by the WHO. Episiotomies should be reserved for specific conditions, such as shoulder dystocia, breech deliveries, or fetal macrosomia. The procedure is not to be routinely performed because it can increase the risk of unnecessary trauma.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Never give warm compress to the perineum</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This statement is incorrect. The WHO suggests using <strong>warm compresses</strong> to the perineum during labor to reduce the risk of perineal tears and improve maternal comfort during the delivery.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Perform labor in lithotomy position</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: While the lithotomy position is commonly used, the WHO recommends allowing the woman to choose her position during labor, including <strong>upright positions</strong> (such as squatting or standing), which are associated with improved outcomes and less perineal trauma.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The WHO recommends <strong>manual support of the perineum</strong> during the second stage of labor to reduce perineal trauma. Routine episiotomies should be avoided unless clinically necessary.</span></span></span></p>",
      "correct_choice_id": 200749,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50188,
      "choices": [
        {
          "id": 200752,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Digoxin</span></span></p>"
        },
        {
          "id": 200753,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Spironolactone</span></span></p>"
        },
        {
          "id": 200754,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Enalapril</span></span></p>"
        },
        {
          "id": 200755,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Furosemide</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A 45-year-old female with NYHA Class III heart failure presents with shortness of breath, peripheral edema, and laboratory findings showing a potassium level of 5.5 mEq/L and a creatinine level of 1.1 mg/dL. Which of the following drugs would NOT be contraindicated in this scenario? </span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">(AIIMS MAY 2017)</span></span></p>",
      "unique_key": "Q2894038",
      "question_audio": null,
      "question_video": null,
      "map_id": 34605761,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Furosemide</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In this patient with heart failure and hyperkalemia (potassium of 5.5 mEq/L), certain medications that can increase potassium levels are contraindicated. Furosemide, a loop diuretic, is preferred in such a scenario because it helps in potassium excretion, thereby lowering potassium levels. Therefore, furosemide is not contraindicated in this patient and may be beneficial in reducing the edema and hyperkalemia associated with heart failure.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Digoxin</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Although digoxin does not directly affect potassium levels, it can become toxic in the presence of electrolyte imbalances, including hyperkalemia. Therefore, close monitoring is required, and digoxin should be used cautiously.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Spironolactone</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This is a potassium-sparing diuretic and is typically avoided in patients with elevated potassium levels, as it can worsen hyperkalemia.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Enalapril</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: An ACE inhibitor, enalapril can increase potassium levels by reducing aldosterone secretion, further contributing to hyperkalemia. Thus, it should be avoided in patients with hyperkalemia.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In heart failure patients with hyperkalemia, furosemide is a safe choice as it promotes potassium excretion. Drugs that increase potassium levels, such as spironolactone and ACE inhibitors, should be avoided.</span></span></span></p>",
      "correct_choice_id": 200755,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50189,
      "choices": [
        {
          "id": 200756,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">NK cells</span></span></p>"
        },
        {
          "id": 200757,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">All nucleated cells</span></span></p>"
        },
        {
          "id": 200758,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">B cells, dendritic cells, mononuclear phagocytes</span></span></p>"
        },
        {
          "id": 200759,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Platelets</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Among the following, which cells express MHC class II molecules? </span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">(AIIMS MAY 2017)</span></span></p>",
      "unique_key": "Q2419747",
      "question_audio": null,
      "question_video": null,
      "map_id": 34287533,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans. C)</strong> </span><span style=\"font-size:12.0pt\"><strong>B cells, dendritic cells, mononuclear phagocytes</strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">MHC class II molecules are predominantly expressed on antigen-presenting cells (APCs) such as B cells, dendritic cells, and mononuclear phagocytes (macrophages). These cells present processed antigens to helper T cells (CD4+ T cells) and play a critical role in initiating immune responses by displaying fragments of ingested antigens for T cell recognition.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">MHC molecules function by presenting protein fragments (peptides) on the surface of cells for recognition by T cells. In humans, MHC molecules are referred to as Human Leukocyte Antigens (HLA), which are encoded by genes on chromosome 6. HLA molecules are highly polymorphic, with thousands of different alleles existing in the human population, contributing to individual variations in immune responses and complicating organ transplantation.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. NK cells</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Natural Killer (NK) cells do not express MHC class II molecules. They play a role in innate immunity by recognizing stressed or infected cells that lack MHC class I expression and killing them without the need for antigen presentation.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. All nucleated cells</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: While all nucleated cells express MHC class I molecules, only specific antigen-presenting cells (APCs) such as B cells, dendritic cells, and macrophages express MHC class II molecules.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Platelets</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Platelets do not express MHC class II molecules. They are primarily involved in clotting and do not function as antigen-presenting cells in immune responses.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">MHC class II molecules are expressed on professional antigen-presenting cells, such as B cells, dendritic cells, and macrophages, which are crucial for initiating immune responses by interacting with helper T cells.</span></span></span></p>",
      "correct_choice_id": 200758,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50190,
      "choices": [
        {
          "id": 200760,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Total Thyroidectomy</span></span></p>"
        },
        {
          "id": 200761,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Total Thyroidectomy plus Lymph node dissection</span></span></p>"
        },
        {
          "id": 200762,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Radioiodine ablation of thyroid</span></span></p>"
        },
        {
          "id": 200763,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Right Hemithyroidectomy</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A 25-year-old pregnant woman presents with a history of thyroid swelling. A fine needle aspiration cytology (FNAC) report suggests papillary carcinoma of the thyroid, and the nodule appears “cold” on scan. Which of the following would not be an appropriate treatment option for her?</span></span> <span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">(AIIMS MAY 2017)</span></span></p>",
      "unique_key": "Q3736216",
      "question_audio": null,
      "question_video": null,
      "map_id": 34843890,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans</span></strong><span style=\"font-size:12.0pt\">. <strong>C) Radioiodine ablation of thyroid</strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Radioiodine ablation (radioactive iodine therapy) is contraindicated in pregnant women due to the potential risk of fetal radiation exposure. Radioactive iodine can cross the placenta and cause severe fetal hypothyroidism or other developmental issues, making this treatment unsuitable during pregnancy. Alternative surgical approaches like total thyroidectomy or hemithyroidectomy can be considered based on the tumor size, lymph node involvement, and other clinical factors.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Total Thyroidectomy</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This is a valid treatment option for managing papillary carcinoma in pregnant patients, especially if there is a concern about the aggressive nature of the tumor. Surgery is preferred during pregnancy over radiation-based therapies.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Total Thyroidectomy plus Lymph node dissection</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Lymph node involvement in papillary carcinoma often necessitates lymph node dissection along with thyroidectomy. This is another viable option during pregnancy.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Right Hemithyroidectomy</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: For small, localized tumors, hemithyroidectomy may be an appropriate option. Surgery during pregnancy can be safely performed, typically in the second trimester to minimize risks to both the mother and fetus.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Radioiodine ablation is contraindicated during pregnancy due to fetal radiation exposure, making surgical approaches the preferred treatment for thyroid cancers diagnosed in pregnant patients.</span></span></span></p>",
      "correct_choice_id": 200762,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50191,
      "choices": [
        {
          "id": 200764,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Annual mammogram</span></span></p>"
        },
        {
          "id": 200765,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Regular checking of LFT once in 6 months</span></span></p>"
        },
        {
          "id": 200766,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Follow-up with tumor markers once in 6 months</span></span></p>"
        },
        {
          "id": 200767,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Yearly bone scans</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A 41-year-old woman has undergone successful treatment for breast cancer (1.2 x 1 cm tumor) with positive axillary nodes. She completed radiotherapy and chemotherapy and is now receiving tamoxifen. What is the appropriate follow-up plan for this patient? </span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">(AIIMS MAY 2017)</span></span></p>",
      "unique_key": "Q3386458",
      "question_audio": null,
      "question_video": null,
      "map_id": 34431282,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans</span></strong><span style=\"font-size:12.0pt\">. <strong>A) Annual mammogram</strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The appropriate follow-up for breast cancer survivors includes regular physical examinations and imaging with mammography. Mammograms are the key imaging modality used for surveillance following treatment for breast cancer. The current recommendation is to perform an annual mammogram to detect any recurrence or new breast malignancy.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Routine blood tests (including tumor markers or liver function tests) and other imaging studies like bone scans are not recommended for asymptomatic patients as part of routine surveillance. These are usually reserved for cases with clinical signs or symptoms suggesting recurrence or metastasis.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Regular checking of LFT once in 6 months</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Liver function tests (LFTs) are not part of routine surveillance for breast cancer survivors unless the patient is on a medication that requires monitoring (e.g., tamoxifen can affect liver function, but LFTs are not recommended unless clinically indicated).</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Follow-up with tumor markers once in 6 months</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Tumor markers such as CA 15-3 or CEA are not recommended for routine follow-up in breast cancer patients, as their role in detecting early recurrence is not well-established.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Yearly bone scans</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Bone scans are not recommended as routine follow-up unless there are symptoms suggestive of bone metastasis, such as bone pain or elevated alkaline phosphatase levels.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Routine follow-up for breast cancer survivors includes annual mammography and periodic physical exams. Other tests like tumor markers or bone scans are reserved for symptomatic patients or those with specific clinical concerns.</span></span></span></p>",
      "correct_choice_id": 200764,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50192,
      "choices": [
        {
          "id": 200768,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Esophagitis</span></span></p>"
        },
        {
          "id": 200769,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Squamous cell carcinoma</span></span></p>"
        },
        {
          "id": 200770,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Adenocarcinoma</span></span></p>"
        },
        {
          "id": 200771,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Barrett's esophagus</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A 35-year-old patient presents with heartburn and increased salivation. Upper gastrointestinal endoscopy (UGE) was performed, and the biopsy results reveal the transition between normal squamous epithelium and mucin-filled glands, indicative of intestinal-type metaplasia with goblet cells. What is the most likely diagnosis? (AIIMS MAY 2017)</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/19/screenshot-2024-10-19-162615.jpg\" style=\"height:306px; width:400px\" /></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/19/screenshot-2024-10-19-162615.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q6653804",
      "question_audio": null,
      "question_video": null,
      "map_id": 34478578,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans</span></strong><span style=\"font-size:12.0pt\">. <strong>D) Barrett's esophagus</strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Barrett’s esophagus is characterized by the replacement of the normal squamous epithelium of the esophagus with intestinal metaplasia, including goblet cells. This condition arises due to chronic gastroesophageal reflux disease (GERD) and is considered a premalignant state because it significantly increases the risk of developing esophageal adenocarcinoma. The biopsy showing mucin-filled glands and goblet cells supports the diagnosis of Barrett’s esophagus.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Esophagitis</span></strong><span style=\"font-size:12.0pt\">: Esophagitis involves inflammation of the esophagus, often due to acid reflux, but does not show the presence of intestinal metaplasia or goblet cells.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Squamous cell carcinoma</span></strong><span style=\"font-size:12.0pt\">: This type of esophageal cancer originates from the squamous epithelium, which would not show intestinal-type metaplasia or goblet cells.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Adenocarcinoma</span></strong><span style=\"font-size:12.0pt\">: Adenocarcinoma can develop from Barrett’s esophagus but is characterized by malignant glandular structures, not just the presence of goblet cells.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Barrett’s esophagus, characterized by intestinal metaplasia with goblet cells, is a premalignant condition that significantly increases the risk of esophageal adenocarcinoma and warrants regular surveillance.</span></span></span></p>",
      "correct_choice_id": 200771,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50193,
      "choices": [
        {
          "id": 200772,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Drunkenness</span></span></p>"
        },
        {
          "id": 200773,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Diffuse axonal injury</span></span></p>"
        },
        {
          "id": 200774,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Concussion</span></span></p>"
        },
        {
          "id": 200775,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Cerebral venous thrombosis</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A 42-year-old man had a fall followed by one episode of vomiting. When brought to the emergency department, he was awake and conscious but had persistent anterograde amnesia. Which of the following is the most likely cause?</span></span> <span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">(AIIMS MAY 2017)</span></span></p>",
      "unique_key": "Q3883995",
      "question_audio": null,
      "question_video": null,
      "map_id": 34963149,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans</span></strong><span style=\"font-size:12.0pt\">. <strong>C) Concussion</strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The history of a fall followed by persistent anterograde amnesia strongly points to a diagnosis of concussion. Concussion is a mild traumatic brain injury (TBI) that commonly results from falls, vehicle accidents, or sports injuries. Anterograde amnesia, where the patient cannot recall events that occur after the injury, is a hallmark feature of a concussion. Other symptoms may include headache, dizziness, nausea, and vomiting. In most cases, patients recover fully with rest and conservative management.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Drunkenness</span></strong><span style=\"font-size:12.0pt\">: A person who is intoxicated would likely present with drowsiness or confusion, not an isolated anterograde amnesia while remaining awake and conscious.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Diffuse axonal injury</span></strong><span style=\"font-size:12.0pt\">: This condition results from high-speed deceleration leading to shearing of axons. It is associated with microhemorrhages and often leads to a persistent vegetative state rather than transient amnesia.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Cerebral venous thrombosis</span></strong><span style=\"font-size:12.0pt\">: This presents with symptoms such as headache, seizures, and visual disturbances due to acute thrombosis in the dural venous sinuses. It would not typically present with isolated amnesia.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Anterograde amnesia following a head injury is a hallmark of concussion, a common type of mild traumatic brain injury.</span></span></span></p>",
      "correct_choice_id": 200774,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50194,
      "choices": [
        {
          "id": 200776,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Thyroid hormone assay</span></span></p>"
        },
        {
          "id": 200777,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Serum prolactin</span></span></p>"
        },
        {
          "id": 200778,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Insulin-like growth factor (IGF-1)</span></span></p>"
        },
        {
          "id": 200779,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Serum testosterone</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A 45-year-old man presents to the clinic with complaints of progressive enlargement of his hands and feet. On examination, he has frontal bossing, a large tongue, and spade-shaped hands. His shoe size has also increased over the past few years. Which of the following tests is most appropriate for diagnosing his condition? </span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">(AIIMS MAY 2017)</span></span></p>",
      "unique_key": "Q4210665",
      "question_audio": null,
      "question_video": null,
      "map_id": 34787670,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans</span></strong><span style=\"font-size:12.0pt\">. <strong>C) Insulin-like growth factor (IGF-1)</strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The patient’s presentation, including features such as frontal bossing, macroglossia (large tongue), and spade-shaped hands, strongly suggests acromegaly. Acromegaly results from excessive secretion of growth hormone (GH), typically due to a pituitary adenoma. Insulin-like growth factor 1 (IGF-1) is the most reliable screening test for acromegaly because IGF-1 levels remain elevated throughout the day, unlike GH, which fluctuates. Elevated IGF-1 levels suggest acromegaly. A confirmatory test is the oral glucose tolerance test, where GH fails to suppress in acromegaly.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Thyroid hormone assay</span></strong><span style=\"font-size:12.0pt\">: Thyroid function tests are used to diagnose thyroid disorders such as hypothyroidism or hyperthyroidism. These tests are not used to diagnose acromegaly.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Serum prolactin</span></strong><span style=\"font-size:12.0pt\">: Although prolactinomas (prolactin-secreting tumors) are common pituitary adenomas, this patient's symptoms are not consistent with hyperprolactinemia. Prolactin measurement would not confirm acromegaly.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Serum testosterone</span></strong><span style=\"font-size:12.0pt\">: While testosterone testing may be indicated for evaluating hypogonadism, it is not relevant to the diagnosis of acromegaly.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The most appropriate initial test for diagnosing acromegaly is measuring insulin-like growth factor 1 (IGF-1) levels, as it reflects chronic exposure to elevated growth hormone.</span></span></span></p>",
      "correct_choice_id": 200778,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50195,
      "choices": [
        {
          "id": 200780,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Endobronchial neoplasm</span></span></p>"
        },
        {
          "id": 200781,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Bronchial Asthma</span></span></p>"
        },
        {
          "id": 200782,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Myasthenia gravis</span></span></p>"
        },
        {
          "id": 200783,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Emphysema</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A 45-year-old woman presents with shortness of breath that worsens throughout the day. Pulmonary function testing was performed, and the flow-volume loop from her spirometry is shown below (Patient 1). Based on the spirometry findings, what is the most likely diagnosis? (AIIMS MAY 2017)</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/19/whatsapp-image-2024-10-19-at-150640.jpeg\" style=\"height:324px; width:400px\" /></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/19/whatsapp-image-2024-10-19-at-150640.jpeg\" alt=\"Question Image\"></p>",
      "unique_key": "Q6191296",
      "question_audio": null,
      "question_video": null,
      "map_id": 34522778,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Myasthenia gravis</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Myasthenia gravis, a neuromuscular disorder, often presents with muscle weakness that worsens throughout the day. It affects the respiratory muscles, leading to a restrictive pattern on spirometry. The patient's spirometry shows a reduction in lung volumes such as total lung capacity (TLC), vital capacity (VC), and residual volume (RV), which are typical in restrictive lung diseases caused by neuromuscular dysfunction, such as in myasthenia gravis.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Endobronchial neoplasm</span></strong><span style=\"font-size:12.0pt\">: Endobronchial tumors usually cause an obstructive pattern on spirometry. This is seen as an increased total lung capacity (TLC) and residual volume (RV), shifting the flow-volume loop to the left. The patient’s spirometry does not match this pattern.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Bronchial Asthma</span></strong><span style=\"font-size:12.0pt\">: Bronchial asthma typically presents with an obstructive pattern on spirometry due to airway narrowing. The flow-volume curve would shift to the left due to increased lung volumes, particularly residual volume (RV) and total lung capacity (TLC). The patient’s spirometry shows a restrictive pattern, not obstructive.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D Emphysema</span></strong><span style=\"font-size:12.0pt\">: Emphysema is another obstructive lung disease where hyperinflation causes increased residual volume (RV) and total lung capacity (TLC). This would shift the flow-volume loop to the left. The patient’s spirometry is more indicative of a restrictive disorder.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Myasthenia gravis is a neuromuscular disorder that causes restrictive lung disease due to weakened respiratory muscles, leading to a reduction in lung volumes and a restrictive pattern on spirometry.</span></span></span></p>",
      "correct_choice_id": 200782,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50196,
      "choices": [
        {
          "id": 200784,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Raynaud phenomenon and sclerodactyly</span></span></p>"
        },
        {
          "id": 200785,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Genital and oral painful ulcers</span></span></p>"
        },
        {
          "id": 200786,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Glomerulonephritis and heart failure</span></span></p>"
        },
        {
          "id": 200787,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Joint pains with nodules on skin</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A 32-year-old female presents with a history of backache and polyarthralgia. Immunofluorescence (IF) findings reveal a nucleolar pattern. Which of the following clinical features is most consistent with her condition?</span></span> <span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">(AIIMS MAY 2017)</span></span></p>",
      "unique_key": "Q4889962",
      "question_audio": null,
      "question_video": null,
      "map_id": 34505067,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans</span></strong><span style=\"font-size:12.0pt\">. <strong>A) Raynaud phenomenon and sclerodactyly</strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The nucleolar pattern observed on immunofluorescence (IF) suggests systemic sclerosis, also known as sclerodactyly. This autoimmune condition often presents with Raynaud phenomenon and thickening of the skin, particularly affecting the fingers and hands (sclerodactyly). The nucleolar pattern reflects antibodies to RNA, commonly seen in sclerodactyly and other forms of systemic sclerosis. In limited systemic sclerosis, patients may develop a constellation of symptoms including Calcinosis, Raynaud phenomenon, Esophageal dysmotility, Sclerodactyly, and Telangiectasia (CREST syndrome).</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Genital and oral painful ulcers:</span></strong><span style=\"font-size:12.0pt\"> These are characteristic of Behçet's disease, an inflammatory disorder that does not typically present with a nucleolar pattern on IF.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Glomerulonephritis and heart failure:</span></strong><span style=\"font-size:12.0pt\"> These symptoms suggest systemic lupus erythematosus (SLE) or another vasculitis, which do not typically display a nucleolar pattern but rather a diffuse or speckled pattern on IF.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Joint pains with nodules on skin:</span></strong><span style=\"font-size:12.0pt\"> This presentation is more typical of rheumatoid arthritis, which is associated with rheumatoid nodules and does not usually present with a nucleolar IF pattern.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The nucleolar pattern on immunofluorescence is most commonly associated with systemic sclerosis (sclerodactyly) and is often accompanied by features such as Raynaud phenomenon and skin thickening.</span></span></span></p>",
      "correct_choice_id": 200784,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50197,
      "choices": [
        {
          "id": 200788,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Central scotoma</span></span></p>"
        },
        {
          "id": 200789,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Bilateral hemianopia</span></span></p>"
        },
        {
          "id": 200790,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Binasal hemianopia</span></span></p>"
        },
        {
          "id": 200791,
          "text": "<p><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Bitemporal hemianopia</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A 50-year-old woman presents with progressive loss of peripheral vision in both eyes. She is diagnosed with a pituitary adenoma compressing the optic chiasma. Which of the following visual field defects is most likely in this patient?</span></span> <span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">(AIIMS MAY 2017)</span></span></p>",
      "unique_key": "Q6713271",
      "question_audio": null,
      "question_video": null,
      "map_id": 34934432,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans</span></strong><span style=\"font-size:12.0pt\">. <strong>D) Bitemporal hemianopia</strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A lesion at the optic chiasma typically causes <strong>bitemporal hemianopia</strong>, where the patient loses vision in the outer (temporal) fields of both eyes. This occurs because the nasal fibers of the retina, responsible for the temporal visual fields, decussate (cross) at the optic chiasma. Compression of the chiasma, as in pituitary adenomas, interrupts this crossing and results in loss of the outer visual fields of both eyes.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Central scotoma</span></strong><span style=\"font-size:12.0pt\">: This refers to a loss of vision in the central field, usually seen in conditions affecting the optic nerve or macula, such as optic neuritis or macular degeneration.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Bilateral hemianopia</span></strong><span style=\"font-size:12.0pt\">: This term is nonspecific but can refer to homonymous hemianopia, a condition where vision is lost in the same side of the visual field in both eyes, usually due to a lesion posterior to the optic chiasma.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Binasal hemianopia</span></strong><span style=\"font-size:12.0pt\">: This is a rare visual defect that affects the inner visual fields (nasal fields) and typically occurs with bilateral compression of the optic nerves at the lateral chiasm, not the midline chiasma.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Visual field defects: </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/19/screenshot-2024-10-19-162811.jpg\" style=\"height:751px; width:919px\" /></span></strong></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/19/screenshot-2024-10-19-162811.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200791,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50198,
      "choices": [
        {
          "id": 200792,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Branchial cyst</span></span></p>"
        },
        {
          "id": 200793,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Cystic hygroma</span></span></p>"
        },
        {
          "id": 200794,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Thyroglossal cyst</span></span></p>"
        },
        {
          "id": 200795,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Cervical lymphadenopathy</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A 25-year-old patient presents with a neck swelling that moves with deglutition. What is the most likely diagnosis? (AIIMS MAY 2017)</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/19/screenshot-2024-10-19-162828.jpg\" style=\"height:383px; width:300px\" /></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/19/screenshot-2024-10-19-162828.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q9048686",
      "question_audio": null,
      "question_video": null,
      "map_id": 34460335,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Thyroglossal cyst</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A thyroglossal cyst is a congenital anomaly that arises due to incomplete closure of the thyroglossal duct, which is the path of descent of the thyroid gland from the base of the tongue during embryonic development. The cyst typically presents as a midline neck swelling, and it classically moves with deglutition (swallowing) and tongue protrusion due to its attachment to the hyoid bone. This characteristic movement distinguishes it from other neck swellings.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Branchial cyst</span></strong><span style=\"font-size:12.0pt\">: This congenital anomaly occurs laterally, not in the midline, and does not typically move with deglutition. It results from failure of obliteration of the branchial clefts during embryonic development.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Cystic hygroma</span></strong><span style=\"font-size:12.0pt\">: A congenital lymphatic malformation often located in the posterior triangle of the neck, cystic hygromas do not move with swallowing or tongue protrusion.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Cervical lymphadenopathy</span></strong><span style=\"font-size:12.0pt\">: Swellings of lymph nodes do not move with deglutition or tongue protrusion and are typically found in lateral positions rather than midline.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Thyroglossal cysts are congenital midline neck swellings that move with deglutition and tongue protrusion due to their attachment to the hyoid bone. The treatment is Sistrunk’s operation, which involves excision of the cyst along with the entire thyroglossal tract and a portion of the hyoid bone.</span></span></span></p>",
      "correct_choice_id": 200794,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50199,
      "choices": [
        {
          "id": 200796,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Protamine</span></span></p>"
        },
        {
          "id": 200797,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Streptokinase</span></span></p>"
        },
        {
          "id": 200798,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Heparin</span></span></p>"
        },
        {
          "id": 200799,
          "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Epsilon-aminocaproic acid</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:11.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A 55-year-old male is brought into the emergency department with acute myocardial infarction and has received fibrinolytic therapy. The patient begins to experience excessive bleeding post-therapy. Which of the following is the best antidote to reverse the effects of fibrinolytic therapy? (AIIMS MAY 2017)</span></span></p>",
      "unique_key": "Q6601834",
      "question_audio": null,
      "question_video": null,
      "map_id": 34321101,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Epsilon-aminocaproic acid</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Epsilon-aminocaproic acid (EACA) is a potent inhibitor of fibrinolysis and is used to counteract the effects of fibrinolytic agents such as streptokinase or tissue plasminogen activator (tPA). It works by inhibiting plasminogen activation, preventing the conversion of plasminogen to plasmin, thereby halting the breakdown of fibrin clots.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Protamine</span></strong><span style=\"font-size:12.0pt\">: This drug is primarily used to reverse the effects of heparin, not fibrinolytic agents.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Streptokinase</span></strong><span style=\"font-size:12.0pt\">: Streptokinase is a fibrinolytic agent and is used to dissolve clots. It would exacerbate bleeding, not treat it.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Heparin</span></strong><span style=\"font-size:12.0pt\">: Heparin is an anticoagulant used to prevent clot formation. It is unrelated to fibrinolytic therapy and does not serve as an antidote for bleeding complications from fibrinolytic drugs.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective :</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Epsilon-aminocaproic acid is the antidote used to reverse bleeding complications caused by fibrinolytic agents like streptokinase.</span></span></span></p>",
      "correct_choice_id": 200799,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}